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Abstract
Knowledge translation (KT) has become a ubiquitous and important component
within the Canadian health research funding environment. Despite a large and burgeoning
literature on the topic of KT, research on the science of KT spans a very narrow
philosophical spectrum, with published studies almost exclusively positioned within
positivism. Grounded in a constructionist philosophical position and influenced by actornetwork theory, this dissertation aims to contribute to the Canadian KT discussion by
imagining new possibilities for conceptualizing KT.
This is an empirical-theoretical study which is based on eight months of data
collection, including interviews, participant observation, and document analysis. This data
collection took place in a basic science laboratory, a clinic, and amongst families involved in
genomic research pertaining to Autism Spectrum Disorder in a Canadian city. Interviews
were transcribed verbatim and organization of the data was aided by QSR Nvivo software.
Theoretical insights put forward in this dissertation are based on a detailed description of the
everyday, local, micro-dynamics of knowledge translation within a particular case study of
an autism genomics project. Through data collection I have followed the practices of a
laboratory, clinic, and family homes through which genomic knowledge was assembled and
re-assembled.
Through the exploration of the practices of scientists, clinicians, and families
involved in an autism genetics study, I examine the concepts of multiplicity, difference, and
coordination. I argue that autism is practiced differently, through different technologies and
assessments, in the laboratory, clinic, and home. This dissertation closes with a new
framework for and model of the knowledge translation process called the Local Translations
of Knowledge in Practice model. I argue that expanding the range of theoretical and
philosophical positions attended to in KT research will contribute to a richer understanding
of the KT process and move forward the Canadian KT agenda. Ethics approval for this
research was obtained from The University of Western Ontario and from the hospital in
which the data was gathered.
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Preface
"Ring, ring, ring!"
I race to answer the phone at a speedy I-just-got-the-baby-sleeping pace. Hurdling a Sesame
Street play toy I grab the phone from the charger and press talk.
"Hello?" I say, trying not to sound out-of-breath.
"Julia. It's Jeff. How are you doing?"
"I'm great. How are you?"
"Good. Is this a good time to talk?"
"Um-hum, sure."
"Ok great. I'm actually in the middle of a Genome Canada meeting and I had to call you.
We're just having a 10-minute break and I stepped out of the room. There is this guy named
Bob Lorenz [pseudonym] who just presented his current research and it's really amazing
stuff. He's got some really interesting findings on copy number variations and autism. I just
had to call and tell you about it…"
This was the beginning of a conversation that took place in the winter of 2008 which
subsequently propelled my research in its current direction. Upon first applying to enter the
PhD program I had tentatively proposed a research site in Montreal at a clinic providing preimplantation genetic diagnosis (PGD). At this point, my partner was still looking for a
teaching position and was relatively free to move around; we also did not have any children.
Fast-forward 18 months and we had a baby, a mortgage, and Ben had found a much-coveted
teaching position - moving to Montreal for 8-12 months suddenly didn't seem so feasible. I
was just returning from a maternity leave and I needed to find another research site. I was
still interested in knowledge translation and genetic research and hoped to find some way of
exploring the day-to-day practices or micro-dynamics of translation. I was especially
xv

concerned with the narrow theoretical scope from which knowledge translation was being
explored in the health sciences literature. I wanted to find a field site that could act as a case
study in which to approach knowledge translation from a constructionist position, in contrast
to the taken-for-granted positivist positions which seemed to dominate KT discussions. I
hoped to be able to demonstrate how knowledge translation could be approached from a
different epistemological and methodological position in order to ignite discussion amongst
those entrenched in positivist approaches to KT. When Jeff called, I jumped at the
opportunity and began to explore autism genomics as a potential case study through which I
could re-assemble KT.
The year following this phone call from my supervisor was spent finishing my course
work and writing my comprehensive exams. In December of 2009 my supervisor and I met
with Dr Lorenz at his lab to talk with him about my ideas and to get a sense for how willing
he might be to have me hanging around his laboratory for the better part of a year. Waiting
outside his office, I remember feeling nervous. This Dr Lorenz [pseudonym] was obviously
one of the top guys in this field. The space was beautiful, modern, state-of-the-art. An
enormous lab filled with machines and bustling white lab coat clad bodies spanned the length
of one side of the main hallway. Jeff told me that Dr Lorenz had previously been named one
of Canada’s “Top 40 under 40” for scientific minds in this country. His office door opened
and we sat down at a round table. Dr Lorenz was very friendly and low-key. He seemed
amused or perhaps bemused that an anthropology/ health sciences student would be
interested in his laboratory as a site that warranted ethnographic investigation. We talked for
about fifteen minutes and by the time we left it was just a matter of doing the necessary REB
paperwork before I could begin fieldwork as far as Dr. Lorenz was concerned. Before leaving
his office, he also invited me to attend an annual meeting that was happening with all the
xvi

people involved in the autism genetics project across the country. It just so happened that this
all-day meeting was to be held in his laboratory conference room in two days time.
Two days later I found myself sitting in a chair pushed against a wall of a very
crowded conference room. There were people from across Canada, both basic scientists and
clinicians. A woman rushed in at the last minute as the doors were closing. She sat down on
the only seat left in the room, which happened to be beside me. We went around the room
quickly introducing ourselves and I came to realize that this woman beside me was actually
Dr Felicia Morten [pseudonym], the director of the Autism Clinic. She was the very woman
with whom I was hoping to talk about extending my field site into her territory. Needless to
say, people quickly shuffled around and space was made for her at the table in the centre of
the room. She was a major player in the Autism Genetics Project and her ability and need to
speak at the table signified her importance. At a break for lunch I did manage to chat with her
for about two minutes about my research and she said she would be happy to discuss it
further with me. I ended up meeting with her again for about twenty minutes in the kitchen of
the genetics laboratory before one of the subsequent Monday morning meetings about a
month later. She was interested in this approach to examining knowledge translation and
agreed to have me extend the fieldwork into the autism clinic.
This dissertation describes some of what I have learned in the two years since these
initial meetings.

xvii
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Chapter 1

1.1. Finding an Entrance
1.2. Research Questions
1.3. Purpose
1.4. Autism or ASD?
1.5. Doing Fieldwork
a) Location
b) Timeline
c) Participants
1.6. Methods
a) Types of Data Collected
b) Limitations to Data Collection
1.7. Process of Interpretation and Representation
1.8. Reflexivity
1.9. Quality Criteria
a) Authenticity
b) Ethnographic Validity
c) Deploying Actors as Networks

1.1. Finding an Entrance
First Entrance
I opened the London Free Press newspaper this morning and depicted on the front page was
a photograph of a 5000 year old body found mummified in an Italian glacier. Scientists have
just completed sequencing this man’s DNA and found him to be lactose intolerant and to
have a predisposition for coronary problems. Strung out, letter by letter, his DNA sequence
appears to be quite similar to that of the many human genome sequences created from
amalgamations of people living today. The article mentions that the DNA sequence is being
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openly shared on a website so that specialists from different disciplines can analyze it as
there is more than a lifetime of work in analyzing this mummy’s sequence. I only scanned the
article briefly as I was also bouncing Eliza on my knee and eating a bagel but I need to
follow up on it when I get a chance. I’m not sure how, but I think perhaps this article might
provide an entrance into my dissertation.
(JB journal entry, March 2nd, 2012)
Genomic research is entering the public imagination and has been for several years.
Popular movies (for example, Gattaca, Bladerunner), fiction (for example, Ian Douglas’s
Inheritance Trilogy, 2009) and popular TV shows (for example, Bones, CSI, Who is my
Baby’s Daddy?) are bringing the idea of genomics into the living rooms of many Canadians.
Scholarly articles covering genomic findings filter through to daily newspapers, discussed
over coffee and toast around the breakfast table. Of course, much of the genomic work
carried out in laboratories across Canada is not on 5000 year old mummies. Within the
purview of health research, genomics has been given the task of uncovering the secrets of
single gene disorders such as cystic fibrosis (Kerem et al., 1989)(Riordan et al., 1989) and
Huntington’s (Gusella et al., 1983) and is now moving on to complex polygenic conditions
such as schizophrenia (Xu et al., 2012) and Autism Spectrum Disorder (Leblond et al., 2012).
I like this newspaper article (Rose, 2012) on Otzi man’s genomic profile. Perhaps I am
influenced by the summers working on archaeological digs during my undergraduate degree,
the monotonous hours of sifting through dirt punctuated by instances of excitement in finding
a clay pipe bowl or post-holes. The public sees the “Indiana Jones” exhilaration of finding
amazing insights into our past. The vast majority of work that lays behind these findings
remains eclipsed. These images conjured up out of archaeology appeal to me; they seem
relevant to the hundreds of movements repeated over and over in the laboratory in order to
map a genome sequence, occasionally yielding something the scientists find “interesting”.
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Most of the work being conducted inside the genomics laboratory is beyond the view
of the public. What really goes on in a genomics laboratory? How does this genomic research
relate to clinical work and to individuals diagnosed with autism and their families? How is it
translated? What if, instead of focusing on the findings, we focus on all the day-to-day work
that lies behind them? If we keep in mind the bottles and beakers, buffers and pipettes, slides
and chips, computers and people, the messiness of the practices in the laboratory, we might
understand better how genomic research is constructed and how it relates and translates to the
equally messy practices of the clinic and the family home.
This is one way I could introduce the reader to my research, but there are other
possibilities to consider as well.

Second Entrance
It is April, 2011. I have been invited by one of the senior clinicians in the clinic where
I will be doing my research to sit in on a conference for parents of children with ASD. A
large screen at the front of the room is showing a movie taken from a hidden camera in a
school yard. In the movie, it is recess and the camera microphone detects a cacophony of
children yelling and playing, seemingly enjoying themselves. There are children running
around or just standing in groups talking. The presenter at the front of the room takes her
laser pointer and tells us to “keep your eyes on this boy in the movie”. The boy in the movie
is sitting alone on the side of the track and field track. He is bent over with his chin resting on
his knees. It looks like he is holding a stick and is drawing in the dirt. Another boy comes
toward him and kicks him, spraying dirt in his face, and then walks away. A minute later
another boy yells at him and calls him a “loser”. The boy is wearing a hidden microphone but
the sound is still kind of muffled amidst all the background noise. The bell rings shortly after
and the boy slowly gets up and walks, head down, back toward the school. Another group of
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kids approaches him and he is shoved hard. A teacher stands near-by but doesn’t seem to
notice with the activity of rounding everybody back inside after recess. The movie ends and
the presenter, a child psychologist, tells us that this boy is diagnosed on the autism spectrum.
He and many other similarly diagnosed children often endure verbal and physical bullying.
Her research has studied the school experiences of children with ASD and she wants to raise
awareness of bullying in the education system.
At the coffee break I talk to some of the people sitting near me. They all have
children with autism. Their children are different ages, some toddlers, school aged, or young
adults. Many of these parents have changed their lives, quit their jobs even, trying to cope
with the challenges that face their children. I meet a woman who works at the autism clinic
that I am studying for my research. She too has an adult son with autism and she has been an
advocate for him and others like him for a long time. She explains that he is entering into a
stage of life, adulthood, which will bring a whole new set of challenges for someone living
with ASD.
This is another entrance, through the lives of the people living with ASD. How is
genomic research related to them and the activities they engage in? Many of the parents are
keen to sign up for genetic research while others are more ambivalent, worried about what
genetic findings might be used for in the future. How is genomic research changing the lives
of people and families living with ASD? How does it translate into their everyday world?

Third Entrance
Autism was first diagnosed by Leo Kanner in 1943 (Kanner, 1943). Since then, it has
become entangled in and constructed through a wide variety of networks of associations,
from psychodynamic to genetic. During the 1950’s and 1960’s a psychodynamic approach to
autism was predominant. Through this approach autism was believed to be caused by
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destructive interactions between a baby and his/her mother. One of the main proponents of
this approach was Bruno Bettelheim (Bettelheim, 1967). Bettelheim believed that the causes
of autism were environmental and could be traced back to infancy. He proposed that an
anxious mother was unable to adapt her reactions to her baby’s cues. He suggested that
children who were quiet and isolated in their first year of life may become autistic in their
second year of life, upon learning to speak and walk, “when their reaching out to relations led
to what they viewed as destructive responses. This, in my opinion, is why they gave up all
initiative” (Bettelheim, 1967). Thus, for Bettelheim, autism was a defence mechanism, a
learned response to a hostile environment. He went so far as to compare the home
environments of autistic children to concentration camps: “In the German concentration
camps I witnessed with utter disbelief the nonreacting of certain prisoners to their most cruel
experience…like others who have worked with autistic children, we were again and again
confronted with a parallel blotting out of all pain”(Bettelheim, 1967).
In The Empty Fortress (1967), Bettelheim describes the relationship between a mother
and her autistic child as “destructive and inescapable…because of the one single relation that
propelled him out of a position of love and ambivalence with overwhelming force he
became, so to say, glued to hate” (Bettelheim, 1967). Bettelheim directed an institution, The
Sonia Shankman Orthogenic School at the University of Chicago, for the rehabilitation of
children with emotional disturbances. Among the residents, autistic children were taken from
their parents and placed in the School, often living there for years. Bettelheim (Bettelheim,
1955) felt that “when a child is securely established at the School and accepts it is a reliable
frame of reference for his life, he becomes able to deal constructively with the experiences
he had in a less secure world, with past failures and disappointments”. Thus, for several
decades following Kanner’s initial description of infantile autism in 1943, Bettelheim and the
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psychoanalytical approach prevailed, blaming so –called “refrigerator mothers” for autism.
Since this time, there has been a complete reversal in how autism is constructed in the
clinic. Mothers are no longer blamed by psychologists for causing autism in their children.
During the 1970’s, as twin studies were published, the genetic underpinnings of autism
gained acceptance amongst the scientific community. Since this time many technological
advancements in microbiology have changed the way that genomics is practiced. How are
recent genomic findings in the laboratory seeping into the clinical practice of autism? How
is autism constructed in the clinical context? Who and what are the various actors that
reassemble autism in the various spaces and activities of the clinic?
Each of these entrances provides a different context from which to explore genetic
research in autism. In setting out to do this study, I wanted to understand how genetic
research translates within and amongst each of these contexts: the laboratory, the clinic, and
the homes of individuals and families living with autism. I wanted to tell a story about autism
genomics as it is assembled and reassembled in these different spaces. But how should I do
this? How do I tell a story about the translations between these places? Stories are often
linear affairs, with a beginning, middle, and an end. The audience is gently coaxed along a
particular trajectory until they arrive at a conclusion. Much of the messiness, the collisions
between voices and the branching off of alternative trajectories, is left untold.
In reading this dissertation, its organization might be interpreted in several different
ways. Upon first glance, the chapters appear to conform to the standard layout. An
introduction and background gives way to some new findings and a conclusion is reached. A
single story is made to unfold. There are other ways of reading this, however. Each chapter is
also its own story containing its own trajectories and voices. For example, the ways in which
the notion of translation is registered varies amongst the chapters in the body of this
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dissertation. In Chapter Four, translation is described as a process of transformation as I
follow the enactment of an individual diagnosed with autism, and then blood, then DNA,
computational outputs and graphical representations, PowerPoint slides, reports, feedback
diagrams, scores on clinical assessments, and then back to the individual and his/ her family.
In Chapter Five, translation in autism genomics is described as a predominantly political
process in which human and nonhuman actors are enrolled in a network and mobilized or
fronted by spokespeople. In Chapter Six, translation is again reassembled; here I explore the
idea of translation as coordination amongst different enactments of reality. While each of
these chapters is ostensibly about autism genomics, on another plane of analysis I am also
critically engaging with the concept of knowledge translation; each of the chapters highlights
aspects of translation (i.e., transformation, the political, coordinating multiplicity) that are
largely absent in the KT discussions found in the Canadian health sciences literature.
There are connections and coherences percolating amongst the chapters. They
interfere and interact with each other. There are philosophical and theoretical stories
entwined within these pages as well. There are also ruptures, deep crevices that hint at the
friction among various voices and trajectories. A break in chapter headings might signify a
break in the cartography of assumptions, and with it the landscape of autism genomics
changes, multiplies. Again, on another plane of analysis, these frictions and ruptures are also
the spaces that hold the potential for new possibilities for imagining knowledge translation.
In reading this dissertation this way, I hope to not only describe multiplicity and
difference within the context of autism genomics, I also want to perform this multiplicity.
The word I is very important here. It is my performance. Each chapter enacts another way in
which I have come to understand autism genomics. All of the accounts are mediated and
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performed through my own body. Some researchers include a separate section or story
describing how the topic of study relates to them personally. I have chosen not to do that. To
do so might risk the creation of a binary opposition between that which is personal and
subjective and that which is impersonal and objective. Such distinctions would be
inconsistent with the constructionist assumptions underpinning this research.

1.2. Research Questions
According to Eakin and Mykhalovskiy (2003) in qualitative inquiry the research
question often "functions more as a compass than an anchor, and is sometimes not really
known until the end of the research. The following questions are those that I have attempted
to address in this dissertation:
1. Within the context of recent findings about copy number variations, how is genetic
knowledge about autism constructed through the various practices, places, and spaces
in the laboratory?
2. How is this genetic knowledge translated amongst the laboratory, autism clinic and
families involved with autism genetics at Hospital X?
Drawing on constructionist, practice theories, this research adopts the view that knowledge is
inseparable from the practices through which phenomena are known. Knowledge does not
merely reflect the world, but also constructs the world. Different knowledge practices
construct different objects. In the context of my research, it is not only knowledge about
autism that is being constructed and translated within and amongst the laboratory, clinic and
home, but also autism itself. Knowledge is viewed as a practice, entangled in the material
reality of the world. Following from this assumption, several other research questions have
emerged in this research:
1. How is autism constructed in the laboratory, clinic and family homes involved in the
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autism genetics research at Hospital X?
a) Who/ what are the actors that are assembled around "autism" in the laboratory?
b) Who/ what are the actors that are assembled around "autism" in the clinic?
c) Who/ what are the actors that are assembled around "autism" in the home?
2. How is "autism" coordinated/ translated throughout the Autism Genetics Study?
a) Where are there controversies/ discrepancies in the practices of "autism" across the
autism genome research at Hospital X?
b) What are the strategies for coordination between scientists, clinicians, and parents of
individuals diagnosed with autism?
c) How is "autism" practiced in the shared/ hybrid spaces within the autism genetics
research?

1.3. Purpose
The purpose of this research is to re-conceptualize knowledge translation within the
particular context of autism genomics, considered from a constructionist philosophical
position and as informed by actor-network theory. It is a descriptive agenda. My hope is not
to prescribe a set of rules or steps to follow when engaging in KT. Rather, I will explore how
knowledge translation can be described and explored when approached from this theoretical
and philosophical position. Description in this context is simply empirical enquiry persuasive
to scientists as well as to participants in the study whose work it hopefully informs.
The need for a broader conceptualization of KT has been suggested by Greenhalgh et
al (2004), with specific calls for more theory-driven approaches (McWilliams, 2007; Reimer
Kirkham, Baumbusch, Schultz, & Anderson, 2007). Following these critiques, the purpose is
to demonstrate how KT can be re-conceptualized and re-positioned within a broader range of
theoretical and methodological approaches, which could complement (or potentially disrupt)
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the current understanding and models of KT predominant in the health sciences literature. In
this way, I hope to ignite a discussion about the limitations of existing orientations to KT,
and offer an alternative approach, thereby expanding the philosophical and methodological
breadth of the Canadian KT agenda.

1.4. Autism or ASD?
Throughout this dissertation I have chosen to use the word “autism” rather than Autism
Spectrum Disorder (ASD). ASD is a complex and heterogeneous diagnosis, a spectrum with
an enormous range of clinical manifestations. In the practice of autism genomics, however,
the complexity of this diagnosis is reduced. As I observed and formally and informally
interviewed members of the laboratory, autism was referred to in a binary manner. In
practice, the complexity of the spectrum is reduced to a binary phenomenon: individuals
diagnosed with autism, siblings, parents, family members in an extended pedigree were
either on or off the spectrum, diagnosed with autism or not. This is not to say that the
complexities of diagnosis and differences and variation within the spectrum were not
discussed and practiced within specific circumstances and locations within the clinic and
home. However, as autism pertained to genetic testing, the complexity and diversity of the
spectrum was reduced.
To some degree, this simplification and reduction of the autism spectrum is also being
reflected in changes being made to the Diagnostic and Statistical Manual V (DSM-V),
forthcoming in May 2013. Particularities and sub-classifications are being reduced. This also
reflects my experience of how clinicians and scientists talk about and think about ASD in the
context of genetics. Participants frequently used the word “autism” to stand in for everything
on the spectrum. In almost all of the conversations and observations I had, participants talked
about autism in a binary way, either you have it or you do not.
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Furthermore, my research is not focused on how autism is clinically diagnosed.
Throughout my fieldwork I never observed a clinical diagnosis being given. The issue of
variations and the differences within the autism spectrum are an entire other realm of
complexity that warrants its own empirical investigation that is well beyond the scope of the
focus of the present research. In all cases that passed through the unit and laboratory that I
observed, the individual already arrived with a diagnosis of ASD. Thus, if I have reduced the
complexity of the autism spectrum to a simple binary opposition in my interpretation and
representation it is because that is the way autism was practiced by those whom I observed
and interviewed in the context of autism genetics. Put in another way, my use of the word
“autism” reflects its emic construction (how it is used and practiced by the people I observed
within the specific contexts of autism genetics), which may not reflect the formal definition
of autism found in medical text books. For example, one clinician described autism in this
way:
Now, the tools that we use, you still need to use clinical judgment. Because the
tools, like for example, you’re either on the spectrum or you’re not. But it
doesn’t mean, sometimes you need to use your clinical judgment to determine,
is it autism, is it Asperger’s, is it PDD-NOS, which is going to be irrelevant
with the next DSM. So it’s going to be ASD or not. So there won’t be those
classifications any more. It’s changing. That’s why sometimes the clinical
diagnosis and the research diagnosis may or may not be the same. But typically
you’re either on or not on the spectrum.

Thus, there are many areas in the autism clinic in which much attention is focused on subclassifications within ASD. Certainly, clinicians spend a great part of their day arriving at
specific diagnoses within the spectrum. The clinic that became my field site was a research
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clinic with a wide variety of research studies. Some of the projects the clinicians were
working under were not connected to genetic research, while other studies were intimately
tied to genetics. Throughout the day, clinicians had to shift between opening up or blackboxing the complexity of ASD as they moved between activities that were not part of genetic
studies and those that were. Within the specific context of autism genomics, which is the
focus of my present research, the distinctions and particularities within the diagnosis tended
to be re-scripted as a binary classification. Following this, I have adopted the word autism
throughout the text. In the few spaces of my descriptions and interpretations where subclassifications on the spectrum are evoked, I consciously turn to using the term ASD.

1.5. Doing Fieldwork
a) Location
This research took place within a hospital in a Canadian city. In order to preserve the
anonymity of participants, all names of places and people have been altered. The hospital
will be referred to as the Hospital. Within this hospital, data collection was carried out in an
applied genomics laboratory and in an autism research clinic. The laboratory will be called
Laboratory X and the clinic will be referred to as the Autism Clinic.

b) Timeline
Final ethics approvals from The University of Western Ontario and from the hospital
research ethics board were granted in February of 2011. As I was on a maternity leave, data
collection did not commence until June of 2011. Much of the data was collected throughout
the summer months between June and September in which I tried to travel to the field sites at
least once or twice a week. Much of the observational data was collected in this time.
Between October and March, many of the interviews were conducted with less emphasis on
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observational data collection. During these months I would travel to the field site a few
times each month. Data collection was completed in March 2012. However, following this,
several key informants were contacted to review the written sections of my dissertation for
feedback. I wanted to ensure that the descriptions of the activities in the laboratory and clinic,
in particular the descriptions in Chapter 4, were being described accurately. I state this,
however, recognizing at the same time that the descriptions are partial and contain less
technical detail than “native” inhabitants of the laboratory or clinic would use.

c) Participants
Participants at Laboratory X had a variety of educational backgrounds including
molecular biology, genetics, zoology, and bioinformatics. They represented a variety of
positions at Laboratory X including post doctoral fellows, PhD students, project coordinators,
laboratory technicians, facility managers, assistant directors and the director. These
participants varied in the amount of time they had been working at the laboratory, from
eighteen months to fifteen years. The laboratory scientists whom I recruited into this study
were purposively sampled. In order to be able to follow DNA as it moves through the
laboratory, I approached people who were experts at each stage of the genomic experimental
process from DNA extraction to report writing.
In the autism clinic, participants included psychology PhD students, psychologists,
developmental paediatricians, project coordinators, a parent liaison, genetics counselors, and
clinical geneticists. The participants from the autism clinic had been working there for a
range of one year to ten years. The clinicians who participated in this research do not
represent a sample. They are an entire population as I interviewed and observed everyone in
the clinic who carried out clinical work as part of the autism genomics project.
Parents of children with autism had all participated in genetic testing at the hospital
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and had received feedback about the results of those genetic tests. In total, six parents
participated in an interview, five mothers and one father. Genetic results varied for each of
the families. While each child had been reported to have a copy number variation (CNV), the
location of the CNV was different amongst families; different genes were affected from one
family to another. Moreover, while five of the families received genetic feedback indicating
the genetic variant was inherited, one family had results indicating a de novo (or spontaneous
and non-inherited) variant. All participants were at least 18 years of age and all of them
spoke English. When children were in the room while I was observing at the autism clinic,
for example when I observed the Autism Diagnostic Observation Schedule (ADOS) and
intelligence testing, parents signed consent forms on the child’s behalf. When possible,
children signed an assent form. The parents were chosen based on a convenience sampling
strategy in which I approached anyone whom I was aware of being given genetic feedback
during the time I was in the field.

1.6. Methods
Data collection included document analysis, participant observation, and interviews
with three groups of people: basic scientists working at Laboratory X, clinical researchers
working through at autism clinic, and parents of children diagnosed with Autism Spectrum
Disorder who were participants in the genetic research taking place within Laboratory X and
the autism clinic. All of the people working or studying as part of the Laboratory and autism
clinic were also part of the same hospital.

a) Types of Data Collected
i) Laboratory X
I conducted seventeen semi-structured interviews with eleven people at the
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Laboratory over the course of data collection. All of the semi-structured interviews were
digitally audio recorded and transcribed verbatim. Interviews ranged from fifteen minutes to
over two hours, with most lasting approximately 45 minutes. I also carried out several
informal interviews, chatting in the hallway before or after meetings or asking quick
questions during observations. I also went down to the cafeteria with participants for lunch
on several occasions which prompted further opportunity for discussion. None of these
informal interviews were recorded or transcribed. Instead, I took field notes either during or
directly after these interactions.
Data collection also included participant observation, or “deep-hanging out”, in which
I followed participants around and made notes on what I was observing as they went about
their daily routines and tasks in the laboratory. I observed different kinds of meetings,
including Monday morning meetings, laboratory meetings, and Exome sequencing meetings.
I was able to observe laboratory experiments taking place such as PCR, microarray and Next
Generation Sequencing (NGS). Almost every time I conducted a semi-structured interview
with someone at the Laboratory, they walked me through the laboratory, taking me through
the various steps in an experiment and showing me the instruments used or the various data
print-outs produced along the way.
Several types of documents were included in analysis, such as PowerPoint
presentations, NGS protocol, meeting agendas and meeting minutes, as well as peer-reviewed
publications that were either authored by Laboratory X members or discussed at meetings.
Email was often used to announce interesting articles being published in the scientific
literature. In addition, several of the web-sites used in the Laboratory X for genomic analysis
were scrutinized for this research, for example, The Database of Genomic Variants
(http://dgvbeta.tcag.ca/dgv/app/home) and the 1000 Genomes Project
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(www.1000genomes.org).

ii) The Autism Clinic
I conducted nine semi-structured interviews with nine participants at the Autism
Clinic. All of these interviews were digitally, audio recorded and transcribed verbatim.
Interviews varied in length from 30 to 60 minutes. I also informally chatted with clinicians
while walking to and from meetings or while eating lunch in the lunchroom. I observed
meetings, presentations, intelligence testing, ADOS testing and assessment scoring and
genetic feedback sessions. I also analyzed various documents, such as patient consent forms,
PowerPoint presentations, peer-reviewed articles authored by Autism Clinic employees, and
ADOS assessment forms.

iii) Parents of Individuals diagnosed with Autism
Data collection with parents included observation of genetic feedback sessions as
well as subsequent semi-structured interviews, which were digitally audio recorded and
transcribed verbatim. I was able to observe four feedback sessions with parents, individuals
diagnosed with autism (called probands), and siblings. In addition, I conducted semistructured interviews with parents at least 2 months after they received the genetic feedback.
These interviews were between 25 and 40 minutes in length. Ideally, I would have liked to
engage in participant observation within the homes of these individuals and families.
However, in discussions with my supervisor and the director of the autism clinic, it was
decided that this form of data collection in the home would be too intrusive and burdensome
for families.
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b) Limitations to Data Collection
i) Laboratory X
One of the biggest limitations was my ability to observe inside the laboratory. Several
of the experiments have steps that require intense concentration for the person running the
experiment. They cost up to twenty five thousand dollars per run and I was told,
understandably, that certain steps would not be open to observation because of this. As a
result, I was reluctant to casually walk into the laboratory and observe without setting up a
formal appointment for being there. I did not want to walk up to a participant working over a
lab bench unannounced and inadvertently introduce error into an experiment.

ii) Autism Clinic
As with the laboratory, there were limitations in my ability to casually “hang-out” in
the Autism Clinic. The area is small with most employees working in cubicles. Telephone
conversations with parents were being conducted in these spaces and so any talking or
informal interviewing would have been distracting for employees trying to carry out their
daily activities. There was physically nowhere for me to stand that was out of the way as
hallways were unusually narrow in this space. The large lunchroom was the only open space
where I felt I was not in the way. The other problem with casually dropping in to observe at
the autism clinic was that a locked door stood between the front waiting room and the rest of
the clinic. On the few times I tried to drop-in to causally observe, I ended up waiting for
hours in the waiting room before anyone realized I was there. This is because there are some
days when there is no receptionist sitting at the waiting room sliding window. If patients are
not booked for a morning or an afternoon on these days, there is no reason to check if anyone
is in the waiting room. Observations, therefore, took place at pre-arranged times such as for a
specific assessment, feedback session or meeting.
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This limitation to accessing participants, to conducting participant observation, is
faced by many anthropologist, but is perhaps particularly characteristic of research that
attempts to engage relatively elite people and institutions. As Gusterson (1997, pp., 115) has
noted, “participant observation is a research technique that does not travel well up the social
structure”. As such, Gusterson called for anthropologists to break with a “fetishistic
obsession with participant observation” (Gusterson, 1997, pp., 116) and instead adopt a more
“polymorphous engagement” of participants which entails collecting data eclectically from
dispersed sites, and across disparate sources. Following this vein, in my own research
participant observation was not hierarchically positioned as more valuable or insightful than
interviews or document analysis.

iii) Family Home
One of the limitations of recruiting parents into my study was that there were very
few parents receiving genetic feedback regarding ASD. In the first three months of fieldwork
only two families received feedback and I was only able to observe one of these. (The
research coordinator forgot to tell me about the other feedback session. So I did not know it
had occurred until after the fact.) Fortunately, there were a few more feedback sessions that
occurred between November and January. Thus, while my sample of parents might appear
small this is because the entire population from which I was recruiting was extremely small.
Indeed, two of the parents interviewed had been given genetic feedback over a year earlier
but had heard about my study through their ongoing involvement with the autism clinic. With
so few families receiving genetic feedback during my fieldwork, I chose to interview these
two mothers as well. Important to note, many of these families had been waiting for nine or
ten years since their blood was first collected for genetic testing. It is only with recent
technological advances that clinically significant variants are being detected.
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Overall, the most significant limitation in my ability to collect data was the distance
between where I live and where Laboratory X and the Autism Clinic were located. It took a
two hour train ride as well as a subway ride or half hour walk in order to get from my house
to my field site. As a result, I could not participate in the kind of day-to-day, deep hanging
out that typically characterizes ethnographic field work. I also had a young, nursing infant as
well as a toddler at home throughout this fieldwork. While there were weeks when I
commuted back and forth every day, I typically went in only once or twice a week.

1.7. Process of Interpretation and Representation
In the social sciences there is only interpretation. Nothing speaks for itself. (Denzin,
2004)

The ongoing process of interpretation and representation consisted of a constant
manoeuvring back and forth between books and articles I was reading and the data I was
collecting in an effort to make sense of what I was learning in the field. All of the data I
collected - interview transcripts, documents, participant observational field notes - were
gathered together in QSR Nvivo 9. This software is purely an aid to organization and allowed
me to hold together, in one place, all of the data I was amassing. From a constructionist
standpoint the researcher is intimately involved and implicated in the interpretation of data.
In the interpretation process relations are made between literature and data. The conceptual
tools, the theoretical assumptions adopted by the researcher precede the doing of
ethnography and shape what is seen in the field and written in a text (Van Maanen, 2004). At
times it is about reading through the data with the literature in mind and at other times it is
about reading through the literature with the data in mind.
I found the train rides to and from the field sites to be particularly productive times, in
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which I would reflect on the relationships between what I was reading and observing and
hearing. My field notebook contains many jottings and bursts of insight that often raised
further questions. These entries came to be known to me as Train Thoughts. The train ride
was a liminal place, between the spaces in which data was collected and the formal writing
space of my “office”. By reading back over these train thoughts I can trace the various
trajectories of my thinking and follow which lines of inquiry were left as loose ends,
questions unexplored, and which I ended up pursuing within this dissertation. As it is for
many, the interpretation was done through the activity of writing (Richardson, 2004),
whether this writing took the form of expanded field notes, jotting in Train Thoughts, or
more formal attempts to solidify my ideas in drafts of this dissertation. As Denzin asserted,
“a situated, writing self structures the interactions that take place among the writer, the text,
and the reader” (2004).
Through interpretation, the researcher imposes an order on the world being studied.
Denzin outlined four phases in the process of moving from the field to a written text: sense
making, representation, legitimation, and desire. Sense making concerns how the researcher
moves from field notes to the actual writing process. I used the time riding on the train to
write out descriptions of how what I had just experienced in the field related to particular
concepts or ideas I was reading in the science studies literature. It was in these “Train
thoughts” that I began to try out theoretical orderings on my field notes. Representation,
according to Denzin, deals with the issue of voice, and reflexivity as the author positions
herself within the text. At the end of this chapter, I describe in more detail the issue of
reflexivity. Legitimation concerns how a text makes claims for its own authority. Reliability,
validity, and generalizability are typical hallmarks of legitimation in post-positivist texts but
are not appropriate in constructionist texts. Verisimilitude or truth is established through
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detailed descriptions of field experiences. Denzin stated, “authentic understanding is created
when readers are able to live their way into an experience that has been inscribed and
interpreted” (2004). I have dealt with this issue of legitimation in further detail in the section
below on quality criteria. Desire pertains to the issue of making a reader enjoy a text, making
it vital and gripping. I have tried to make the text readable by attempting to portray vivid
descriptions of the places and people I encountered.
The codes I developed were not seen as inherent within or emerging out of the data
itself but rather as signposts to the ideas and concepts about which I was reading. I interpret
codes as a nexus between author, data, and influential literature. I developed coding schemes
for each of the three sub-groups (laboratory, clinic, family) within my study. I was then able
to compare across these three coding schemes to look for similarities and differences
amongst them. I further coded the instances and circumstances in which the actor-networks
of these three sub-groups came together. As such, the coding scheme and the way the data
were approached is directly related to the research questions, with three coding schemes
focused on each of the spaces (lab, clinic, family home) as separate actor-networks and
another coding scheme focused on the hybrid spaces in which networks became entangled.
What I have written is a complex entanglement of field notes and memories that have been
assembled and reassembled through the art of interpretation. The theoretical ideas presented
in this dissertation are not new; there is nothing original in writing about post-humanist
constructions of scientific knowledge; these concepts are borrowed from the published
literature. My contribution is to take these ideas and to begin to relate them to another arena
of discussion in which I have not seen these ideas surface before, that of Knowledge
Translation (KT).
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1.8. Reflexivity
According to Kinsella & Whiteford (2008), reflexivity "goes beyond pragmatic
reflection to embrace a critical dimension and to carefully interrogate the very conditions
under which knowledge claims are accepted and constructed. Reflexivity recognizes the
sociality of the process of knowledge generation". With this definition in mind, science
studies or the sociology of scientific knowledge (SSK) is synonymous with a reflexive
endeavour; the raison d'être for this field of study is to explore how science actually works,
its assumption and practices on the ground which contribute to the making of scientific
knowledge.
Lynch (2000) asserted that there are actually many different meanings and uses of
reflexivity, depending on who is doing the reflecting, on what they are reflecting and what
are the intended outcomes or goals of reflecting. In Lynch's words, each kind of reflexivity
"involves some sort of recursive turning back, but what does the turning, how it turns, and
with what implications differs…" (2000).
Reflexivity is utilized by Latour (1988) to indicate "any text that takes into account its
own production and which, by doing so, claims to undo the deleterious effects upon its
readers of being believed too little or too much" (Latour, 1988). Infra-reflexivity, supposes
that no amount of layering of self-consciousness will ever bring a text closer to a referent.
For Latour, infra-reflexivity is a process of "displaying the knower and the known and the
work needed to interrupt or create connections between them" (1988). Since any account is
always a story, Latour proposes that we add as many genres and styles of narration as
possible. He stated (1988) "the reflexive character of our domain will be recognized in the
future by the multiplicity of genres, not by the tedious presence of 'reflective loops'". In this
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way, the knower or the writer is pushed off stage and the spot light is turned once again to
things in themselves.
According to Latour the Actor-Network Theory (ANT) account "has to be able to
register differences, to absorb multiplicity…" (Latour, 2005), much the same way that
Woolgar calls for sustained uncertainty and the juxtaposition of multiple interpretations.
The text itself is a mediator in ANT. Here, then, more recently Latour has recounted his
claim that all we can do is write stories. He laments the claim that just because there is no
absolute Text, all texts are relative. Instead, he contends that "textual accounts are the social
scientist's laboratory and if laboratory practice is any guide, it's because of the artificial
nature of the place that objectivity might be achieved…" (2005). The artificial and the
objective, truth and fiction are not set in opposition to one another but instead are intimately
mixed together. Latour continues by stating:
A good text is never an unmediated portrait of what it describes - nor for that
matter is a portrait. It is always part of an artificial experiment to replicate and
emphasize the traces…The simple act of recording anything on paper is already
an immense transformation that requires as much skill and just as much artifice
as painting a landscape or setting up some elaborate biochemical reaction
(2005).
As described previously in this chapter, this dissertation attempts to perform
multiplicity, to register differences in the ways that I experienced, approached, and
interpreted the activities I encountered during field work. I have tried to keep myself, as
author, in focus, to show how I was entangled in the activities amongst the different spaces I
entered. My feelings, anxieties, naivety break through the surface of various descriptions and
interject, in an italic font, another voice. My body, clumsy and unfamiliar with the
choreographed rhythms and movements of the laboratory or the clinic, offered another
vehicle from which to register and compare the practices in these different spaces. As such,
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data was not only gathered through listening or observing but also through my body as a
physical object that had to squeeze between, hover around, had to become partially
disciplined in the fashion of these various spaces so as not to bump into temperamental
machines, for example. I had to learn when I could ask questions and when I needed to
remain silent. Thus, as will be explored in the following chapter, knowledge production was
experienced as a fleshy, corporeal event rather than a mental bi-product. From this
perspective, knowing becomes a practice, an activity intimately tied to the material world.
Reflexivity, then, is about keeping those connections and ties in focus and refusing to allow
insights to be black-boxed and severed from the bodies, machines, feelings, and tools through
which they are constructed.
I can not claim to offer the story of autism genomics. This is because the interactions
and activities I observed cannot be reduced to a single story. Moreover, the observations and
conversations I entered into were confined to a single year and doubtless some of the actors
have changed already. It is not a story about what autism genomics is, but instead, I aim to
tell a story about the tensions and differences in the way that autism genomics is becoming. It
is a story of the doing of autism genomics.

1.9. Quality Criteria
The whole point of 'evoking' rather than representing is that it frees ethnography
from mimesis and the inappropriate mode of scientific rhetoric that entails
'objects', 'facts', 'descriptions', 'inductions', 'generalizations', 'verification',
'experiment', 'truth' and like concepts that, except as empty invocations, have no
parallels either in the experience of ethnographic fieldwork or in the writing of
ethnographies.
(Geertz, 1988, p. 136)

How does one assess the quality of research? What are the standards or criteria for discerning

25

a high-quality versus a low-quality text? As will be described further in the following chapter
on Philosophical Background, I argue that actor-network theory is a methodological
approach very much akin to ethnography. As such, I put forward two key criteria for
assessing the quality of research, which are typically associated with ethnographic works.
These two criteria are authenticity and ethnographic validity. In addition, I propose an ANTcentred quality criteria, that of deploying actors as networks.

a) Authenticity
Ethnography is about trying to "persuade readers….that what they are reading is an
authentic account by someone personally acquainted with how life proceeds in some place, at
some time, among some group" (Geertz, 1988). The quality or 'author'ity of an ethnographic
text rests in its claim to authenticity. The ethnographic text must persuade the reader that "I
was there". This can be done in different ways. Geertz is often quoted for his example of
thick description (2001). Similarly, Atkinson describes the rhetorical device called
hypotyposis as a key means of establishing a narrative contract. Hypotyposis is:
the use of a highly graphic passage of descriptive writing, which portrays a
scene or action in a vivid and arresting manner. It is used to conjure up the
setting and its actors, and to 'place' the implied reader as the first-hand witness
(P. Atkinson, 2001, p.98).

Thus, one criterion for a good ethnographic account is authenticity - the ability to persuade
the reader that "I was there".
Chapter four is a detailed account of the activities that I observed in the various
spaces of the laboratory, clinic and family home. I have tried to leave the reader with my
sense of what these spaces are like and what it is that people do in these spaces. There are,
without doubt, huge gaps in my understanding of what is going on in these spaces. My
interpretations of the practices that occurred as DNA passed through these spaces are based
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on my understanding as someone who is not a genetic scientist, not a clinician, and not a
parent of a child with autism. Many of the complexities and details with which insiders might
be grappling in their daily work remain beyond my understanding. And yet, with the
fundamental, basic insights that were shared with me in each of these spaces I am able to
offer descriptions which begin to open up the complexity of translation.

b) Ethnographic Validity
The issue of validity is one discussed amongst post-structuralist social scientists with
much ferment (Lather, 1993). The positivist definition of validity rests on a correspondence
model of truth. This view of validity does not resonate well with a research project
underscoring ontological multiplicity and non-coherence. Instead, validity must be
repositioned as “multiple, partial, and endlessly deferred” (Lather, 1993, p.675). Richardson
(1993), for example, describes a “transgressive validity” using poetry to “make visible both
context and labour” (Richardson, 1993, p.696). Validity, then, involves illustrating the
process through which a researcher comes to construct a particular representation.
According to Sanjek (1990) there are three canons on which ethnographic validity rests:
theoretical candour, the ethnographer's path, and field note evidence. These all point to a
reflexive stance in which the researcher engages with the process of constructing a textual
account of the field site(s).

i) Theoretical Candour - A good ethnographic account will discuss how theory
guides the process of fieldwork. The ethnographer cannot attend to everything at once while
in the field. The ethnographer makes choices about what he/she attends to and these choices
are guided by theory. In order to establish validity, an ethnography must be explicit about the
theoretical reasoning behind these choices (Sanjeck, 1990).
In my research, I am interested in how autism is practiced and translated through the
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assembling together of human and nonhuman actors in the laboratory, clinic and home
settings. Thus, participant observation is integral to my research. Semi-structured interviews
alone would not allow me to describe the mundane day-to-day practices of autism in the
laboratory and clinical contexts. In my research, practice theory has implications for my
choice of data collection methods. The interpretation and representation of the data that I
have presented is also influenced by several theoretical concepts such as multiplicity and
difference.

ii) The Ethnographer's Path - Ethnographic validity, according to Sanjek
(1990), is also established by a detailed account of how the ethnographer was introduced to
various people and contexts. The ethnographer's path is a kind of road-map to the fieldwork
process, allowing the reader to follow along from point of first contact through to exiting
fieldwork. The path brings the reader along, exploring how the ethnographer became
connected to the people and places explored in fieldwork.

iii) Field note Evidence - The third canon of ethnographic validity requires the
ethnographer to be explicit about the relationship between the field notes and the written text.
Like the Ethnographer's Path, the issue of field note evidence is concerned with explicitly
stating how the notes of the field inform the final text. This third canon might also draw on
what Ottenberg called 'headnotes': "the notes in my mind, the memories of my field research"
(Ottenberg, 1990, p.144). As Sanjek explained,
[W]e come back from the field with fieldnotes and headnotes. The fieldnotes stay
the same, written down on paper, but the headnotes continue to evolve and change
as they did during the time in the field…the headnotes are more important. Only
after the anthropologist is dead are the fieldnotes primary (1990, p.93).
Ethnographic validity, according to Sanjek, requires that the ethnographer reflect on this
process of how hundreds of pages of hurried scratches jotted in the field amount to the

28

chosen impressions and examples unfolded in a text.
In this dissertation, the various chapters draw from different experiences and
interpretations of field work. For example, the story that unfolds in chapter four in which I
map out and follow the route of genetic information as it is translated amongst laboratory,
clinic and home is one way of ordering my fieldwork experiences. However, chapters five
and six draw on particular theoretical concepts such as Callon’s (1986) notion of translation,
Mol’s (2003) idea of multiplicity, and Law’s notion of coordination. Thus, each of these
chapters pulls out different experiences, allowing me to present different ways of assembling
or ordering the data.

c) Deploying Actors as Networks
A good ANT account will deploy actors as networks (Latour, 2005). This means that the
account must follow the translations and transformations of actors as they move in and out of
various networks. An actor and the networks through which actors become associated are not
conveyed as rigidly bounded or stable but rather are imagined as moving, changing, and in
flux. Heterogeneity and complexity proliferate as the ANT account re-constructs the
pathways through which actors move, subverting certainties about what any actor is. In my
own research, I have attempted to trace the transformations of actors as they move through
the networks of laboratory, clinic and family home in the context of autism genomics.

In the next chapter, I unfold the intricate layers of philosophical assumptions which have
guided data collection, interpretation, and representation.
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Chapter 2
Groundwork: Philosophical Footings
2.1. First Layer: Theoretical Position
a) Theories of Practice
2.2. Second Layer: Methodology
a) Actor-Network Theory (ANT)
b) Criticisms of ANT
c) How does ANT as a Methodology relate to Ethnography?
2.3. Third Layer: Epistemological Mooring
a) Constructionism
b) Epistemology or Ontologies?: Practiced Knowledge, Practiced Realities
c) Both Constructed and Real
2.4. Relating my Philosophical Position to Knowledge Translation

"It is not a matter of looking harder or more closely, but of seeing what frames our seeing"
(Lather, 1993, pp. 693).
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Plate 2.1: Situated Author

In this chapter I will attempt to position myself and make explicit the assumptions
underpinning each stage of this research. These assumptions have informed the questions I
have asked, the methods for data collection, the theories influencing the analysis of the data,
and the way I have performed and presented the research in this written text. In this chapter I
have organized these assumptions into three layers. To be sure, there are issues and debates
which cut down through these philosophical strata, at times overlapping and folding these
layers like the convoluted striations on a mountain rock face. As I work down through these
philosophical layers in this chapter, these percolating issues and debates will be followed and
mapped out as well.
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Plate 2.2: Rock Strata
The top strata I will address are theoretical. Theories of practice have influenced this
research. If we dig down a little deeper, we find the second layer, which is methodological.
Although the word theory is embedded within Actor-Network Theory, I argue that this is
actually a methodological stance. I will also discuss how this research relates to another
methodological approach, that of ethnography. I argue that ANT and ethnography are
overlapping methodologies. Finally, digging further, we find the third layer, which is
epistemological. A description of the epistemological position I have adopted,
constructionism, reveals assumptions about knowledge and the relationship between the
knower and that which is known, subject and object.

2.1. First Layer: Theoretical Position
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2.1a Theories of Practice
Practice theories are a heterogeneous response to structural determinist theories
(Ortner, 2006). Ortner (2006), for example, traced the history of practice theories and
described how practice theory emerged as an alternative to three major paradigms (symbolic
anthropology, Marxist political economy, and French structuralism) which were all
essentially theories of constraint. Through these three paradigms human behaviour was seen
as shaped by external cultural forces. Practice theory, as it emerged in the late 1970’s and
early 1980’s sought to explore the processes that produce these cultural constraints. Early
practice theorists attempted to define a “dialectical, rather than oppositional relationship
between the structural constraints of society and culture on the one hand and the practices of
the social actors on the other” (2006). Ortner described practice theory as evolving over the
last few decades, addressing the issue of power and the situatedness of practices in a
historical context. Furthermore, the concept of culture is reworked through practice theory
(Ortner, 1999). Culture is “loosened up” and tied less to geographically defined groups of
people, acquiring a geographic and temporal mobility.
There is no single, unified approach underlying practice theory. However, while
there are important distinctions between various theories of practice, at the core these
theories all insist that human action is both constrained by a social or cultural order and that
human action makes, reproduces, and transforms that socio-cultural order (Ortner, 1996). As
such, practice theories tend to reject the dichotomy between macro and micro, structure and
individual, instead reformulating these positions as mutually constituting one another through
practice. It is through practice that dichotomies between subject and object, micro and macro
might be described as being mangled (Pickering, 1995). It is through the central issue of
agency that some of these dichotomies will be explored in this section.
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Before delving into these issues and distinctions within practice theories, I first
consider what is meant by practice. According to Schatzki (2001), “practices are arrays of
human activity”. These activities are embodied and materially mediated. The embodied
nature of practice is crucial as it is the body that is assumed to be the meeting place, the point
of connection between the individual and the social, the micro and the macro. The material
nature of practices is taken up by some more than others. In particular, Latour and those who
engage with actor-network theory are especially concerned with a focus on non-humans in
the study of practices. Most practice theorists also approach practice as shared, collective
actions. A distinct social ontology has arisen in which practice theories approach the social as
“a field of embodied, materially interwoven practices centrally organized around shared
practical understandings” (Schatzki, 2001). The social then, can be understood by exploring
how humans (and non-humans) interact with one another through shared practice. Barnes
(2001) stressed that practice theories are not compatible with individualism, noting how
humans “cannot be understood as independent calculative social agents, they stand revealed
in their practice as profoundly interdependent, mutually susceptible social agents”. Thus,
practice theories aim to show both how the social influences individuals and how individuals,
through practice, make the social.

i) Where does agency lie?
Pickering (2001) outlined how agency is situated in a post-humanist theory of
practice. Distinct from most social theory in which key concepts revolve around humans, a
post-humanist position “recognizes from the start that the contours of material and human
agency reciprocally constitute one another” (A. Pickering, 2001). In The Mangle of Practice
(1995), Pickering sets out to describe how science is practiced in real-time. Rather than
exploring how science represents nature, Pickering prefers to adopt a performative idiom. He
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starts from the position that the world is constantly doing things; it is filled with agency.
Science is a means of coping with this agency. Scientists, as human agents, build machines to
“capture, seduce, download, recruit, enrol, or materialize that agency, tamping and
domesticating it, putting it at our service” (1995). Through examples from old and new
particle physics, Pickering describes the reciprocal process of “tuning” between human and
non-human agency. He further describes this process as a “dance of agency”, which is
elucidated in this quote:
Scientists tentatively construct some new machine. They then adopt a passive
role, monitoring the performance of the machine to see whatever capture of
material agency it might effect. Symmetrically, this period of human
passivity is the period in which material agency actively manifests itself.
Does the machine perform as intended? Has an intended capture of agency
been effected? Typically the answer is no, in which case the response is
another reversal of roles: human agency is once more active in a revision of
modelling vectors, followed by another bout of human passivity and material
performance” (1995).

This dance between agencies is a dialectic of resistance and accommodation. The world
initially resists some human attempt to capture it and in turn humans accommodate this
material agency and modify their instruments and machines. It is through this dialectic, this
constant shifting back and forth between human and material agency, that Pickering’s posthumanist position on agency emerges. This dialectic which he calls the mangle of practice,
attempts to keep in view simultaneously human and non-human agency. In this posthumanist space human and material agency are intertwined and reciprocally defined. This
post-humanist space is one in which “the human actors are still there but now inextricably
entangled with the nonhuman, no longer the centre of the action and calling all the shots”
(1995).
Knorr-Cetina (2001) has further elucidated the post-humanist position in the context
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of epistemic practices. According to Knorr-Cetina, epistemic practices are based on a form of
relationship, a relationship between subjects and objects. Scientific objects, objects of
knowledge are those things that are at the centre of investigation, that are in the process of
being defined through research. They “are characteristically open, question-generating and
complex. They are processes and projections rather than definitive things” (Knorr-Cetina,
2001). In this way, knowledge objects are different from objects that we encounter in
everyday life, such as tools or goods that can be characterized as a closed box. Conversely
knowledge objects are characterized by their lack of completeness as they are in the process
of being materially defined. She describes epistemic objects as having an “unfolding
ontology” which highlights changes in these objects over time. She states that inquiry tends
to increase rather than reduce complexity of knowledge objects.
Moreover, epistemic objects often exist in a variety of forms simultaneously. For
example, in her field of high-energy physics, Knorr-Cetina notes how the detector
“continually circulates through a collaborating community of physicists in the form of partial
simulations and calculations, technical design drawings, artistic renderings, photographs, test
materials, prototypes, transparencies, written and verbal reports” (Knorr-Cetina, 2001).
Knorr-Cetina approaches epistemic practices as a type of relationship between subject
and object. When epistemic objects are in the process of being materially defined scientists
attempt to capture the object, to represent it. Through initial experiments an object is partially
defined and the representations often imply what is still missing, suggesting directions from
which to approach the object in future. Knorr-Cetina describes this desire to capture the
object as a “chain-of-wanting”. This structure of wanting between the scientist and the
epistemic object offers a view of practice that is embedded in relational dynamics. Through
practice objects and scientists are mutually engaged: “objects provide for the chain of
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wanting through the signs they give off and what they still lack and scientists (subjects)
provide for the possibility of the unfolding of the objects through experiment. In this way,
practice is oriented toward the future as the nature of an epistemic object unfolds through the
successive attempts of experts to pin it down. Knorr-Cetina points to the emotions, the
excitement and pleasure, involved in epistemic practice through which subject and object are
mutually engaged.
The issue of how agency emerges in this dichotomy between individual actors and
over-arching structure is addressed by Latour more recently through the idea of scripts
(Latour, 2012). Individual actors are involved in several competing scripts simultaneously.
At times our actions are guided by scripts and at other times we write those scripts. At time
we live under the script; here the script delegates instructions to us to be carried out. At other
times we live above the script and as such we insert instructions into the script. Latour
proposes, however, that we are “never simultaneously but always sequentially fabricators and
fabricated, and we shift roles at specific deadlines that are themselves scripted” (2012). The
individual-structure dichotomy is made more complex here as Latour interrogates the
concept of the individual, instead highlighting the possibility for a single actor to take the
form of many characters inscribed into different, and often contradictory, scripts. The
structure is nothing more than what is written in these various scripts. The relations between
individual and structure are registered through flip-flopping below and above the scripts over
time.
In this research, I have adopted a theoretical position based on practice theories. In
particular, I have been influenced by post-humanist theories of practice, which acknowledge
the agency of both humans and nonhumans in the activities of science. This dissertation
adopts the position that individuals make the social and that the social influences and
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constrains individuals. Thus, practice theories enable one to simultaneously focus on
divergent ends of the individual-social and subject-object dichotomies. As will be explored
more fully in the discussion of methodology and epistemology, this bi-focal perspective is
achieved by foregrounding nonhuman actors. While practice theories ideally illustrate both
how the social constrains the individual and how individuals make up the social, this research
has focused on the latter. The methodological approach found within actor-network theory,
explored below, details why only one half of the practice theory agenda has been dealt with
in this research, as the social (or cultural) is viewed as a category that needs to be explained
rather than one that is used to explain other things.

2.2. Second Layer: Methodology
2.2a Actor-Network Theory
Methodology denotes how the would-be knower, the researcher, can go about finding
out whatever he or she believes can be known (Guba & Lincoln, 2004). As Crotty (1998)
explained, methodology is “the strategy, plan of action, process or design lying behind the
choice and use of particular methods and linking the choice and use of methods to the desired
outcomes.” Actor-Network Theory (ANT), I argue, can be considered a methodology, one
that shares similarities with ethnography. ANT surfaced in the 1980’s in the field of the
social studies of science. It was initially put forward by Bruno Latour. Law (1999) has
described ANT as the semiotics of materiality or relational materiality; “It takes the semiotic
insight, that of the relationality of entities, the notion that they are produced in relations, and
applies this ruthlessly to all materials – and not simply to those that are linguistic” (1999).
Further, ANT proposes that these relations between materials are not inherent by themselves
but that these relations have to be performed. It is through semiotic materiality and
performativity that ANT becomes a methodology informing how researchers approach a
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research question and the desired outcomes of research.
In this section I will outline some of the main components of ANT: actors, networks,
and the tension between actors and networks. I will discuss how this methodology informs
one’s plan for carrying out investigations and the intended outcomes of using this
methodology. I will also briefly address one of the key criticisms levied against ANT
regarding its ability to address issues of power and politics. Finally, I will briefly address
how an ANT methodology might be described as overlapping with ethnography.

i) Actors
Anything that modifies a state of affairs is an actor. In actor-network theory, the
activity of acting is spread widely; it is not only humans that act. For example, in the context
of genetic research on "autism", actors might include equipment, tools, tests, statistics, printouts, journal articles, blood samples, and granting agencies along with technicians,
administrative personnel, and scientists. Each of these could be considered a potential actor
depending if and how they are drawn into controversies. Thus, ANT studies often describe
both human and non-human actors as they are entangled with one another. Instead of
assuming objects are passive, ANT focuses on how the material world pushes back on people
(Latour, 1992). This is not to suggest that ANT confers intentionality to non-living objects,
but rather that action loses any humanistic assumptions. Nonhuman actors can be anything
that forces others to do something. For example, the flashing or beeping seatbelt signal that
warns a driver to put on his/ her seatbelt when starting a car could be a nonhuman actor (B.
Latour, 1992). The same language of agency is used to describe objects on either side of the
traditional dichotomy between things that belong to nature and things that belong to society.
This is arguably one of the most defining characteristics of ANT - the inclusion of nonhuman actors.
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Latour wrote about the "underdetermination of action…the uncertainties and
controversies about who and what is acting when 'we' act” (2005). Just as an actor on a stage
in a theatre is never alone (there are props, backstage crew, lighting, audience reactions, a
script, a playwright…the list could go on), the word “actor” in actor-network theory indicates
a dislocation of action. Latour suggested that we should "remain puzzled by the identity of
participants in any course of action" (2005) instead of deciding too quickly who and what is
doing the acting. Latour has described ANT as "a very crude method to learn from the actors
without imposing on them an a priori definition of their world-building capacities" (1999b).
It is in this sense that ANT can be approached as a methodology rather than a theory. As
Latour stated, it is “simply a way for the social scientists to access sites, a method and not a
theory, a way to travel from one spot to the next” (1999b).
ANTs approach to studying non-human actors is not without its critics. There have
been several arguments and discussions within the field of science studies addressing this
inclusive definition of the "actor". For example, Yearly and Collins (1992) questioned how,
as humans, we can speak for non-human agents who cannot speak for themselves. They
chastised Latour for what they called his "absence of methodological control over fantasy"
(1992). Moreover, they were concerned about the essentialist implications of taking nonhuman actors too far:
If non-humans are actants, then we need a way of determining their power.
This is the business of scientists and technologists; it takes us directly back to
the scientists' conventional and prosaic accounts of the world from which we
escaped in the early 1970s (Yearly & Collins, 1992).
Thus, Yearly and Collins, along with Bloor (1999) and those in the Edinburgh school,
prefer to adopt a humanist approach. Jensen recapitulated Yearly and Collins's position and
stated:
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On the one hand the epistemological realist position of science is granted, but
it is then doubled by the position of the sociologist who is able to really point
to how realism is the result of the open and negotiable work of scientists (but
notably not the open and negotiable work of natural entities) (Jensen, 2004, p.
239).
Thus, for Yearly and Collins it is the sociologists who are really able to provide an
account of science and how it works.
Latour's aims are different, choosing to trace the networks between human and nonhuman actors, all of whom have agency. Similarly, Pickering (1995) has portrayed the
practice of science as a "mangle" in which "the dance of agency…takes the form of a
dialectic of resistance and accommodation" (1995). He elaborated on his concept of the
mangle by noting that from this perspective science is seen as an "evolving field of human
and material agencies reciprocally engaged in a play of resistance and accommodation in
which the former seeks to capture the latter" (1995). Thus, contrary to the Edinburgh school
which, for the most part, obfuscated the role of non-human agency in science, Pickering and
Latour call for a gaze that captures both human and non-human agency simultaneously.
Actors become Black-Boxed
One of the difficulties with following actors is that many actors quickly become
black-boxed once a controversy is resolved or an innovation is taken for granted. Black
boxing is a process in which an idea/ knowledge is rendered "distinct from the circumstances
of its creation" (B. Latour & Woolgar, 1986). This process of black-boxing is also referred to
in the ANT literature as 'punctualization' (Akrich, 1992). As an example, we might say that
the double-helix model of DNA is a black box. It is taken for granted. All the actors discussions, models, alternative hypotheses, people, tools, and tests - that were part of the
context in which the double-helix model was developed have dropped from the description.
DNA is a double helix: order is created out of disorder. In other words, as a network
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becomes stronger and more stable a network can be treated as a point or a node rather than a
network.
When phenomena are black-boxed it is tricky for the ANT analyst to unpack those
boxes and recover all the important actors. In this light, Latour (2005) has offered a few
suggestions on how to attune oneself to situations in which actors are more likely to become
visible. For example, one suggestion is to study innovations (e.g., the scientists' laboratory),
where objects are not yet taken for granted and are made visible through meetings, plans,
sketches, and regulations. A second setting in which actors become more visible is in
accidents or breakdowns. At these times, objects that were a moment before taken-forgranted, automatic, and invisible are suddenly scrutinized and quickly made visible.
In my research on knowledge translation in the context of autism genomics I have
adopted this approach. Autism as a genomic object is still in the process of being constructed
and in this sense its construction is visible. It has not yet become black-boxed, allowing me
to trace how it is assembled in the networks of the laboratory, clinic, and family home.

ii) Networks
"…[T]he elements bound together in a network (including people) are
constituted and shaped by their involvement with each other" (Lee & Brown,
1994, p. 775).
In ANT, the actor is not explored in isolation. Rather, actors act in relation to other
actors within a network. The word network in ANT has a very specific meaning that was
intended to convey two key attributes: instability and transformation. Deleuzian concepts
such as the “fold” and the “rhizome” underpin the ANT notion of the network (Jensen &
Rodje, 2010). "Network" is a common-place word today and has lost the meaning that was
intended when actor-network theory was first named. Specifically, Latour explained:
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At the time, the word network, like Deleuze's and Guattari's term rhizome,
clearly meant a series of transformations - translations, transductions - which
could not be captured by any of the traditional terms of social theory. With
the new popularization of the word network, it now means transport without
deformation, an instantaneous, unmediated access to every piece of
information. That is exactly the opposite of what we meant" (Latour, 1999b).

Latour (2005) described "double-click" information which is associated with the
internet. Double-click information travels from one user to another without change; inputs
and outputs are the same. Unlike a network of highways which is stable and transports
vehicles from one place to another without any change, in ANT, actors are modified by their
involvement within a network. The second characteristic of networks in ANT is that they are
unstable and ambiguous. Actors can have multiple ties to many networks simultaneously
(Singleton & Michael, 1993). If actors leave a network it will change or even fail altogether.
The work by Williams-Jones and Graham (2003) on genetic testing demonstrates two
of the key attributes of the ANT network - transformation and instability. Williams-Jones and
Graham (2003) demonstrated the ambiguity and instability of networks over time,
underscoring the work needed to maintain the enrolment of actors. The network, in ANT,
does not have to be composed in a certain way; it could always be different; networks may
fail and fall apart. These authors mapped the networks of 'BRCA-testing' which included
actors such as technicians, geneticists, counsellors, patients, families, reagents, sequencers,
laboratories, corporate interests, and stockholders. For a time, Myriad Genetics was able to
hold together one version of the BRCA-test network; key actors such as the British Columbia
government were enrolled. For example, public testing was halted through cease and desist
letters as the British Columbia provincial government laboratories stopped providing public
testing, instead referring patients to Myriad. However, in 2003, after a period of two years,
the B.C. government reversed its position on gene patenting and resumed 'in-house' testing.
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Thus, the network that Myriad had attempted to stabilize eventually broke down and changed
as key actors left to join other networks.
In the example above, the two key characteristics of the network in ANT are
apparent. First, the network is unstable. The BRCA-test network that Myriad Genetics
attempted to hold together eventually broke down and changed altogether when the B.C.
government bypassed the pharmaceutical company. The transformative nature of networks is
also emphasized; for example, a genetic test is modified into a commercial resource in the
Myriad network.
Networks and the Research Analyst
Networks do not just apply to the human and non-human actors brought together by
the members of the groups we study. Consider Strathern's statement that the "theorists’
interpretations are as much networks as any other combination of elements" (1996). In an
ANT account, the analyst has been typically situated outside the network being described
(Schwartz Cowan, 1987). This warrants further consideration. How do the networks of the
analyst and the networks of the field site interact in the written account? How does the
analyst situate him/herself in relation to the networks being traced? Law (2000) explored this
issue directly. He contended that there are many different ways of ordering what we describe
in our fieldwork, with different aspects of the personal being drawn into the stories we tell.
He urges researchers to consider what he calls "narrative interference", to pay attention to
how we are performing the stories we tell about our research site. Attending to our bodies as
a site for ordering, in particular at times when different orderings cannot be aligned into a
coordinated, singular story, we "become sensitive to the multiplicities of the world" (Law,
2000). As there are multiple ways in which the networks we study can assemble and change,
so too can the network within which our account is situated. Thus, Law seems to suggest that
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just as actors influence and are influenced by the other actors in a network, so too is the
author/ researcher. We too become de-centred, located in different subject positions as we
relate to different objects.
In other words, in ANT the analyst may be thought of as a network builder among
network builders. Latour has stated, "the text, in our discipline, is not a story, not a nice story.
Rather, it's the functional equivalent of a laboratory. It's a place for trials, experiments, and
simulations" (B. Latour, 2005, p. 149). Here, Latour reframed Law's idea of performing
narratives (2000); to Latour we are like scientists in a laboratory when we write. Considering
Laboratory Life (B. Latour & Woolgar, 1986), by invoking a laboratory he implies that we
very active in ordering our world(s).
One of the difficult decisions when adopting an ANT approach is in knowing when a
network has been fully traced. How do we stop the network-tracing activity and declare data
gathering and analysis to be finished? Strathern (1996) asked how to "cut" the network. She
stated:
the power of such analytical networks is also their problem: theoretically they
are without limit…one can always discover networks within networks; this is
the fractal logic that renders any length a multiple of other lengths, or a link in
a chain of further links. Yet analysis, like interpretation, must have a point; it
must be enacted as a stopping place (Strathern, 1996).

Doubtless, there are probably many network-cutting possibilities. Ownership is one example
offered by Starthern: "…[B]elonging divides and property disowns. So where technology
might enlarge networks, proprietorship can be guaranteed to cut them down to size" (1996).
She considers the example of an invention; the academic article outlining the invention may
include 50 names, while the patent contains only six. The network is quickly cut and
boundaries are inscribed through ownership. Thus ownership and authorship are one means
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of truncating a network. Others have suggested "promoting incompleteness and ambiguity
[are] positive aspects of a theoretical strategy (Neyland, 2006, p. 43). Interpretation could be
treated as a multiple, disputable, ongoing, fluid affair. Moreover, the length of the
dissertation also dictates when the network is cut. Latour stated, "you stop when you have
written your 50, 000 words" (Latour, 2005, p. 148). Elsewhere, Akrich and Latour have
commented, "It is never clear where the 'real' limits of a setting are even though it has
inscribed precise walls to itself - a book does not end with the word 'end'" (Akrich & Latour,
1992, p. 261). Perhaps the question to be concerned with is not where and how the network is
cut but how the connections are traced within the part of the network explored. The text
either does or does not capture the movement, activity, and translations in the actor-network
being studied.

iii) Holding onto the Tensions in the "Actor-Network"

Micro-macro, local-global, individual-collective: there are many possible
dichotomous positions that could be held in the space-holder of the "actor-network". The
hyphen between actor and network in ANT implies that these two terms are brought into
relation with one another. Law (1999, p.1) has described the actor-network as an
"intentionally oxymoronic term".
This is perhaps the source of much confusion about just where an ANT approach is
situated. According to Latour (2005), one of the main difficulties with these dichotomies is
that they imply a change of scale. He described the tendency of social scientists to explain
the local by jumping up to "social context", "frameworks" or "structure" and then later
swinging back down to the individual setting. For Latour, the question is "to decide whether
the actor is 'in' a system of if the system is made up 'of' interacting actors" (B. Latour, 2005,

46

p. 169). In ANT, one is not led away from the local; the macro/ global/ collective are
described by focusing on the interconnections between many local sites. "Macro no longer
describes a wider or a larger site in which the micro would be embedded like some Russian
Matryoshka doll, but another equally local, equally micro place which is connected to many
others…" (Latour, 2005, p.176) For Latour "there exists no place that can be said to be 'nonlocal' (Latour, 2005, p. 179). The network half of the actor-network term does not denote a
larger "context" but rather describes the connections between the actors.
In ANT a researcher does not attempt to decide whether a phenomenon or interaction
is best described as micro or macro. Instead, "scale is the actor's own achievement" (Latour,
2005, p. 185). The job of the ANT researcher is to trace how scale is achieved by following
the actors themselves. This means that the tensions between large and small, individual and
collective, micro and macro are not overcome by ANT; rather, these tensions become even
more emphasized. The purpose of ANT is precisely not to overcome these dichotomous
positions but rather to follow and describe how these positions are constructed through the
process of translation.
In another example of how the tensions between dichotomous positions are held
together in ANT, Law and Callon (1997) explained that anything can be thought of as
simultaneously a point (an individual actor) and a network (a collective). This is because,
according to these authors, an individual actor can be conceptualized as a black-boxed
network. If we look closely at any actor, we begin to see the connections between a great
number of elements assembled together. The authors explain that a black box:
"translates the various materials that make it up. It translates them by coordinating them, by fronting them, and by standing for them in a simple and
coherent form. This means that for the moment the fronted network acts as a
single unit" (Law & Callon, 1997, p. 170).
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In this way, the actor and the network, the individual and the collective - each of these is
understood in relation to the other. We do not want to have to choose one half of the
dichotomy over the other as each is crucial to understanding the process of translation. ANT
attempts to hold onto the tensions that emerge between two ways of seeing, simultaneously
following both the individual and the collective, the actors and the networks. One does not
replace the other; rather they are like two sides of a single coin.

iv) Context
Law and Callon (1992) suggested that "the notions of context and content …may be
transcended if projects are treated as balancing acts in which heterogeneous elements from
both 'inside' and 'outside' the project are juxtaposed" (1992, p.22). Here Law and Callon
move away from the idea of a determined actor and a determining structure; instead they aim
to show how networks and actors are mutually shaped. They do this by exploring the
development and eventual abandonment of a military aircraft called the TSR.2.
In the production of the TSR.2, the local network consisted of designers, designs,
production teams, management, subcontractors, engine and wing positions, and the like.
Initially, the global network included the Ministry of Defence, the Treasury and the Navy.
New actors joined the global network, however, and threatened the success of the local
network in carrying through with the construction of the TSR.2. For example, the Labour
Party became a new actor, when they won an election over the Conservatives; moreover, an
alternative aircraft called the F111 comparable to the TSR.2 was already in production in the
US. Law and Callon (1992) point out that the success or failure of a technology rests on the
ability to build and maintain local and global networks. Therefore, context amounts to the
associations, the connections, between various actors in different networks. The context
changes as new actors are introduced or old actors are called into question.

48

b) Criticisms of ANT
A primary criticism frequently levied against ANT is the claim that ANT is amoral
and apolitical. However, there are many different ways of measuring politics. ANT perhaps
captures the political in an unconventional way. According to Mol and Mesman (1996,
p.436), "it generates new axes of difference. It creates new political categories". ANT pays
attention to how a particular order is generated. By detailing the micro dynamics of how a
particular order is achieved, ANT brings to the foreground places and times when alternative
orderings could have arisen; the current ordering is not inevitable and networks of
associations between actors can always fail.
Latour (1986) specifically addresses the issue of power, distinguishing between
diffusionist and translational models of power. In the diffusion model, power rests on an
initial force. In this model, one focuses on those who have power and those who do not.
Power is used as an explanation. The translation model of power focuses on how power is
shaped and transformed. It emphasizes the chain of actors needed for power to exist. For
example, Latour proposed, "people who are 'obeyed' discover what their power is really made
of when they start to lose it. They realize, but too late, that it was made of the wills of all the
others" (1986, p.268). In this way, Latour understands power to be a consequence (a
consequence of enrolling, convincing) rather than a cause of collective action. Thus,
according to Latour, power is not something that can be possessed, but rather is practiced and
made. The key point in moving from a diffusion model to a translational model of power is
that power is not used to explain something else; instead, it is power itself that requires
explaining.
Latour's account highlights the work involved in maintaining power; yet, ANT also
records how some networks become robust, irreversible (M. Callon, 1991) and standardized
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(Star, 1991). Star examined how stabilized networks exclude some actors. Specifically, she
stated, "part of the public stability of a standardized network often involves the private
suffering of those who are not standard - who must use the standard network, but who are
also non-members of the community of practice" (Star, 1991, p.43). Star (1991) also
acknowledged, however, that the multiple memberships any actor has in several networks
simultaneously could be regarded as a mechanism for resistance.

Thus, contrary to

criticisms of being amoral or apolitical, I interpret ANT as having the potential to offer novel
ways of exploring power and politics. Of particular relevance to this dissertation, I argue that
the political is explicitly brought to the fore in an ANT-informed discussion of knowledge
translation. The ANT notion of the political in the context of autism genomics and
knowledge translation will be further explored in Chapter 5.

c) How Does ANT as a Methodology Relate to Ethnography?
“The only viable slogan is to follow the actors themselves” (B. Latour, 2005).
ANT is a methodology in so far as it guides the inquirer as to how to approach a
question. ANT proposes that we trace the inter-connections between actors and that it is these
connections which constitute the social. Latour has described ANT as “simply an attempt to
allow the members of contemporary society to have as much leeway in defining themselves
as that offered by ethnography” (2005). Inquirers have to engage in the world-making
activities of those they study without deciding in advance who the actors are and what makes
them act (Latour, 2005). Much like ethnography, the ANT inquirer must follow the actors
themselves, follow the natives. So the ANT inquirer has the task of tracing connections
between actors, registering differences in the ways that actors come together around
controversies.
An ANT inquirer starts in the middle of things, in medias res. This methodology
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points to certain methods such as conducting interviews, taking notes, leafing through
documents, and clumsily loafing around (Latour, 2005). Through these methods the inquirer
traces how actors become connected in different ways within different networks. In this way,
the goal or intended outcome of an ANT account is descriptive rather than prescriptive. The
task is to deploy actors as networks. A good account will perform the social, will bring
together various actors into a collective (Latour, 2005).
All of this is very similar to and compatible with ethnography. I would suggest that
ANT and ethnographies are over-lapping methodologies. Ethnographer means, literally,
“writing culture”. An ANT methodology similarly aims to write an account of the social.
They have different vocabularies but in practice an ANT inquiry is very similar to an
ethnographic study. Perhaps, it would be helpful to describe ANT as a particular type of
ethnography, one that focuses on culture or the social as a network of materially
heterogeneous related entities. Indeed, many of the leading proponents of ANT have claimed
to be engaged in ethnography (Latour & Woolgar, 1986; Latour, 1987). Others have
described this methodology as a type of “praxiography” (Mol & Law, 2003). While there are
similarities between ANT and ethnography, to be sure, there are also instances in which ANT
is distinct from ethnography. These instances are described in the following section.
The Ambiguous Relationship between ANT and Ethnography
Disciplines define and redefine themselves interactively and competitively.
They do this by inventing traditions and canons, by consecrating
methodological norms and research practices, by appropriating, translating,
silencing and holding at bay adjacent perspectives. They articulate, in tactically
shifting ways, the solid core and the negotiable edge of a recognizable domain
of knowledge and research practice (Clifford, 1997).
Ethnography and ANT are dynamic and changing methodologies. Neither of them is
fixed and therefore it is difficult to outline the boundaries of one in relation to the other.
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Further adding to the complexity, ethnography refers both to “the manner in which
observations are made and to the process of compiling a description” (Strathern 2000,
accessed at http://virtualsociety.sbs.ox.ac.uk/GRpapers/strathern.htm). In presenting an
argument that ANT can be a distinct methodology, I am not proposing that ANT and
ethnography are necessarily mutually exclusive in all circumstances. Certainly, many,
perhaps most, scholars engaged in ANT research propose that they are simultaneously
engaged in ethnography (Bruni, 2005; Heath, 1998; Hine, 2007; Latour & Woolgar, 1986;
Neyland, 2006; Williams-Jones & Graham, 2003). I merely want to pause before making the
knee-jerk genuflection to ethnography and ponder; can ANT stand on its own legs as a
distinct methodology? I argue that while there are ways in which ANT and ethnography
coincide, there are also tensions between the two methodologies; ANT can push hard against
the limits of ethnography, compelled me to situate my own research within ANT specifically
and more tenuously in relation to ethnography.
There are two principal reasons why I am uncomfortable with claiming the
ethnographic label. The first is the centrality of prolonged participant observation to the
ethnographic endeavor. While the role of participant observation as a necessary element of
ethnography has been challenged over the last few decades, deep hanging out over and
extended time remains an iconic right of passage for the ethnographer. The second reason
why ethnography does not fit well with the approach I have taken to my research is the
emphasis on meaning-making at the core of ethnography. Each of these tensions (long-term
field work, and meaning-making) is discussed below.
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i) Long-Term Participant Observation and the Ethnographic Psyche
Ethnography is not an easily bound methodology. Indeed, Atkinson et al (Atkinson,
Coffey, Delamont, Lofland, & Lofland, 2001) celebrated the idea of “unity in diversity”.
The borders of ethnography are being stretched and blurred with a growing proliferation of
ethnographic sub-types (auto-ethnography, critical ethnography, cyber-ethnography,
institutional ethnography, multi-sited ethnography, etc.), which each have their own
particular emphases and contexts. The practice of ethnography typically conjures up images
of prolonged contact with research participants in which the method of participant
observation is paramount. Classic ethnographies such as Malinowski’s Argonauts of the
Western Pacific (1922), Margaret Mead’s Coming of Age in Samoa (1928)(1928) or EvansPritchard’s Witchcraft, Oracles and Magic Among the Azande (1937) reinforce long-term
participant observation as a requirement to claim the identity of ethnographer. However,
since Nader’s (Nader, 1969) call for increased ethnographic research on the powerful (such
as corporations, federal bureaucrats, political leaders), this expectation for prolonged
participant observation as an integral aspect to ethnography has been challenged. Such
expectations are not feasible in many of the field sites that arise when one chooses to “study
up”. For example, the power dynamics and gate keeping involved in Gusterson’s (1997)
study of a nuclear weapons laboratory presented significant obstacles to participant
observation. While deep hanging out and prolonged engagement with research participants
may be typical, ethnography cannot be reduced to a particular method. However, the focus
on prolonged and deep engagement with a field site has left some science and technology
scholars who “study up” more sensitive and less confident in their assertions that they are
doing ethnography. Some have found it necessary to describe their studies as having
“ethnographic sensibility” (Star, 1999). Meanwhile, Hine (2007) somewhat tongue-in-cheek,
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described her methodology as “a methodologically eccentric historico-ethnographical
autobiographically-inflected thematic analysis of the material and communicative cultures of
systematics rather than simply ethnographic”(Hine, 2007). My own disciplinary movement
from anthropology to health sciences has left me with less confidence in claiming the label of
ethnographer given the way in which I have engaged with my topic of investigation, pushing
hard against and perhaps transgressing what traditionally counts as ethnographic.

ii) Meaning-Making
The dynamics of doing fieldwork in private and privileged spaces, “studying up”, has
perhaps loosened the grip that participant observation traditionally held around ethnography.
Long-term participant observation may be an example of what Clifford (in the quote above)
has described as the “negotiable edge” (1997) of research practice. If ethnography is not
merely participant observation, then what is it? I argue that central to an ethnographic
methodology is the practice of describing meaning-making, often in relation to the notion of
culture. Geertz’s Interpretation of Culture (1973), for example, explores culture as semiotic.
He wrote,
Believing, with Max Weber, that man is an animal suspended in webs of
significance he himself has spun, I take culture to be those webs, and the
analysis of it to be therefore not an experimental science in search of law but
an interpretive one in search of meaning (Geertz, 1973).
Thus, meaning-making is perhaps an example of the “solid core” (Clifford 1997) of
ethnographic research practice.
Why ANT is not necessarily Ethnographic
The primary tension between Actor-Network Theory, as I have engaged with it, and
ethnography is this fundamental aim of ethnography to describe “meaning-making” through
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the notion of culture. From my perspective, where ethnography and ANT rub up against each
other with some friction is in how “culture” or the “social” are imagined. Through the
interpretive turn, led by Geertz, culture came to be recognized as socially established
structures of meaning embodied in symbols (1973).
The thing to ask about a burlesqued wink or a mock sheep raid is not what
their ontological status is…The thing to ask is what their import is: what it is,
ridicule or challenge, irony or anger, snobbery or pride, that, in their
occurrence and through their agency, is getting said (Geertz, 1973)
Thus, meaning, meaning-making, the meaning-ladeness of cultural life are central to
the ethnographic agenda. By claiming that ANT and ethnography are overlapping, I am,
perhaps, pushing hard against this ingrained meaning-centredness of ethnography. This is
because I have not explicitly focused on what autism genetics means to those in the
laboratory, clinic, and family home. I have instead focused on how it is done, enacted,
practiced in the material world. Even as I write this I am uncomfortable with this, as
obviously meaning is intimately related to and tied up in practice. I stress however that in this
dissertation I am more concerned with the objects themselves - DNA, autism, the patient and how they are done through practice rather than focusing on the meanings that humans
attach to these phenomena. Contrary to Geertz’s (1973) assertions in the quote above, I
propose that the (multiply emergent and sometimes ambiguous) ontological status is
precisely the thing to ask about autism! Thus, I have chosen to focus on ANT as a distinct
methodology, albeit a methodology that shares many similarities with ethnography.

2.3. Third Layer: Epistemological Mooring

[W]e are not denying the existence of real, painful stress and suffering.
There is, of course, a biological reality, but the moment that efforts are
made to explain, order, and manipulate that reality then a process of
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contextualization takes place in which the dynamic relationship of biology
with cultural values and the social order has to be considered.
(Lock & Gordon, 1988)

Epistemology is concerned with knowledge, how we come to know what we know
about the world and how this knowledge relates to nature. The dichotomy that comes to mind
in the context of epistemology is that between realism and idealism. If one imagines various
epistemological positions as being stretched out along a single axis with realism at one end
and idealism at the other end, constructionism would be somewhere in the middle. Also
central to a discussion of constructionism is the dichotomy between subject and object, and
natural and social. Indeed, these dichotomies are intimately related to one another. I have
tried to tease them apart in the discussion that follows.

a) Constructionism
Constructionism is often preceded by the word “social”. According to Hacking
(1999), the underlying aim of social constructionist arguments is to raise consciousness.
Specifically, these arguments critically examine how whatever it is that is said to be socially
constructed is not inevitable; “that X as it is at present, is not determined by the nature of
things” (Hacking, 1999) and it could always be different. Social constructionist arguments
usually appear when X is taken for granted and seems to be inevitable. Hacking identified six
grades of constructionism ranging from historical, ironic, reformist, unmasking, rebellious to
revolutionary. In the historical vein, X is contingent upon historical events. Those who adopt
this position are usually noncommittal about wither or not X is good or bad. The ironic
commitment to constructionism follows that X is a contingent product of history but yet X is
something that we cannot, at present, avoid in our interactions. Reformist feel that X is quite
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bad and by demonstrating how it is constructed and not inevitable we might be able to
change some aspects of X. The unmasking commitment to constructionism seeks to expose
the function of X and thereby strip it of its authority. A rebellious constructionist believes
that X is not only constructed but that X is bad and we would be better off without X.
Finally, a revolutionary commitment tries to change the world in respect of X (Hacking,
1999).
In examining Hacking’s six categories of commitment to constructionism, I find that
my own position does not fit anywhere. While I would describe this research on autism to be
perhaps most akin to Hacking’s ironic category, it does not quite work. This is because, as
Hacking states, “X, which we thought to be an inevitable part of the world or of our
conceptual architecture, could have been quite different” (Hacking, 1999). Approached from
within theories of practice, however, I feel that there is perhaps another category of
constructionism that could be teased out: multiplicity. A multiplicity category explores how
X is contingent and not inevitable. It also aims to show that not only could X be quite
different, but that X is quite different. In a commitment to constructionism as multiple, the
aim is to unpack how different constructions of X exist and interact with one another, how
they might resist, conflict and at times relate and borrow from one another. Thus,
approached from theories of practice and a methodological stance of actor-network theory, I
am committed to construction as multiple.

i) What is it that is constructed?
Again, I draw on Hacking (1999) to clarify what I mean when I position myself in a
constructionist epistemology. Hacking distinguished between objects, ideas, and what he
calls “elevator words”. The boundaries between these three classifications are tenuous and
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slippery but the distinction is helpful, I think, in clarifying what precisely I am referring to as
being constructed. The first category of objects are in the world, according to Hacking.
Autism can be examined as an object, as can DNA and individual people. The second
classification is called ideas and includes ideas, concepts, beliefs, attitudes to and theories.
Ideas can be shared or private. Autism could also be approached as an idea; one could study
how the idea of autism has been constructed differently over time or in various contexts. For
example, disability rights constructions of the idea of autism differ greatly from the ideas of
autism held by some parent-driven groups such as Autism Speaks, which seek to cure autism.
The third category is elevator words. Elevator words include facts, truth, reality, and
knowledge. These words, suggested Hacking, are not objects in the world but say something
about the world and the way we think about the world. One could, for example, study the
construction of knowledge within a particular context, like autism genomics.
Throughout the chapters of this dissertation that which is being explored as
constructed differs. For example, in chapter 3, I describe how the idea of autism has been
constructed through technological advancements in genomics. In chapters 4 and 5, I explore
how knowledge is constructed within the contexts of autism genomics. In chapter 6, I unpack
how the nature of autism, its ontology, is constructed multiply in the laboratory, clinic and
family home.

ii) Can something be Constructed and Real?
I am very concerned that in taking a constructionist approach this research might be
misinterpreted as taking the position that autism and the objects of science under
investigation are not real. I want to make clear my position - that I hold autism to be real,
very real. I contend that it is, however, both real and constructed. To say that the idea of
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autism or knowledge about autism is constructed is perhaps less risky. However, in chapter 6,
I also explore how the nature of autism, its ontology, is constructed. It is here that I must be
most clear in how I relate and connect a multiply-constructed object to one that is also, in no
uncertain terms, real.
Here, I want to draw on Pickering and Latour again to help me elucidate what I mean
when I say that autism is both constructed and real. The issue of realism, as has been
discussed above, is usually problematized by knowledge on the one hand and the world or
nature on the other hand. The central question is whether or not and to what degree
knowledge is able to represent or correspond to the real world. Pickering (1995) enlists his
concept of the mangle of practice in a position he calls pragmatic realism. In my reading of
Pickering, scientific knowledge is real in so far as scientist are engaged in this dialectic of
resistance and accommodation with nature, in so far as knowledge is finely tuned to the
world.
The problem is that humans can be engaged in this dance of agency with the world in
different ways. The various tools, the technologies, and the machines that are used by
humans allow us to become entangled with the world in different ways. As will be
demonstrated in this dissertation, for example, autism is constructed in the laboratory through
a process in which scientists use various machines, tools, and objects (e.g., DNA) to explore
the world. Here, not only knowledge about autism but in certain instances autism itself is
constructed in terms of genes and DNA. At the same time, autism is constructed in the clinic
through a very different process in which clinicians use tools and technologies (e.g., tests and
observation schedules) to engage with the world. Through practices of the clinic autism is
constructed behaviourally. Both of these constructions are at once real; knowledge from the
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laboratory and knowledge from the clinic can both be described as particular ways of
practicing or ordering autism.
In this way the world can simultaneously support multiple entanglements and
dialectics of resistance and accommodation. Even though, at times, these constructions may
in certain ways conflict with one another. Two constructions may actually be
incommensurable; that is, there may be no common yardstick from which to measure and
compare two constructions, two different ways of approaching and engaging with the world.
Yet, they both may be real. Sometimes these constructions coexist temporally and in other
examples one way of engaging with the world overtakes another. I feel that it is through the
process of knowledge translation that we shift and maneuver between and amongst various
entanglements with the world.
Like Pickering, Latour also focuses on nonhumans as central to dismantling the
dichotomy between subjects and objects, culture and nature. By considering associations of
humans and nonhumans in a state of uncertainty, Latour attempts to end the volleying back
and forth between subject and object (2004). I draw on Latour also as he points out that once
an object becomes a fact, once it is given a name, once it has been probed and prodded
through various tools and practices, it becomes real; it assumes an ontological weight, so to
say. In this way ontology is intimately related to practice. The nature of an object is
determined through practice, through various “socio-technical assemblages”. At this point we
must take it for granted as being real. It becomes a closed box. Latour, for example, analyzed
a scientific experiment by Pasteur (Latour, 1993a) and contends that an experiment is "an
action performed by the scientist so that the non-human will be made to appear on its
own…The experiment creates two narrative planes: one in which the narrator is active, and
one in which the action is delegated to another character, a nonhuman one" (Latour, 1993a).
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We constantly shift between frames of reference. Latour described how Pasteur acted so that
the yeast could act alone. Depending on which of these two actors is stressed, the same text
becomes constructivist or realist (1993).
When an object comes to be defined through various trials in the laboratory, an act of
ventriloquism arises. At first, when the contours of the object are still uncertain, the scientists
speak for the object. Later, after the object has been established as fact, the object speaks for
itself (Latour, 2004). It is real. If and when a new controversy opens up around an object, a
new paradigm or new technology is developed that allows the object to be probed and
prodded in different ways, the question of its constructed nature opens up once again. The
arena in which it is come to be known, the technologies, the field of practices that constrain
how scientists accommodate nature’s resistance – all of this becomes visible again. After a
while some agreement is reached and the apparatus of practice fades away again leaving
nature to seemingly exist independently of the tools and practices through which we engage
with the world.

2.3.b Epistemology or Ontologies?: Practiced Knowledges,
Practiced Realities
David Bloor, a sociologist in the Science Studies Unit at the University of Edinburgh,
has been a major champion of the Strong Programme in sociology. The key idea attributed to
the Strong Programme is the symmetry postulate. Bloor has explained this postulate as
follows:
Both true and false, and rational and irrational ideas, in as far as they are
collectively held, should all equally be the object of sociological curiosity,
and should all be explained by reference to the same kinds of cause. This
requirement was formulated in opposition to an earlier prevailing assumption,
still defended in many quarters, which has it that true (or rational) beliefs are
to be explained by reference to reality, while false (or irrational) beliefs are
explained by reference to the distorting influence of society (Bloor, 1999, p.
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84).

This postulate marked a radical shift in science studies. As a result, all knowledge and beliefs
could be explained in the same way. The concern for Latour, however, is that this postulate is
limited to epistemological concerns. It proposes symmetry of knowledge and ideas about the
world, but continues to uphold the traditional view that the world (reality) itself is out there,
untouched. The world (reality) is not within the purview of social science; only descriptions
of the world should be subjected to sociological scrutiny:
The important point is to separate the world from the actor’s description of the
world. It is the description that is the topic of enquiry, and the proposed
separation is one of our resources. This is all just another way of saying we
must respect the distinction between the object of knowledge and the subject of
knowledge (Bloor, 1999).

The preceding quote points to Bloor's modern separation between subjects and
objects, human representations and things-in-themselves. As such, Bloor restricted his
research to scientific knowledge, rather than the broader domain of science itself. Scientific
knowledge could be explained by society. As the following passage suggests:
All knowledge always depends on society. This is because, as I have argued and
as case-studies demonstrate, society is the necessary vehicle for sustaining a
coherent cognitive relation to the world (Bloor, 1999).

Meanwhile, Latour claimed that Bloor and other champions of the Edinburgh school's
Strong Programme assume "unequally the sources of uncertainties, so that all the
uncertainties reside with humans, while the sensory inputs remain utterly neutral" (Latour,
1999a, p.117). Latour aimed to problematize nature itself. Latour claimed, "Bloor aligns
himself with the most reactionary philosophers of science who insist that science studies is
all very well as long as it sticks to epistemological questions and leaves entirely aside—that
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is to the scientists!—the ontological ones" (1999a, pp.122). Alternatively, Latour insisted that
instead of leaving aside nature, we should focus squarely upon it. He stated, "the alternative I
would prefer is to engage in a complete reworking of the origin of the notion of ‘nature’.
Nature is the concept to topicalize. It is through nature that the whole history of absolutism
has been developed" (1999a, p.127).
For Latour, nature and society can be explained by things themselves if we follow,
step-by-step the chains of association, which include "psychological, ideological, cognitive,
social, and material entities, many of which are non-human agents. Along these chains, each
element takes the meaning given to it by the adjoining elements in the series" (B. Latour,
1999a). Latour depicted Bloor, the Strong Programme and those in the Edinburgh unit of
Social Study of Scientific Knowledge as subjectivist (emphasizing the role of society or
culture) and at the same time realist (not questioning the ontological status of things in
themselves). In this way, it is assumed that there are different types of causalities attributed
to different types of reality; a wedge is driven between nature and society, object and subject
and each side of the chasm is explained according to different standards. Latour, on the other
hand, aspired to push the symmetry postulate one step further, eschewing this divide between
subject and object, a relic from the modern project. His aim was to illustrate how this divide
is produced. For example, Latour and Callon aimed to introduce an alternative ontological
axis, one that would break the tug of war between natural realism and social realism. They
contended:
Our general symmetry principle is thus not to alternate between natural realism
and social realism but to obtain nature and society as twin results of another
activity…network building…we have to make ninety-degree turn from the SSK
yardstick and define a second dimension" (Latour & Callon, 1992).

Thus, instead of starting with nature and society, for Latour and Callon, these divisions were
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an end result of the activities and networks of humans and non-humans. Later, Latour
(1993b) further explicated this alternative ontological dimension. This north-south dimension
"registers variations in the stability of entities from event to essence" (1993b). In other
words, the vertical dimension traces the historical process through which a thing becomes
stabilized. The essence of the thing is the trajectory that links all of the events in the thing's
history. Thus, Latour's project is to focus on the process and practices through which things
become stabilized. Latour later offered a more sophisticated explanation of his deviation
from the traditional subject-object dualism (Latour, 2008, p.105). He stated: "in the first
frame, all the attention is concentrated on two loci: the object intact ‘out there’ and the
subject that has shifting versions ‘in there’. In the second frame, the two anchors have
disappeared: there is no longer one subject and there is no longer one object. Instead there are
threads woven by the crisscrossing pathways." Thus, he was interested in "successive
temporally marked versions of the objects and subjects" (Latour, 2008). In this way, Latour
has granted ontological status to knowledge activity. Truth becomes an event and knowledge
a trajectory.
The notion of time becomes paramount. When one takes a synchronic snapshot of the
relationship between subjects and objects, they appear frozen, hardened in opposition to one
another. The subject looks outward at objects as they are already recognized. In a diachronic,
historical view, we can see how the "things" (not necessarily subjects or objects) are
continuously shifting in relation to one another.
Likewise, according to Pickering, pragmatic realism subverts the realist/ idealist
debate, claiming instead that "the world will support an indefinitely diverse set of ontologies
and bodies of knowledge" (1995). In this way, Pickering, like Latour, is at once realist and
relativist. What Pickering highlighted within this pragmatic realist perspective, is the
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importance of time. For example, Pickering described the "irremediable historicity of
scientific knowledge (and culture in general): what counts as knowledge now is a function of
the specific historical trajectory that practice has traced out in the past" (Pickering, 1995).
Latour echoed this emphasis on time and went so far as to position facts and
knowledge as having ontological status or weight; they are events that can be marked and
traced through time. Thus, what counts as an object or a subject is a result of a particular
stabilization of practice over time. In this way, it seems to me, that ontology can only be
understood in relation to epistemology. To say that something is ontologically multiple, is to
say that the nature of that thing is multiple. But nature is only apprehended through
interaction with the world and that interaction, I am arguing, is in the form of practice.
Ontology is practiced; it is not given a priori. This is how it can be said that an object exists
ontologically in multiple ways, because it exists through multiple practices. This is not to say
that the object is not real. Its existence can only be understood through practice, through our
interactions with the world, and these interactions are mediated by and through tools,
technologies, and practices.
In exploring multiple ontologies, I am exploring knowledge. Ontology and
epistemology are conflated. How so? They are conflated through the idea of practice.
Specifically, the notion that knowledge is practiced upsets the dualistic opposition between
inside and outside, subject and object. Instead, when knowledge is regarded as practice rather
than understood as something which lives in the human mind, knowledge becomes a
materially heterogeneous activity. Knowledge is thus imbued with an ontological status.
Casper Bruun Jensen (2004) further explores this move in ANT, emphasizing the comingling
of humans and nonhumans, subjects and objects as challenging traditional epistemology: "
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because activities such as observing or representing are not seen as distinct from intervening
or constructing…in this way epistemology collapses into ontology and the sciences are
reformulated as practical activities aimed at rebuilding the world by adding new elements
with new capabilities and new relationships to it" (Jensen, 2004). As Latour has suggested
"we have abandoned, as illusory, the demarcation between ontological and epistemological
questions" (Latour, 1999c).This is a crucial point, that realities and knowledges of realities
are constructed together. As Law has recently stated, “we need to replace an attitude of
innocence with the recognition that our knowledges are complicit and collusive in the
real…knowledges are embedded in and enacted alongside and together with realities that
they purport to describe” (Law, 2012). Similarly, Latour describes knowledge as a “mode of
existence” (2008).
Mol (1999; 2000; 2002) in her work on the ontological politics of atherosclerosis,
described how a disease is enacted differently through different practices in the same
hospital. The different realities of atherosclerosis butt up against one another, sometimes they
are held within one another, and other times they are contradictory. The key point is that
there is no single coordinated network to support a singular reality of atherosclerosis. There
are actually multiple modes of ordering reality. So the construction metaphor no longer
works. Reality is much too tentative and fragile, too fluid and relational to be described
through images of concrete and steel conjured up by the word “construction”. The project is
no longer to describe the construction that could have been constructed otherwise, but rather,
to describe the ways in which several simultaneous realities being performed at once hang
together. Ontology is multiplied along with ways of knowing and doing. As Law has
similarly stated, “if practices and knowledge practices are performative, then…reality is also
heterogeneous: it, the real (or they, the reals), is (or are) simply being done differently in
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different places” (2012).
Mol (2002) described how the different practices and enactments of atherosclerosis
are distributed over different local spaces. When they do run into each other, when traffic
between sites forces one reality to come up along side another, there are forms of
coordination. They manage to coexist together. Mol, for example explores two different
technologies and how they are coordinated. An angiographic image shows the vessel lumen
while a duplex gives information on blood velocity; the objects of these two techniques are
different but they are made comparable. There are ways to translate them. Velocity increase
is translated by a technician into loss of vessel lumen. Thus, as Mol (2002) contends "the
threat of incommensurability is countered in practice by establishing common measures.
Correlation studies allow for the possibility (never friction free) of translations."
Mol explained,
the knowledge incorporated in practice does not reside in subjects alone, but
also in buildings, knives, dyes, desks…This then may be a way out of the
dichotomy between the knowing subject and the objects-that-are-known: to
spread the activity of knowing widely…Instead of talking about subjects
knowing objects, we may then, as a next step, come to talk about enacting
reality in practice (Mol, 2002, p. 50).

A turn toward practice and activities precludes knowledge from living in the mind.
Knowledge is done - it becomes a fleshy, corporeal affair of the bodily world in which we
move.
Reality, for Mol, is performed in a variety of practices and is therefore multiple. She
writes of ontologies rather than ontology; the distinction is made, however, between multiple
and plural, setting her viewpoint apart from those who espouse a perspectival or
constructionist approach. According to Mol, perspectivalism" broke away from a
monopolistic version of truth. But it did not multiply reality. It multiplied the eyes of the
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beholders…And this in turn brought pluralism…While in the centre the object of the many
gazes and glances remains singular, intangible, and untouched" (Mol, 1999). Alternatively,
constructionist stories articulate the possibility for alternative constructions of reality that
might have been by unpacking the processes through which accepted "facts" were produced
and other potential facts were lost along the way.
Instead, Mol's description of multiple ontologies is contingent on the ideas of
performance and practice: reality is "done and enacted rather than observed" (Mol, 1999). In
this way, there are multiple versions of the object, multiple forms of reality itself. However,
"[t]hese are not perspectives seen by different people - a single person may slide in her work
from one performance to another…So they are different versions, different performances,
different realities, that co-exist in the present" (Mol, 1999). She explained further that while
these various realities may clash at some points, different performances of an object also
depend on and collaborate with one another. Thus, they do not necessarily co-exist
independently and side-by-side, but rather might be found inside one another.
While Latour emphasizes how constructions of reality could be otherwise, tracing
how particular constructions arise through time, Mol concentrates on how reality is
performed or practiced multiply in the present. Considering all the emphasis on time by
Latour and Pickering, this dissertation is noticeably atemporal. Despite my indebtedness to
Latour’s ideas, it is Mol’s concern for multiplicity and ontological politics in medicine that I
find particularly relevant and generative in my pursuit to explore the concept of knowledge
translation from a constructionist position. In this dissertation I seek to take up the issues of
multiplicity and coordination as integral to a new way of framing the practice of knowledge
translation.
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c) Both Constructed and Real
In Science in Action (Latour, 1987) Latour unfolds the story of how objects are
slowly made into being, first a fuzzy thing on which the tests must be conducted to define its
edges, figuring out what it does what it doesn't do. Nature or objects do not come into being
until after they are "isolated from the laboratory conditions that shaped them, things with a
name now seem independent from the trials in which they proved their mettle" (Latour,
1987). Through this process, reality becomes reified. Thus, Latour alludes to the two-faced
Janus. On the left side of Janus, Nature is cause, on the right side consequence. On the left
side scientists are realists, on the right side relativists. On the left side science is cold, hard
and certain. On the right side, science is warm, soft, and unsettled. Stengers (2010)
reinterpreted the two-faced Janus as consisting of what she calls “bearded science” on the left
and beardless youth on the right. She describes a:
“struggle for a less dissociated or amnesic personality than the Janus figure, for
a bearded old man who would remember and celebrate the adventurous,
intricate constructive processes that any scientific achievement entails, instead
of describing the achieved result as the direct consequence of a normal,
rational method” (Stengers, 2010).
The suggestion to shift between frames of reference allows Latour to adopt a realist
perspective without absolutism. Things are real; they exist, whilst also being constructed.

i) Construction as Process
When we talk about a construction, we often imply a maker, an architect. What
Latour wanted was to think not about an all-powerful creator, but rather the process of
construction. He proposes that we think of engineers instead of architects; "learning how to
become responsive to the unexpected qualities and virtualities of materials is how engineers
will account for the chance encounter with practical solutions: they will never think of
describing themselves as little kids moulding reality at will" (Latour, 2003). In other words,
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by using the word “construction”, agency must be shared across a wide variety of actors and
uncertainty introduced into the final construction. Adopting a constructivist position,
according to Latour, means "to learn how to become sensitive to the contrary requirements,
to the exigencies, to the pressures of conflicting agencies where none of them is really in
command" (2003). A potter, for example, may throw a pot with a particular shape, but she is
constrained by the properties of the clay (is the clay uniformly wedged, is it too wet or too
dry), the speed of the wheel, or gravity’s effect on abrupt curves. As any fledgling potter
knows, certain shapes hold up better than others (pots collapse and fold at weak spots - so we
learn which shapes are possible and which can be maintained). Thus, the potter constructs a
pot, but not without the constraints of the material world.
Latour views constructivism as the only way to bypass the dichotomy between an
unconstructed world that is "already there" and a world made purely of subjective value
claims (Latour, 2005). Elsewhere, Latour (1993) has described science studies as situated in
a no-man's-land between the two cultures of sciences and humanities, between absolute
realism and absolute relativism. In the no-man's-land, relativism is relative and realism is
more realistic. In this no-man's-land relationism comes to replace both terms (Latour, 1993).
Empiricist notions of knowledge remain deeply cognitive and cerebral; detached minds gaze
out at the world. Conversely, Latour and ANT hope to plug the wriggling brain back into
the body; he stated in Pandora's Hope (Latour, 1999), "we no longer have a mind dealing
with an outside world, but a lived world to which a semi-conscious and intentional body is
now attached." In this way, the outside world is granted a warm, human, historical existence,
a more realistic realism or relative relativity.
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2.4. Relating my Philosophical Position to Knowledge Translation
Practice theories, actor-network theory and constructionism provide a set of concepts
and ideas from which to draw upon when exploring knowledge translation. In closing this
chapter, I would like to briefly outline how knowledge and translation (the two fundamental
components of KT) are informed by the particular theoretical, methodological, and
epistemological positions I have adopted.

a) Knowledge
In this research I have approached knowledge as a practice. Specifically, following
practice theories, I suggest that knowledge is a materially heterogeneous practice with an
unfolding ontology. Actor-network theory has been described as the semiotics of materiality,
emphasizing how things are produced in relation to other things. An ANT methodology
allows me to decentre knowledge and trace the connections between the various human and
non-human actors that make up a particular enactment or practice of knowledge.
Constructionism brings to the foreground the idea that knowledge is entangled with the way
the world is enacted. Knowledge is conceptualized as a particular way of ordering the world.
Different knowledge practices rebuild the world anew. In a constructionist approach,
knowledge does not only describe reality but creates it. Thus, knowledge practices are not
treated as distinct from ontological practices. When knowledge practices change or multiply,
so too does reality.
This particular conceptualization of knowledge, informed by practice theories, ANT,
and constructionism, can be contrasted with the conceptualization of knowledge that is
typically found in the health science literature pertaining to KT. In my reading of this
literature, I interpret knowledge to be predominantly conceptualized as a representation of
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reality rather than a practice or construction of reality; a reified possession rather than a
process; a black-boxed actor, rendered distinct from the circumstances of its creation, rather
than a network of connections relating many actors to one another. This typical
conceptualization of knowledge will be further explored though the example of the
Knowledge-to-Action (KTA) model promoted by the CIHR in the final chapter of this
dissertation.
Thus, in re-conceptualizing knowledge through a philosophical lens informed by
practice theories, ANT, and constructionism I am altering what it is that is being considered
as undergoing translation. The knowledge that I am considering in this thesis bears little
resemblance to the knowledge that is considered in the health sciences KT literature. That
which is under investigation differs from what is typically included in KT research.

b) Translation
Following these changes in the conceptualization of knowledge, my understanding of
translation is also markedly different from the dominant conceptualization of translation in
the health sciences literature. Informed by practice theories, ANT, and constructionism, my
view of translation implies a process in which different knowledge practices are related to
one another. Following ANT methodology, in describing translation I am describing how
actors change as they enter new networks. An ANT-informed understanding of translation
requires that I register differences in the way that actors come together as they move amongst
different networks. In my conceptualization, translation and transformation are synonymous.
As my conceptualization of knowledge relates knowledge practices to the construction of
ontological realities, it follows that translation also entails creating connections between
multiple ways of enacting reality. Drawing on the notion of multiplicity, following Mol, I
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will suggest that hidden within the process of knowledge translation is an ongoing process of
ontological politics.
It is in this notion of ontological politics that my conceptualization of translation
differs from the translation that is discussed in the health sciences KT literature. In this
literature, translation is not generally approached as a political process. Further, while many
models discuss the need to adjust knowledge so that it can be adopted to a particular context,
translation is not typically defined by change and transformation of knowledge. Rather, it is
assumed that at its core knowledge being translated remains constant and unchanged when
moved from producers to users. Finally, as implicated in the previous sentence, translation
often entails two distinct groups of people: those who produce knowledge and those who use
it. In the health sciences literature the translation process implies an intentional and directed
attempt to move knowledge from producers to users.
In relating my philosophical position to a discussion of KT I have highlighted the
differences between the ways in which I have approached knowledge and translation and the
ways in which they are conceptualized in the health sciences KT literature. The body of this
dissertation, which draws on my field work experience, explores autism genomics as a case
study in which to examine KT using particular conceptualizations of knowledge and
translation that are informed by practice theories, ANT, and constructionism. I argue that
developing theory-driven approaches to KT, as I have done in this dissertation, will enable a
larger network of KT researchers to think critically about what is typically included and
precluded from investigation and open up possibilities for re-configuring what KT entails.
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Chapter 3: Research Ethics

3.1. Approaching Anonymity
7.1a Anonymity of individuals diagnosed with autism and
their family members
7.1b Anonymity when "studying up"
3.2. Tensions in the research process: Anonymity? "Thick
description"? Or somewhere in between?
3.3. Expectations of Research Participants

At the end of a Monday morning meeting on March 6th 2012 a genetic counsellor
relayed to the group that in a recent feedback session one of the probands had withdrawn his
consent and no longer wished to participate in the autism genetics research. This proband
happened to have a particularly interesting copy number variation. A discussion ensued about
how to best go about the withdrawal process. One person in the room, a post doctoral fellow
in bioethics who had been invited to work with the group, noted the impossibility of
retrospectively taking data out of past compilates. Others noted the need to trace where the
proband’s information had gone as it had been part of a central public repository used by
other scientists internationally. Still others noted the implications of his withdrawal, that they
could no longer publish the results. This conversation led to the above statement made by the
director of the laboratory:
“You can see that ethics is overtaking the science now”
(Director, Laboratory X – March 6, 2012, Monday morning meeting).
In this chapter I would like to take this statement made by the Director and apply it
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specifically to an ethical quandaries that emerged from my research, that of providing context
of the research participants while at the same time providing anonymity in the context of
knowledge translation of genomic science from the laboratory to the clinical setting and back
again.

3.1. Approaching Anonymity
The word “anonymity” has been used to specifically describe the protections to prevent
the identifiability of participants (Walford, 2005; Tilley & Woodthorpe, 2011). Tilley and
Woodthorpe (2011, p.198), for example, make the distinction between confidentiality and
anonymity stating, “confidentiality refers to the management of private
information…anonymity refers specifically to removing or obscuring the names of
participants or research sites, and not including information that might lead participants or
research sites to be identified”. Confidentiality is a broader concept that entails more than
merely protecting the identity of research participants and sites. For example, confidentiality
also includes issues pertaining to security measures for protecting data, and foreseeing legal
reasons to disclose information to third parties (TCPS, 2010). These broader issues
associated with confidentiality are not being challenged in this chapter. Rather, following
Tilley and Woodthorpe (2011), this chapter specifically focuses on the issue of anonymity in
the context of qualitative inquiries. Anonymity, according to Walford (2005, p.85),
[M]eans that we do not name the person or research site involved, but, in
research, it is usually extended to mean that we do not include information
about any individual or research site that will enable that individual or research
site to be identified by others.

In the Canadian research context, the Tri-Council Policy Statement (TCPS) 2 2010 is the
joint ethics policy guideline prepared by Canada’s three federal research agencies (Canadian
Institutes of Health Research (CIHR), and Natural Sciences and Engineering Research
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Council of Canada (NSERC). The TCPS2 is guided by three core principles: respect for
persons, concern for welfare, and justice. In the TCPS2 (2010), the notion of anonymity is
not defined and is instead subsumed within the concepts of privacy and confidentiality,
which are important aspects of these three core principles. According to the TCPS2, “privacy
risks in research relate to the identifiability of participants, and the potential harms they, or
groups to which they belong, may experience from the collection, use and disclosure or
personal information” (2010, p.55). Confidentiality refers to the obligation to safeguard
entrusted information; specifically, ‘researchers shall safeguard information entrusted to
them and not misuse or wrongfully disclose it” (2010, p.56). While the TCPS2 does not use
the word anonymity, it does acknowledge, however, that confidentiality “can be a particular
challenge in qualitative research because of the depth, detail, sensitivity and uniqueness of
information obtained” (2010, p.143-44). Here the TCPS2 demonstrates sensitivity to the
unique challenges involved in protecting anonymity for highly descriptive research
methodologies.

Anonymity of research participants are commonly demanded across Research Ethics
Review Boards at Universities and other institutions (Giordano, O'Reilly, Taylor, & Dogra,
2007). However, the orthodoxy of anonymity is beginning to be questioned in qualitative
research (Kaiser, 2009; Kelly, 2009; Snyder, 2002; Van den Hoonaard, 2003; Walford,
2005). Van den Hoonaard (2003, p.141) argued that anonymity “is a virtual impossibility in
ethnographic research” and pointed to the marked differences between the “front-stage”
promises of anonymity made to REBs and the “back stage” reality of research in practice.
Complicating the issue of anonymity, Walford (2005) argues that while the identity of a
particular site or community might be concealed, pseudonyms will probably not conceal the
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identity of individuals in relation to others from that same site or community. For example,
there have been studies in education research (Burgess, 1985) in which pseudonyms did little
to protect participants from colleagues and principals discerning individual identity. Walford
(2005, p.88) warned,
The head teacher and other teachers will know which teachers were involved in
the research and few details may be sufficient to identify the person being
quoted…Moreover, the people who are in a position to identify individuals are
exactly those to whom exposure has the greatest potential risks of harm or
embarrassment.
Scheper-Hughes (2000) has written similarly:
I have come to see that the time-honoured practice of bestowing anonymity on
‘our’ communities and informants fools few and protects no one—save,
perhaps, the anthropologist’s own skin. And I fear that the practice makes
rogues of us all—too free with our pens, with the government of our tongues,
and with our loose traditions and interpretations of village life (ScheperHughes, 2000), p.128.
Thus, the typical way in which anonymity is preserved (pseudonyms) ensures what
Tolich (2004) has described as external confidentiality (to the outside world). However, as
Kaiser (2009 pp.1636) has noted, “this approach does little to ensure that persons with whom
respondents have relationships such as spouses, coworkers or neighbors will be unable to
identify respondents”. Meanwhile, Tilley and Woodthorpe (2011) raised concerns about the
challenges of maintaining anonymity amidst increasing pressure to disseminate and translate
research findings in an on-line era. These authors suggested, “it is now common practice for
a lot of information about research activities to end up in various places, especially on the
internet…the sheer volume of this information can challenge the principle of anonymity in
identifying sites” (2011, pp. 205).
Nespor (2000) has identified other problems with anonymity. In particular, he
suggested that strategies to improve anonymity, such as glossing over details, invite the
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reader to generalize the findings of a particular study to any place and time. Readers might be
more apt to apply findings to other situations or sites, without considering important and
unique socio-historical contextual factors. Concerned for the anonymity of participants in my
own study, I considered the idea of removing any traces of the particular context of autism
and instead using [

] in place of the world autism throughout my dissertation. Nespor’s

(2000) concerns regarding the decontextualizing of findings and the risk for readers to
generalize findings into other contexts influenced my choice to remain close to the particular
context in which my research was situated.
My research involved engagement in a genomics laboratory and autism clinic. While a
pseudonym might hide the identity of the participants in the short-term, any description of
the spaces and the technologies in those spaces narrow the range of possibilities
immeasurably, such that the laboratory and by extension the clinic are quickly identifiable.
Such description, however, is essential for a serious discussion of the construction of
genomic knowledge and its translation amongst the various participants in the laboratory and
clinic. Moreover, actions taken to hide or gloss over the particulars of the research site in the
interest of preserving anonymity would simultaneously impede my ability to demonstrate
authenticity (showing the reader that I was there) and thereby threaten my own claims to
research quality. In my research, the challenges associated with anonymity differed between
and among individuals diagnosed with autism, family members, scientist, and clinician
participants and are explored separately below.

3.1a Anonymity of individuals diagnosed with autism and their family
members
One of my primary concerns is ensuring that individuals diagnosed with autism and
their families are not identifiable within my writing. This was actually more difficult to
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achieve than I had initially anticipated. The main difficulty in ensuring anonymity of the
families that participated in my research is that there have been so few families given genetic
feedback in the Autism Genetics Study, as it moves from the basic science laboratory to the
clinic. In order for social science to accompany rather than follow cutting-edge basic and
clinical research, as has been argued (Timmermans & Berg, 2003), social research must
begin with a small group of participants, and thus strategies to address the related
complexities of anonymity should be pursued. Feedback has only been given in the last three
to four years with less than a total of twenty families actually involved. This is because
parents only receive feedback when a genomic variant is found which is of “clinical
significance”. Most of the genomic variants that are found in the laboratory are either not
clinically significant (these variants are common in control populations) or, increasingly,
they are what are termed “unknown clinical significance”.
Trying to provide anonymity increases in complexity when one considers the many
different people for whom a research will seek anonymity. For example, in my research I
hope to ensure the individuals diagnosed with autism and their family members are not
identifiable. This becomes complex in relation to other family members, friends, co-workers,
or acquaintances as well as from the researchers and clinicians in the autism genetics study.
To promote anonymity I have used pseudonyms and modified demographic information as
much as possible. However, pseudonyms do little to protect the anonymity of individuals
with autism and their family members from the clinicians and scientists in the autism
genetics research. With so few parents involved in my study, and so few families having
received genetic information from the Autism Genetics Study, clinicians would quickly be
able to identify who said what. This concern is further complicated by the fact that these
scientists and clinicians were listed as co-investigators on my research project, as per
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research ethics board requirements; as such, they have access to signed consent forms clearly
identifying the parents who participated. The parents were aware of this, as the information
letter and consent form has the names of the clinic and laboratory directors at the top. In parts
of my dissertation, parents may offer concern regarding the clinical genetics feedback
process, offering potentially useful suggestions about the need for continued opportunities for
follow-up meetings with the genetic counsellor. In the interest of increasing anonymity from
the scientists and clinicians in the autism genetics research, I have tried developing
composite descriptions, based on stories from several research participants that have been
combined. For example, when I describe the process of meeting with a genetics counsellor to
receive genetic feedback, the story is told from the perspective of a mother. The experiences
and feelings recounted here are morphed together from several different mothers I
interviewed and from the four different feedback sessions that I observed. I have thus
collected data verbatim but to promote the anonymity of the research participants I have
brought together, and reassembled it.

3.1b Anonymity when “studying up”?
While I had anticipated the challenges to anonymity for individuals diagnosed with
autism and their families early on in the research process, the difficulties related to
anonymity for the scientists and clinicians became increasingly apparent as I began to write
descriptions of the spaces in which they were working. There are few people involved in
autism genomics research in Canada with the resources and infrastructure to carry out the
types of cutting-edge experiments I describe, let alone on such a large scale. The laboratory
and its director have an impressive public presence in the world of autism genetics research
and, as such, are highly visible. With a little effort, anyone who reads my dissertation could
probably figure out the group I was studying if they really wanted to. Considering this and
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that there is only one director of the laboratory and one director of the clinic, anonymity
becomes difficult, if not impossible, to achieve.
Over forty years ago, Laura Nader (1969) called for anthropologists to “study up”, to
focus on the elite individuals and institutions with power. She identified four factors which
contributed to the paucity of studies focused on those with power: access, attitudes, ethics,
and methodology. Traditionally, in many anthropological studies, the researcher traveled to a
distant country and had relatively more power than the research participants. Participants
may not have spoken the same language in which the anthropologist would eventually
publish findings and would have little opportunity to scrutinize the interpretations made by
the researcher. While anthropology “at home” has become increasingly common in the last
few decades, many researchers continue to focus their studies on relatively marginal or
disenfranchised people. As Gusterson (1997) has noted, “In many cases, anthropology’s
traditional taste for the marginal and exotic has not so much been transgressed as imported
and transposed upon American society, leaving us with more studies of scientologists and
crack dealers than of federal bureaucrats and corporate executives” (1997, p.114).
Recently, Edwards (2007) focused squarely on the challenges that emerge when
“studying up”. Edwards (2007) conducted an ethnography of the Japanese women’s soccer
team and the broader issue of corporate sports. She quickly found herself dealing with
corporate scandal involving Japanese mafia and some of Japan’s most powerful and elite.
The taken-for-granted power imbalance that traditionally favours the anthropologist was
reversed creating complex new ethical questions that were not yet explored in the literature.
“What happens”, Edwards (2007, p.564) has asked, “when the power vector points in the
other direction?” The novice researcher is left in uncharted waters, with little guidance on the
ethical or methodological issues pertaining to researching those with more power than
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ourselves. My aim is to contribute to the nascent conversation about the ethical challenges
that may arise when one engages in this activity of studying up, across, and down. In
particular, I explore some of the issues I confronted in the context of doing a multi-sited
study with a heterogeneous mix of participants who had varying degrees of power vis-à-vis
myself as researcher.
Arguing against the automatic adoption of anonymity of research participants,
Walford (2005) suggests a process in which the participants are themselves given a platform
in which to present their interpretation alongside the researcher, an idea previously put
forward elsewhere by Lawless (1992). Such an exchange, in which the researcher and
researched present ideas alongside one another, would indeed be another source of data and
might possibly lead to ongoing interpretations.
Giordano el al (2007) considered the possibility of allowing participants the choice of
maintaining anonymity and confidentiality. These authors describe the debate between
retaining anonymity of participants and revealing identities as a collision between different
constructs of agency. Giordano et al raise several important questions in the debate whether
or not to offer the choice to refuse anonymity to participants. For example, is the participant a
vulnerable participant who needs to be protected or is the participant also an individual,
separate from the study, who may benefit from giving voice to their own experiences? Can a
participant recognize and predict the implications and ramifications of choosing to be
identified as a research participant?
The issue of choice regarding anonymity is made more complex when considering
research with multiply positioned participants who are linked by association with one
another. There is often an unspoken assumption that research participants in a single study
are a homogeneous group (Edwards 2007). However, when purposefully including a diverse
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range of participants is integral to your research questions, what might be ethical research
practice for some participants may in fact confer risk, harm or stress on other participants
within the same study. In my research on autism genomics, for example, allowing scientists
to waive anonymity and naming the laboratory might, by association, implicate the few
families who have received genetic feedback pertaining to autism involved in my research.
While conducting fieldwork I came to realize that the scientists and clinicians who
participated in my research had the expectation that they would be co-authors on publications
that arose out of my dissertation. Journal articles in genetics begin with lengthy lists of
authors, name after name, sometimes filling an entire page. Anyone who has contributed in
any way is included as an author. Thus, of course, I came to realize it was natural for them to
assume that by letting me hang out in their facility and clinic, interview them and generally
take up their time they would expect to be authors on publications related to this project. I
realized it would be a cultural faux-pas not to include them as co-authors and I would
probably be regarded by them as “not playing by the rules”.
So the scientists and clinicians expect to be named, along with the laboratory and
clinic sites. But what risk would their identification confer on the few families who have
received genetic information from this laboratory and clinic? While some parents I
interviewed had no problem being identified, indeed they openly appeared in journal articles
previously published by the autism genomics researchers, there were other parents and
families for whom anonymity was important. The issue of waiving individual anonymity
reveals tensions and complex dynamics, not only between different groups of participants
(scientist/clinician or family) but also within single families. One family, for example, had
several adult siblings involved in the genetic testing process and two of these siblings were
identified as being on the autism spectrum. During one of my observations, one sibling
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revealed to the genetic counselor that he no longer wanted to be a part of the research. During
this observation in which feedback was being given to the family, this individual looked very
unhappy and had in fact been several hours late for the appointment. It seemed to me that he
was attending the feedback session under duress, as other family members were very keen on
the project.
How would offering choice of anonymity work in this case, in which participants are
related. Let us say, hypothetically, that one sibling chooses to be identified, waiving their
right to remain anonymous. However, let us suppose that the other sibling does not want to
be identified and wishes to remain anonymous. When the topic of the research is genetics,
entire families are implicated by association with an individual who might choose to be
identified. Identifying oneself as having a genetic marker associated with autism is also by
extension opening the doors for speculation about one’s family members. While for one
sibling, being identified might be an empowering and positive experience in the research
process, for the other sibling identification may confer risk, harm or stress. Thus, the concern
over offering participants the right to waive anonymity is more complex in the context of
genetics as a tension could arise between an individual participant’s wishes and the
preferences of other family members who may be implicated. Nisker and Daar (2006) have
suggested increased precautions and protections for individuals and family members in the
context of genetics-based narratives. Likewise, the TCPS (2003) stated in Article 8.2,
Because the potential for gathering genetic knowledge about biological
relatives or groups by studying only a few individuals is unique to genetic
studies, an individual may not be assured of privacy within the group, unless
extra precautions are taken.
Many of the scientists and clinicians who participated in my project expected to be
identified, while some individuals diagnosed with autism and families expect to remain
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anonymous. However, identifying scientists and clinicians (and therefore the particular
laboratory and clinic) could also identify the individuals with autism and their families, of
whom there are so few who have received feedback to date. Again, the Tri-Council Policy
Statement (2010) offers some help.
In some instances, participants may waive anonymity (e.g., if they wish to be
identified for their contributions to the research). Researchers should obtain the
consent of these participants, and negotiate agreements with them that specify
how they may be identified or recognized for their contribution. Where an
individual participant waives anonymity but other members of the participant
group object because identification may cause harm to the group, researchers
shall maintain anonymity for all members of the participant group (2010, p.58).
The implication of this TCPS statement for my research is that, despite scientists’ and
clinicians’ expectation to be identified, I should maintain anonymity of all participants since
some expect to remain anonymous. With so few people being given clinically significant
genetic feedback to date, I feel that I must at least refrain from divulging the actual names of
the hospital, laboratory, and clinic. Likewise, I have chosen not to include the names of
participants, whether they are people working in the laboratory, clinic, or the names of
individuals diagnosed with autism and their family members. While the descriptions of the
spaces in which I carried out my research might be identifiable to those within the Canadian
autism genetics community, and indeed the international community of genomics
researchers, it is unlikely that anyone outside of the autism research group I studied would be
able to identify specific families from the descriptions I provide in this dissertation.
Moreover, sensitive to this issue of ensuring anonymity, this dissertation was printed out and
couriered to examiners so as not to risk electronic transfer of information.
What is more challenging, however, is trying to maintain anonymity of participants
amongst each other. In practice, using a pseudonym alongside descriptions of the activities of
participants does little to hide their identities from each other when there may be only one
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project coordinator or a few psychology PhD students. What are the ramifications for
“Claudia” who questioned the possible end uses of the genetic results or for the liaison who
condemned the “cure speak” of the laboratory director? These participants talked about
important issues that have yet to be openly discussed amongst members of the laboratory and
clinic and dissemination of these findings could potentially instigate fruitful discussions
therein. Alternatively, these questions raised by some participants could perhaps contribute to
a straining of relations between these participants and the directors, their employers. While
my consent form clearly stated that data and findings would be accessed by members of the
research team (including the directors of the laboratory and clinic listed on the consent form),
did the participants understand the ramifications of this, that their anonymity vis-à-vis their
co-workers would be difficult to preserve?

3.2 Tensions in the research process: anonymity? "thick
description"? or something in between?
Thus far in this chapter, I have tried to unpack some of the challenges to anonymity in
the dissemination of qualitative research findings that include descriptive nuanced accounts
of highly identifiable people and spaces. The process of working through the issues
surrounding anonymity has brought into relief the inherent tensions in the research process,
tensions between doing everything one can to protect anonymity of participants (such as
using square brackets rather than the word autism) on the one hand and on the other hand, the
value of in-depth, rich or "thick" descriptions of the particular contexts in which fieldwork is
carried out. In anthropology, the discipline in which I feel most at home (although I have
been nomadic in my PhD), there is great value in providing detailed and nuanced accounts of
particular spaces and events and to unpack the complex socio-historical particularities of
those spaces and events. Moreover, an Actor-Network Theory account requires descriptions
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of the local assemblages of actors as they move from site to site. Maintaining anonymity
could be difficult when recounting the detailed minutia of a setting in which actors come into
contact with one another. As social scientists travel into new domains of research, including
cutting-edge genomics, ethical issues, such as those surrounding anonymity, may require us
to reconsider those practices which have traditionally defined us.
In Table 3.1 I have taken excerpts from my dissertation and considered how these excerpts
might be re-written to strictly protect participants’ identities. The first example in Table 7.1
illustrates how anonymity might be better protected by removing the name of the particular
condition (autism) from the dissertation, such that the easily identifiable people and places
associated with autism genomics research in Canada might remain anonymous. A generic
condition [-] is made to stand-in for the actual context in which field work was conducted. In
the second example, details of the physical space in which my field work took place are
truncated in order to hide the identity of Laboratory X from those within the broader autism
genomics research community who have visited Laboratory X for annual meetings. In the
third example, the types of activities and work that occur in the Laboratory are deleted as is
the number of employees, as the fee-for-service facility and the magnitude of the staff may
be another way for readers to figure out where the research was conducted.
Table 7.1
Anonymity Protected
1. i) Individuals diagnosed with [
] and
their family members give blood in the
blood lab located on the main floor of the
hospital. The genetics project
coordinator, Claudia from the [
]
Clinic, typically walks them over to the
triage area in the new atrium of the
hospital.

Description and Contextual Information
Preserved
1. i) Individuals diagnosed with autism and
their family members give blood in the
blood lab located on the main floor of
the hospital. The genetics project
coordinator, Claudia from the Autism
Clinic, typically walks them over to the
triage area in the new atrium of the
hospital.
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ii) Thus, the genetic variation in one
individual with [ ] is likely to be
distinct from the genetic variance of
another individual with [ ]. In
reviewing the literature, several genomic
loci were described as contributing to
susceptibility for [ ].

ii) Thus, the genetic variation in one
individual with ASD is likely to be
distinct from the genetic variance of
another individual with ASD. In
reviewing the literature, several genomic
loci were described as contributing to
susceptibility for ASD.

iii) I often wonder does that gene
impact on, my question, I have a
number of questions. So what it
does is it brings forth more
questions about myself. So
because I have the gene I am the
carrier or do I have [
] on a
lower part of the spectrum? What
does it exactly mean is my
question?

iii) I often wonder does that gene impact
on, my question, I have a number of
questions. So what it does is it brings
forth more questions about myself.
So because I have the gene I am the
carrier or do I have autism on a
lower part of the spectrum? What
does it exactly mean is my question?

2. i)The laboratory is housed in a Medical
Research Centre. It’s on my right as I
walk along Rainier Street now. A
beautiful old building sits stalwart on my
right. A shadow is cast down on the
rugged stone bricks by a tall, smooth,
modern tower now joined at a seam onto
the far end; this is the Medical Research
Centre. As I approach, a custodian is
cleaning the glass of the revolving doors
so I push open the swinging door. The
noisy street is shut behind me and my
footsteps echo in the vast foyer as I walk
through toward the elevators. To my right
is a set of stairs that leads down into the
food court, the underbelly that joins the
research tower to the hospital. I know if I
head down the stairs the tables will be
full with groups of people huddled
together around laptops, chatting over
morning coffee from Timmies.
ii) Several framed photos hang from the
walls at regular intervals. On closer
inspection, they are not just photos but
actually the covers of journals related to

2 i)The laboratory is housed in the Medical
Research Centre. It’s on my right as I
walk along Rainier Street now. As I
approach, a custodian is cleaning the
glass of the revolving doors so I push
open the swinging door. The noisy street
is shut behind me and my footsteps echo
in the vast foyer as I walk through toward
the elevators.

ii)
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genomics or the first page of articles
published by Laboratory X employees.
One of the frames contains a photo with
humans: two children – twins – one
with the phrase “I’m with Nature” and
the other with the phrase “I’m with
Nurture” written in block letters on
their matching T-shirts.

3. About one hundred people work here at
the Laboratory X, with the vast majority of
those working in the service facilities. This
is the business part of the facility which
conducts fee-for-service genomic work.
Only about ten or fifteen people are part of
the academic team, which consists of
principle investigators, post-docs and
graduate students.

3. Only about ten or fifteen people are
part of the academic team, which consists
of principle investigators, post docs and
graduate students.

The purpose of this table is not to indicate how descriptive social science research
should proceed with regard to protecting anonymity. Rather, my aim is to highlight the
competing tensions in the research process that emerge when studying easily identifiable
people and places. In my own case, it took time for me to gain an understanding of how the
research site is positioned in relation to the broader national and international context. Upon
entering the field I was not aware of how special and unique my particular field site was and
thus I did not anticipate in advance the challenges involved in maintaining anonymity. It was
only through the process of writing detailed descriptions (Richardson, 2004) that I came to
understand the complexity involved in maintaining anonymity within descriptive social
science research about easily identifiable participants. The two research ethics boards from
which I obtained approval to carry out this research also did not probe me to think about this
issue.
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The statements in the Letters of Information indicate that no personal information
about participants will be published and yet through the descriptions and contextual
information about the field sites made throughout my dissertation personally identifying
information could be figured out. In the lengthy ethics protocol submitted to the hospital
ethics board I indicated that only pseudonyms would be used in place of the actual names of
Laboratory X and the Autism Clinic. However, the data sharing agreement between the
hospital where my research was carried out and my university ethics board contains back-toback contradictory statements that underline the difficulty in safeguarding anonymity while
meeting expectations for authorship. This data sharing agreement demands that I: i) not
include personally identifying information, and ii) include investigators (lab and clinic
directors) as authors in publications (thereby disclosing their identity as well as their
institutional affiliation). Figure 3.1 illustrates that exact phrasing pertaining to confidentiality
that was used in the Letters of Information and Data Sharing Agreement.
Figure 3.1: Ethics Documents Statements Pertaining to Confidentiality

90

Letter of Information for Families
We will respect your privacy. No information about who you are (your child is) will
be given to anyone or be published without your permission, unless required by
law.
Letter of Information for Scientists and Clinicians
We will respect your privacy. No information about who you are will be given to anyone
or be published without your permission, unless required by law.
REB Submission
As an additional precaution to uphold confidentiality, the name and location of the
laboratory and clinic will not be given in JB’s dissertation or any written presentations
of this research; instead pseudonyms will be used.
Data Sharing Agreement
RECIPIENT shall not include any personally identifying information in any publication
or presentation. [Hospital] Investigator’s contribution to the Study and authorship
contributions, as applicable, shall be acknowledged appropriately in any such
publication or presentation in accordance with academic standards.

Thus, the Letters of Information and REB submission promise to protect the identity
of participants. However, descriptive details about the study sites along with nuanced
accounts of the activities carried out by particular individuals may reveal the identity of
participants to some readers. Furthermore, the data sharing agreement undermines these
precautions being taken by suggesting that some participants (Directors of the laboratory and
clinic) should be named as authors on publications, thereby revealing the names of the
particular field sites.
As descriptive social science moves into field sites such as cutting-edge genomics
where participants may be easily identified how can the friction between a descriptive
methodology and the need for anonymity be lessened? What steps should be taken to satisfy
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these documents and at the same time provide the nuanced descriptions and depth which
make the research meaningful within a particular context? How do I comply with
expectations for confidentiality and anonymity while at the same time meet the academic
expectations surrounding authorship? Does the consent process need to change in order to
inform participants about the limitations to anonymity in descriptive research that “studies
up”? My research brings to the foreground the complex implications of engaging in
descriptive methodologies amongst highly visible or easily identifiable participants with
regard to anonymity and the need for a greater awareness of this issue amongst research
ethics boards.

3.3. Expectations of Research Participants
While anonymity is my primary concerns in this chapter, there is one other issue to
briefly address in relation to “studying up” that provoked my discomfort and concern at
various times throughout my research. At times, I struggled with the interrelated issue of
loyalty to my participants and “for whom is this research being written?” (Priyadharshini,
2003). For example, I have a particular interest in knowledge translation, specifically in
developing new conceptual models of KT based on a constructionist philosophical
foundation. Approaching KT from this lens has enabled me to interpret my field notes about
observations and interviews in a way that is probably unfamiliar and unanticipated by the
participants. For example, exploring knowledge as being constructed rather than discovered
might be received as a critical attack on the values and assumptions underlying much of the
work in the laboratory and clinic. I worry that not only might the participants not agree with
my interpretation but that they would also not find such discussion valuable.
Priyadharshini (2003) has previously discussed this issue. He stated. “subtle constraints
imposed on my research from the point of gaining access to the end of fieldwork contained
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my natural inclinations and made it harder for me to wear the badge of critical researcher…”
(2003, p.426). These subtle constraints about which Priyadharshini writes were present in
my fieldwork experience as well. For example, early on, while establishing the laboratory
field site I had a meeting with the director of Laboratory X. He made a passing remark at
some point in our brief meeting that they did not need another theoretical or philosophical
piece but rather he felt the findings should be “practical”. This brief statement caused me
great concern over the course of my research. Will he find this dissertation “practical”? To
me, thinking through knowledge translation from a different philosophical position is
practical. It has practical implications for how KT is approached. I feel that my integrity as a
researcher would be compromised if I were not able to critically explore the assumptions
underpinning much of the work currently being done in the area of KT. On the other hand,
those who participated in my project gave their time generously and I feel an obligation and a
desire to have them appreciate the work I have done. I would hope that my research would
have some meaning or use to the participants. What kind of loyalty or allegiance is assumed
when you are allowed access to a field site? What responsibility do I have as a researcher to
ensure that my findings have some sort of practical utility, that they reciprocate in some way
for the many hours the scientists and clinicians have given me as research participants? These
are questions that are equally important to researchers who are not “studying up”. Further,
knowing that your participants can and probably will engage with what you have written and
that they have the power to respond in an articulate and scholarly way is a sobering thought
that makes these questions about loyalty and expectations all the more poignant to the
fledgling researcher.
In this chapter I have discussed the concept of anonymity as it relates to multiple sets
of research participants in new and emerging sites of inquiry where "studying up" brings to
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the foreground a tension between methodological rigor and research ethics. In addition,
questions surfaced regarding loyalty to participants and negotiating participants’ expectations
alongside a researcher’s individual interests and aims. This chapter raises more questions
than it answers and I suspect many of these issues will be ongoing in the future as I prepare
sections of this dissertation for journal publication. Far from presenting tidy answers and
conclusions, this chapter merely opens up a discussion about some of the ethical complexities
that have emerged through an anthropologically-inspired study of genomics.
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Chapter 4
Inside-Out and Upside-Down: Tumbling into the World of
Autism Genomics
4.1. Diagnosing Autism Spectrum Disorder
4.2. Genomic Constructions of Autism
a) Research Paradigms
b) Linkage and Association Studies
c) The “Multiple Hit” Model

In this chapter, I will first briefly familiarize the reader with how autism is diagnosed
today and some of the statistics pertaining to prevalence and incidence. While my research
was not focused on issues of diagnosing autism (all of the proband participants had been
previously given a clinical diagnosis of autism before engaging in genetic research) the
clinical tools and technologies engaged in the process of diagnosis were very important
actors in the network of the autism clinic in so far as they were used to establish an
individual’s phenotype. Thus, this initial introduction of the diagnosis of autism will be
followed in later chapters by a more in-depth description and discussion of some of the tools
involved in the diagnostic process.
The second aim of this chapter is to provide the reader with a background
understanding of the current genomic practices within which autism is being constructed
today. An overview of the current genetics literature related to autism will prepare the reader
with a baseline understanding of autism genetics to facilitate in following the descriptions
presented in the subsequent chapters.
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4.1. Diagnosing Autism
According to the DSM-IV, the umbrella term of Pervasive Developmental Disorders (PDD)
is comprised of five related clinically defined categories. Three of these categories compose
what is commonly called the autism spectrum, including: Autistic Disorder, Asperger's
Syndrome (AS), and Pervasive Developmental Disorder Not Otherwise Specified (PDDNOS). Rett disorder and childhood disintegrative disorder (CDD) are less common but
included within PDD. Moreover, a broad autism phenotype (BAP) has recently been applied
to label subtle cognitive or behavioural attributes that are similar but less severe than those
exhibited in Autism Spectrum Disorder (ASD) patients (Freitag, 2007). The diagnosis of
ASD has become standardized with two instruments: the Autism Diagnostic InterviewRevised (ADI-R) (Lord, Rutter, & Le Couteur, 1994) and the Autism Diagnostic Observation
Schedule (ADOS) (Lord, 1989).
Leo Kanner first identified autism in 1943 (Kanner, 1943). Originally, Kanner
defined "autism" based on two criteria: "autistic aloneness" and "insistence on sameness"
(Kanner & Eisenerg, 1956). Recent diagnostic criteria for autism, as it is described in the
American Psychiatric Association's DSM-IV (American Psychiatric Association, 2000) and
the World Health Organization's International Classification of Functioning, Disability, and
Health (ICF) (World Health Organization, 2001), are structured around the three core areas
of social impairment, communication difficulties, and rigid and repetitive interests and
activities. Typically, onset occurs before age three (Gillberg & Coleman, 2000). Asperger's
syndrome is diagnosed when individuals meet the criteria, but without showing language
deficits or "mental retardation"2 (Lord & Spence, 2006). Many people with Asperger's
syndrome may be regarded by their peers as odd, but not perceived as psychiatrically
abnormal (Gillberg & Coleman, 2000). A diagnosis of PDD-NOS indicates milder
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difficulties (Lord & Spence, 2006).
Nadesan (2005) has traced the historical changes in the classification of "autism",
drawing attention to recent broader and more inclusive criteria for diagnosis which has led to
the notion of a continuum or spectrum. Kielinen et al (2000) described a striking variation in
the rates of "autism" that result when different diagnostic criteria are applied to the same
survey data. It behoves us to bear this in mind when comparing measurements reported
across time; different diagnostic criteria can result in radically different epidemiological
statistics. For example, incidence (the number of new cases in a population over a period of
time) is difficult to determine with diagnoses on the "autism" spectrum as several variables
(i.e., changes in diagnostic criteria, increased public awareness and improved service
availability) have not remained constant over time. Fombonne (2005) warns that upward
trends in prevalence (the proportion of individuals in a population with a disorder) cannot be
attributed to increased incidence because of the aforementioned variables. The prevalence
estimates of Autistic Disorder is approximately 13 / 10 000 (Fombonne, 2005). Prevalence
rates for Asperger's is about one fifth that of autism, approximately 2.6/ 10 000; however,
epidemiological studies of Asperger’s are very sparse, as it was only recently acknowledged
as a separate diagnostic category (Fombonne, 2006). Meanwhile, PDD-NOS has a prevalence
rate of about 20.8 / 10 000 (Fombonne, 2005). Most of the available statistical data which
support prevalence rates are based on surveys conducted in urban areas (Fombonne, 2006).
There is also a marked sex differentiation in autism, with a 4:1 male to female ratio
(excluding Rett syndrome which is more common in females) (Bartlett, Gharani, Millonig, &
Brzustowicz, 2005).
Comparing measurements of an ASD diagnoses is further complicated by the possible
political ramifications of attaching this label or code to a child. Grinker (2007), for example,
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highlights that an ASD code will usually get your child more services that benefit him - more
hours of speech therapy, more aide support, more of almost everything the school has to
give" (2007, p.267). Thus, a diagnosis may be sought in some situations. Defining and
measuring "autism", therefore, is a complicated endeavour with many factors to be taken into
consideration.

4.2. Genomic Constructions of Autism
In the 1970s, the first twin studies were conducted showing a significant difference
between monozygotic and dizygotic concordance (Rutter, 2000). A major shift in the
conceptualization of autism and its causes began to occur. Twin studies replicated these
findings in the 1980s and 1990s presenting a 60% concordance rate for autism in
monozygotic twins compared to a 5% rate in dizygotic twins (Rutter, 2000). Current
heritability estimates for ASD are ~90% (C. Marshall et al., 2008), suggesting that "autism is
one of the most heritable neuropsychiatric disorders" (Bonora, Lamb, Barnby, Bailey, &
Monaco, 2006, p.51).
While there have been major advances in the study of genetics over the last decade,
for example the mapping of the human genome and new technologies such as micro array
analysis, there remains much to be explored in the aetiology of "autism" (Bonora et al.,
2006). According to Pickler and Elias (2009) there are currently over two dozen genetic
syndromes (e.g., Fragile X syndrome, Angelman syndrome and Rett syndrome) that have
been associated with "autism", likely because "autism" is defined by such a heterogeneous
mix of behaviours. Given this heterogeneity it is most likely that a large number of genetic
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variations and possible epigenetic occurrences are involved in the development of ASD
(2006).

4.2a Research Paradigms
Genetic research in the area of autism is typically conducted within one of two
paradigms: common disease-common variant and common disease-rare variant (Cook &
Scherer, 2008). The common disease-common variant model is oligogenic in that it assumes
disease results from "the combined action of multiple interacting genes" (Abrahams &
Geschwind, 2008, p.342). In this model, it is assumed that multiple alleles that are common
to the general population each contribute small effects to the phenotype. Distinct
characteristics of ASD (e.g., communication difficulties or repetitive and rigid behaviour) are
related to independent genetic factors (Happe & Ronald, 2008; Ronald et al., 2006). This
model has been supported by linkage studies indicating different locations for various traits
or characteristics of "autism" (Schellenberg et al., 2006). Risch et al (1999), for example,
argue for at least 15 susceptibility loci. Happe and Ronald (2008) described the idea of the
"fractionable autism triad"; the idea of fractionability suggests that "different genetic loci
may be associated with the different core behaviours that currently define the autism
diagnosis" (Happe & Ronald, 2008). These authors raise the question of whether autism
should really be conceptualized on one continuum, "or whether each individual should be
mapped in a three dimensional space along three, perhaps orthogonal, dimensions: social
interaction, communication, and RRBIs [rigid and repetitive behaviours and interests]"
(Happe & Ronald, 2008, p.299). The implications of the common disease - common variant
model of autism are that genome-wide association studies which look for susceptibility genes
would be more successful if they geared their search towards specific behaviours within the
autism triad rather than searching for genes underlying autism as a whole. One of the key

99

challenges is the difficulty to define the phenotype, especially considering the broad
spectrum of autism. Such a diverse and variable set of characteristics and behaviours would
likely involve genetic heterogeneity, as well as epigenetic factors. Bartlett et al (2005) have
considered this difficulty and stated:
While phenotypic heterogeneity does not necessarily imply genetic
heterogeneity, the breadth of phenotypic variation, which cannot solely be
accounted for by any one etiological theory, and the linkage findings converge
on the same conclusion, that autism is not a unitary phenomenon (Bartlett et al.,
2005, p.224).
The task is complex as genetic effects may operate on components of autism rather
than at a syndrome or diagnostic level (Rutter, 2000). As Abrahams and Geschwind (2008)
have suggested, "diagnostic categories used in clinical practice might not properly represent
underlying genetic risk". Thus, the clinical diagnosis of autism can be thought of as a
grouping of characteristics or traits which are not necessarily held together by the same
genetic and biological markers.
Conversely, the alternative common disease-rare variant model emphasizes
overlapping risk factors (Pritchard, 2001). This rare variant hypothesis posits that many
alternative rare variants underlie susceptibility to common complex conditions (Cook &
Scherer, 2008; Pritchard, 2001). Recent work in the area of ne novo (spontaneous) copy
number variations (CNVs) is rooted in this model (PGCC Committee, 2009). (This common
disease-rare variant model was the model that guided the research in Laboratory X, where I
conducted my fieldwork for the present dissertation.) Copy number variations may include
deletions or duplications of DNA segments. Several studies have examined whether copy
number variations are more frequent in case subjects versus comparison subjects. For
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example, Sebat et al (2007) found increased rare de novo (spontaneous) copy number
variants in case subjects (10%) versus comparison subjects (1%). Several studies have also
reported an increase in deletions or duplications on chromosome 16p.11.2 in case subjects
versus comparison subjects (Kumar et al., 2008; C. Marshall et al., 2008; Weiss et al., 2008).
While researchers typically work within one or the other model (common disease - common
variant or common disease - rare variant), Abrahams and Geschwind (2008) have
commented on the necessity for the integration of findings from each of these models.
I learned, when talking with a post-doctoral fellow in Laboratory X, that this distinction
between theoretical approaches is also accompanied by a slight difference in language.
Whereas those using the common disease- common variant hypothesis tend to talk about
“polymorphisms” (single nucleotide polymorphisms or SNPs), scientists who adopt the
common disease- rare variant model tend to use the word “variant” (SNVs). During my
fieldwork it seemed that people were using these terms interchangeably. When I asked a
post-doc if there was any real difference between SNPs and SNVs this was her response:
Ahhh! This is something that I find very irritating because many people are
rather loose in their use of polymorphism and variant. It’s all about frequency;
so a polymorphism (ie a SNP) is generally taken to be a position that varies
commonly in the population usually with a given minimum frequency (eg 1%, 3%
or 5%). Whereas a variant is something that is more rare and may never have
been described before.

4.2b Linkage and Association Studies
An alternative way to unpack the genetic construction of ASD is to examine how
genetic-related conditions are explored. Linkage studies and association studies are two
primary means of analyzing the relationship between genotype and phenotype (observable
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expression of genes). The purpose of linkage studies is to map genes in families in order to
locate susceptibility genes. Linkage studies concentrate on affected sibling pairs in multiplex
families (Abrahams & Geschwind, 2008). Linkage is defined as "the tendency for alleles
close together on the same chromosome to be transmitted together, as an intact unit, through
meiosis" (Freitag, 2007, p.7). Lander (1996) proposed that most single nucleotide
polymorphisms (SNPs) are ancient and common to most people in a population. SNPs
become common because they are neutral or favourable to survival and get passed down to
the next generation; however some may have harmful effects. Linkage analysis, then, starts
with a particular phenotype found in families and then tests genetic locations on the genome
to find linkage between genes and phenotype (Bartlett et al., 2005). Linkage has also been
called reverse genetics, as the scientist moves from the phenotype back to the genotype
(Bartlett et al., 2005). Several chromosomal regions have been linked to an ASD phenotype.
Some linkage studies have stratified their sample of individuals with regard to phenotypic
traits. From these studies, chromosome 2q and 7q35 appear to influence language
development, while 1q is linked with obsessive-compulsive behaviour (Freitag, 2007). Thus,
according to linkage studies, different components of autistic behaviour may have different
underlying causal factors. The difficulty with linkage studies is that any one gene has a small
overall effect size. Thus, it may be difficult to achieve statistically significant results.
Association studies start with the genetic or genomic information (genotype) and then
search for associations with phenotypes. In other words, they are genotype-driven rather than
phenotype-driven. Association studies use high-resolution microarray technologies to detect
balanced and unbalanced structural variants or copy number variations (CNVs) (C. Marshall
et al., 2008). CNVs involve segments of DNA that are at least 1 kb in size. Balanced
variations involve no loss or gain of genetic material (Buchanan & Scherer, 2008).
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Unbalanced variations included deletions or replications. Locus 1q21.1, for example, is
associated with duplications in a form of ASD (Cook & Scherer, 2008). CNVs can be de
novo (spontaneously arising rather than being transmitted by a parent) or they can be
inherited. Adding to this complexity, the position or context of CNVs within the genome can
influence expressivity or penetrance (Buchanan & Scherer, 2008).
Marshall et al (2008) reported a 7.1 % and 2% rate of de novo CNVs in simplex and
multiplex families compared with a <1% spontaneous CNV mutation rate in non-disease
samples. These authors found that CNVs in ASD are often in loci with genes functioning in
postsynaptic density and regions associated with mental retardation. SHANK3, NLGN4, and
NRXN1-PSD are three genes involved in synaptic functions and have been shown to have
CNVs in ASD probands. Berkel et al (2010) found de novo copy number variations in the
SHANK2 synaptic scaffolding gene in patients with ASD and mental retardation (MR). Two
loci for ASD CNVs overlap with mental retardation. In particular the 16p11.2 CNV region
was found at almost 1% frequency in ASD samples and not controls (C. Marshall et al.,
2008).

4.2c The “Multiple Hit” Model
According to Leblond et al (2012), while there are many diverse causes of ASD, the
“main category of genes associated with the disorder is related to development and function
of neuronal circuits.” Genes such as neuroligens (NLGN), neurexins (NRXN) and SHANK
are important for formation and stabilization of synapses and coding for scaffolding proteins.
Mutations in these genes have been widely reported in patients with ASD. The “multiple hit”
model suggests that the co-occurrence of deleterious variations in multiple genes could act
together in the same pathway to increase the risk of ASD. For example, Leblond et al (2012)
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suggested that the NRXN-NLGN-SHANK pathway and CNVs in the 15q11-q13 might
together increase susceptibility to ASD. Recent data suggest that common genes/ pathways
are being identified across a broad range of neurodevelopmental disorders. For example,
ASD, schizophrenia, ADHD, and obsessive compulsive disorder all have overlapping
susceptibility regions (C. Marshall & Scherer, 2012). Lionel et al (2011) stated that there
seem to be “common genes and pathways implicated in several disorders…[suggesting that]
different human disease-phenotype groups might arise from overlapping molecular
causation”.
Specific genes thought to be associated with "disease" are called candidate genes.
There is no single gene for ASD; rather, there appear to be several different regions in the
genome that may confer susceptibility to ASD when perturbed. For example, Levy et al
(Levy & et al., 2011) stated:
A striking finding of all the studies of de novo mutation in children with ASDs is
the apparent number of distinct target loci. Even discounting 25% of events as
incidental (based on a 2% frequency in sibs and 8% in probands), there are a
large number of target regions and few recurrences. Only CNVs at 16p11.2 are
present in more than 1% of cases (ten out of 858 children).
Thus, the genetic variation in one individual with ASD is likely to be distinct from the
genetic variance of another individual with ASD. In reviewing the literature, several genomic
loci were described as contributing to susceptibility for ASD. For example, using extended
family pedigrees from 42 extended ASD families, Salyakina et al (2011) reported twelve loci
that co-segregated with disease which may be involved in ASD susceptibility. Screening for
CNVs is often used as a method for identifying susceptibility regions in the genome.
One of the most recurring regions for variants in ASD is called 16p11.2. This region
has been described by Čiuladait÷ et al (2011), Kumar et al (2008), Marshal et al (2008),
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Weiss et al (Weiss et al., 2008) and Barge-Schaapveld et al (2011). Ciuladaite et al (2011),
for example, suggested that the 16p11.2 deletion is a recurrent genomic event and a
significant risk factor for autism. However, a deletion in the 16p11.2 region is associated
with a wide range of clinical phenotypes. Deletions in the 16p11.2 locus are risk factors for a
variety of developmental and psychiatric conditions, such as MR (mental retardation), ASD,
attention deficit hyperacativity disorder (ADHD), language delay and seizures (Ciuladaite et
al 2011).
Recently, CNVs have also been found in individuals with ASD at the x-linked
PTCHD1 locus (Pinto et al., 2010). All of these variations were inherited from unaffected
mothers. Marshall and Scherer (2012) have suggested that these X-linked variants may
provide an explanation for the skewed male to female ASD diagnoses. Females, with two X
chromosomes, are protected by CNVs in this region; whereas males, with only one X
chromosome, are not protected.
Given the range of loci involved in ASD, a “threshold” model has been proposed to
understand the role of CNVs in ASD (Cook & Scherer 2008). Marshall & Scherer describe
this threshold model as follows:
Some CNVs have a large impact on ASD susceptibility and these are typically de
novo in origin, cause more severe ASD symptoms, are more prevalent among
sporadic forms of ASD, and are less influenced by other factors like gender and
parent of origin. Other CNVs have moderate or mild effects that probably require
other genetic (or non-genetic) factors to take the phenotype across the ASD
threshold (C. R. Marshall & Scherer, 2012; C. Marshall & Scherer, 2012).
Devlin & Scherer (2012) have suggested a possible multigenic threshold model for ASD in
which multiple CNVs, smaller sequence variants, and variants in apparently non-coding
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regions of the genome (intron) may all interact. This gene-gene interaction may work to push
an individual over the ASD threshold.
The diverse phenotype and complex aetiology of ASD make replication of study results
a difficult task. Bartlett et al (2005) explain two key concepts that have an enormous impact
on the possibility for replication of findings. Locus heterogeneity describes a situation in
which different genes may be involved in causing the same disease in different individuals.
Allelic heterogeneity implies that different alleles of the same gene may confer susceptibility
to the same phenotype. Thus, it is very difficult to achieve replication of a positive
association between a candidate gene and autism. This challenge is compounded when one
considers possible environmental exposures (Hertz-Picciotto et al., 2006; Lawler, Croen,
Grether, & Van de Water, 2004) and multiple interacting genes.
The technology to assay the entire human genome has instigated a transition in the
way scientists think about disease, highlighting the need to simultaneously integrate
information from many sources. Paradoxically, while the sensitivity and resolution of new
genetic technologies improve and enable scientists to interrogate specific alleles on particular
genes, there is also an increase in uncertainty about the nature of disease. According to
Schaaf & Zoghbi (2011), rare de novo CNVs account for 7-20 % of individuals with ASD,
single gene disorders account for 5-7 % and metabolic disorders account for approximately
5% of ASD cases. This leaves at least 70% of all ASD cases for which a genetic cause cannot
yet be identified. Schaaf & Zoghbi further stated, “It is very likely that there will be hundreds
of autism genes and proteins; thus designing treatments for ASDs tackling one gene at a time
will be a challenge” (Schaaf & Zoghbi, 2011). Marshall & Scherer (2012) have specified that
the challenge is in the correct interpretation of the clinical significance of each variant. To
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address this challenge, the International Standards for Cytogenetic Array Consortium has
established a working group to develop an evidence-based process for evaluating and
interpreting genetic finding so that they can be used to inform clinical practice (Riggs et al.,
2012). Moreover, knowledge translation amongst scientist, clinicians and the public is
increasingly being recognized as an important aspect of genomic research (Zwaigenbaum et
al., 2011).
In reviewing the complex genetic aetiology of ASD, the need for research describing
the process of translation amongst basic science, clinical, and family milieus is made evident.
Drawing on concepts such as ontological multiplicity and the mangle of practice, outlined in
the previous chapter, the remainder of this dissertation will explore the processes involved in
translating amongst the heterogeneous groups of people, practices, places and objects that
partially connect through the overlapping networks of the Autism Genetics Study at the
particular sites in which I conducted fieldwork.
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Chapter 5: Translation as Transformation
[B]ehind the texts, behind the instruments, inside the
laboratory, we do not have Nature, not yet…what we have is
an array allowing new extreme constraints to be imposed on
'something.'"
(Latour, 1987, p.89)
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5.1 Setting the Stage
The dry heat of the office building gives way to the cold November air as I push
through the revolving doors onto High Street West. The wind feels crisp against my face as I
step further out onto the sidewalk. Inhaling, I catch a brief hint of fragrant spices from the
little East Indian restaurant across the road. A long line of cars stretches beside me as I walk
quickly along the bustling, morning rush-hour sidewalk and round the corner onto Peele Ave.
A large group of ESL students huddles outside the door of an International School. I weave
through them and quicken my pace, hoping to catch the walk signal ahead. Just missed it.
Standing at the corner waiting for the light to change, I can see the boney, finger-like
branches of the trees reaching up around the hospital. As if misplaced by summer, two
bronze women in sundresses hold down a bench, blossoming and rounded with their
sculptured children playing at their feet. Four other hospitals huddle up to the street in this
one small stretch of the block; if one was ever to find herself ill or injured, surely this would
be the ideal location.
Passing a half-empty bank of Bixi bikes, I walk a little further and turn right on
Rainier Street. It’s 9:00 am and I’m heading to Laboratory X to find out if I can observe
anything this morning. I’ve just come from the Autism Clinic and I have a follow-up
interview scheduled in an hour from now with one of the genetics post-docs. The laboratory
is housed in a Medical Research Centre. It’s on my right as I walk along Rainier Street now.
A beautiful old building sits stalwart on my right. A shadow is cast down on the rugged stone
bricks by a tall, smooth, modern tower now joined at a seam onto the far end; this is the
Medical Research Centre. As I approach, a custodian is cleaning the glass of the revolving
doors so I push open the swinging door. The noisy street is shut behind me and my footsteps
echo in the vast foyer as I walk through toward the elevators. To my right is a set of stairs
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that leads down into the food court, the underbelly that joins the research tower to the
hospital. I know if I head down the stairs the tables will be full with groups of people
huddled together around laptops, chatting over morning coffee from Timmies. Many of them
have probably been working for hours already, taking a break before heading back to the
hospital or up to one of the laboratories in the tall medical tower.
Approaching the bank of elevators, I push the “up” button and see a poster
advertizing an upcoming colloquium on stem cell research. The elevator dings and the shiny
metal doors open. Several other people step into the elevator with me. There are sixteen
floors and Dr Lorenz’s laboratory is on the fourteenth. All of the people in the elevator have
name tags hanging around their necks, partially obscured by scarves and winter jackets.
Some people are quietly talking about the snow forecast for later this week while three others
appear to be deep in conversation about a recent conference. The elevator stops at several
floors before the fourteenth. As the others step off the elevator they each pull out their name
badge and swipe it across a security scanner to unlock an interior set of heavy beige doors
before they can enter into the laboratories awaiting them.
The elevator dings for the fourteenth floor and I step out. It looks different from the
other floors we’ve just passed through with their prosaic beige paint and uninviting locked
doors allowing only a few to enter. Here, there is a black leather bench perched in front of a
window as you step off the elevator and green leafy ferns in shiny black planters adorn the
corners. It’s quiet. The clean foyer is bathed in natural light from the large square window,
deeply recessed in the end wall. The heavy, security-protected double doors are wide open,
inviting customers to enter. To the right of the double doors, slightly obscured by a plant,
there is a sign warning that ‘This facility is under video surveillance’. The floor is glossy
grey with a brightly coloured helix pattern winding through it, a subtle indication of the work
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being done here.
This is what Erving Goffman (1959) would call the “front stage” of the laboratory. Clean
and bright with carefully planned signs telling the client or visitor that this lab is wellfunded, high-tech and state-of-the art. All of the messiness of doing genomics takes place
“back stage”, behind the glass wall of the laboratory or behind closed-door conference room
discussions.
I follow the helix pattern through the inner double doors and pass a large window
with sliding glass doors on the left with a sign above that reads “DNA sample drop-off”. All
the samples that will eventually end up in the lab have to first pass through this window. The
samples come from a variety of places; some from the DNA extraction lab in the hospital
down the street that I just walked past a few minutes ago. Other samples are mailed from
cities across Canada or from other countries. They can be from blood, tissue, or saliva. With
luck the samples have been stored properly in the little glass tubes as they have made their
various journeys to this window. If caps were not screwed on tightly they might have spilled
and technicians will have to try to collect any remnants remaining in the surrounding
package.
I look at the clock on the wall inside the small office on the other side of the drop-off
window: 9:15. Brittany looks up and sees me. I wave and she smiles before turning back to
her computer screen. Brittany is in her late thirties and has a PhD in molecular biology. She
is thin, angular, but her soft, quiet voice bends in an unexpected way. She is precise, detailed,
meticulous in the way she manages all of the records, accounting for all the samples that
have been dropped off and delegating them to the various technicians in her the lab. She
spends most of her time in this little office, receiving samples and managing the workflow of
the microarray facility. One of her main tasks is to organize and keep track of all the orders

112

coming in on the Laboratory Information Management system, or LIMS. She is busy at this
time of morning, as many samples have been dropped of by technicians as they begin their
work day. The samples will continue to pass through the drop-off window all day. I continue
to walk past the window.
If you were standing here beside me and looking straight ahead, you would see the
laboratory, through a huge transparent glass wall. On the door leading to the laboratory there
is a Biohazard sign that says “containment level 2”. There is also a sign informing
sequencing costumers to proceed to aisle N. Through the glass, you would see rows and rows
of machines with people wearing white lab coats and safety glasses standing bent over their
work benches or perched atop stools gazing at computer monitors. The walls are white and
the ceiling is made from white ceiling tiles interspaced with florescent lights. You would see
that the laboratory is very bright, that the opposite side of the laboratory is also made of a
large wall of windows letting in ample natural light even on this grey November day. The
main part of the lab is just one large room divided by several aisles. Each aisle seems to
loosely correspond to a certain activity; for example, there is an aisle where all the
microarray data is done and another for Next Generation Sequencing (NGS).
Figure 5.1: Wet Laboratory
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Now, if you were to turn your head to the right and look down the hallway,
immediately to the right you would see a swipe card machine for people to clock in and out
as they start and finish their work day. About one hundred people work here at the
Laboratory X, with the vast majority of those working in the service facilities. This is the
business part of the facility which conducts fee-for-service genomic work. Only about ten or
fifteen people are part of the academic team, which consists of principle investigators, postdocs and graduate students. Beside the swipe card machine there is also a magnet board with
the academic’s names on it and In/ Out beside them. Each person moves their magnet to “In”
when they arrive and “Out” when they leave. I’ve frequently seen people doing this.
A little further down the hall to the right there are rows of grey lockers with locks
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dangling. This is where lab technicians store their lab coats and other laboratory
paraphernalia. Indeed, the aisles between the workbenches in the laboratory are quite
narrow. I always felt a bit like a bull in a china shop when I would come to the lab to do
observations or interviews. I never knew where to place my backpack holding my laptop,
books, notebook, as well as a coat or sweater. Beyond the lockers is the large conference
room that holds the regular Monday morning meetings, which I have often attended. Beside
the door is a keypad entry. There is also a bulletin board which hangs on the wall beside the
conference room. Here there are advertisements for all manner of instruments used in the lab.
Everything from refrigerators that keep the samples cold, to reagents, to little gel dots. There
are posters advertizing conferences and upcoming talks. Some of the talks are actually
information sessions hosted by the companies that make the instruments for the lab.
On the other side of the conference room door, there is a large, four foot by four foot
brightly coloured red sign against the white wall. The sign reads:
Finding disease-causing genes in DNA is 100,000 times harder than finding the
white pins in this wall. We did it. Can you? Hint: use the microscope. Hospital X.

There are double helix images all over the sign. Further beyond the conference room is a
section of cubicles and a few offices. A washroom is located a little further on and then
beyond that are the offices of some other labs, not associated with the Laboratory X. I have
heard that Laboratory X has, in the past, acquired some office space down there as other
researchers have moved out of the building. Space is highly coveted.
Now, if you were to turn your head around to the left, looking down the hallway in
the opposite direction, you would see a kitchen at the far end. This is a busy room with a
fridge, microwave, sink, cupboards, table and chairs. It is morning and as I walk down the
hallway toward the kitchen I am greeted with the smell of freshly brewed coffee. Several
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framed photos hang from the walls at regular intervals. On closer inspection, they are not just
photos but actually the covers of journals related to genomics or the first page of articles
published by Laboratory X employees. One of the frames contains a photo with humans: two
children – twins – one with the phrase “I’m with Nature” and the other with the phrase “I’m
with Nurture” written in block letters on their matching T-shirts. Just to the left of the
kitchen, near the end of the hall, is the door to the academic offices. Tyler, one of the senior
research coordinators here, used to sit at the first cubicle but has recently been moved into his
own office. He is still unpacking boxes. Penny, the main administrative assistant has an Lshaped desk in the middle of the room. Beyond this desk are more cubicles, primarily
housing the bioinformaticians. The director of the whole laboratory has an office to the right
of the admin desk. His office is fairly small, the size of a typical university academic office,
but is adorned with a beautiful view out a large picture window.
For the most part, people in the academic office are sitting at their cubicles working
on laptops. They do not have telephones (something I learned when trying to set up a
telephone chat with one of the post-docs). The people who inhabit the research office do not
wear lab coats or safety glasses. Everyone is dressed very casually, not surprising since many
of these people are students of one sort or another. Jeans and a long sleeve jersey or sweater
seems to be the preferred attire. There is beige carpet on the floor in here and the office
somehow feels warmer and more relaxed than the rest of the facility.
I can hear Dr. Lorenz approaching the academic office. He is telling someone that he
took the subway to work and was surrounded by people more sick than he. He is wearing a
red sweater with a dress shirt collar neatly folded over the top along with blue jeans and
black shoes. A large black leather shoulder bag/ brief case is slung over one shoulder,
bulging. His brown hair is cut short and he looks tired this morning. He sneezes. There is a

116

group of people standing in the hallway. Tyler and Brittany are among them. Dr. Lorenz says
jokingly, “I thought the meeting wasn’t happening until 9:30”. A woman approaches him
and tells him that she is having a problem with someone who has not been showing up on
time. Dr Lorenz and this woman disappear around the corner into his office.
So far you have met a few of the people that will become important in my recounting
of the travels of DNA as it moves throughout the laboratory. I have given you a general
description of the spaces that make up the Laboratory X, as you might see them upon
entering the facility for the first time. Now, I will shift gears. I want to give you a more
detailed account of a sample of DNA as it moves through the facility. I will move from
describing not only what you would see with your eyes but also what is being done, with
hands and robots and computers. I warn you, the number of actors you are introduced to is
about to magnify significantly as we zoom in on the trail of a single DNA sample.

5.2. From Individual to Blood
And I think for their lab it’s a lot more biology and science and that kind of stuff,
not clinical like it is here... sometimes they don’t understand what we’re doing or
why it takes us so long to do things. So for us, I feel like we have to balance that a
lot around here versus them, they just look at the data, they look at the blood. It’s
more straightforward, cut and dry. (Excerpt from interview with psychology
student/ research assistant at the Autism Clinic)

5.2a Collecting Blood
Just prior to the start of my data collection, the protocol for the genetics study
changed. Previously, every participant was first “deep phenotyped” and then their blood was
taken and sent onto the lab for genetic testing. The deep phenotyping included all the
psychological assessments (i.e., ADOS, ADI-R) and took two days to complete. In the new
protocol, however, only a brief phenotypic profile is gathered before blood is taken. The
limited phenotypic data collected includes a photograph of the individual and the parents, as
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well as having some questionnaires filled out by the parents. Deep phenotyping is now
reserved for only the very few participants who have “interesting” genetic findings. In the
new protocol, genetic testing comes first with phenotypic assessments after for select
participants. I was told that this change in protocol was implemented in an effort to reduce
costs, as phenotypic assessments are time-consuming and expensive.
Individuals diagnosed with autism and their family members give blood in the blood
lab located on the main floor of the hospital. The genetics project coordinator, Claudia from
the Autism Clinic, typically walks them over to the triage area in the new atrium of the
hospital. I will recount one of the blood draws that I observed early on in my fieldwork; at
this time everything was new to me and my notes are particularly detailed about this event.
Through revolving glass doors, we arrive at the new atrium with a mother named
Jane, a father named Bruce and their teenage daughter, Alexis, who was diagnosed over ten
years ago on the autism spectrum. Claudia takes Jane over to the desk where she has to fill
out some paper work. A woman behind the desk takes all of their health cards and runs them
through her computer. While Claudia stays with Jane I sit down with Bruce and Alexis on
one of several green leather padded benches scattered in the waiting area. Alexis leans her
head against her father’s shoulder while he puts his arm around her. Nestled against her
father, her red hair pulled back in a pony tail, she begins quietly humming to herself. I can
not tell if her eyes are closed or if she is just looking down. There are large glass windows all
along the wall and plenty of natural light. The walls are painted green and yellow and lively
murals depicting beach scenes surround the upper walls around us. This is the new part of the
hospital. Lots of people come and go through the revolving doors behind us. From where we
are sitting the reception/ check-in area is off to my right and to the left is a cafeteria. A large
stairwell ascends to the second floor and a glass walkway spans the atrium above us, leading
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to another part of the hospital. The ceiling is very high and everything echoes. I can hear the
sound of water falling, coming from a fountain in the cafeteria. While we wait, I tell Bruce a
little more about my study. After a while, Claudia comes back to our bench and asks Bruce if
he could roll up Alexis’s sleeve so that Claudia can rub a small amount of numbing cream
onto her arm at the spot where the needle will later be inserted.
Claudia asks them to wait here where their daughter is comfortable while we rush
ahead to the blood lab to make sure they are ready. We return to the atrium, bringing a wheel
chair with us for Alexis. While we walk out of the atrium and down the hallway leading to
the blood lab, I can tell that the mother and father are feeling a little anxious. Being poked by
a needle in order to fill six or seven tubes is not fun for any of us, to say the least. For people
with autism it can be extremely frightening and disturbing. Bruce must be anticipating this
while we approach the blood lab because he reminds me that this is a very stressful event for
them. He says I can observe but if Alexis gets very agitated I should leave the room. He
might have to hold her down in order to do the blood draw.
There is an ethical issue here that I faced repeatedly throughout this research. Although I
had obtained informed consent from each participant,I was constantly aware that observing
these very intimate, private and stressful events (such as feedback sessions or blood and
tissue collection) was an unbelievable privilege. I was a complete stranger to all of these
people and they allowed me to follow them into highly emotional and private events. What
right did I have to be there? Was my presence contributing more stress in an already
stressful situation, just so that I could collect data for my PhD? I was constantly on the
verge of apologizing for even asking to be there. In these situations I tried to make myself as
small and unobtrusive as possible.
The hallway outside the blood lab is very busy and often noisy, as there is a constant
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stream of hospital employees and patients walking past the lab in order to reach a bank of
elevators located nearby. The canteen is also located down the hall from the blood lab.
Once in the lab, Claudia gives the paperwork to the administrative assistant behind a desk.
We all wait in a small, grey-walled waiting room with a television playing in the corner. The
television helps to distract Alexis while Bruce and then Jane are taken out into the main
room. A curtain is pulled around so that there is some privacy for the parents while their
blood is drawn. Alexis is sitting in a wheel chair watching Toopy and Binoo on the television
in the corner. She grows a little anxious when, for a few minutes, her mother and father are
both out of the room getting blood samples collected. She holds on tightly to a small Fisher
Price children’s tape player. It sounds familiar: Raffi. Periodically she bends down to tap her
fingers on one of her neon pink running shoes. She probably doesn’t understand who we are
or why she’s here or where her parents have gone. Claudia reassures her that her mother and
father will be returning to the room very soon.
After a few minutes her parents are finished with their blood draws and we all file
into a small room. A hospital bed stands immediately to the left of the door. Rows of tubes
are lined up across the starched white sheets pulled tightly across the bed. The tubes are each
labelled and capped. The caps are different colours. Some are for clinical testing and others
will be passed on to Laboratory X for genetics research.
It struck me that these tubes were significant. They marked a demarcation between the
individual as a human body, whose emotions, behaviours and personal characteristics were
perceptible and the individual as a number, a tag on a tube. Without that labelled number,
the blood inside the tube would be unidentifiable from any other blood. The patient ID
number becomes a place holder for all the individual characteristics that make a human an
individual. In the language of actor-network theory, the ID tag is made to ‘stand in’ for the
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individual, temporarily suspending a whole network of actors.
Alexis is wheeled into the centre of the room. There are six of us jammed in around
her in this tiny space. One nurse brings over a DVD player to try to distract Alexis. Jane says
“no thank you”; it probably won’t work for the needle. It’s better if her daughter can just
listen to her mom’s voice. Alexis remains sitting in her wheelchair while a large, friendly and
confident nurse rolls up the sleeve of the girl’s sweater and inserts a needle. Alexis pulls
away slightly but is calmed by her mother who stands directly in front of her. The nurse
keeps a friendly banter going. Alexis is doing very well. Her agitation was noticeable only
through the noises she makes which grow louder and by the tears welling up in her eyes.
Both her parents are touching her and talking to her to try to keep her calm. I edge back
closer to the doorway behind me, ready to leave if things start to escalate. I can feel that my
heart is beating faster. I feel like such an intruder. It only takes a few minutes to fill all of
the tubes with dark red blood. After all of the tubes are filled, Jane gives Alexis a croissant as
she has not eaten since dinner last night. It had been a fasted blood draw for her. The cheerful
nurse reassures Alexis that it is all finished and praises her for doing so well. We all quickly
walk back to the new atrium and say good-bye. Alexis is tired and needs to eat and go to bed.
The parents had to medicate her with Ativan prior to arriving today. I am exhausted after just
observing the event as a “detached” outsider. I can only imagine how tired the parents and
child must be feeling.
We walk the family back to the atrium of the hospital. While they drive away in a
grey sedan, their collected blood remains behind. For the family, the ordeal is over for now.
They go home to recuperate. Their work is done. For the little tubes of blood, the journey is
just beginning. At this point, the tubes with different coloured caps go their separate ways.
Some of the tubes go to the clinical lab at hospital where information is collected pertaining
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to iron or thyroids but unrelated to the genetics investigation. Another set of tubes that was
collected will go to the Laboratory X for biobanking. Here an “immortalized” cell line is
established and refrigerated indefinitely, a back-up source of DNA. Still a third set of tubes
will first move through the DNA extraction lab before making their way into Laboratory X
for genetic testing. It is this third set of tubes that I followed.

5.3. From Blood to DNA
The DNA extraction lab is located in the hospital in the Department of Paediatric Lab
Medicine. DNA extraction for the autism genetics project is performed by a robot, an
automated machine called Autopure, made and distributed by Ciagen (formerly Gentra). The
Autopure is the size of a large laboratory refrigerator, perhaps five feet tall and four feet
wide. One of the laboratory technicians explained the extraction process from her
perspective: you just “pour your blood into barcoded tubes, scan them, load them and then
when it comes off in about an hour and a half, it’s DNA!” When pressed to describe what she
and the robot do with the blood in more detail the story unfolded in this way:
First, the DNA extraction lab receives one eight millilitre tube containing the blood
from an individual with autism. If the blood is fresh and “uncompromised”, they log it into
their database and assign it a DNA number. They check the identifiers on the tube to make
sure they match with what is written on the requisition form. For clinical bloods they require
two identifiers. For research, however, they allow just one identifier, a study number, to
accommodate the concerns over confidentiality enforced by the ethics review board. The
Autopure extracts DNA in batches of sixteen. At the front of the machine there is a rack of
sixteen large 50 ml red-capped tubes, two rows of eight, each with a small barcode on the
top. The technician scans the barcode and matches each one with the DNA sample number.
The blood is poured into the barcoded tubes, the lids are closed. Next, an uncapper comes
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down, a vacuum manifold, and lifts up the red tube caps. It holds onto them in rows of eight
at a time. The tubes are lifted up on a rack and slid over under a pumping dispenser. The
pumping dispenser has tubes that run back to large four to ten litre jugs of reagents. An
appropriate volume of reagent is pumped into the tubes and then they are re-capped,
transferred to the back of the robot and locked into a rotator where they are inverted. The
machine can gently rock the tubes or vigorously vortex them. This is what I can see with my
eyes. What is not visible is what is happening to the blood at the cellular level. The Autopure
isolates the white cells because there are no nuclei, no DNA, in red blood cells. The nuclei of
the white blood cells are ruptured and the DNA is released. The proteins are separated away
from the DNA and then several washes in ethanol rid the DNA of any contamination. At this
point, when the machine is doing the washes, the DNA in the tubes looks a little like cotton
baton, white and fluffy. The DNA is “pelletted down” and put into a blue-capped tube,
inverted so the ethanol evaporates off. The DNA has now been extracted but it still needs to
be put in a hydration solution and rotated over night. The solution contains a buffer to protect
the DNA from degradation. The samples are then stored at four degrees and every two weeks
the lab technicians generate a “send out”. A technician pulls all the samples and checks that
the DNA number, aliquot volume and concentrations match. The technician signs off on this
and then puts the samples in a basket. At this point, Lisa from Laboratory X walks over and
picks up the extracted DNA tubes.
Since the blood was taken from the child’s arm it has been given a patient number, a
DNA number and a barcode number. Poured from one tube into another, white blood cells
have been isolated from red, nuclei shattered, proteins separated from DNA. It has been
washed in ethanol, dried and alluted into a buffer solution and stored in a refrigerator at four
degrees. The blue-capped tube containing extracted DNA now sits in a basket, waiting to be
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picked up and walked over to the Laboratory X.

5.3a Into Laboratory X
Lisa is a project coordinator in her mid-forties. She has a Bachelor’s degree in
microbiology and has been working at Laboratory X for fifteen years. She works four days a
week here and one day a week at the autism clinic. When Lisa walks over to the DNA
extraction lab to receive the tubes of blood they usually already have a unique identifier tag
or label on them. Back at her own desk, she inputs these data into a database, which
generates a spreadsheet. She double checks to make sure that all the data are correct (e.g.,
date of birth). The tube of extracted DNA is kept in storage until the coordinator of the
academic section is ready to run experiments on it.
There are three main types of genetic experiments that occur in this lab, each
associated with a different scale or resolution of detection. At one end of the spectrum there
is cytogenetics, which focuses on microscopically visible cells. Karyotyping or fISH are
examples of cytogenetic experiments. For autism cases, these experiments associated with
cytogenetics are primarily reserved for validation of other findings. At the other end of the
spectrum is Next Generation Sequencing (NGS). This technology is used to find single
nucleotide polymorphism or SNPs (pronounced snips). NGS is able to detect a change in a
single base (e.g., a T that is now a C). In between cytogenetics and NGS is a technology
called microarrays. Microarrays, frequently referred to as arrays, are able to detect deletions
or duplications in stretches of DNA. These deletions or duplications are called copy number
variations or CNVs.
After arriving in Laboratory X, an autism DNA sample flows through these various
experiments and technologies. The first line of investigation is a microarray followed by its
associated cytogenetic validation experiments. Based on certain criteria, the sample might
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then move through an NGS experiment. If an interesting mutation is found along the way, the
case might be discussed at one of the laboratory meetings before being written up in a report
to be given back to the clinician. What arrives in the laboratory in a little glass tube will leave
the laboratory as words on a research report. Below, I will try to describe all the work, the
activities, the ways of seeing, probing, investigating, the various and multiple conversions
and representations that occur within the laboratory. I have pieced together a story that
follows what happens to the DNA in a little glass tube: from microarray to NGS to
computational analysis, until eventually it exits the laboratory as words on a research report.

5.4. The Microarray Process: From DNA to CNVs
Much of what I learned about the details of the microarray process came from a 5thyear PhD student named Ankit working under the supervision of Dr Lorenz, the director of
Laboratory X. I interviewed him several times and interviews would often last for two to
three hours. We also had lunch together on several occasions when I would learn about the
more informal, behind-the-scenes operating of Laboratory X. During his undergraduate and
Master’s training in microbiology Ankit used to spend a lot of time in the laboratory but now
his time is almost exclusively devoted to analysis and interpretation of results.
Consequently, he was able to talk me through the entire process. I was also able to interview
the manager of the microarray facility and to observe the two technicians who run the
Illumina array platform on several occasions. The entire experiment can take several days to
complete with different activities occurring on different days of the week. Through these
various observations and interviews I have pieced together below the microarray process.

5.4a Clinical vs. Research Microarrays
Before describing the microarray process, a distinction must be made between clinical
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and research microarrays. The microarrays run at Laboratory X are research microarrays.
They are high-resolution, meaning that they interrogate the human DNA strand at many
points allowing for a more detailed view in more locations along the genome. In comparison,
the clinical microarray probes the genome in only a few places. It targets only those areas in
which genetic variation is already known to be associated with pathogenic outcomes. The
linkage between the clinical array lab at the hospital and the research arrays at Laboratory X
is a strong one. I frequently saw members of the clinical array laboratory at the Monday
morning meetings at Laboratory X. Many of the cases that were discussed at these meetings
were originally from the clinical lab. If the clinical lab is unable to find any CNVs on their
clinical array platform but they still suspect a CNV to be involved, they will send the sample
on to Laboratory X so it can be run on a higher resolution research array.
Significantly, just prior to the beginning of my field work, effective March 1st, 2011,
the Ontario Ministry of Health and Long-Term Care began funding post-natal clinical
microarrays for children with intellectual delays. The cost of the clinical array is now
covered by OHIP, the Ontario Health Insurance Plan. Now, if a family doctor or
paediatrician wants to refer a patient to a clinical geneticist because the individual has a
developmental delay or autism, a clinical microarray must first be ordered before the referral
can be made. There are two things that are important about this change. First, since March
2011, any physician can order a microarray (a family physician or paediatrician, for example)
and not just a clinical geneticist. This also means that the results of the array are being sent
back to and interpreted by the family physician or paediatrician. This is important for a
discussion on knowledge translation as, according to the participants in this project, there is
much concern over whether or not the referring physician will be able to interpret the results
of a microarray. In particular, arrays with results of “unknown clinical significance” can be
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confusing and tricky to interpret for even the savviest of clinical geneticists. Secondly,
important for theoretical consideration, the clinical microarray has now been made a
mandatory step in the referral process. The micro array is one of the criteria that must be
fulfilled prior to being seen by a clinical geneticist. In the language of actor-network theory,
the array has become a significant actor, an “obligatory passage point”.

5.4b Running a Research Microarray
We are at the far end of the laboratory. When you first take in the scene it is
overwhelming, visually exhausting. There are so many things to take in at once; my eyes
don’t know where to land. There are bottles, boxes and machines crowding the rows of black
benches. Every inch of space seems to be packed with labelled jugs of solutions with names
that are unfamiliar, glass beakers, boxes of tubes, fridges, and many different machines. Two
long, scratched up canisters stand at the end of the bench, for oxygen or some other gas I
guess. They seem to me like they might be relics unearthed from a long ago submerged
submarine, faintly reminiscent of a sepia-toned wartime photograph I might have seen. I have
no reference for many of the items around me. For someone who has never stepped foot in a
laboratory before, it feels as though I’ve stepped into another world. I recognize almost
nothing. The only thing that looks familiar is a white fridge that appears very similar to the
one that stands in my kitchen at home. The similarity stops there as the contents inside are
alarmingly different. No milk jug or yogourt in here; instead, there are stacked up plates with
rows and rows of tiny labelled tubes containing DNA extracted from hundreds of individuals.
The air in the laboratory is warm from all of the heat given off by the machines. A constant,
loud humming sound drones on in the background.
Today I am watched two different technicians, Mitsie and Chang. Mitsie tells me to
set my backpack and coat on one of the chairs against the wall. She wears a long white lab
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coat, her jeans and running shoes poking out the bottom. Light green plastic gloves are
stretched over her hands. Her black shoulder-length hair hangs loosely around her neck. The
aisle where she is working today is about three feet wide. On one side is an Illumina
microarray machine. It is about three feet by three feet and two feet deep, essentially a big
box sitting on the top of the black bench. It has a dark grey, opaque, plastic shell. There is a
monitor attached at eye level and a keyboard sits in front. A large metallic arm is located to
the side of the machine, the auto-loader which moves the plates carrying the prepared
microarray chips inside the machine. Across the aisle sits another computer. Beside this is a
large robot, about four feet long and three feet high and three feet deep. It too sits atop the
bench. It has a glass front which can be raised up or down and a slit cut out along the bottom
where the technician can reach her hands into the machine. There are other machines near by
as well, a centrifuge for spinning samples, a hybridization oven, and more computers. There
are a few spaces between machines and equipment so that I catch glimpses of the man
working on the other side of the bench, bent over a computer. I see him glance at me
quizzically a few times. Strangers are an anomaly in the laboratory where an intimacy
develops amongst technicians over years of working side by side with each other. Hands and
bodies seem to effortlessly slide into well-choreographed, predictable movements. Although
I try to stand out of the way, try to be aware of the movements of the other scientists in the
aisle, as I concentrate on capturing the details of the practices surrounding the microarray I
am often encumbering somebody’s pathway.
Before the array can be run, the lab technicians have to wait until there are enough
samples collected because arrays are run in batches. Typically there are ninety-six samples
on one plate. The tubes that Lisa picked up from the DNA extraction lab are sitting in the
fridge. Mitsie takes them out and lets them sit so that they will be brought up to room
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temperature before being loaded onto the microarray chip. There are several different
machines and robots involved in the whole process of a microarray experiment. The first step
is to scan the barcode numbers on each of the Illumina chips. The chips come in an orange
box. Inside the box are maybe ten chips, each individually wrapped in a metallic package. On
the front of each is a label with a barcode. Illumina makes each of its chips slightly different
so that the probes on one chip are not identical to the probes on another. The barcode tells the
robot where to look for the position of the probes along the genome. She scans each package
into the computer using a little hand-held scanner. It reminds me of a price scanner at a
department store. On the computer screen in front of Mitsie, there is an Excel spreadsheet
open and every time a package is scanned a number appears in one of the boxes on the
screen. She is meticulous about checking the order of the packages. The order she scans them
in is telling the computer the order they will appear on the plate. There are specific loading
patterns and each chip needs to be positioned in a specific place on the plate. Before scanning
them she numbers the outside of the foil package. When I first observed I was not sure what
she was doing and asked her a question. She ignored me for several minutes and answered
later; I quickly learned that this was not the time to be asking questions. She joked that if she
makes a mistake in the ordering of scans, a sample that is from a female may be switched
with another and could come out as a male. “Then you know you’ve screwed up!” Each of
these chips cost three thousand dollars. Today they are preparing twenty four chips. It takes
her about twenty minutes to scan all of the chips. Inside each foil package is a small chip. It
is about the size of my second (“peter pointer”) finger. The barcode that was on the outside
of the package is also on the bottom of the chip. As Mitsie explained, “every chip has a map
of where the probes are”. On this particular chip there are two and a half million probes. The
chip she is using has eight different bands across it and each band will hold a different
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sample. She calls these different bands “grids”. At this point, each chip only holds the
probes, beads that were loaded on by the Illumina company. The patient sample has not been
added yet, that comes next in the hybridization stage of the experiment.
Before the patient samples can be added to the chip, the samples first go through a
stage called “amplification and digestion”. At this point, there is a clear plastic 6” square
plate with 96 little wells in it, arranged in a grid. Each of the little wells holds a small amount
of DNA, each a different sample from a different individual. Various reagents are added to
each well and left for a twenty hour incubation. Then it is pelletted down during a
purification step, leaving only the material that they want. The pellets are then dissolved into
a solution again. Enzymes are added to the DNA to “de-nature” them. This was explained to
me in the following way:
PhD Student:

So what you do is they first chop up the patient’s DNA so it’s not 3.1
billion base pairs together. It’s sort of fragmented into different…I
don’t know if you know about restriction enzymes?

Julia:

No.

PhD Student:

It’s not very important. Restriction enzymes, it’s a reaction mix that
helps you slice up ‘DNA.

Julia:

It kind of loosens them up or something?

PhD Student:

So it actually slices them. Slices a large chromosome into smaller
fragments. So it slices it up into small pieces.

After the samples are “de-natured” (sliced up), they are hybridized. During hybridization, the
probes on the Illumina chip are attached to the DNA sample from the patient. In the entire
human genome there are approximately 3.1 billion base pairs. The array company designs
chips so that they target specific areas of the genome. Each probe is twenty-five base pairs
long. On the particular chip they are using today, the company has built two and a half

130

million probes. The more probes, the greater the resolution and the greater the ability to
detect smaller deletions or duplications. If ten thousand probes are stretched across the
human genome the variation has to be much larger in order to be detected. If 2.5 million
probes are stretched across the genome the array has a greater ability to detect smaller CNVs.
For hybridization to occur, the sample of patient DNA has to be physically added to
the chip. I observed as Mitsie did this for 192 samples one day. The technicians have to be
extremely organized, knowing where each sample is being loaded. It takes two technicians
working in tandem along with the hybridization robot to load the samples on the chips. First,
Mitsie opened up the glass front door on the machine and fit in the first of two 96-well plastic
plates containing the 96 DNA samples in eight rows of twelve. This plate was fit snugly in on
the left of the machine. On the right side of the machine Mitsie places nine black containers,
each holding a glass chip (each chip will hold eight samples). Dangling from the machine
there is a little arm which holds eight thin needle-like prongs (called pipettes) pointing
downward in a row. These pipettes are spaced apart so that they fit exactly into the wells of
the sample plate. The arm moves back and forth a few times to orient itself and then lowers
into the sample plate, dipping into the first eight wells and sucking up the DNA. (I looked in
the plate later and saw that a small amount of DNA is left behind in each well as a back up in
case there is a mistake and the hybridization needs to be repeated.) After the DNA is sucked
up, the arm then moves up and over to the right so that it hovers above the top of the first
chip. Two of the eight pipettes lower down and touch the chip at exactly the spot where two
of the bands run across. Mitsie has reached her hand in through the slit in the glass front of
the machine to help guide the pipettes, making sure that they drop the DNA sample at exactly
the right place. The needles move up and the next two needles move down hitting the next
two bands on the chip. Again, Mitsie guides the robot so that the DNA enters the band on the
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chip at exactly the right place. This is repeated until the chip is filled. The robot arm then
moves back to the left of the machine and dips the eight pipettes into an ethanol solution,
cleaning them so that they can then be dipped into the next eight wells of DNA and the
process can be repeated on the next chip.
While the robot cleans itself, Mitsie takes the black cartridge out of the machine and
passes it to Chang. She takes the slide out of the black cartridge and places it in another black
cartridge. Using a pipette, she adds a small bead of water to each band on the chip. This is to
make sure that the DNA does not dry. If it dries, the DNA from the patient sample will not
bind to the Illumina probes. I can see that the little bands have changed colour slightly now
that they have DNA in them. At one point Chang told Mitsie they need to do one of the bands
again; not enough DNA sample was added and it hasn’t gone all the way across the band.
They will manually add more of that particular sample at the end. A top cover is secured over
the chip and from here it will be placed in the hybridization oven at 44 degrees Celsius for
eighteen to twenty hours. While the chip sits in the oven over night, the Illumina probes align
and bind to specific regions of the DNA sample.
I imagine the hybridization process is a bit like a grade six school dance. The oven doors
are closed on the microarray chips. I imagine that Queen starts playing or perhaps in
today’s ovens it would be some sort of techno music with a booming bass. At first all of the
rna probes are lined up against one wall while the sliced up fragments of patient DNA selfconsciously chit-chat across the chip. With the heat of the oven, like the music in the gym,
rna probes and DNA fragments begin to mix. Eventually, couples pair off and begin to dance.
A frantic flurry of activity begins as DNA fragments try to bind with an rna probe. There are
far more DNA fragments than rna probes. Anxiety sets in as more probes and fragments bind
off together. Everyone is jostling and bumping around on the dance floor. A shorter fragment
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is dwarfed by some of the other larger fragments. Suddenly, the shorter fragment bumps into
a probe. They circle around one another first, checking each other out. They realize they fit
together. They align! Their hydrogen molecules begin to bond. Eventually, all of the rna
probes are aligned to the corresponding DNA fragments. The remaining DNA fragments
bump around for a while, relentless in their search for a probe with whom they might bind.
Eventually these remaining fragments settle down and enjoy the warm heat of the oven,
perhaps chatting together in small groups and comparing stories about the previous ordeal
of being extracted from their intra-cellular friends a few days or weeks earlier.
I came back to the laboratory the following day and watched as the chips were
removed from the oven. At this point the chips need to be washed. The washing will get rid
of all the bits of patient DNA that did not bind to a probe. The only thing that is left on the
chip after washing is the segments of DNA that have bound to a probe. Below, are my notes
describing the washing process:
Chang tells me to come closer and stand by her. She has placed several chips,
horizontally, lying on their side, into a little wire basket and she is vigorously dipping it in
and out of a clear buffer solution. She does this for a few minutes. Bubbles are forming at the
top. At times one of the chips will become dislodged from the basket with the force of her
moving the basket up and down. She stops and carefully puts it back into the basket and
continues dunking it. The buffer is washing away all the non-binding DNA.
While Chang is doing this, Mitsie dumps the buffer out of a black container sitting on
top of the bench in front of her where the four chips were resting that she has now moved
aside. Chang pulls out the chips she has just been dunking and puts them into little black
cartridges. Mitsie puts on a rubber strip around the perimeter of the chip. Chang pours in
more buffer and Mitsie then puts on a glass slide. While Chang is dunking the next batch of
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chips, Mitsie is taking scissors and trimming away the excess plastic strips that hang over the
edge of the black metal cartridge. I can still see the little bar code on a white sticker sticking
out from the bottom of the black cartridge. Once these are trimmed they are put into a
container that holds four chips.
Chang and Mitsie are working silently, passing things back and forth without asking
or signalling to one another. It is obvious that they have done this many, many times together
and they have a carefully planned out rhythm and detailed choreography of their movements.
While their legs are standing still, if you were to watch just their arms and hands it does
almost seem like a duet or a dance of some sort that is being performed together.
At one point, when Chang is washing the next batch of chips, Mitsie walks over to the
next aisle. I follow her. She is loading all the black cartridges into the glass-fronted
“Freedom Evo” machine, the same machine that added the patient sample to the chips
yesterday. This time, the chips are placed vertically in a large black metal box. This is the
space in the machine to the right of the area where the hybridization took place yesterday. So
the same robot is capable of doing different tasks in the different spaces within the machine.
She closes the glass front. She walks over to the computer beside the machine and clicks the
mouse on a window that has popped open on the screen. A green light turns on at the top of
the machine. And immediately the little row of 8 needles/ pipettes goes down at the left and
submerges in a clear solution. There are a few different plastic wells along the back. One of
the wells is labelled RA1. The needles suck up some of the solution and then move up and
over to the right of the machine above the vertically placed chips. At this point Mitsie shows
me how each of the glass slides, which she had clipped on over the chips, has a little slant
descending toward the chip. The pipettes drop the solution into this little divot and it slowly
sinks down across the chip, moving across all 8 samples on the chip. Mitsie says she does not
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have to use her hand to guide the robot pipettes for this washing stage as she did for the
hybridization. This is because the divot in the slide is the entire width of the chip and as long
as the pipette hits it somewhere in that little well it will be fine. She just has to be sure she
has put the slides in the right way or the solution will just run over the top and not have a
little well to sink into. The pipettes go back to the left of the machine and dip themselves into
another solution. She shows me the different buffers it goes through and then says that the
last two, on the right, are the stains. These stains are dropped into the chips in the same way
as the buffers. The stains are what allow the DNA to become florescent when they are
imaged in the microarray machine. After that, all the slides and clips are removed from the
chips and they are washed once more and then a coating is put over top of the chip. They are
dried and then they are ready for the array machine.
From here, the chips are loaded into the microarray machine. It takes about an hour
and a half for each chip to run through the machine. Because there is an opaque plastic cover
on the microarray machine, I can’t actually see what is happening inside. To the side of the
machine several chips are stacked up waiting to be put through the array. There is a coat on
the top of them that Mitsie says she would not want to touch. She always wears gloves at this
point. She says I should ask Chang to show me the image on the computer monitor. Chang is
just putting out the garbage, a clear plastic bag filled with various empty bottles that they
were using this morning for washing. She places the garbage just outside the door of the lab
and comes back in. She nudges the mouse and the microarray screen lights up. The upper
half of the screen is full of green and black dots. The lower half of the screen is full of red
and black dots. Chang tells me that if a location is green and red it is heterozygous. If a
position on the chip appears as only green or only red, then it is a homozygous call. A runner
along the left edge of the screen displays a rectangle for each of the 8 samples that are
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currently passing through the machine on one chip. A blue box sits on top of the sample that
is currently being scanned. It is on the 4th sample right now. As the machine finishes a chip
the rectangle on the left side of the screen becomes coloured. The top sample, that has
already been scanned looks different from the others that have already been scanned. The
others are all green. Each square, representing a sample, is divided into four horizontal bands.
On the top sample rectangle, there are alternating red and green bands. Two of the bands that
should be green are red. This means that something has gone wrong. Chang tells me that it
could be the decode data that was downloaded. Sometimes they have to download the decode
data again and it will be fine. Alternatively, it could be the sample. I talk with Mitsie about it
later and she thinks it’s not the decode data; it’s the sample because all of the other sample
rectangles seem to be coming up fine. Sometimes the sender gives them enough DNA to do a
re-run, but sometimes they don’t and they have to go back to the sender and ask them for
more sample to trouble shoot.
Although I cannot see what is happening inside the microarray machine, the process was
explained to me in this way:
PhD Student:

These probes are sort of fluorescent and when they bind to something they
light up. So every probe that’s bound to something, it lights up with a
certain intensity. You take a picture through a fluorescent scanner and you
get an idea of the intensity of each probe. So each probe will be a dot in this
picture. The chip itself is very small but it has 1.8 million probes on it and
you have data from 1.8 million points in this picture.

At this point the DNA has been converted to little green and red dots on an image. The
computer file is then sent out of the lab to one of the post-docs or graduate students in the
academic office. This is another significant conversion. The material being worked with from
here on is no longer the physical substance of the human body. It is computer generated
graphs and numbers that make their way out of the wet laboratory and into the research
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office. Of course, these computer files are carefully linked to the DNA through patient
identification numbers.
Although, for simplicity, I often describe this research as following DNA as it is translated
between three locations (clinic, lab, home), each one of these locations is actually a complex
arrangement of spaces and networks. What I call “the lab” could also be described as
several distinct locations, spaces within spaces. For example, there is the “wet lab” where
patient materials – DNA – is sliced, buffered, hybridized, warmed in an oven, washed, dried,
and photographed. Gloves, goggles, lab coats, bottles, pipettes, tubes, and a lot of different
chemicals are all integral to the network of this space. The academic office, or “dry lab”,
however, contains none of these artefacts. Computer files, spreadsheets, mathematical
algorithms, journal articles are the property of this space. There is movement between these
spaces and their close proximity is important. People from the dry lab might periodically
move into the wet lab, checking on a procedure if a result does not seem quite right. For the
most part, technicians from the wet lab do not, however, move into the dry lab. In the wet lab
patient materials are translated into computer files. In the dry lab, the computer files are
interpreted, graphed, written up into reports. So while “the laboratory” may be described as
a unified whole, a single place when it is discussed by clinicians, it is also a complex
arrangement of distinct, highly differentiated but related spaces for those who work inside it.
Figure 5.2: Flow Chart Depicting CNV Interpretation Process
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Once the microarray data is moved from the array machine in the laboratory to the
computer of one of the academics, it is actually a binary code to a text file called a .cel file.
This file contains the probe intensity information. The scientists take this binary information
and load it into the company software, which then converts the information to text. There are
different microarray companies (Illumina, Affymetrix, and CGH), and each company
produces its own proprietary computational software. However, academic lab groups also
develop their own open-source software for analyzing microarray data. The scientists I talked
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to explained that they used multiple tools (software) in interpreting microarray data,
combining the results to increase specificity. A PhD student explained:
If you used just one tool to identify CNVs on your microarray, you’ll find that
there’s a false-positive rate, which can be as high as thirty or forty percent. So,
for example, if you get an array from a lab for a patient and use a single tool, it
tells you there are like a hundred CNVs. But if you actually went to the lab and
tried validating them by quantitative PCR you would find that only 60 of them
would be real and forty of them would be false. This would be a case for any
tool. So if you take three different tools and you take only the CNVs that were
detected by at least two of the three, those tend to be real. So the validation rate
for those is like ninety percent. This is actually a big deal because we have too
many patient samples to go and validate all of them together. So we just stick to
the stuff that is more likely to be real.
There is another reason why combing results and increasing “true-positives” are important. It
not only saves time by allowing lab techs to run validation experiments on fewer samples; it
also is important because CNVs have to be reported back to the clinic. Ankit explained in an
interview, “It reduces the chance of them being false, which is a big deal when you’re
reporting results to a patient. So, you need to make sure it’s true before they make any
clinical decisions or something based on that.”
The software provides a visually friendly format from which to analyze the data. The
microarray information can be plotted on an intensity graph. The intensity of a probe is
directly related to the amount of DNA that has bound to it. If more DNA binds to a probe, it
lights up more. If no DNA binds to a probe it won’t light up at all. If there is no light signal
from it then it will show up black. This can all be captured on an intensity graph, which has
an X-axis as the central line. Most probes cluster at this central line. This line corresponds to
a copy number of two. Usually a person has two copies of every base, one inherited from the
father and one from the mother. When the probes on this graph dip below the central line it
means there is less genetic material binding to this probe and only a copy number of one.
This means that there has been a deletion of genetic information. The microarray has “called”
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a deletion.
Ankit clicked on the program and was able to zoom in and out on the chromosome,
quickly changing scale and allowing him to analyze the data in different ways. With another
click, the program showed him the “break points” for the deletion which told him the exact
position of the deletion. It also showed him which genes were located there. This is the first
indication that there might be a deletion in this region. However, the person interpreting the
graph is not certain. The intensity graph cannot be trusted on its own. This is because
sometimes probes fail because of technical problems. If a probe fails, it would look like a
deletion on the graph, but it’s not real. A PhD student explained:
PhD Student: So this is why you have to validate everything the array calls with something
else before you report to patients or to clinicians. You’ve got to show that it
exists. So this is why we use either fISH which I showed you before or we
use something called quantitative PCR, qPCR, which is sort of the same
thing. It’s an independent experiment with confirmation of a deletion or a
duplication.

Once the CNV has been validated with qPCR, the next step is to identify whether this
deletion or duplication is in a region (usually a gene) that is already known to be associated
with autism.
In addition to the graphical view of intensity information, the microarray software
program produces something called a CN segment summary. This provides a list of all the
CNVs that the software found for each sample run in a batch on a microarray. The segment
summary shows several columns including: sample name, copy number state (whether it’s a
loss or a gain), chromosome number and coordinates within the genome. For each sample
there will usually be about forty or fifty CNVs found. However, most of these are found in
the general population. The scientists need to distinguish between those CNVs that are rare
(and most likely contributing to the phenotype) and those that are common in the general
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population. In order to do this, there is a comparison between patients (called cases) and
controls.
When talking with me about the analysis process, Ankit switched on his laptop and
brought up something called the DGV, the Database of Genomic Variants. It’s a free on-line
database, which I later looked at more closely at home. Throughout my fieldwork, this tool
was repeatedly used in meetings to discuss variants. The DGV allows you to zoom in on any
region of the human genome. There are various tracks that can be turned on or off. It
distinguishes between exons and introns. An exon is the part of the genome that codes. It is
made up of genes. An intron is a region of DNA that does not contain any genes, but
sometimes it is important for regulating genes. It used to be called junk-DNA but scientists
are realizing that it might actually have important epigenetic functions. On the DGV, the
exons are represented as vertical bars and the introns are horizontal bars. So, for example,
you could look at the NRXN gene on chromosome 2. The DGV will tell you that you are on
Chromosome 2 and give you the coordinates. Chromosome 2 is approximately one hundred
fifty megabases long. The position on the DGV might zoom in to display between fifty and
fifty one. It will also show you the probe distribution in this region. The green bars show you
that there are plenty of probes in this location. So if there is a CNV, it should be picked up.
The DGV is also an amazing resource for interpreting CNVs. This is because the DGV also
compiles all the information published in academic papers that report CNVs. For example,
according to Ankit, in the last seven years there have been about one hundred studies of
CNVs in the general population. One study might look at CNVs in a thousand Europeans and
another might look at CNVs in a thousand Africans. The DGV builds up all this information.
This is important because all people have CNVs and so the people looking at patient samples
have to interpret whether or not these are rare in the general population, if they are primarily
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seen in cases and not in controls. For every gene, the DGV tells you what deletions or
duplications have been commonly found in the general population. A blue line would show
you a duplication and a red line a deletion (the colours sometimes change). So if a deletion
has been validated using qPCR the PhD student will then go to that exact region in the DGV
to see if that same deletion is frequent in the general population. If there are very few
deletions or duplications in that region amongst controls that information also supports the
significance of that genetic variation as potentially related to the variation in phenotype.
Another way to determine if a particular CNV is found in the general population is to
look at the CN segment summary. Here, there is a column titled “percentage overlap”. This
column indicated how much of the sample CNV overlaps with CNVs already found in the
DGV, which are found in the general population. Most CNVs that are called overlap 100%
with the DGV, meaning they are common in the general population. So, you only investigate
further the ones that say zero percent. These are the CNVs that are not found in the DGV and
are therefore not found in the general population. This means that they are rare deletions or
duplications. Roughly one CNV from each sample will not overlap with the DGV. At this
point you can further filter out the CNVs that do not touch on genes; these ones are intronic
and are less likely to be significant.
Ankit opens up PubMed and types in the name GPHN, the gene symbol for Gephrin.
Immediately, fifteen papers appear in which this gene has been described. Some of the papers
describe a particular disorder in which GPHN is involved and other papers describe
functional information, telling the reader what the particular protein does. This is useful for
new genes. However, when a gene has been well described over time Ankit uses the OMIM
database. OMIM stands for On-line Mendelian Inheritance in Man. He stated:
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So, there are twenty thousand genes in the human genome, give or take a few
thousand. A certain fraction of those have been reported in disease before. If you
run a genetic test on somebody and certain genes come up you want to know if
the genes that you found have been reported with a particular phenotype before.
So, essentially they compile papers together and they come up with lists of genes
that have been reported as mutated in specific disorders.
Thus far in the process of detecting CNVs, a microarray was run and a deletion was
found by looking at an intensity graph. Then this was validated using qPCR. Following this,
the region was compared to the DGV and found to have no similar mutations in this region in
controls. At this point, the PhD student needs to learn more about this CNV. Was it inherited
or de novo? De novo CNVs are deletions or duplications that are not inherited. They arise
spontaneously in individuals and often seem to be more likely to be associated with
phenotypic variations indicative of autism. If the laboratory already has DNA collected from
the mother and father of the case (called the proband) then a micro array can be run on them
separately. The PhD student told me that autism was particularly successful at getting trios
(mother, father and child DNA) because diagnosis tends to happen early on and the child is
accompanied by his or her parents at clinic visits. (In comparison, in schizophrenia it is much
more difficult to acquire complete trios because patients are often in their thirties or forties
and sometimes their parents are no longer alive.) Once you have all three samples plotted on
an intensity graph you can easily see if the mutation is de novo. If the probes on the mother
and father’s graphs are all clustered along the central axis, then they both have a copy
number of 2. The dip in probes below the axis on the proband’s graph is not inherited from
either mother or father.
There are other ways that CNV data are interpreted and analyzed. The PhD student
explained:
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PhD Student:

So they run the microarrays and they give us the data, like, the fluorescence
data. So obviously the CNV data is computational because you can’t go
through probes individually. So the array that they are currently running is
from this company called Ilumina. So they give us this software called
Genome Studio. So it sort of streamlines the whole analysis procedure. So
the arrays are fed into this software, like the information on the arrays, like
the intensity information.

He showed me how Genome Studio worked. He was able to change chromosomes in the
browser and to zoom in and out. Here is another excerpt from one of our conversations:
PhD Student:

So that’s SNP data. This is intensity data. Now how does this CNV look? A
NRXN1. So this is zoomed in [moving the mouse around], Chromosome two,
zoomed in. [Clicking with the mouse] So if you want to see the [clicking] so
this is the whole of chromosome two. Like it’s generally along this baseline.
But you’ll see at some of the positions, some of the probes are lower. These
could be deletions. In fact, the NRXN1 is here. So if you zoom into this
position, it looks like this. So this is just the NRXN1 locus, it shows you
where the gene is. And here is your baseline which corresponds to copy
number 2. So you see that they always cluster around the baseline. So most
of the regions of chromosome two, the person has two copies. This is what
you’d expect. Except here you suddenly see these probes fall off a cliff.

Julia:

Right.

PhD Student: So that is where your deletion is expected to be. And the interesting thing, you
can sort of see a pattern in the genotypes as well. So if two copies are
present, of DNA, you’d expect there to be three combinations, right.
Homozygous for one base, homozygous for the other base or heterozygous.
So you can see that the heterozygous was present when there was two. It can
be homozygous, heterozygous or homozygous. But in the deletion region
there’s no heterozygosity possible. So it calls it homozygous so this sort of
supports the intensity information.

At this point, after examining the CNV through the DGV and the Genome Studio software,
the case might be discussed at an upcoming Monday morning meeting as an interesting
finding.

5.5. Validation – From CNVs to Real CNVs
Several times in my field work I heard people talking about fISH or qPCR. These are
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techniques that are used to validate microarray results. fISH stands for fluorescent in situ
hybridization. When a technician finds an unbalanced rearrangement of genetic material (a
deletion or duplication) they cannot be sure that it is real. Microarray results can be “a bit
noisy”. Investigators need to add another layer of evidence, another independent test to
confirm the variation. Ankit explained it this way:
You’ve got to show that it exists. So this is why we use either FISH which I
showed you before or we use something called quantitative PCR. qPCR. Which is
sort of the same thing. It’s an independent experiment with confirmation of a
deletion or a duplication.

With an array, you put the DNA on a slide and see right across the human genome. With
fISH or qPCR, you have to know the specific region you’re testing. For example, an array
showed that there was a segment on Chromosome 16 that was duplicated in an individual
diagnosed with autism and Ankit needed to have that verified.

5.5a fISH
fISH is within the purview of cytogenetics. The cytogenetics office sits off to the side
from the main lab, a small room, perhaps ten feet square in area. The walls are circumscribed
by lab benches with a few work stations (designated by stools or chairs) in various places.
There are two microscopes in the room. One day, when I was interviewing the manager of
the cytogenetics lab she showed me around. A more junior cytogeneticist sat perched on a
stool, clad in a white lab coat, bent over a microscope. Around the perimeter of the room, are
a series of “chromosome paints” in bright colours. They’re quite beautiful actually, like
modern abstract art. The manager of the cytogentics lab explained to me that the work carried
out in her lab is considered quite obsolete compared to most of the newer technologies. The
objects that are worked on in this lab, chromosomes, are microscopically visible. The
scientists who work in this lab are tuned to or oriented toward an entirely different object.
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The landscape of the cell, interrogated through a microscope, is comprised of completely
different components that the landscape of extracted DNA which is probed through
microarrays or sequencing. There is very different work going on here in this small
laboratory by these few scientists, sequestered off from the large main laboratory room.
fISH was first developed in the 1990’s as a technique in which fluorescently labelled
probes are hybridized to a patient’s chromosomes (George et al., 2011). If a florescent signal
is detected, it indicates the presence and copy number of that region in the patient’s genome.
To conduct a fISH experiment, the scientist needs to have live, growing cells. They cannot be
frozen or prefixed. Depending on where they stop the cell growth, cytogeneticists can do
different things. At interphase the chromosome fibres are more loosely packed than at
metaphase. If there is a segment of DNA that is duplicated close by to the original segment
you can see it better in interphase than in metaphase. The resolution is higher. If you want
chromosomal positional information, however, cytogeneticists arrest the cell growth in
metaphase. When checking for a duplication, the cytogeneticist will use interphase nuclei but
will also use metaphase nuclei to check that the probe was in the correct position. The
manager of the cytogenetics facility, a clinical cytogenetist whom I will call Gloria,
explained the fISH process as follows:
So you have your slide with your chromosomes on it and then you denature your
chromosomes so that the DNA goes apart, like, separates. And then you have your
probe which is your sequence of DNA with your little florescent tag. You denature that
and then you put it onto the slide. So both of them are denatured and you leave them to
renature and it will go to the targeted region, yeah.
Once the probe has hybridized to the patient DNA the cytogeneticists can arrest cell growth
in various stages of development and count the copy numbers of the florescent probe. Gloria
showed me an example of a 22p11.2 deletion in an autism case. She opened up her laptop
and found the image depicting the florescent signals. “So you see two reds and two greens.
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And here you see two reds and two greens. And then, yes…see, over here, there is only one
signal being picked up.” The green signals are from the control probe while the red is from
the test probe targeting the 22q11.2 region. While the green control probe is consistently
there, the red test probe is absent.

5.5b Polymerase Chain Reaction (PCR)
Rabinow’s book (1996), Making PCR, describes the development of PCR in detail.
The story goes that Kary Mullis, the man awarded the Nobel Prize for his idea of PCR, while
driving in his car to his cabin, starting thinking about DNA polymerases and DNA
sequencing. Polymerases are enzymes that repair and replicate DNA. The first step in this
process is to separate the double strands of DNA. While this is a normal part of cell division,
in can be mimicked in the laboratory through heating. By adding a primer (a section of DNA
that acts as a starting point) the polymerase builds on the primer along the template,
following the principle of base-pair complementarity. Mullis realized that by iterative cycles
of heating and cooling, a chain reaction could be started in which a defined and specific
target of DNA sequence could be exponentially reproduced. The products would be of a
defined length, the length between the outside ends of the two primers. This was Mullis’
“eureka” moment.
Mullis and other scientists at the Cetus Corporation where Mullis worked had
stumbled on a technique, PCR, which completely altered the practice of microbiology. As
Rabinow asserted in the mid-1990’s, “it is no exaggeration to claim that PCR is a
fundamental tool that makes feasible such magaprojects as the Human Genome Initiative”
(Rabinow, 1996). PCR was a ubiquitous component within many of the experiments I
observed in Laboratory X. What follows is a brief description of one of the PCR experiments
I observed in the summer of 2011.
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I observed as Heather did a PCR this morning. She microwaved a liquid in a
container, adding euthidium bromide (a carcinogenic substance) to the mix. After
microwaving the liquid for a couple of minutes she took it out and brought it back to her
bench space. The substance had turned into a kind of viscous gel. There are several small
wells or indents along one edge of the rectangular container that holds the gel. With really
tiny fragments of DNA, you need a very firm gel. Our DNA fragments today are fairly long
so the gel does not have to be quite so firm. Heather told me to think of it like a sieve. She
said, “So imagine you’ve got a big bag of frozen peas that are all different sizes. Some of
them are really tiny and some of them are really big. So it’s like a sieve to sort out the
different sizes of peas that you’ve got”. She’s not sure how large her DNA fragments are
because she doesn’t know the break points. She guesses the fragments are between two and
ten kilobases. She’s trying to amplify across a deletion of unknown size and she’s not
actually positive it is actually deleted.
To run the PCR she needs to put a dye in the gel. It’s coloured and lets her see. The
dye is also heavy and pulls the DNA down into the wells so it doesn’t float around. At this
point there is no DNA in the wells yet. The DNA is still in a row of little plastic tubes. The
tops of the little plastic tubes, each filled with sample DNA, are bent over from melting a
little in the heating cycles of the PCR machine. Heather shows the guy sitting at the bench
beside her and says she will not use these tubes again. It’s tricky to fit the end of the pipette
in them. There is a little dial on the pipette that changes the amount of liquid that will be
sucked up. She rotates this with her thumb. There is a tiny amount of liquid in the tubes,
about five microliters. We put the gel in the fridge to wait for it to set. After ten minutes we
take it out of the fridge and load the DNA sample. Alongside the sample DNA there is
something called a ladder. It contains many DNA fragments, all of known sizes. So you can

148

compare your samples and the ladder. Each of the little wells or holes in the gel along one
side has a buffer solution. When the DNA is added it sinks into the well. Heather sets her
timer for thirty minutes. A current runs through it on an electrophroesis, a small machine that
sits beside her on her bench. Heather tells me that because DNA is charged, it will separate.
The small fragments will move through the sieve faster than the big ones. After the gel and
DNA has sat in the electrophroesis for about half an hour, we come back. Taking the
rectangular container with us, we walk to the end of the aisle and toward the wall by the door
of the laboratory. Here there is a UV light box called a UV transilluminator. Heather puts the
container into the box and waits while it takes a picture. The euthidium bromide that she
added to the gel makes the DNA glow. After a minute a black and white photograph is spit
out of the machine. It shows the ladder along the side, basically a line of vertical bands going
down the photograph. There are other rows of vertical bands beside the ladder. These are
running down from the wells where the sample DNA was dropped. With the photograph in
hand, we walk out of the laboratory and back to Heather’s desk in the research office. Several
black-covered lab books are line up at the back of her desk. They look much like the black
notebook I carry around and scribble in during fieldwork. Heather is involved in so many
different projects; she juggles between five lab books. She describes her lab books as a
“historical recipe book with everything I’ve cooked”. Each of the pages is filled with detailed
notes of all the steps of each experiment she has done, along with taped in print-outs
generated along the way. She opens one of the books to the last used page and tapes in the
black and white photograph of the PCR.
I asked Heather what the next step would be. At this point, she would repeat the experiment.
She said, “in the words of my old supervisor – anything real will happen twice”.
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5.5c PCR to real-time quantitative Polymerase Chain Reaction (qPCR)
The description above is about the PCR process. The PCR process in not used for
validation but it led to another technology, real time quantitative PCR or qPCR that is used in
validating microarray results. While a cytogenetic experiment called florescent in situ
hybridization (fISH) can be used to detect and verify microdeletions and duplications, fISH is
usually only used when the region in which the CNV is located is already known. Moreover,
fISH is time-consuming, costly and sometimes does not have the resolution to detect small
CNVs (Weksberg et al., 2005). PCR is used to amplify DNA fragments, with 20 cycles
producing a million-fold increase in DNA. This amplification, however, introduced the
potential for a lot of error, as all fragments may not amplify with the same efficiency.
Eventually, the PCR cycles no longer produce an exponential increase in DNA fragments,
with some cycles generating more than others. This is called the “plateau phase”. Real-time
PCR, (VanGuilder, Vrana, & Freeman, 2008) first described in the mid 1990’s, plots the gain
in florescence against time (the number of PCR amplification cycles). Real-time qPCR
allows one to measure the PCR products as they are accumulating. Therefore, the scientists
can determine the amount of florescence while the experiment is still in the exponential
range. It is only during this exponential phase of the PCR experiment that the scientists can
extrapolate back to calculate DNA copy number measurements of the starting sample.
After the microarray and qPCR validation, the little tubes of extracted DNA
frequently move on to another place in the laboratory, continuing on their journey, to be used
for sequencing. Not all samples continue, however. There is a prioritization that occurs. An
academic project coordinator explained the prioritization to me, with the caveat that as prices
start to come down all samples will be run on Next Generation Sequencing in the future. For
now, samples are sequenced if they have:

150

1) high resolution array data
2) a known CNV of interest (to see if other variants were detected)
3) high quality DNA from blood
4) good phenotype information with family members available for follow up
He explained that the second point is a bit counter-intuitive but they want to find out if other
variants could explain or at least contribute to the phenotype. What follows is a description of
the sequencing experiments that I observed and talked about with scientists in Laboratory X.

5.6. From CNVs to SNPs - Next Generation Sequencing
Next Generation Sequencing (NGS) is a technology that can detect all types of
variation in the genome but is most often used to find a variant called a single nucleotide
polymorphism or SNP (pronounced ‘snip’). Compared to CNVs, SNPs are much smaller.
They might be only one or two base pairs in length. For example, if a length of DNA in the
human reference genome reads A, C, G, T, C and a length of DNA in a sample of DNA reads
A, C, T, T, C, then this could indicate a SNP at the third base. Where there is a G in the
reference there is a T in the case sample. In order to detect SNPs, an entirely different
technology is used. Whereas microarrays were used to detect CNVs, sequencing is used to
detect SNPs. Traditionally, sequencing was carried out using Sanger biochemistry and was
limited to smaller, targeted investigations. Recent Next-Generation platforms are able to
sequence whole genomes. There are three different NGS sequencing platforms used in
Laboratory X (454 sequencing, Solexa, and SOLiD platform); each has specific uses
depending on a customer’s budget and the size and quantity of the samples being processed.
Each of the platforms has specific advantages and disadvantages (i.e., read length, types of
error, and cost). According to Shendure and Hanlee (2008), “Although these platforms are
quite diverse in sequencing biochemistry as well as in how the array is generated, their work
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flows are conceptually similar”. During my fieldwork the SOLiD 4 machine was updated to
a SOLiD 5500. My observations are based on experiments using the SOLiD platform.
There are several steps involved in a NGS sequencing experiment. In the lab where I
conducted my fieldwork, the scientists were involved in exome sequencing rather than whole
genome sequencing. In exome sequencing, only the exonic parts of the genome are captured
and explored with the intronic stretches of nucleotide bases being washed off in the process.
The first step is to prepare the library. The second step is called hybridization where the
DNA is captured. The final step involves adding barcodes and doing an emulsion PCR. The
barcodes are added if DNA is being pooled during the experiment. In this section, I will
describe the NGS process for an exome sequencing experiment. This description has been
pieced together based on five different interviews with two post-docs and a manager, as well
as three different observations of sequencing in the laboratory.
The first step for Heather to do is to prepare the DNA. Other people have already
extracted the DNA from a blood sample. What matters is the quality of the DNA. All she
needs is the extracted DNA. She reaches into her fridge and pulls out a tube containing clear
liquid. This is DNA in solution. I’m quite fascinated and ask her if she can tell that this is
DNA in here. She says, “It’s just a tube. It’s not very exciting. If you know what you’re
looking for you can tell. If it’s really high concentrations you can tell because it’s gloopy.”
She lets me pick up a tube and look more closely at it. At the bottom is a tiny bit of clear
liquid. I gently wiggle the tube but the liquid doesn’t slosh around at all. She says this is
because the tube has been stored at such a cool temperature. So she takes her DNA in a tube
and does an enzymic reaction to purify it. The next step is the hybridization. This is
important because they are not doing whole genome sequencing for the Autism Genetics
Study; they are doing exome sequencing. This means that they only want to capture the
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exome, the genes, and not all of the intronic bits. So she needs to capture the exome and
wash away all the rest of the genome. This is called hybridization. This step is done early in
the morning, while the lab is quiet and nobody is there to interrupt her. She explained the
process like this:
So, what we have is a little sequence, little RNA baits basically that
correspond to the exons and so we attach these to the DNA in our sample. We
shatter our sample into tiny fragments, prepare those and repair them and
stuff. And then we bind those with the RNA bait that corresponds to the exon
so they stick. And then capture the RNA bait using magnets. So then with the
magnet we can pull out the DNA fragment and wash off everything that
hasn’t stuck to a fragment.
The fragments are very small, approximately 200 bases long. The RNA baits are about 120
bases long. She adds the RNA baits to the extracted DNA sample and leaves them at 65
degrees Celsius for about twenty four hours. Hydrogen bonding occurs between the
corresponding fragments during this time. After this, the washing process takes about five
hours of adding solutions (like ethanol), mixing it, pulling the beads to the side with a
magnet, sucking out the solution and putting in another solution. Over and over.
In the first part of this step the RNA baits bind to the DNA sample. A fishing analogy is
often used in the lab to talk about this process of capturing regions of the genome. Heather
explained,
I need baits because in some of my experiments I’m only interested in some
of the genome. So if you imagine a fishing experiment, I go in and fish out
the bits of genome that I’m interested in. So to carry on this kind of fishing
analogy, they call them baits. So the baits represent a complementary
sequence to the sequence I’m interested in. So you use the baits to fish out the
bits you want.

Then the rest of the DNA is washed away with various solutions. So all she is left with are
the exons.
The next step is to give each sample of extracted DNA a bar code. This is because she
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runs six samples at the same time and needs to mix them together. The barcode on each
sample will enable her to figure out which fragments belong to which sample at the end of
the sequencing. The barcode is a short stretch of sequence included within a primer. A primer
is a sequence of base pairs that is unique to a very specific region of the human genome.
Most of the primer is the same for each of the samples but at the end of each one is a little
sequence tag. This is attached to each fragment. So the first thing that is sequenced is the
little tag which tells the scientist who the fragment belongs to.
Below is an excerpt from my field notes when I observed the hybridization and adding the
barcodes:
Heather holds onto a long magnet with red handles at either end. Hanging over the
length of the magnet are eight tubes. The lids of the tubes have tiny patient ID numbers handwritten in green marker. Each of the tubes is quite small, about half the length of my baby
finger. They each contain a clear liquid. At the side of the tubes resting along the magnet
there is a small brown line. Heather explains that these are actually tiny magnetic beads being
pulled over to the magnet. The DNA fragments are attached to these beads. She spins the
tubes on a round centrifuge and the liquid turns brown as the beads become dispersed or
resuspended in the solution. Then when she puts them on the magnet they are pulled to the
side and the solution becomes clear again. This way she can fill the tubes with different
solutions and then take her pipette and suck the liquid out again without sucking up the
beads. She does this several times with different solutions. The pipette seems to be almost an
extension of her gloved hand, as she quickly presses a button at the top of the pipette with her
thumb to draw up the solution. A self-proclaimed “techno-nerd”, she explains that she has
been doing this for over ten years. She thought it was funny that I didn’t know what a pipette
was because she has worked with them almost every day of her adult life.
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She is adding the barcode tag. She sets the timer which is stuck to her workbench at
eye level when sitting. There are lots of plates in front of her on the work bench. After a
while the timer beeps as she is adding primer to each sample. She has lots of tricks to make
sure that she doesn’t make a mistake when adding the primer. Finally, she takes a pipette and
draws liquid out of one tube and drops it into another plate which contains several small
holes. The holes in the plate are numbered along the top from 1 to 12 and there are letters
going down the side from A to H. She is removing the water and DNA and leaving the beads
behind and then adding the DNA to the primer that is already in the holes in the plate.
She is using rows C-F and columns 3 -10 on the plate. These are tiny amounts of
liquid that she is moving around, only 50 microliters. She can’t talk to me right now. It is
very important for her to concentrate and make sure that the she doesn’t add two different
samples of DNA to the same hole in the plate. She has lots of little tricks to remind her which
of the holes she has already added the DNA. Each of these experiments costs several
thousand dollars to complete. Once all of the holes in the plate are filled she presses on a
clear, thin plastic sheet which looks like a big square sticker, to prevent any of the liquid
from spilling or evaporating during the PCR. We walk over to the end of the aisle and open
the lid of the PCR machine and lay the plate inside. She pushes several buttons on the display
at the front and the machine starts. She says it will take about an hour.
Once the samples are in the SOLiD machine, it takes about two weeks to run. The
SOLiD machine is basically a robot. She describes the machine in this way, “They’re like
children. They have tantrums like children. The one I’m running at the moment, you can’t
touch it. It crashes as soon as you touch it.” When she took me on a tour of the lab she
showed me a few of their NGS machines and there was a hand written sign on a piece of
paper saying ‘do not touch!’ on one of the sequencers. Once the samples are put into the
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SOLiD machine for sequencing a light is emitted for each base and the machine then
photographs each one of these lights. Each base pair has a different colour light. The absolute
raw data from these machines are the millions of photographs taken of each of these lights.
This is called “colour-space”. This then gets converted to nucleotide letters. After this the
nucleotide letters are aligned to the reference genome.
What actually happens is you get reads that look like someone’s thrown some
Smarties on them because there are so many errors. Most reads, or a lot of reads,
have an error in them. So you’ll get a load of position that match to the reference
and then on nearly all the reads there’ll be one base scattered around and
different. But basically you get a pile of reads that all correspond to your region.
(Heather, post-doc)

These Next Generation Sequencers are “high through-put” meaning they can process a lot of
data. However, they are also very error-prone. According to Shendure & Hanlee (2008,
p.1137) “base-calls generated by the new platforms are at least tenfold less accurate than
base-calls generated by Sanger sequencing”. If she finds any mutations that she thinks are
interesting she has to validate using a second method of sequencing. This second method is
called Sanger sequencing. She explained, “This is just traditional Sanger sequencing. This is
how sequencing was done before Next Generation Sequencing and we use it for validation of
NGS because it’s cheap and cheerful and you can do a small targeted region for not much
money very quickly.” Sanger sequencing does the same thing as Next Generation
Sequencing except that it does a very small, targeted region. If she finds a variant in a
particular exon in the NGS data, she will only Sanger sequence that particular exon. It might
be about 300 base pairs in size. It takes about four days to do the Sanga validation and at the
end “you get very nice, clean data”. She went on to describe the data that she gets from the
Sanger,
So you know exactly what it is; you know exactly where it’s coming from.
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It’s very simple to interpret and it doesn’t require massive amounts of
bioinformatics and huge quantities of data storage and stuff like that. It’s all
just really simple.

5.6a The Computer Pipeline
The NGS machine produces several spreadsheets. All of the data runs through a
computational pipeline. Intense interest and concern over the quality scoring of the generated
sequences gave way to lively discussions at weekly lab meetings. There are a variety of
different software and data analysis tools available for processing and interpreting data.
Different software have different functions in the data analysis process, such as aligning the
sequence reads to a reference genome, base-calling or polymorphism detection, de novo
assembly from paired or unpaired reads, and genome browsing and annotation (Shendure and
Hadlee 2008). SHRiMP, for example, is an algorithm used for alignment of SOLiD data. At
one point in my fieldwork, I interviewed the bioinformatician who developed the pipeline. I
also observed an exome sequencing meeting in which she delivered a one-hour presentation
about the pipeline. A young Asian-Canadian woman in her late twenties, she had a calm,
quiet voice and smiled easily. When she began to speak about her work on the computer
pipeline it was like she was speaking another language. Despite, or perhaps in spite, of my
father making my siblings and I work through computer programming books in Quick Basic
when I was seven and eight years old, I have not taken an interest in computer languages or
taken any computer science classes in University. The description of the pipeline process is
limited by my lack of familiarity with computer science.
The NGS data in its most raw form is actually a huge series of photographs. These take up
three to four terabites of disc space for each run and are almost immediately converted into
colour space. Once the bases are “called” in colour space, the image files are erased. Each
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colour corresponds to a different nucleotide and along with the colour the SOLID machine
will also give a quality score, indicating how confident the machine was in calling each
colour. So the colour space is actually based on numbers from 1 to 4. If the machine is unable
to make a call about a base it will insert a dot. Colour space is then quickly converted into
nucleotide space (e.g., T, C, G, A). All of this data is taken off the sequencer and put on the
computer cluster, where the bioinformaticians access it and analyze it. Once it has been
converted into nucleotide space, the data is then put into the “Pipeline”. There are several
steps to the pipeline process. The first step is to align the nucleotides to the human reference
genome. When there are differences between the sample and the reference genome it could
indicate a SNP or it could mean there is an error. If there is a “true SNP” there will be two
colour changes. If there is only one colour change, it is most likely a sequencing error. In this
case, the pipeline will insert a base from the reference genome at this point. This, however,
introduces something called “reference bias”.
The next step is to remove duplicates or PCR “artifacts”. The problem is that if one
allele has an artifact and the other has a true SNP, they both get thrown out. There are various
complicated algorithms that recalibrate the sequence. For example, if a reference base was
inserted in an earlier step, it gets recalibrated to N at a later step. The whole pipeline is
designed to try to increase the number of true SNPs and decrease the number of false
positives. There are all sorts of scores and statistics used to estimate the probability that when
a SNP is called it is true. They want to be sure that if they are “calling” a SNP that it is really
real. For example, during a meeting someone suggested that they could adjust one of the
computer filters to give Tyler more SNPs and Tyler responded, “We don’t want more SNPs,
we want more real ones!” The entire pipeline is very complicated and involves a lot of
computer science to understand. However, as the NGS facility manager stated, “Basically
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what’s important for people is two types of data. One would be the sequences themselves.
And the quality scores associated with those sequences”. Sequencing technologies are
changing quickly and were described by several people in both the laboratory and autism
clinic as a “constant moving target”. What seems clear is that the challenges likely to face
this area of research in the coming years are those associated with how to interpret and make
clinically relevant all of the masses of data that are generated by these high through-put
technologies. As Shendure & Hanlee stated,
Analogous to microarrays, we also expect that the challenges will quickly
shift from mastering of the technologies themselves to the question of how
best to go about extracting biologically meaningful or clinically useful
insights from a very large amount of data” (2008, p.1143).
I feel I should briefly interject in the description here to make a point about agency. In
Chapter 2 I discussed the notion of agency and how it is problematized within practice
theories and actor-network theory. Particularly relevant here is the idea of the dialectic
between the social structure and the individual or the actor and the network. Each constructs
the other. Through my research in Laboratory X, this post-humanist, dynamic relationship
between different agencies is witnessed in surprising places, even at the very core of how
science itself is practiced. The human genome, micro array testing, PCR and all the tools,
robots, protocols and material entities that are implicated in these technologies are in fact
pushing back on the scientists. The scientists are not only involved in their creation but are
also created by them. For example, since the human genome and technologies such as the
micro array which have been developed to probe the human genome, the way in which
scientists conduct research in the field of molecular genetics has been completely altered.
Whereas research used to be hypothesis-driven, the paradigm has shifted to a discoverydriven model. Hypothesis driven research is no longer realistic or productive with the unruly
multitude of actors now opened up by these new technologies for mapping and probing the
genome. As one scientist explained to me:

159

PhD Student: But now we have access to pretty much the whole genome so that helps a great
deal in finding disease genes. So previously before the sequence of the
genome was known, say you wanted to find a gene for a disorder, you were
restricted to a handful of genes for which function is known. And so you go
and look at only those genes, any sequence with those ten genes and then see
if they have any mutations. So this is what’s called a candidate gene
approach. So you are obviously restricted by what you know. Because there is
no other way to approach that. But now that you have sequence from the
Human Genome you can sort of look at everything in one go and you might
find a mutation in an unknown gene and it could be interesting, it could not be
interesting; it’s hard to interpret, especially if the gene is of unknown
function. But it’s opened the door to a whole other level of detection. Now
we’re not restricted by what we know anymore. We’re sort of moving from
hypothesis driven research into discovery driven research. So they are sort of
two different approaches. Like, hypothesis driven would be like if you took a
single gene and you think it’s involved in a certain disorder because it has a
known function and say my hypothesis is that this is involved and we want to
look at this. That’s hypothesis driven. Discovery driven is, you’re just going to
take a patient’s DNA and put this on a whole genome micro array and see
what’s going to fall out. (interview)
So scientists are influenced by, constructed through, the technologies which they create. They
developed the human genome, microarray, and sequencing machines and in turn these
technologies are forcing scientists to completely alter how science is ordered, organized,
practiced. Scientists do science differently because of the agency of these technologies;
hypothesis-driven research is no longer always manageable or desirable. The scientific
method, at the core of science, is changing as technologies change. The world is approached
differently now because of these new technologies. Agency is shared in a dialectical dance
among human and non-human actors.

5.6b Monday Morning Meeting
The door is locked to the conference room. I’m early as usual. A few minutes later,
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Tyler comes along and opens the door, propping it open with a chair he’s pulled from along
the wall. He’s wearing blue jeans and a black long-sleeved shirt. His dark hair is starting to
grey at the temples. He must be about forty. We talk for a few minutes while he sets up the
laptop and projector. After a few minutes, others start to walk into the room, finding seats
and quietly chatting. Some wear coats, indicating they’ve made the trek here from other
buildings. Others have already shed their jackets and instead carry coffee. Felicia, Claudia,
and Loren walk in, arriving from the Autism Clinic. They sit down beside each other at
chairs near the head of the table.
The Monday morning meetings are held every second Monday in the conference
room of Laboratory X. The conference room is large, at least 25 feet long, with one big
wooden table running the length of the room. There is a white board at one end of the room
and windows at the other end. There are two doors through which one can enter the room,
both automatically locking. Black chairs hug the edge of the table and a second ring of chairs
flank the outer walls of the room. I have been to meetings with as many as forty people are
crammed into this space. Monday meetings begin at 9:30 and run for an hour. An agenda is
circulated by email ahead of time and electronic PowerPoint slides are distributed early on
Monday morning. The meeting is organized and chaired by Tyler, the main project
coordinator in the academic lab. Dr Lorenz often attends but the meeting is not cancelled if
he is going to be absent. Only academics attend this meeting. Technicians are not invited.
From Laboratory X, there are post doctoral fellows, PhD students, bioinformaticians, and
other lab directors involved in autism genomics. From the Autism Clinic, the director who is
a developmental paediatrician, the genetics project coordinator, and one of the psychologists
are present. There are also clinical geneticists and genetic counsellors present, although they
sometimes have their own clinics to run and can not always attend the Monday morning
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meetings. As well, there are often a few people from the clinical laboratory at Hospital X
who attend this meeting. Typically, there are about twenty people in the room, although the
numbers were sometimes fewer over the summer months.
Since the Autism Genetics Study is a large, multi-site project, there are always people
who phone into the meeting. From the other geographically dispersed groups who are
involved in the Autism Genetics Study are project coordinators, psychologists, clinical
geneticists and co-principal investigators.
Tyler opens the meeting by going over the agenda, which appears in point form on
the large screen behind him. He reviews the minutes from the last meeting and then passes it
off to the first person to present. Presenters at these meetings are almost always from
Laboratory X. In other words, the PowerPoint slides primarily convey information about
genetic experiments and findings. The clinicians in the room tend to be observers, sometime
interjecting to add phenotypic information pertaining to a specific case. (In the eight months
that I observed these meetings, only two presentations were made by someone who did not
work at Laboratory X – my own presentation to recruit them into my project and presentation
by a woman from the federal Ministry of Health who was setting up an autism surveillance
program.) I was told that occasionally, in the past, a clinical geneticist has presented cases.
Usually, however, it was the scientists who presented genotype information and then asked
the clinicians for more phenotype information from which to interpret the genetic results.
Typically, the agenda would contain three or four cases to be discussed. Some might
be results from the micro array and others from Next Generation Sequencing. There might
also be informal discussion about a conference or discussion about a research ethics board
(REB) application. Often they discussed the protocol that was being developed for a newly
funded project, which was really just another way of acquiring samples for the Autism
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Genetics Study.
At the beginning of the meeting, the case studies to be presented would be listed by patient
number. For example, one Monday meeting contained the following list:
H1243/H5204 (NRXN1 nonsense mutation) – report sent
H3980 (IL1RAPL1 maternally inherited intronic deletion) – 5M analysis?
H5763 (NRXN1 intronic deletion) – Ankit to get report
H1376-03 – 19p12 and 4q32.1 gains (report sent)
As the presenter introduces the case, I can hear the clinicians whispering to each other,
conjuring up the people represented by the patient number. “Is this the Fuller kid? The boy
from [Y]?” Loren asks in hushed tones. “No, this is the Stevens family. His sister was
diagnosed first and he is part of the sib study.” Claudia has brought a stack of patient charts
with her. The email from Tyler the previous day has given her time to pull the relevant
charts, ready to offer more detailed information if asked by a presenter.
The presenter, usually a post doc or grad student, first describes the type of mutation
found and offers a brief description of the function of the particular gene in which the
mutation was found. Here they might show a slide with a list of scientific articles that have
already published about this gene. Then they indicate which type of experiment was used to
find the mutation and how it was validated. If the mutation is a CNV found with a microarray
then the next slide is often a screen shot from the Database of Genomic Variants.
A slide from the Monday meeting on October 17th was laid out in the following
manner. At the very top of the slide is a chromosome overview which looks like a striped
ruler. It is divided into segments. Each segment denotes ten megabases (ten million bases) of
the human genome. At one point a red line crosses the ruler perpendicularly. Under this is
says, for example, “4q32.1 - 14kb gain”. This tells the audience the location of the mutation

163

and the size of the mutation and whether it was a loss or gain (deletion or duplication) of
genetic material. Under this there is a second line that runs across the width of the screen.
This line is divided at regular intervals so that it looks like a ruler. This is illustrating a
particular region of the chromosome. It is at a different scale that the top line above, showing
just the portion of the chromosome where the perpendicular red line intersected the first line.
This zoomed-in ruler, for example, might increase by ten thousand base pairs with every
notch, spanning a total of fifty thousand base pairs across the slide. Under this line are
various blocks of coloured lines that indicate where particular genes are located in the human
genome relation to the ruler across the top. These are called RefSeq Genes. Under this are
another set of coloured lines which indicate where OMIM genes are. OMIM is a database
which contains all of the known disease-causing genes. Directly under the coloured OMIM
lines there is also a brief description. For example it could say, “FGA Afibrinogenemia,
congenital, 202400, (3) Amyloidosis, hereditary renal, 105200…” In this way, the slide
allows you to compare the location of the CNV found with the location of other known
disease genes. (See Figure 5.3 for an example)
Figure 5.3: Example of a DGV slide
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Following this screen shot, the presenter would often then show a slide with a pedigree. The
pedigree is a particular type of family tree. At the top of the pedigree is the family
identification according to the patient number. Different levels of the pedigree correspond to
different generations, just as with a family tree. A circle is used to depict a female and a
square is used to illustrate a male. On the pedigree, if the circle or square is coloured in
black, this means they have been given a diagnosis of ASD. If the circle or square is
coloured in grey it means they have been diagnosed with another neurodevelopmental
disorder. The pedigree also gives information about any deletions or duplications associated
with a particular circle or square. For example, it might say “de novo NRXN1 deletion”.
Sometimes there are several deletions or duplications listed under a single circle or square.
Some circles and squares have deletions or duplications listed under them but they are not
coloured in black, meaning they do not have a diagnosis of autism.
Some pedigrees are small, containing just two levels or generations. A trio (mother,
father, and proband) is a frequent pedigree that appears. Others are large and expanded
pedigrees. The pedigree shows visually who has autism, who carries a CNV, whose blood
has not yet been collected and it can also indicate other phenotypic traits that are not
standardized. For example, some pedigrees contain information yielded through
conversations with the parents of the proband. One pedigree contained information below a
square that stated “very shy when younger” another square stated “quiet and reserved, keeps
to himself”; several other circles had the word “scoliosis” written underneath them. One
pedigree went so far as to indicate below a square “organizational difficulties, recites
Shakespeare”. There was some discussion about this particular inclusion on the pedigree,
with the director of the Laboratory X stating with exasperation, “but maybe he was a high
school English teacher! I can recite the 1984 statistics from the Montreal Canadians hockey
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team but that doesn’t mean I have autism”.
Needless to say, the pedigree is a site where information from the laboratory is joined
with phenotypic information gleaned from the clinic. (Sometimes the junior members of the
laboratory are not clear on which phenotypic information is appropriate for a pedigree.)
Indeed, very frequently the presentation of the pedigree segued into a discussion in which the
scientists would ask the clinicians present at the meeting if they had or if they could obtain
any other phenotypic information about members of the family. This information could help
the scientists further interpret their data, determining if the phenotype segregated with the
same distribution of the genotype.
In addition, the pedigree was often followed up with a discussion about whether or
not there was a need to try to contact the family to get more blood from other relatives. If
more blood samples were needed a research report would first have to be written and given to
the clinical geneticist to explain that there had been a new finding. From there a feedback
session would be booked with the family to explain the finding and to ask if they would be
willing to contact extended family members for purposes of obtaining a blood sample. The
decision of whether or not to write up a research report is a common outcome of these
Monday morning meetings. Minutes from these meetings commonly contained statements
about which reports were to be written and by whom.

5.7. From Data to the Report
Reports are written by several different people at the Laboratory X. For one of the
post-docs, this seemed to be one of her main duties. A PhD student who was heavily
involved in microarray analysis was also responsible for writing research reports. At the top
of the report is the date, the physician’s name and the sample ID number. The CNVs are then
categorized into four different classes. The following excerpt details a particular report that
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the PhD student named Ankit showed me:
PhD Student:

So class four is CNVs that are in controls as well, Class three is CNVs that
are not in controls but don’t overlap any genes, Class 2 are not in controls
and they overlap some genes but we’re not sure what they mean. Like, they
could be significant or they might not be. And class 1 is it’s a known
syndrome or a known pathogenic locus. So for this particular patient the
array computational analysis programs spat out a list, in this case, there
were 37 copy number variants. So they are listed in this table. So we give
the physician the position, the start position and the stop position, size of the
variant. The type, loss or gain, and each of them is given a class.

Julia:

Wow.

PhD student:

So you’ll see that of the 37 copy number variants [scrolling with his mouse],
31 are class 4. They were seen in controls. So two of them are class three
which don’t overlap any genes. We don’t know what they mean. Two are
class two. They overlap some genes but for these particular genes there is
not much functional evidence in the literature. Not much is known about
their function. So they call it class 2. And there are another 2 which are
class one. So, one of these is the NRXN deletion. So we say that ‘one class
one deletion overlaps NRXN1 and there is evidence in the literature for the
[?] of exonic deletions.” And we also say “this deletion was detected in
samples from the dad and sister but not in the mom by qPCR”. So it sort of
summarizes.

The report then leaves the laboratory and moves the genetic information back into the clinic.
This report speaks for all the work that was done in the laboratory. Since arriving in the
laboratory in a little glass tube, the DNA has been sliced, put on a slide, washed,
photographed with a florescent scanner, magnified, plotted on graphs, turned into pedigree
diagrams in power point presentations, and now categorized into four different classes. What
came into the laboratory in a tube has been converted and transformed many times and now
leaves the laboratory on a research report. All of the work that took place in the laboratory is
behind the scenes, or backstage. For the clinician, it is the report that matters. Just as the tube
of blood seemed somehow significant for me so too did the report. In the same way that a
tube of blood “stands for” a person, a report is made to “stand for” all the work of testing,
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discussions, conversions and representations that are done in the laboratory. Weeks and
months of work are summarized in a few typed paragraphs on a page.
During my fieldwork I witnessed a lot of discussion concerning whether or not a
report should be written and if so, the precise wording of the report. Several times, a research
report would be written up to the frustration of the clinical geneticists who would remind the
scientists that if a report is written there has to be a feedback session with the family. This is
because once a report is written it becomes part of the patient chart and the patient needs to
be properly informed about the information. The clinical geneticists indicated that it would
be best if reports were only written for cases that had “clinically significant” findings.
The issue of the wording of reports is exemplified in another interaction that I
observed. I was sitting in on a monthly meeting between two post-docs from the laboratory,
two clinical geneticists, a genetics counsellor, and the main research coordinator for the
genetics research at the Autism Clinic. The conversation was not recorded but I captured the
discussion in detailed notes. The conversation unfolded something like this:
Research Coordinator:

Clinical Geneticist:

Normally we don’t give the research report to the parents at the
feedback session. But these parents have requested a copy of it.
They want to leave with it in their hands at the end of the
feedback.
You can give them a service report but not the research report.

Genetic Counsellor:

Why can’t they have the research report?

Clinical Geneticist:

It’s too complicated for them.

Genetic Counsellor:

But the wording is appropriate.

Clinical Geneticist:

Alright, but we need a statement at the bottom of the report that
says it’s a snapshot at this date. It needs to be explicit that the
interpretation and the technologies could change over time.

The biggest difficulties arise when clinical significance is uncertain. These are sometimes
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termed “fence cases”. These are difficult to communicate to families in feedback sessions
because they are so complicated and often much of the information is not there. The literature
is inconclusive. The interpretation of the data is uncertain and couched in several modifying
hedge words when discussed in meetings. There is a tug-of-war between not wanting to
cause the individual undue anxiety and frustration and wanting to make sure that the
individual has all the relevant information with which to make clinical decisions.
The issue of ambiguity is a growing concern among the clinicians. In a meeting at the
autism clinic I listened as Dr. Morten explained how previous versions of their consent forms
stated that the genetic testing would help to reduce ambiguity and uncertainty. They have
now taken this statement out of the consent forms because they find that genetic testing
actually increases uncertainty and ambiguity; it opens up more questions than answers as the
technology continues to change.
This issue of ambiguity is well described in the science studies literature. Hedgecoe &
Martin have described the impact of genomics on the reclassification of disease, for example.
Even cystic fibrosis, one of the most simple, monogenetic disorders, has endured complex
expansion into neighbouring conditions (Kerr 2000; 2005; Hedgecoe 2003). Genetic
classification of disease is messy, unpredictable, and can lead to increased ambiguity rather
than clarity.
When results are clearly clinically significant the research report is then written up
and sent to Dr Morten at the autism clinic. The project coordinator phones the parents and
schedules an appointment for a feedback session. Often, it has been several years since the
individual gave blood. Then, out of the blue, the telephone rings and the parents are told they
need to meet with a genetic counsellor as there is new information about their DNA that
could be contributing to their child’s autistic behaviours.
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5.8. Exit the Laboratory: The Feedback Session
Once a report has been written and sent back to Dr. Morten at the Autism Clinic, the
family is contacted and asked if they would come in as there have been clinically significant
findings from the genetic testing. Dr. Morten or Claudia usually makes the phone call. For
some families, it has been years since they’ve had contact with the Autism Clinic. The phone
call takes them by surprise. “We’d like to make an appointment to talk with you. We have
some interesting genetic findings about your son and we’d like to update you.” An
appointment is made; a date and time are set. At the meeting there will be a genetic
counsellor and often either a clinical geneticist or Dr Morten, a developmental paediatrician.
During my fieldwork, I was able to observe several feedback sessions. In addition, I
interviewed six parents about their experiences in receiving genetic feedback. The story that
follows is an amalgamation of stories based on the various feedback sessions I observed and
my interview conversations with parents. The story is told from the point of view of a mother
as most of my interview participants, within families of children with ASD, were mothers.
They weren’t sure what to expect after receiving the phone call. Dr. Morten didn’t go
into any detail about what the “interesting findings” were or how they might impact the life
of this family. The mother lay awake all night. She was excited to finally have an answer. It’s
been nine years since their blood was collected. Could there be a major breakthrough, some
new findings with therapeutic implications? Technology has changed a lot in that time. So
has this family. When they first brought little Davey into the clinic he was just two years old.
Despite already suspecting there was some sort of developmental delay, the diagnosis of
autism was still an overwhelming shock for the mother and father. Their imagined lives that
lay ahead, talked about with excitement, suddenly crumbled before them. Since then, they
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have adjusted their expectations. They have learned to go on in their daily life with their son,
whom they love dearly and whom they can not imagine living their life without. There have
been difficulties along the way but routines were established and a new normality quietly
settled around them long ago. The phone call has stirred it all up again. While she has been
content and enjoyed her life these past years since her son was diagnosed, the mother can’t
help but feel her heart beat faster when she thinks about the news they might receive. She
tries not to let herself get too excited or hope for too much. Still, lying in bed on the night
before the meeting, in the quite minutes before sleep finds her, she imagines how their son’s
life might change with the news they are about to receive.
They left home with plenty of time to get to the Autism Clinic, but traffic was
unusually slow and they find themselves walking off the elevator only a few minutes before
their scheduled appointment. They have both taken the day off work, he a sales manager and
she a dental hygienist. On most days off work they dress in casual comfortable jeans and
sweatshirts. Not today. She looks at her husband. He’s wearing freshly ironed Dockers and a
dress shirt and tie. The tie is what gives it away, the importance of the day. She wears her
dark green skirt and cashmere sweater, a silk scarf hanging loosely over her shoulders. They
approach the reception desk and give their name. “I’ll let her know you’re here”, the friendly
receptionist smiles and tells them to take a seat before she disappears down the hall. A few
minutes later a diminutive, middle-aged woman approaches them, a younger woman
following behind. The first woman extends her hand toward them, “Hello, I’m Donna”, a
genetic counsellor. She introduces the young woman who stands slightly behind them. The
mother and father are told that she’s a student who would like to observe the meeting.
Glancing at each other, they nod in acceptance. The student pulls out a piece of paper which
describes her study. They quickly read it over and sign the consent form. They follow Donna
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down the hallway and into a conference room.
The conference room is fairly small with two couches and two chairs placed in a
circle around a small central coffee table. Along one wall is a large window which looks out
onto a busy street six floors below. It is grey outside today but the sun keeps trying to break
through the clouds and for a moment sunlight beams through the window, spilling across the
dark grey carpet. A brightly coloured painted canvas depicts a part of the large mural that
adorns the walls of the waiting room. The woman and her husband sit down beside one
another on one of the small couches and the genetic counsellor, Donna, sits across from
them. The younger student sits off to the side. Donna starts by telling them that there has
been an explosion of research in the last five to ten years. Their son’s sample has been in the
laboratory a long time, as it was collected almost ten years ago. There have been recent
advances in the technologies used to explore genetics and that is why we are here today. She
asks how much background they have in genetics. The couple respond that it has been a
while, since high school biology probably. Donna pulls out a thick, white, three-ringed
binder. “We have over thirty thousand genes. As you know”, she says, “our genes are like a
blueprint of instructions. Genes are everywhere in our bodies and we can get at them through
a blood test to look at chromosome structure”. She flips the binder open to a page with
several little black and white worm-like squiggles on it. “Our genes are on chromosomes.
You can think of these chromosomes like a necklace and the genes are like the beads”. She
explains that in previous technology scientists could look at a blood sample under a
microscope and see each of the chromosomes. She shows them that there are 23
chromosomes and that there are two copies of each chromosome. One copy is from your
mother and one copy is from your father. “With new technologies, we are able to look for
subtle changes. We can detect missing or extra pieces that are very small”. She says you can
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imagine that the chromosomes are like a map and the new technologies are like the little
blown up insert on the map that shows one area in more detail. With your son’s blood
sample, we blew up each chromosome to look for missing or extra pieces. Donna then takes
out a sheet of blank white paper and begins to draw. First she draws two vertical lines and
marks a small x on one of them. She then writes “16” underneath the lines. Donna explains,
when looking at your son’s chromosomes with this new technology we have found that there
is a small piece that is missing on chromosome 16. She writes the word “DELETION” in
capital letters on the piece of paper. “When we look at the literature to see what other
scientists have found in this region of chromosome 16 we find that there are two different
sizes of deletions here, one larger and one smaller.” She then draws two horizontal bars, one
smaller and one larger. She explains that there are about 50 people reported and described in
the literature with the larger deletion in this region but the smaller deletion is not as well
understood. It seems to be more variable. There have not been any other reports in the
literature with individuals with this deletion who are on the autism spectrum. However, some
individuals have been described as having learning or behavioural difficulties. Donna draws
another line and above it writes “range of difficulties”. She explains that some genes are
cause and effect and you can almost be sure that they will be on the spectrum if these genes
are interrupted. Other genes, however, seem to be risk factors but are not totally responsible.
At this point Donna stops and asks if the mother and father have any questions. The woman
asks, “What does this mean for us?” Donna responds, “At this point in time we cannot give a
more effective intervention. It is just information. But knowledge is power and we felt that it
is important for you to know what we have found so far. There will be lots of new
information in the next few years as technology continues to advance”.
The meeting continues with Donna collecting information about both the mother and
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father’s family history. She asks if there have been others in the family diagnosed on the
spectrum or with any other neurodevelopmental diagnoses. She creates a kind of family tree
with circles and squares, writing in all the information about grandparents, aunts, uncles,
cousins, and siblings. She also asks if there were any learning difficulties, speech problems
or quirky behaviours in any of the extended family members. After several minutes, Donna
explains that they would like to get a blood sample from the mother and father to understand
if the deletion on this chromosome was passed down or if it arose spontaneously in their son.
The woman and her husband look at each other and nod, saying they would be interested and
willing to participate in this. From the stack of papers in the binder Donna produces two
consent forms and leaves the room while they read through them. Donna and the younger
student return about ten minutes later and Donna asks if there are any questions about the
consent forms. The woman and her husband do not have any questions and they have already
signed their names at the bottom. With this in hand, Donna leads them out of the office and
directs them to the blood lab on the first floor of the hospital.
The couple walk silently out of the office. Waiting at the elevator in the hallway the
father says he is a little disappointed that all they received was information, that it doesn’t
really change anything for their son Davey at this point. The mother agrees and says she had
been hoping for more. “But” she says, “it is really interesting and hopefully some day it will
make a difference, maybe not for Davey, but for some other family in the future”. The
elevator door dings as it opens and the couple walk in, heading down to the blood lab below.

5.9. Back into the Clinic
5.9a Diagnoses: Clinical and Research
When a family first arrives at the autism clinic to give blood for genetic testing, they
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arrive with a previously given clinical diagnosis of ASD. This diagnosis will have been given
by a paediatrician or family physician or perhaps even a neurologist. It is usually based on
brief examinations of the individual and information gleaned from parents about the medical
history and development of the individual. This clinical diagnosis is a criterion for being in
the genetics study in the first place. When the family returns to the autism clinic for deep
phenotyping sometimes years after their initial visit, following the genetic testing in the
laboratory and the feedback session, they are involved in much more rigorous assessments.
When the assessments are completed the individual will get a research diagnosis, which
usually confirms the clinical diagnosis of ASD.
As I stated earlier, the protocol for the genetics study had recently been changed prior
to my fieldwork. Previously, everyone received the rigorous deep-phenotyping assessments
before the genetic work-up. According to the clinicians at the Autism Clinic, many of the
participants wanted to participate in the genetic research because these diagnostic
assessments are so difficult to obtain otherwise. There are long wait lists for these goldstandard tests. Children often remain for up to a year on waiting lists of educational
psychologists to be tested. If a family is wealthy, these tests can be paid for and obtained
privately. For many families this cost of private testing is out of reach and so they must wait.
Participating in this genetic research, with its accompanying battery of clinical assessments
included, was a means of obtaining assessments and was a big incentive for families to
become involved. As the research coordinator stated, “I have never had to go out and actively
recruit patients. In the nine years that I’ve been working here, there has always been a
waiting list of people wanting to be in our study.” There was some concern, therefore, that
the change in protocol would see a marked decline in families willing to participate in this
research. During the following year, while I conducted my field work, they did not see a
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decline in participants on the waiting list. There must be other motivations for people to be
involved in this research, as the deep clinical assessments are no longer guaranteed, given
only to those found to have clinically significant genetic variants.
After the family has received the genetic feedback another appointment is made to
come back to the autism clinic at a later date in order to do all of the clinical testing or “deep
phenotyping”. The purpose of these clinical assessments is to help interpret the genetic
information by developing a more detailed picture of the physical and behavioural
characteristics of the individuals in the family. Here I will discuss three important types of
formal assessment along with informal conversations, which contribute to the phenotype
information. These three assessments include the Standford-Binet Intelligence Test (5th
Edition), the Autism Diagnosis Observation Schedule (ADOS) and the Autism Diagnostic
Interview Revised (ADI-R). These are gold-standard assessments for the diagnosis of ASD.
These are primarily conducted by a practicing psychologist or psychology PhD students. In
addition to these assessments, a digital photograph is taken of the patient and the parents in
order to be used for a dismorphology exam, performed by a trained clinical geneticist. All of
the deep-phenotyping takes place at the autism clinic.

5.10 Setting the Stage: The Autism Clinic
The large foyer of the grey office building contains a glass-covered desk with a list of
all the offices and their floor numbers. Within the list, there are government offices, lawyers,
and several offices and clinics associated with the hospital. A coffee shop bustles with
activity as professionally-dressed people line up for coffee or muffins. The building is tall
with twenty-four floors. As I step on the elevator several other people squeeze in beside me.
Some are wearing hospital name tags around their necks but many are not. I step off the
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elevator at the sixth floor. To the right is a law firm. I head to the left. A sign on the wall
indicates that this is the Autism Clinic. An arrow below the sign directs me to continue down
a smaller hallway to the right to find the door to the waiting room. I follow the arrow.
Stepping through the door to the waiting room, the florescent lights shine brightly. The room
is about eight feet by twelve feet in area. There are green, vinyl padded benches pushed
against two of the walls for people to sit down. On the wall opposite the entrance is a large
sliding glass window. Small Smurf figurines and a little wild-haired troll are poised on the
ledge of the window, inviting little hands to reach up and play with them. The friendly
administrative assistant sits at her computer behind this window. The walls are light blue.
There is a bulletin board reserved for articles and notices that pertain to ASD in adolescence
and adulthood. On the far wall, there is a large bookshelf containing binders and pamphlets
as well as videos. Some of the pamphlets are several years old. A shelf with several small,
labelled cubby holes holds various toys and puzzles. A child-size table and two small chairs
are placed in the centre of the room. Artwork drawn by children hangs in black frames along
one wall. One frame hangs askew on the wall, empty. There is a recess in the wall beside the
reception window where another locked door is located, always closed. On the back of the
door are posters advertizing various research studies inviting individuals with autism to
participate.
The administrative assistant has seen me and opens the locked inner door to let me
through to the back. I’m here to observe some assessments today. The inner door opens and
to the right is the administrative office. The carpeted hallway is narrow and leads past a few
offices on the right. The first office is where Mary sits. She is a psychology PhD candidate
and she does a lot of the testing for the infant sibling study as well as for the genetics study.
She shares her office with another psychologist who is currently on a maternity leave. The

177

next office on the right is Dr. Morten’s. It is much larger and holds a large desk as well as a
round table and chairs. There is a window that runs across the length of the office. Filing
cabinets and book shelves are crammed in against the walls. Across from these two offices,
on the left side of the hallway are two other rooms. One room is used for testing and contains
a small table and chairs as well as a brightly coloured play mat and lots of different toys. The
adjacent room is very small and is used for observations.
Continuing down the hallway, there is a section with dividers. Claudia and Don sit to
the right of the hallway (Don is a summer student in microbiology and hopes to go to
medical school one day) and Florence often sits in one of the cubicles to the left. Florence is
a research coordinator for one of the non-genetic studies but during my fieldwork she started
working on phenotypic assessments for the genetic study. There are large beige coloured
filing cabinets lining the walls. I’ve seen them being pulled open, the heavy drawers holding
tightly packed patient files. There are well over two thousand patient files in this office.
Further down the hall is another office on the right. This is where Loren sits. Finally, at the
end of the hall is the large kitchen area with a large square table. This room also serves as the
conference or meeting room. In addition to fridge, tea pot, toaster and microwave, this room
has a white board and projector screen at one end. Windows at the far wall let in natural light.
At lunchtime employees come in this room to sit and eat together.
Compared to the Laboratory X, the autism clinic space occupies a much smaller
footprint. There are also far fewer employees here. At most, there are ten people who work
here. I sit down at the table and wait until they are ready to do the ADOS testing that I will
observe today.
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5.10a Assessments: ADOS, ADI-R, and Intelligence Test
There are numerous assessments, both standardized and non-standardized as well as
questionnaires that are filled out during the process of the deep-phenotyping individuals who
have been involved in the genetics study. The three assessments I will present here are
hallmarks of a research diagnosis of ASD and are considered by the clinicians I talked with
to be gold-standard assessments.

i) Autism Diagnostic Observation Schedule (ADOS)

I am sitting in a very small room. With me are two other women. One is a PhD
psychology student and the other is a project coordinator who has a Master’s degree in
psychology. There are three chairs in the room on which we sit down. Around me in this
room are another desk and three other computer monitors and a recycling bin. Several boxes
are piled up. At the end of the room, the wall is lined with a floor to ceiling bank of blue
filing cabinets. In front of us, perched atop a desk is a video monitor, a panel with buttons
and what looks like a joy stick. We are watching the interactions between the developmental
paediatrician and a young three-year old boy in the room beside us. They hand me two paper
booklets, two versions of the ADOS assessment. They are each holding these forms in their
hands and writing on them every time the boy on the screen engages in any type of social
interaction. At first, they are not sure which ADOS forms to use. There are different forms
that correspond to different levels of child development (preverbal, early verbal, or later).
The development paediatrician has never met this little boy before and has to determine
through his interactions which of the measures she should use. She is “blinded” as to whether
he has been previously diagnosed with autism. She will initiate a different set of interaction
and play activities depending on where she thinks the child is positioned developmentally at
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this point in time. At first the child is alone in the room with the paediatrician. The first part
of the observation is called “free play”. The paediatrician sits in a small chair at the table
while the young boy explores the various toys on a brightly coloured mat on the floor. He
picks up some blocks. The paediatrician watches him and asks if he can build a tower. He
ignores her, drops the block and moves onto a different toy. The paediatrician writes
something down in her ADOS form at the little table. He flits around from toy to toy for a
few minutes, picking them up, looking at them and then dropping them again. The
paediatrician is trying to engage the boy and get his attention. She calls his name but he
doesn’t look or respond. The boy finds a figurine that he seems particularly interested in and
holds it up for the paediatrician to see. She writes in her ADOS form again. The paediatrician
gets down on the mat too. She shows him a bubble machine. It blows bubbles out and the
little boy loves it. He is squealing with delight and chasing the bubbles. He wants to try it
too. He says the word “bubbles” and everyone in the room with me, hovering around the
video monitor, quickly writes this down. The boy is making eye contact and interacting a
little more now with the paediatrician. She is laughing with him.
The child’s mother enters the room and sits on a chair at the far wall. The boy runs to her
and she gives him a hug. “Come see bubbles” he says. He is speaking a little more now that
his mother has arrived. Everyone in the little room writes this down and they all seem to be
switching to a different ADOS form, one that is targeted toward children who use phrase
speech rather than the pre-verbal/ single word module. The boy comes back to the
paediatrician while the mother sits on a bench against the wall. The paediatrician asks the
boy to come sit at the table with her. They sit across from each other in small child-sized
chairs. The table is not very wide and their hands can easily touch. The paediatrician asks
him to pretend he is getting ready for bed and brushing his teeth. She asks what he usually
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does. The boy is having difficulty sitting in his seat. He wants to use the bubble machine
again. He ignores her when she asks about brushing his teeth before bed. He gets out of his
chair and walks around to where she has placed the bubble machine. He wants it. The
paediatrician says he can use it in a minute as a treat once they have played a little more at
the table. The boy sits back in his seat, reluctantly. The paediatrician brings out a picture and
puts in on the table. She asks him what the picture is about. From the little observation room,
we cannot see what the picture depicts. The boy sits rocking in his chair and says something
quietly. The paediatrician asks him if he likes horses. (It must be a picture of a horse that she
is showing him.) She asks him what else he likes. He doesn’t say anything. She gets out a
picture book. She opens it up and asks him what is going on. He reaches up and turns the
pages. He briefly describes what is in each picture. Again, he gets out of his chair and tries to
reach the bubble machine. She lets him use it briefly. He is laughing and chasing the bubbles
around the room. The paediatrician directs his attention
“Here’s one. Try to pop it!” The boy follows her gaze and runs over to pop the bubble. His
mother is laughing too and the boy is clearly enjoying himself. After a few minutes he is
directed back to the table and the paediatrician takes out a small doll. She says it is the doll’s
birthday party! She has little plates on the table. The boy is uninterested. He says something
about blowing out the candles on her cake. He sits back in his chair and doesn’t seem to want
to play. She asks if he wants to take a break and have a snack. No, he is not ready for a snack.
Once the ADOS is finished, the boy and his mother leave the room. This boy has
participated in the ADOS as part of the infant sibling study, another study being conducted
out of the Autism Clinic. He has siblings who have been diagnosed with autism and so he has
been monitored closely at intervals since birth. Now they are going into the hospital to have
their blood drawn for the genetics study. This is quite common at the Autism Clinic; a single
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family participates in several on-going research studies and the researchers share tests across
studies. It reduces duplication and saves time and money. If a child has an ADOS performed
through the infant sibling study the genetics study can use this clinical (phenotypic)
information to later help interpret genetics results.
We say goodbye to the little boy and his mother and then we all head down the
hallway toward the kitchen at the back. We sit around a large table and compare our notes
and scoring in the ADOS booklets. The coding is organized into five groups: language and
communication, reciprocal social interaction, play, stereotyped behaviours and restricted
interests, and other abnormal behaviours. The child is scored on several items in each
category. He can receive a zero, one, two, or three for each item. For example, one item
under the Language and Communication section is Overall level of non-echoed language. A
zero is given if the child uses three or more words per utterance and some grammatical
marking such as plurals or tense. A score of three is given if the child uses single words only
or no spoken language. I listened as they talked about what tenses the boy used, pointing,
looking, visual referencing. They said that vocally he would not get a zero. He whispers a lot.
They went through the list of different items for each of the groups to be scored, comparing
what they heard and saw and then giving a score. At one point one of the students who was in
the room said she was having difficulty deciding between a score of one or two for some of
the items. The developmental paediatrician who had experience doing the ADOS said that
the way she decides between a score of one or two is she mentally tries to think through the
list of things that the patient did well and then a list of things that are off. She then compares
these mental lists and it gives her the distinction between a score of 1 or 2. A score of 1 has a
longer list of good things and a score of 2 has a longer list of things that are off.
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ii) Autism Diagnostic Interview – Revised (ADI-R)
The ADI-R is a detailed interview with the parents, which often takes about two or
three hours to complete. The interview is historical in nature, asking intimate and involved
questions about everything from the pregnancy, birth, early development and into school
experiences, depending on the age of the child being clinically investigated. On three
occasions I planned to attend and observe an ADI. I would make the 2 and a half hour
journey to the Autism Clinic, however, each time the parent cancelled or did not show up to
the appointment. Consequently, my description of the ADI is based on interviews with a
psychologist and a psychology PhD student who conduct the ADIs at the Autism Clinic, as
well as document analysis of the ADI-R questionnaire guide.
The ADI questions are divided into several topic areas: background, early
development, acquisition and loss of language/ other skills, language and communication
functioning, social development and play, interests and behaviours, and general behaviours.
The background questions are designed to give the person doing the assessment an overall
picture of what the “subject” is like. For example, questions are asked about family
composition, past playgroups and schooling, or any current concerns. Early development
questions deal with the onset of symptoms. For example, the examiner asks “how old was
[subject] when you first wondered if there might be something not quite right with his/her
development?” This section also contains questions related to motor milestones, toilet
training and bladder control. The acquisition and loss of language/ other skills section
contains questions such as: “How old was s/he when s/he first used words meaningfully,
apart from ‘mama’ and ‘dada’? What were her/his first words? How did s/he show that s/he
knew their meaning? [Get Examples]” Other questions try to understand whether the
“subject” experienced a regression, losing a skill that he/she once had. For example, ‘Was
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there ever a time that s/he stopped speaking for some months after having learned to talk?
The next set of questions relates to language and communication functioning and contains
questions such as: “How much speech does [subject] have now?” Other questions are
designed to illicit information on stereotyped speech patterns, social chat (small talk),
reciprocal conversation, intonation, volume, rhythm, rate, pointing, nodding, imitation, and
imaginative play. Social development and play questions ask the parent to describe the
“subject’s” use of direct gaze, social smiling, directing attention, sharing, sharing enjoyment,
offering comfort, facial expressions, favourite activities and toys, group play with peers,
friendships. The interests and behaviours questions ask about unusual preoccupations,
repetitive use of objects, compulsions, unusual sensory interests. For example, “Does s/he
seem particularly interested in the sight, feel, sound, taste or smell of things or people? For
example, does s/he tend to sniff toys or people inappropriately?” This section also asks
questions about negative responses to specific sensory stimuli, difficulties with minor
changes in routines or personal environment, hand and finger mannerisms. The section about
general behaviours includes questions related to gait, aggression toward care takers or family
members, self-injury, hyperventilation, and special, isolated skills. Special isolated skills
include abilities that the subject has such as visuospatial ability (puzzles, patterns), memory
skills, musical ability, drawing skills, reading ability, or computational ability.
The ADI is 85 pages long. On the top of each page is a brief summary of the purpose
of the question or in some cases an operational definition will be given here to clarify what is
meant by the question. For example, item 51 on page 45 is about social smiling. At the top of
the page it says “defined as spontaneous smiling directed at a variety of people, including
smiling back at someone smiling at her/him, smiling during an approach, and smiling as a
response to what someone does or says to her/him”. On each page, below the purpose of the
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question and operational definitions, are the question and a few probes that can be used to
further specify behaviour. To the right hand side there is a scoring system. The interviewer
scores each question in real-time, as s/he is going through the interview questions with the
parent. Question 58, for example, is about inappropriate facial expressions. The scoring
system is listed as follows:
0 = facial expressions almost always appropriate to mood, situation and context
1 = facial expressions slightly or occasionally inappropriate or odd
2 = facial expressions obviously inappropriate in several different situations
(SPECIFY)
8 = N/A (almost no variation in facial expression, appropriate or inappropriate)
9 = N/K or not asked
At the far right side of the page are two tick-boxes, labelled “current” and “ever”, used to
determine if the behaviour being described is current or has ever occurred in the past.
Included in the ADI interview protocol is also an ADI-R Comprehensive Algorithm
Form. A PhD student in psychology who conducted many of the ADI-R interviews explained
the scoring system in one of our interviews:
Julia: How does the algorithm work for the ADI? Is there a scoring system?
P:

There’s a scoring system and you have to be trained and get reliability on that.
And the scores go from 0 where there’s nothing that indicates autism or any
kind of developmental issue, to a score of one or two. Two or three are usually
the highest you can get. So the diagnostic algorithm only uses scores of 0, one
and two. So, a three turns into a two. There are other, in certain questions, in
language or motor movement where if a kid has a severe physical disability or
has a different type, like a stutter or something then you would put a different
type of score. So each question indicates which number you should be putting
in… They do give descriptions about what each score would mean and then
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you’re supposed to be scoring as you go along with the parent. So if there’s
anything that you’re not sure about you have to really probe deeper.

On the Algorithm Form, the interviewer copies down the score given for specific questions.
These scores are added up for each section and a total is arrived at. For example, section A is
called Qualitative Abnormalities in Reciprocal Social Interaction. It is comprised of four
sections with each section drawing on various questions from the ADI-R interview protocol.
Different questions pertain to different subject ages, so that the questions involved in the
algorithm for a two-year old are different than those included in the algorithm for a five year
old. On the front page of the Algorithm Form there is a space for the score summary. The
interviewer writes in the sum of all the scores corresponding to the questions in section A, for
example. There is a diagnostic cut-off given for each section’s total score. For example,
section A has a cut-off of 10. If a “subject’s” scores were above the cut-off scores for each of
the sections, then the ADI-R would be interpreted as indicating ASD. This ADI information
would be compared with scores for the ADOS and other questionnaires as well. Moreover,
the clinician meets with the patient to get an overall impression. Several of the psychologists
I interviewed suggested that clinical judgement is an important component of diagnosis.

iii) Intelligence Testing – Stanford-Binet 5th Edition
Another standard assessment that is conducted at the Autism Clinic is Intelligence
Testing. The same PhD student who did many of the ADI’s was also responsible for much of
the intelligence testing at the Autism Clinic. I observed him conduct the testing and
interviewed him about the process. In addition, several of the other people I observed and
interviewed in the Autism Clinic described various aspects of the intelligence testing.
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The first functional intelligence test was developed in France in 1905 by Binet and
Simon. Initially, the test was not well received. Lewis Terman, from Stanford University
bought the publishing rights from Binet for the sum of one dollar and in 1916 the first
Stanford-Binet Intelligence Scale was published, translated and adapted from its original
form (Viney & King, 2003). The Stanford-Binet Intelligence Scale, 5th Edition, was released
in 2003. It is a one-on-one, individually administered test in which an examiner uses various
cognitive tasks to assess the intelligence of an individual. The test is used or a broad range of
ages (from two years to 85+ years) and can be used to test a wide variety of disabilities and
exceptionalities. Intelligence is broken down into five categories or factors underpinning
cognitive ability: fluid reasoning, knowledge, quantitative processing, visual-spatial
processing, and working memory. Some of the advantages of the 5th edition over earlier
editions are its game-like qualities with more colourful artwork, toys and manipulatives and
its balance of verbal and nonverbal content. The game-like qualities of this newest edition are
especially important considering the pervasive concern for examinee fatigue. Indeed, the
testing that I observed at the Autism Clinic was often punctuated by several breaks as young
examinees would often begin squirming in their seat after a little while.
As with the ADOS testing, I watched the Intelligence testing from an adjacent room
through a video monitor. The intelligence testing room was quite different compared to the
room set up for the ADOS testing. Two chairs were arranged on either side of a small table
pushed up against one wall of the room. A round clock was mounted on the wall. The room
was painted in a neutral colour and was, with the exception of the table and chairs, empty
with no stimuli to distract the examinee from concentrating on the tasks presented to him or
her. The testing consisted of various cognitive tasks that were worked through across three
different booklets. The various factors (ie., working memory) contained different items or
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tasks for the examinee to respond to or perform. The items would begin more simply and
increase in difficulty. The books were set up like a tent on the table between the examiner
and the examinee, with one page facing the examinee and the backside of the previous page
containing scoring information and instructions facing the examiner. As the testing was in
progress, the examiner recorded the scores for each item. In the exams that I observed, the
child being tested was alone with the examiner while his or her parents waited in the waiting
room. Once each of the three testing booklets had been worked through the psychologist
would apply an algorithm to interpret the scores gleaned from the testing process. This
information is then combined with scoring from other assessments and taken together they
form the basis of a research diagnosis.
At this point, I have followed DNA as it has moved through many different places
and spaces within the laboratory and clinic, being translated and transformed many times
along the way. From blood, to extracted DNA it moved into the laboratory. Here it was
sliced, washed, photographed, amplified, plotted on intensity graphs, compared to reference
genomes, compared to other findings in the literature, displayed in PowerPoint presentations,
run through a sequencing experiment, tagged with a barcode, validated through PCR, and
written up in a research report. Out of the lab, the DNA was discussed in a feedback session
with parents, represented in photographs of chromosomes, through metaphors of necklaces
and beads, and blueprints. Moving into the clinic, the DNA is combined with phenotypic data
gathered through standardized observations, interviews, and intelligence testing. A clinical
report is written and given to the parents.
There have been several different humans involved in translating and transforming
the products that have moved through these spaces: the patient and his or her family
members, the developmental paediatrician, and project coordinator, the nurses in the blood
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lab, the laboratory technicians in the DNA extraction lab, PhD students, post docs,
technicians, and a wide variety of scientists at the Monday-morning meetings, genetic
counsellors and medical geneticists in the feedback sessions, psychologists and paediatricians
in the clinical testing.
There have also been a large number and variety of non-human actors that have
connected to the DNA along the way as it has moved through the laboratory and clinic.
Arms, hands, numbing cream, needles, blood, tubes, robots, slides, chips, ovens, pipettes,
magnets, buffers, computers, mathematical algorithms, statistical pipelines, intensity graphs,
research reports, clinical reports, diagrams and doodles, PowerPoint presentations, peerreviewed manuscripts, consent forms, standardized observation schedules, scoring sheets,
video monitors, toys, bubble machines and databases are but a few.
Thus far, I have not described what DNA or autism means to individuals but rather
have focused on describing how autism is done through the interaction of human and nonhuman actors.

5.11 Entrance: Into the Family Home
Unlike the story I have recounted from the laboratory and the autism clinic, the story
that I want to tell about the families involved in genetic research are based on interview
conversations only. I was not able to observe these families as they went about their daily
routines. I could not see with my eyes how autism was done in the family home. Through
interview conversations, however, I was given glimpses of how autism and the genetic
information these families have received is enacted in everyday life. I have tried to unfold the
different ways that autism is materially enacted by these families. I wanted to at least offer a
glimpse of how the genetics of autism is reassembled beyond the walls of the hospital.
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5.11a Demographic Information of Parents
The people interviewed included parents from six families who had participated in
genetic testing and received genetic feedback about autism. The interviews were conducted at
least 8 weeks after the families received the genetic feedback. Five mothers and one father
were interviewed. Four of the mothers who were interviewed described themselves as single
parents. All of the participants had completed at least some college or university. When
asked about ethnic background each participant described his/herself as Canadian. The
current age of the child diagnosed with autism in each family ranged from eleven to twenty
one. The age of the child at the time of the original diagnosis of autism ranged from three to
eleven. Three of the six families had more than one child diagnosed on the autism spectrum.
The specific genetic findings varied with each family, such that across the families a number
of genes had been identified as associated with autism including: NRXN, SHANK,
PTCHD1, and SH2B1. Some parents were not sure of the gene involved but were aware of
the location, for example chromosome 16. All of the genetic findings involved copy number
variations (deletions or duplications) found through microarray testing. In the following
section I would like to discuss how autism is constructed in relation to daily routines and the
process of diagnosis. After exploring how autism is enacted or done through daily routines
and the process of diagnosis, I will then be able to describe how genetic information becomes
entangled with the enactment of autism in the daily life of families.
During the feedback session, genetic information about autism is given to parents. At
this point, this information enters entirely new networks as it becomes entangled with all
kinds of human and non-human actors that make up the daily life of the family. The networks
into which genetic information enters are elucidated by exploring the daily routines of
children and families living with autism. All of the families described the importance of
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keeping a routine. In the description that follows, I have cobbled together the daily routines
gathered from each of the parents and presented them in one short account of a day in the life
of “Bobby”. I have created an amalgamation of the stories, condensed into a single character
named “Bobby” because I am concerned with the anonymity of participants and their family
members. Bobbie’s routine is recounted in the third person, from a mother’s perspective.

5.11b Bobbie’s Daily Routine as Told by His Mom
Bobbie has always had a strict routine. From the time he was a tiny baby I became a
single mother and so I always had to work to financially support our family. I had to get up
and go to work every morning so the kids always had to get up early too. Bobby wakes up in
the morning around 7:00 am. He is often in a bad mood and swears at me or picks on his
brother or sister. I do my best to make a nutritious breakfast: pancakes or French toast, fruit,
and milk or something like that. I make milkshakes with berries a lot because I think the
berries are good for Bobby’s brain. I want to know that I’ve done my best to start him off on
his day in the best way I can. Often, when I’m racing to get breakfast ready for everyone and
to get myself ready for work Bobby will have a meltdown about something. This morning,
for example, he demanded that I come to his room at once because he did not like the
particular socks I had laid out for him to wear. “I don’t care what you’re doing mom; I hate
these socks and I want you to get me new ones, now!” Eventually, we all scarf down some
breakfast and I drive Bobby to school. My two older children take the bus to their school but
I’ve always been nervous about putting Bobby on the bus. He can get taken advantage of
easily. So I drop him off at his school. He is in an LD (learning disabilities) class but it is
partially integrated. So he does take some of the usual subjects that other kids take, like
drama or computers. I usually get called by the school, most days. Bobby spends a lot of time
in the principal’s office and sometimes they let him practice being the secretary to give him
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something to do. Sometimes Bobby gets sent home from school because he is acting out. So
I’ve had to change my job, rearrange my work life so that I can have the flexibility to come
home and be with him if I need to. Even though Bobby acts out and gets in trouble at school,
I know he really enjoys it. It is the only place he has any real friends. He doesn’t have any
friends anywhere else. He goes to an amazing school with an army of people taking care of
him.
So at the end of the school day I pick him up. School ends at 3:00 but I pick him up at
2:30 so he can avoid the commotion of the hallways when all the students get out of class. As
soon as we get home he immediately goes onto his computer in his room. He likes Facebook
and has thousands of “friends”. My other two kids try to track him on Facebook; they’re
worried someone might try to take advantage of him. Around 4:00 he starts to talk about
food. We have dinner. Then it’s time for a shower. At 7:00 pm we watch Wheel of Fortune.
At 7:30 we watch The Simpsons. At 8:00 he goes up to bed. He doesn’t go to sleep then but
he always went to bed at 8:00 and he can’t get over that. He has to be in bed by 8:00 then
even if he’s not tired yet. That’s how it goes, over and over, Monday to Friday.
In this short description about Bobby’s routine, a slew of new actors are introduced
that are not part of the actors of the genetics laboratory or the autism clinic. The description
is very shallow and does not relay the kind of thick description gained from participant
observation. Even so, one is introduced to socks, fruit milkshakes, school buses, principal’s
offices, Facebook, Wheel of Fortune, parents, siblings, teachers, and friends. The networks of
the family home are further elucidated when the diagnostic process is considered.

5.11c Becoming Diagnosed on the Autism Spectrum
Although my research was not focused on constructions of ASD within the diagnostic
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process, the diagnostic process was referred to by several parents in relation to their
motivation for participating in genomic research. Two of the parents described getting a
diagnosis quite quickly, by the time their child was three years old. For these children, early
intervention was a possibility. For four of the parents I interviewed, the process of getting
their child diagnosed with ASD was a long and arduous journey which was fraught with
challenging encounters with physicians and school boards as well as misdiagnoses along the
way. For these children, early intervention was not possible. Several of the parents knew
very soon after their child was born that something was wrong. Severe colic and non-stop
crying for hours at a time was described by some. Difficulty talking or walking was
described by others. In these stories of diagnosis the binary opposition of either being on or
off the spectrum began to crumble and fragment into particular sub-classifications within
ASD. One parent retold the story of her son’s diagnosis with Asperger’s in the following
way:
Mother: So he was eventually diagnosed in grade eight. So what happened was
we had suspected it in grade four. He was identified as gifted, LD in grade four.
And then a doctor, a paediatrician gave me a book about autism and I read it
and if fit [my son]. You see he was very eccentric since he was little and he was
brilliant, absolutely brilliant. At two and a half he could recite the Night Before
Christmas. And he would tell me when to turn the page and it was word-forword. So we knew. And he always had difficulty socially and sensory and then
in grade four when he got identified gifted LD, like I said, the doctor gave us
this book. But he didn’t suspect it. You see we’re both into sports and music.
Well, I was into the arts. So our son was always involved in sports when he was
little. So his gross motor was a little bit more developed. But he still had, he
was still a bit of an awkward walker. But he was still very good at sports,
especially football. So then, as the years went on, we found out more about
him. Like in grade six I knew that he had a writing disability. He had difficulty
doing things. But no one did anything about it so I finally took it upon myself
in grade six to find out that he did have a writing disability. I had him tested.
And then in grade eight they had ‘Toonies for Autism’ at his school. So they
had somebody from the autism foundation come in and talk about autism. And
he came home to me and he said, ‘You know what mom, I have a lot of those
traits’.
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Julia: So he identified it himself!
Mother: Yeah. So then there were huge sensory difficulties and social
difficulties in grade eight and his grade eight teacher didn’t pay attention to his
IEP. So he literally shut down before Christmas. So that’s when we phoned a
specialist, a child psychiatrist, and we got him in and he was diagnosed.
Another mother recounted the long and frustrating route to a diagnosis of Autism for her son
in this way:
Mother: It was a long road. Right after he was born, everybody knew there was something
different but nobody could put their finger on it. Of course, it took us eleven years
to figure out is was the chromosome 16 deletion, right. But we noticed issues in his
development, issues with tolerating formula when he was an infant and once he was
around a year or so there were some issues with some milestones…But when I went
to the doctor he opened up my file and said, ‘you had post-partum depression after
he was born, right.” And I said are you kidding me? Like he was telling me that I
was crazy! So we continued to see developmental milestones not being met and we
really started to see the stickiness, like he couldn’t handle change. Change the
colour of his socks and he’d freak out. He had this hat he had to wear. A hundred
degrees and he still had to wear a wool hat.
I really had to kick down our family doctor’s door to get a paediatrician
involved. So we went to the paediatrician sometime between two and three, closer
to three. And I had done my own research and I went in there and said I think he
has autism. And the paediatrician gets out a list and he goes through and he checks
them off and he goes, ‘well the problem is he only has fifteen out of sixteen
characteristics’. And I looked at him and said are you kidding me? And I asked
what one is he missing and he said, ‘well according to your statements he seems to
sleep through the night’. And I said he screams for eighteen hours a day, of course
he’s going to sleep! …So I had to fight the whole hospital board and this took
another year and finally they came back and said they would do it. But by this time
early intervention had also got us a referral to [Hosptial X]. And I said I feel more
comfortable going to [Hosptial X] because other parents at our local hospital would
go in for an assessment and they said we’d be in the waiting room and the staff
would be arguing and then they’d compromise; one thought it was autism and one
didn’t so they’d call him Asperger’s. It was a compromise. So I said, I feel better
going to [hospital X]. I’m so glad we did. So we didn’t actually get in there
[hospital X] until [my son] was six and he was seen and given a diagnosis of
autism.
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5.11d How Does Genetic Knowledge about Autism Relate to the
Daily Routines and Experiences of the Diagnosis Process?
In practice, the genetic knowledge that parents learn in the feedback session at the
autism clinic does not change the routines of these families at all. As one mother said:
I found during that process, where you’re all excited, like, ‘wow, we have an
answer’ and it’s like, nothing’s different. Okay, we know what’s causing it but it’s
going to be years before they can figure out if there’s any treatment or anything
else.
For all of the participants interviewed the genetic knowledge was practiced in an orientation
toward the future. Some of the parents had difficulty getting their child diagnosed with
autism and it is this experience that they hope to prevent for future generations through
advancements in genetic testing.
I think the thing for me is you absolutely feel helpless. All you want to do is
help your child and they sit there going we don’t know what to tell you.
Everything is a mystery. And I think at that point my hope was that some day
they would be able to have some answers for parents.
These families who participated in the genetics of autism research are aware that the benefit
of the research will primarily be felt by future generations of families. One mother stated:
How I feel is I know there is probably nothing that is going to help with my
family but in future generations, putting my genes together with the others that
they found had something in common. We could be part of the cure for the
future. Finding out where this is happening in and what’s going on and maybe
there could be a test in the future to say hey, if you are breeding with this
person, there is a high chance that you could have a child with autism or you
have the gene. And you might decide who you’re marrying. You would at least
have the chance to say, hey I have the autism gene, we might not want to have
kids. I don’t know.
The ways in which the future is mobilized in expectations and motivations for engaging in
medical technologies has previously been explored by Brown et al (2000). The genetic
knowledge that the families received in the feedback session was also described as important
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and beneficial in relation to family planning for siblings of individuals with autism. One of
the mothers whom I interviewed had two sons with autism and a daughter who was not
diagnosed on the spectrum. She said she planned on telling her daughter about the genetic
results when her daughter was older. She said:
So if I said to my daughter, be careful [daughter] because you’ll probably have a
child with autism. It would be helpful for anyone to know that, right, at a certain
age. I don’t think they should know that before a certain age. I think if you knew
that before a certain time in your life it could be very depressing.
During one feedback session that I observed two “unaffected” siblings were present. Both of
these siblings were over 18 years old. They told the genetic counselor that they wanted to
have their own DNA tested. Specifically, they wanted to know if they also had the copy
number variation as their diagnosed brother. They wanted to know if they might pass this on
to their own children some day. This idea of family planning was also a concern for some
participants. One mother described her son’s concerns about the possible implications of
genetic testing:
But one of his concerns, he voiced it with [Dr. Morten], was that he was worried
that the information taken with the research, that he was worried, I think it was
[the genetic counselor] had mentioned something about possibilities for down the
line for interventions. And he was concerned that it would be a negative
intervention. In that if somebody knew they were going to have a child with
autism would they abort the child? So he was concerned about the moral
implications of that.
Participants talked about other benefits of receiving genetic information. For
example, one mother described always wondering if she had done something wrong when
she was pregnant or when her son was a baby. Receiving genetic information enabled her to
stop blaming herself for her son’s condition. She found out that her son’s genetic variation
was de novo, in other words it was a spontaneous mutation and was not inherited from either
his mother or father. She stated:
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I think in some sense, you know, before we had this piece, you always have this
sense of did I do something wrong? Is this my fault? You’re dealing with this
child and you’re going to all these places and in the back of your head you’re
wondering, what are they thinking? What did you do wrong? But, to realize the
genetics of it all, you know, when you think back fifty years ago it was blame
the mother, blame the mother. Those poor women.
Another mother described feeling a similar anxiety about what had caused her child
to have autism. She stated:
I always often wondered what factors may have influenced it. If it was something
in the environment, something I had done, blah, blah, blah. And then when you
hear finally, ok, there is a genetic component you think, well, OK. You know, so
they’ve discovered something. I mean, I had always wondered how it had come
to be and always thought there could have been some genes involved. I didn’t
know. I had to figure out what it could have been. So I thought it could be
environmental, did something happen in the womb? You know.
Another woman whom I interviewed found out in the feedback session that her son had
inherited the clinically significant genetic variant from her. She too carried this variant and
passed it down to him. During the interview she talked about the complicated feelings she
had about learning the genetic information, a sense of relief as well as feeling guilt:
OK, I think at that point I felt bad in a sense, a certain amount of guilt. But I
think also a certain amount of relief because now I could talk to my daughter
and we need to really, and knowing now that there was something, it wasn’t
just something that happened during pregnancy. There was some sense of relief,
you know, there was mixed emotions. But at the same time you’ve lived with it
for so long that you know you’re, whatever, this is the way it is.
Genetic information was also expressed by some parents as giving them a long awaited
answer to questions they had been asking for years. One mother in particular described the
difficulties of getting a diagnosis and how she had felt belittled by family physicians and
paediatricians. She recalled getting a call from the autism clinic at 10:30 at night. She was
dozing off watching TV in bed. Dr. Morten told her about their findings:
She said that it turned out that [my son] was one of the children with the
deletion. I remember she said, ‘so it’s official. You’re not crazy!’ All the issues
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with his walking and his speech, they’re all related to that deletion on the
sixteenth chromosome. I remember when she said it’s official I wasn’t crazy I
asked if I could have it in writing. (laughing) … I didn’t sleep all night. It was
kind of like all of a sudden the answer to everything. Like poof there it was. It
was one simple thing that could explain everything.
For others, genetic information opened up more questions:
So my point is that I have more questions. So that’s something I’d be interested in
pursuing is finding out more questions about the gene, answers to the questions
and what does the gene, what does NRXN3 mean compared to NRXN1? So I did
have the meeting with [the genetic counselor] and then my husband had the
meeting with [the genetic counselor] but with one meeting you still have lots of
questions.
Thus, for families participating in autism genomics research, autism is, in part, constructed in
relation to everyday routines and in relation to the experience of getting a diagnosis.
Participating in genomic research and receiving genetic information, the parents who
participated in interviews with me describe a variety of experiences. Some parents felt
genetic information gave them long-awaited answers, while others felt the information
opened up more questions. For some mothers, the genetic results relieved them of guilt,
while for others feelings of guilt were sustained and reaffirmed. All of the six participants
who were interviewed described an orientation to the future, hoping that the genomic
research of today would change the diagnostic process, opportunities for early intervention,
and possibilities for family planning for people in the future.

5.12 Summary
In this chapter I have attempted to follow DNA as it moves around the laboratory,
clinic, and family home in the process of genomic testing in autism. Starting with blood
collection and DNA extraction I then moved into the laboratory. From here DNA was sliced,
amplified or “denatured”, aligned to probes and primers, tagged with barcodes, scanned, and
photographed. Intensity graphs are made along with comparisons with a reference genome.
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Described in the language of CNVs and SNPs, DNA is talked about via PowerPoint
presentations at meetings and classifications are later made as research reports are written up;
a genotype is established. Here the DNA has exited the laboratory and enters into another
network of actors in the Autism Clinic. Children played with bubble machines, toys; they
made eye contact or they do not. Talked or remained silent. Gestures were scrutinized by
clinicians in a tiny room watching through a video monitor. Parents were interviewed about
pregnancy, infancy, breastfeeding, toilet training, friendships, school and other intimate
details of family life. Psychometric tests designed to measure intelligence were administered;
questions were asked and answered. Assessments were scored. A phenotype was established.
Through the Laboratory and Clinic, genotype and phenotype data were brought together, a
phone call was made to parents. Here, the DNA entered another network in the family home.
Routines, socks, school buses, siblings, friends, bedtimes were the actors found here. DNA
became entangled in new associations with guilt, futures, diagnoses, divorce, relief, questions
and answers.
I have tried to illustrate, by following the translations of DNA, some of the different
practices of the laboratory, the clinic, and the home. Through the practices enacted in each of
these spaces, DNA is constructed in relation to very different networks of human and
nonhuman actors. Knowledges that are produced within these spaces are intimately tied to
materially heterogeneous actors. For the most part, this chapter has pushed down explicit
discussion of the theoretical and philosophical ideas that informed my interpretations. I have,
except for a few comments, attempted to describe events, activities, people and technologies
in their own terms. The following chapters, however, will attend more explicitly to practice,
constructionism and actor-network theory.
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Chapter 6: From Problematization to Mobilization: An
Actor-Network Theory Account of Translation
6.1. Overview of Callon’s Framework for Translation
6.2. Problematization in Autism Genomics Research
6.3. Interessment in Autism Genomics Research
6.4. Enrolment in Autism Genomics Research
6.5. Mobilization in Autism Genomics Research
6.6. Conclusion

In the previous chapter, I laid out a story following the production of genetic
knowledge about autism as it moves between the family, the laboratory and the clinic. As I
traced the route through which genetic knowledge flows, I described some of the most
important actors (both human and non-human) along the way. As I re-read this last sentence,
something strikes me as not quite right, not really reflective of what I experienced in my
observations and conversations during field work. It occurs to me that the word flow is what
bothers me. Does knowledge flow through a route? What is concealed by this verb, to flow?
This is what the next section must elucidate, the work, the tensions, the non-coherence and
the strategies for bringing disparate networks of actors together in order to make knowledge
appear to flow.
When I first thought through the layout of this dissertation, I imagined a general
overview of the route through which genetic knowledge is produced in the first section and a
deeper, more focused analysis in the second section. I realize, however, that it is not just a
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matter of looking more closely, zooming in. Instead, I need to unfold an entirely different
story altogether. One that if layered on top of the first story will align in some places and not
in others. There are points of connection as well as areas that will not cohere. In Chapter
four, the story is recounted in a linear, chronological fashion. The blood is collected from a
child diagnosed with ASD, DNA is extracted, an array is run, the DNA is sequenced, it is
discussed in meetings, written about in reports, and then conveyed through different charts,
graphs, and diagrams in a feedback session with clinicians and parents. However, much of
my data is not captured within this linear story. In order to convey more of what I
experienced during my field work, I need to tell another type of story, introducing a few new
actors along the way. I need to add another narrative layer by describing what happens to
knowledge as a story of translation.
Translation, as it is captured in this chapter, has a very particular meaning, a
historicity. It is situated within a specific place and time: 1980’s French science studies.
Nestled within actor-network theory, translation was first unveiled by Callon in 1986 as a
story of scallops, fishermen and scientists. Translation, in this specific instance draws on
Actor-Network theory and describes an ongoing process in which one actor becomes the
spokesperson for several other actors. When an actor (human or nonhuman) becomes
translated it becomes black-boxed, represented, and fronted by another actor. For example,
when a scientist presents a Power Point slide that lists recently found candidate genes for
ASD, there are several actors being translated within this slide, including: patients, DNA,
microarray and sequencing technologies, journal publications, and distant laboratories and
scientists involved in conducting experiments that discovered and validated each of the
candidate genes. By invoking this specific notion of translation I am introducing a specific
way of breaking translation down into four distinct phases: problematization, interessement,
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enrolment and mobilization. Unlike the previous chapter, the story of translation is not
necessarily chronological. Each of the four components of translation requires constant
ongoing work in order for the network to be upheld.

6.1. Overview of Callon’s Framework
One of the most often cited papers on the issue of translation in the science studies
literature was written by Callon (1986). In this paper the authors outlined four components or
'moments' of translation: problematization, interessement, enrolment, and mobilisation. This
framework for translation is grounded in three basic principles: agnosticism (impartiality
between actors in a controversy), generalized symmetry (which explains conflicting
viewpoints in the same terms), and free association (abandoning distinctions between the
natural and the social). Callon tells a story in which fishermen and scientists came together in
an attempt to increase the production of scallops. The scientists came with a technique for
cultivating scallops they had learned from the Japanese. Neither fishermen nor scientists
knew much about the relationship between larvae and adult scallops. The fishermen were
worrying about dwindling stock in St Brieuc Bay. Callon captured the interdynamics
between these actors (scientists, fishermen, and scallops) with his four moments of
translation.
The first moment, problematization, refers to the process by which a particular actor
attempts to define the nature of a problem and thereby rendering itself an obligatory passage
point for its resolution. Translation involves the imposition of a particular way of defining a
situation for others. The scientists in Callon's story set themselves up as an obligatory
passage point by defining the problem; they want to know if the techniques used in Japan for
cultivating scallops can be applied in France. Through this problem a network of alliances
between actors is assembled: fishermen, scientist colleagues, and scallops themselves.
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Interessement describes how one attempts to capture others in particular roles. In
order to address the problem that they have identified as important, the scientists must
convince the other actors to adopt certain roles and identities. The tools (towline) that the
scientists put into the water in order to capture the scallops are an example of interessement.
The scallop larvae are taken from their context and protected from predators. In order to
convince the fishermen, the scientists hold meetings in which they show graphs representing
the decline in stock in the Bay.
Enrolment depicts the scenario in which actors accept the roles assigned to them. Any
of the actors may refuse. For example, the scallop larvae may not attach themselves to the
towline device or the fishermen may decide to fish and capture all the scallops being
preserved by the scientists. Enrolment highlights the negotiations that take place in order for
actors to accept their identities.
Mobilization encompasses the methods used to ensure that the spokesperson for
related collectives are not betrayed by the collectives or thwarted by competing spokespeople
(Callon 1986). For example, it is not the fisherman themselves but their official
representatives that sanction the research project proposed by the scientists. If all the actors
are enrolled, the scientists are able to speak on behalf of all the fishermen and scallops. The
scientists may go to a conference and present graphs and figures with numbers to a small
group of experts. These diagrams and tables represent different populations of silent actors scallops and fishermen - who have been mobilized, displaced, and translated into a graph. A
host of alliances have been built up in order for the graph to exist. At any point the alliances
may fall apart; the scientists may fail to enrol actors with their particular definition of the
problem.
Callon’s (1986) framework emphasizes the work that is needed to keep disparate
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actors together in a group or network. Put in the context of the day-to-day activities of autism
genetics research this framework highlights the negotiations and the trials that a research
project must survive in order to be translated. In the remainder of this chapter I will address
each of Callon’s four moments of translation as they pertain to the various networks
(laboratory, clinic and family) brought together in the autism genomics project. At the end of
the chapter I will highlight how this framework might contribute to a discussion of
knowledge translation.

6.2. Problematization in Autism Genomics Research
Problematization is a way of identifying and framing matters of concern so that the
envisioned path to follow appears inevitable (Callon, 1986). Problematization does not only
indicate the matters of concern but also sets up a particular network of actors as integral to
the solution of the problem. There are always, however, other ways of framing a particular
problem, alternative courses of action that could be pursued. Each way of framing a problem
rests on differing sets of values and assumptions.
There are several examples of Problematization that I observed and recorded in my
field notes. The most prominent of these was an advertizing campaign distributed by a major
Canadian newspaper. This campaign was sponsored by Autism Speaks, a parent-driven
NGO whose aim is to fund genomic research related to autism. Through this campaign,
autism was problematized in a particular way such that the genetic research conducted at
Laboratory X became a natural, obligatory passage point for a solution to be achieved. I will
first describe the campaign and how a particular problematization was presented.
On a large four foot by four foot bulletin board on one of the walls at the entrance to
the research office of the Laboratory X hang several full-page newspaper advertisements.
The advertisements are dated from the summer of 2010. Along side some Christmas cards
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from participants in the genetics project, these newspaper clippings have hung on this board
throughout my field work. They are an example of a highly visible public articulation of a
particular way to problematize autism. For several weeks, between May 2010 and July 2010,
a national newspaper displayed full-page advertisements, sponsored by Autism Speaks. The
advertisements depicted a jigsaw puzzle, almost fully completed. A final piece was missing
and remained to be filled in. Across the puzzle was a photograph of a famous person’s face.
Don Cherry, a legendary Canadian hockey commentator, for example, was presented in one
of these campaign advertisements. On one day, the advertisement displayed a photograph of
Dr. Lorenz (pseudonym), from Laboratory X, as the face in the puzzle. Along with his
photograph was a quote, “I will not stop until a cure for autism is found”. Within the ad some
information about Dr. Lorenz was given. By having his photograph and that quote appear in
this ad, Dr. Lorenz and his research were (likely non-intentionally) aligned with a particular
way of problematizing autism.
In this problematization, autism is a disorder that needs to be cured. Genetic research
and in particular research on copy number variations are offered as a means through which
the problem might be solved in the future. Autism is described as the problem and a cure as
the solution with Dr. Lorenz and the Laboratory X as an obligatory passage point between
problem and cure. A large network of actors are implicated in this problematization:
individuals diagnosed with autism, genes, award-winning scientists, all the equipment and
robots in the laboratory, the human reference genome, technicians, project coordinators
recruiting patients, the list goes on. The challenge is to get all of these actors to align
themselves with this particular articulation of the problem.

6.3. Interessment in Autism Genomics Research
In order to address the problem as it has been identified, each actor in the network
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must be given a specific role to play. This designation of roles is called interessment,
according to Callon’s (1986) framework of translation. Among the scientists, clinicians, and
families I observed, interessment took many forms, perhaps the most visible of which was
the letter of information and consent form, written by the research investigators and handed
to potential research participants.
Early on in my field work, I observed a situation that highlighted some of the
difficulties in getting actors to accept their defined roles. In this situation, a project
coordinator was talking with a parent of a child on the autism spectrum. The parent was
initially interested in becoming involved in the genetics research. She was eager to
participate and had previously phoned the project coordinator several times in an attempt to
get her child moved up on the waiting list. Claudia (pseudonym), the project coordinator,
responded and a date was set for the child to come in and have blood drawn. Prior to this
date, Claudia had sent the mother the letter of information and consent form for the research,
so that the mother would have ample time to read over and consider the project. I attended
the autism clinic on the day of the scheduled blood draw so that I could observe. When I
arrived, Claudia explained that she had been on the phone with the mother all morning. After
reading the consent form the mother was no longer interested in participating in the genetic
research. She was concerned about the section in the letter of information that described
implications for her or her child being able to get insurance. According to the project
coordinator, this was a fairly typical concern:
It’s one of those things that has to be in there to protect the hospital. And we
don’t know that, even the mom today asked something about putting that in their
medical records. I told her, right now I don’t have anything to put in your medical
record, but if we find something that’s clinically significant then we’ll have to
write a report and that possibly will go in your medical records. We’ve had
families that have refused because of that. They don’t want to be involved
because they don’t want it to affect their insurance. And we can’t guarantee
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because we don’t know what’s going to happen.
Each actor is involved in many different networks. In the scenario described above, the
mother and her child are asked to play the role of patient. As part of this role they would be
accompanied by another actor, the patient medical chart. The mother, however, is already
potentially enmeshed in a separate network, one set up by her insurance company. She
refused to accept her role as patient in the autism genetics research because the potential
findings, if included in her patient medical record, could adversely affect her or her child’s
future insurance coverage.
Several examples of interessment take place in the laboratory. Here, attempts are
made to capture a non-human actor, the DNA, in a particular role. First, blood or saliva are
collected in a tube. The little glass tube is one way in which scientists try to physically
capture DNA. Later on, microarray machines are brought into the lab, at great expense. The
scientists try to make these machines play particular roles. For example, the hybridization
machine must play the role of mixing genetic samples with Illumina probes. The array
machine must be captured into the role of making florescent images. The human genome
reference must be captured to play the role of representing the “standard” human.

6.4. Enrolment in Autism Genomics Research
Enrolment describes the negotiation process through which actors are convinced to
play their allotted role (Callon 1986). Actors may refuse. A complex and dynamic dance
occurs amongst the actors in order to get all the actors to accept their role and continue to
play that role over time. If enough actors refuse to enrol, the network will fall apart. In
Callon’s article, the fishermen had to be enrolled in the network, agreeing to refrain from
fishing the scallops in the bay during the experiment. The fishermen had been convinced by
the problematization laid out by the scientists and had agreed to leave the scallop larvae

207

alone in order that they be further studied. The graphs and charts depicting dwindling scallop
numbers had been presented to them by the scientists and had temporarily convinced the
fishermen to suspend fishing. One night, however, the fishermen dissented and drudged the
bay with their nets within the towline. The network set up by the scientists failed to capture
the fishermen as actors and as a result the scallops could not be captured either. The network
crumbled.
There are parallel examples of failed enrolment in the autism genome story as well.
One of the crucial actors in the autism genome network is the proband (an individual
diagnosed with ASD). Without probands the network could collapse. In the clinic, there are
many tools used to assess and confirm a diagnosis of ASD. The ADOS is one of those tools.
In the ADOS assessment, children are asked to play with various toys and engage in
conversation with the examiner. As one psychology student at the Autism Clinic explained,
however, sometimes the ADOS fails to capture individuals in a diagnosis of autism. She
explained:
A lot of times, especially for the higher functioning kids, and especially girls, like
girls with Aspergers, the ADOS does not capture autism very well. So, most of
the time they will actually come out not autistic. They won’t meet the criteria.
But that doesn’t mean they don’t have autism. So we have to figure out ways to
support our decision in giving them a diagnosis…[O]n the ADOS you score for
things like if they don’t talk a lot, but they’re very chatty. But those things aren’t
what you score on the ADOS. They don’t score for that but that is social
impairment. So the ADOS itself doesn’t capture those individuals very well.

Other means of capturing particular social impairments are needed in order to enrol these
individuals in the autism genome network. The phenotyping visit is a two-day affair, during
which time several assessments and discussions take place. If the individual is not captured
as a patient in the ADOS, there are other assessments, such as the ADI-R, which will help to
include and enrol more people in the role of patient. Moreover, several participants described
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the crucial role of clinical judgement. Built up over time, with increased experience, clinical
judgement is what allows a psychologist to make diagnoses when the ADOS does not. In
this way, through multiple tools, the individual who eludes a diagnosis through the ADOS
might still become enrolled in the network as patient.
Part of the work of enrolment is to ensure that individual actors remain committed to
a particular problematization. In the context of the autism genetic research, autism had been
problematized as something that required a cure, a cure which could be reached through
genomic research. During my interviews with some of the participants, it slowly emerged
that some of the participants whom I interviewed were not entirely comfortable with this
particular way of problematizing autism. Some were concerned that when autism was
problematized as needing a cure, with the obligatory passage point of genetic research, future
outcomes could include solutions that were, in their eyes, undesirable. One participant who
worked in the autism clinic stated,
Because you don’t really know because the technology keeps changing, which
scares me a little bit too. I’m worried that I’m going to be old and grey and then
realize this study I’ve been doing my whole life is doing prenatal tests on people
and aborting kids because of this. It’s really going to bother me if that’s what it
comes to. But I feel like it could come to that. But it’s going to be hard because
it’s not going to be one gene and you don’t know. In one family two kids could
have the same rare CNV, they don’t look anything alike. One could solve some
crazy thing and be a genius.
This research involves problematizing autism as something that needs to be cured through
genetic research. The concern of the individual quoted above was the ambiguity of what the
results of genetic research might lead to or be used for. In particular, she was concerned that
genetic information might be used for prenatal diagnosis in order to prevent individuals with
genes associated with autism from being born. (In deed, this participant’s concerns are
similarly discussed elsewhere in a burgeoning literature that has grown up around the
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concept of geneticization (Lippman, 1992; Lippman, 1998; Nelkin & Lindee, 1995) and the
ethics of prenatal genetic testing (Lippman, 1994)(Asch, 1999).
Another participant described her concern over the problematization of autism and
specifically mentioned the newspaper campaign with the puzzle pieces. She stated:
Participant: The main concern obviously adults with autism have is what is
the implication for this. What are you really . . . What is the
purpose? Is it better intervention or is this going to go the way of
Down’s Syndrome? And are you really saying that you want to
understand the genetics for what purpose? Why are we doing
this research? I am also very mindful about who funds research.
Like genetics and their taglines of their organizations. So when I
hear someone say Cure Autism Now by the leading scientists
here at [the hospital], what does that mean, what does he mean
by that?
Julia:
Is this the [newspaper] thing?
Participant: Exactly. That is a very Autism Speaks driven mandate and
Autism Speaks believes in that I think.

She continued by explaining how she is involved in recruiting adults with autism to
participate in the annual research conferences. She felt that they would no longer participate
because they did not agree with this particular problematization of autism. She stated,
I’ve always been in charge of bringing adults on the spectrum to talk and I don’t
know if they’ll do it. Once [Laboratory X director] came out with that ‘cure’
thing, I know many of my adult contacts wouldn’t be comfortable now.
Thus, competing problematizations can pull actors out of one network and into another. The
quotes above indicate that this participant was simultaneously engaged in a different
network, one that was sceptical of the word “cure”. Advocates of disability rights do not
problematize autism, but instead problematize a society that does not offer resources and
opportunities to support families living with autism (www.neurodiversity.com). Asch (2000;
2005), has put forth a social paradigm of disability, questioning whether disease and
disability are the problem or whether the challenges associated with disability stem from
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particular social arrangements that are amendable to change. This alternative
problematization, brings together a very different network of actors: accommodation
resources, educational resources, respite care, employment opportunities, etc. In the
problematization of autism disability rights advocates genetic research is not an obligatory
passage point in the network.
My research suggests that keeping a network of actors together requires constant
work at every stage. Over the course of my field work, there were several instances in which
the members of the autism genetics research at the Hospital publically articulated a particular
problematization. Newspaper ad campaigns, radio and television interviews each contained a
representation of the problem such that genetic research became an obligatory passage point,
defining particular roles for various actors to play.
Another actor, integral to the autism genome network, is DNA. DNA must
consistently be enrolled in order to be captured in the network. At any point along the way,
through multiple experiments, DNA can refuse to be enrolled in the network. There are many
examples throughout my field notes and interview transcripts that describe instances where
DNA is not being captured and the scientists have to respond. For example, in order to
acquire the DNA, a blood or saliva sample needs to arrive safely in the laboratory for
extraction. I listened to a project coordinator describe in a Monday morning meeting an
instance in which obstacles were met when trying to transport a sample. The lid had not been
properly screwed on and the saliva leaked. The courier would not accept the package and
refused to deliver it to the laboratory. In response, the scientists found a company that
developed padded packaging specifically designed for carrying genetic samples. If the
sample leaked, the package soaked up the sample and a cell line could still be established
from this in the laboratory; the DNA could still be extracted and captured in the network.
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Almost all meetings were, at least in part, devoted to enrolling DNA as an actor
within the autism genome network. There were so many places in which the DNA could fail
to be captured along the experimental pathway. One example that repeatedly arose in
discussions between scientists was the issue of GC-rich areas on the genome. These are
stretches of the genome that have a disproportionate number of G-C base pairs and fewer AT pairs. These areas are very difficult to capture in Next Generation Sequencing.
Unfortunately, one of the gene families recently found to be associated with autism, the
SHANK family, is highly G-C rich. When I asked one of the molecular biology post docs to
tell me more about the G-C problem I kept hearing about, this is what she said:
Post doc: SHANK 1, 2 and 3. So they have a really high GC content which
means that a lot of the bases are G and C, not A and T. I don’t know
how much genetics you have…
Julia:

I understand that part.

Post doc: So A and T, when they bind together, they only have two hydrogen
bonds. G and C have three hydrogen bonds. So a GC bond is stronger.
If you have a high GC content that region of the genome will be more
tightly bound than an A-T rich region. Um, and that can make
sequencing really difficult because it’s harder to separate your DNA
and it’s just harder to use, well, it’s hard to use data that’s AT rich or
GC rich but for different reasons. So if you want something easy to do
you want a good mixture of bases and you want them all mixed up as
well. So even if it’s say 50-50 G and C but it’s all GGGGG, CCCC,
AAAAA, that makes it difficult as well. So easy things are all kind of
mixed and balanced. But the SHANK family have got a really high
GC content so just doing any of the steps with them is more difficult.
So, for a lot of the samples we’ve sequenced so far, we’ve got really
bad data.
The post-doc continued by explaining that she spends a lot of time tinkering with the
experiments to overcome problems like the GC coverage issue. She calls herself a “technonerd” because while other post-docs prefer to analyze the data, she enjoys figuring out ways
of capturing more data and making sure it’s real. The GC problem is just one issue that can
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affect coverage of the genome. There are some areas of the genome that are repeat-rich. All
of these issues can result in “dirty” data. The qPCR experiment, used to validate microarray
results was described as being “dirty”. One day while walking through the lab, I saw a handwritten note taped to some machine (I’m not sure what the machine was for) that read, “This
is a clean machine. Please, no pcr products!” I asked a participant why PCR and qPCR were
considered “dirty” and this is how he responded:
It’s quick, it’s fairly cheap, and it can give you an idea but it can be very
ambiguous. Like some I was looking at yesterday for example, the results are half
way between deleted and not deleted. So how do you interpret that? My control
samples look beautifully not deleted. My actual samples are kind of half way
between a deletion and a no deletion and I’ve done it three times and I’ve got the
same result three times. So what does that mean? And that comes up time and
time again. Because a lot of experiments are kind of specific to a region and if
that region just doesn’t, it’s just riddled with problems. So sometimes it can be
great, it can take a couple of days, you get a really clean result, you think ‘great,
my deletion is beautiful. It’s inherited from dad and it’s in the unaffected sib or
it’s not in the unaffected sib. Beautiful’. The next day you do qPCR and you
think, well what does that mean?

Thus, DNA has to be captured at several steps in several places within the laboratory.
Even if it is captured by the microarray, it could still refuse to be captured in the qPCR,
refuse to be validated. Certain regions of the genome are more difficult to capture than
others. This has quite significant implications. At one Monday morning meeting, the
scientists had just returned from a large international genome conference held in Montreal,
attended by over 8000 people. On this Monday morning the scientists took turns around the
table describing interesting talks or posters they had observed. One post doc complained that
she felt there wasn’t anything new being presented at the conference, no new and exciting
areas of the genome showing up. Another post doc responded. As usual, I was madly writing
notes through this meeting and this is what I have captured about her response:
Heather says that some genes just sequence really well compared to others - so genes they

213

[at conference] are talking about are found in these regions for technological reasons. She's
not convinced it is not highly dependent on the technological limitations. Other genes don't
sequence very well so people are not finding mutations there.
In other words, some stretches of DNA are not being captured at various places in the
laboratory. This DNA is failing to be enrolled, not only in the small, immediate network I
observed at the Laboratory X, but these regions of the genome are not being captured by
hundreds of other laboratory networks represented by posters and talks at the conference
either.
As I stated earlier, much of the work being done in the laboratory can be thought
about in Callon’s terms as “enrolling” the actors. It is a continuous, on-going process that
needs to be managed across several steps and stages in each experiment. One particular way
of measuring the quality of “enrolment” is through computational analysis. An entire team of
computer scientists is employed in order to measure and ultimately increase the quality of
what is being captured by the various technologies in the laboratory. In Next Generation
Sequencing, for example, all of the data is taken directly off the machine and run through the
Exome Pipeline. Each indel (insertion or deletion) is given a quality score which indicates
the confidence in calling that mutation. When the sequencer fails to “read” a nucleotide base
from the sample, the pipeline will insert a dot and this later becomes replaced with a base
from the human reference genome. The concern is that the scientists don’t want data dumped
because of one missing base in a read. Equally of concern, scientists also want to ensure that
the SNPs they are reporting are real, that they are not artefacts of the technology.
Complicated algorithms are applied in order to capture the most data, while still minimizing
‘false positives’.
Callon’s (1986) framework describes the many trials that a network is put through

214

and the constant work that is done in order to maintain the enrolment of all of the actors
along the way. In the network he described, the towline did not initially successfully capture
the scallops. Many alterations had to be made in order to get the scallops to play the role they
were supposed to play in the scientist’s network. Likewise, the fisherman had to be
convinced and cajoled into accepting their role in order for the network to be maintained.
Similarly, the autism genome network requires several actors to be enrolled. The proband
and DNA, described above, are two of these important actors. The ongoing work of keeping
actors enrolled was visible at every meeting and in each interview I conducted.

6.5. Mobilization in Autism Genomics Research
According to Callon’s framework, mobilization refers to the process by which actors
are displaced and represented in some other form by a spokesperson (1986). All of the trials
and work that has ensured the enrolment of the actors are bracketed off. In the case of the
autism genome network, mobilization is frequently achieved in the form of the research
paper, published in a peer-reviewed journal. The patients, the DNA, the machines, consent
forms, assessments, blood, saliva, technicians, pipettes, glass slides, glass tubes, coloured
caps, classification scales, protocols, and robots – all of these come to be subsumed within
the article. The authors of the article speak for these actors, as long as the network has been
maintained. There are other examples of mobilization: a conference talk, a poster
presentation, a PowerPoint slideshow. What carries the most weight, however, what
mobilizes these silent actors and makes them travel farthest is the journal publication. Once
mobilized in the form of a journal article, these silent actors as represented on a graph or a
table will be drawn into hundreds of other laboratory networks around the world, if even for
a short time as competing or collaborating scientists read the article.
All of these forms of mobilization, the journal article, poster presentation,
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PowerPoint, are highly transportable, easily taken up and communicated. All of the work and
effort done in the laboratory is represented in these mobilized forms. It is extremely timeconsuming (it takes decades to develop a laboratory on the scale of the Laboratory X) and
expensive to hold together a network of actors such as the one in the autism genetics project.
This is why these mobilized representations are so coveted, so valuable. There is often a race
to publication between competing laboratories so that all of the effort, the work of keeping a
network held together, is not wasted. Talking to some of the post-docs and PhD students in
the laboratory, I learned about the scavenger-like behaviour of the drug companies who
attend the scientific conferences. One post-doc described the drug companies as “predatory”.
They run around between posters at poster sessions taking notes about any new gene that
might be implicated in a disease, peppering the presenter with questions about the details of
the genomic location. In one meeting, I heard the director of the lab state that conference
presentations are precisely where you’re not going to describe your most interesting findings,
exactly for that reason.
Journal publications are more likely the first place where new experimental results are
announced. As I learned from one of the assistant directors at Laboratory X, the journal
publication is also important because the number of articles produced by a laboratory is
ultimately what gets measured by funding agencies, and thus journal articles become an
important form of mobilization for the laboratory and the genetic research reported in each
article. More articles will result in more funding, which in turn enables further future
research.
The importance of mobilization in the form of journal publications was visible in
several instances in my field work. Often, PowerPoint presentations would include a slide
with screenshots depicting several journal titles. For example, when trying to convey the
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importance of the NRXN gene in autism research, one presenter flipped to a slide with the
names of published articles that contained “NRXN” in their titles. The presenter could have
just said, “I’m exploring this region of the genome where the NRXN gene is located because
it is known to be associated with autism”. But, what if an audience member were to disagree
and argue that NRXN is not where this presenter should be focusing? Calling up all the titles
of the related articles, however, gives weight to what he is saying. Each of the titles
represents an interesting experimental finding from a laboratory. Subsumed within each title
is a huge network of silent actors. By listing the titles, the presenter is calling up all of these
actors that were brought together and maintained in a network through all the stages of
various experiments in all of these different laboratories. By including this list of articles in
the PowerPoint, it is as if the presenter is saying to the audience, ‘go ahead, challenge me.
But you’ll have to challenge all of these networks and the hundreds of silent actors that have
been mobilized behind me and represented in these titles’. Thus, publication is an effective
way to mobilize diverse actors within the genetics network.
The genetics group on whom my research is based are proving to be very successful
at problematizing, enrolling and mobilizing actors. With enormous grant funding, high-tech,
cutting-edge technology, an ever-flowing line-up of patient samples to be processed - this
network appears to be durable with strong associations amongst human and non-human
actors. The framework provided by Callon provides a way of examining the work that is
needed in order for a network of actors to be maintained. Future improvements in
technology, for example, will be a vital means of enrolling non-human actors, such as
particular G-C rich genes that are associated with autism.
While an exploration of competing, alternative problematizations of autism is beyond
the scope of my research, some participants suggest some ambivalence toward the current
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problematization of autism in the genetics research project. Positioning genetics as an
obligatory passage point is not what worries the individuals I interviewed. One could imagine
a problematization in which genetic research is set up as the obligatory passage point to
enable earlier interventions for children with autism. In deed, this was the problematization I
often heard in the autism clinic. There seemed to be a flexibility in the way that autism was
problematized within the different spaces of the laboratory-clinic network. It was only when
the director of Laboratory X made a very public articulation about finding a cure for autism
that a few participants became concerned about enrolment.

6.6. Conclusion
The four stages outlined by Callon apply equally to human and nonhuman actors.
This framework allows for an account of translation in which agency is shared. In this way, it
resonates with Pickering’s dialectical mangle of practice. I am, in part, uneasy about
including this chapter in this dissertation. In many ways, Callon’s (1986) framework
underscores the political nature of the translation process, drawing attention to all of the
enrolling, convincing, and ongoing negotiations that are necessary to keep disparate actors
playing their allotted roles. Indeed, Callon (1986, p.199) described his article as providing “a
better understanding of the establishment and the evolution of power relationships…the
capacity of certain actors to get other actors – whether they be human beings, institutions or
natural entities- to comply with them”. Doing fieldwork is itself a political process in which
alliances were made between me, my supervisor, and the director of the laboratory field site,
among other actors. In writing about the on-going work and negotiations that take place
throughout the process of translation I have not conveyed the personal animosities between
competing laboratories or competing scientists. While that may well be a part of the process
of knowledge production, and this has been attended to elsewhere (e.g., (Latour & Woolgar,
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1986)), I have tried to illustrate how the political transcends human-to-human interactions.
The politics of translation is embedded in the non-human technologies, tools, protocols,
DNA, probes, and reference genomes as well as the human actors assembled in the autism
genetics network.
I have included this chapter because it is this political nature of translation that is
noticeably absent in the KT literature. For example, “identifying a problem” is one of the key
components in the CIHR’s Knowledge to Action (KTA) model. (This model will be
discussed in detail in the final chapter of this dissertation.) In the KTA model the political
dynamics of identifying a problem is not described. Similarly, the KTA model proposes
stages such as “adapt knowledge to local context” and “select, tailor, and implement
interventions”. In contrast, the notions of interessement, enrolment, and mobilization provide
a new language and a novel entry point from which to critically approach the neutral
representation of translation in the various components of the CIHR’s KTA cycle. The
framework proposed by Callon (1986), which highlights translation as an inherently political
process, may contribute to and enrich current understandings of the KT process in which the
political is rarely addressed.
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Chapter 7: Translations Amidst Difference and Multiplicity
Medicine is not a coherent whole. It is not a unity. It is, rather, an amalgam of
thoughts, a mixture of habits, an assemblage of techniques. Medicine is a
heterogeneous coalition of ways of handling bodies, studying pictures, making
numbers, conducting conversations (Berg & Mol, 1998).
[M]edicine does not merely describe a pre-existing
biological reality, but instead creates its own objects of
analysis (Lock & Gordon, 1988).

7.1 Overview of Key Concepts
a) Difference
b) Multiplicity
c) Coordination
7.2 The Practiced Individual with Autism
a) The Clinically Practiced Individual with Autism
b) Laboratory Practices of the Individual with Autism
c) The Individual with Autism Practiced at Home
d) Strategies of Coordinating the Multiply Practiced Individual
7.3 Autism(s) in Practice(s)
a) Practicing Autism in the Clinic
b) Practicing Autism in the Laboratory
c) Autism in the Family Home
d) Non-Coherence in the Practices of Autism
e) Strategies of Coordination
7.4 Conclusion
In this chapter I explore the idea that medicine is not a unity, that a phenomenon can be
practiced quite differently within the same hospital. Through the concepts of multiplicity and
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coordination, I explore the tensions that arise when practices shape a phenomenon in
divergent ways and examine what happens when these practices rub up against one another.
In doing this I aim to explore the concepts of difference, multiplicity and coordination. The
subsequent chapter will then consider how the concepts of difference, multiplicity and
coordination might inform the notion of knowledge translation.
In order to consider these ideas I will examine two specific phenomena as they are
practiced in the clinic, laboratory and home. The first phenomenon is the individual
diagnosed with ASD. This may seem an unoriginal and over-worked choice. Social scientists
have been complaining for years that medicine reduces the human body in different ways,
that the unified person becomes dehumanized and fragmented as various parts are
sequestered off, counted, imaged, scanned (Casper, 1998; Lock & Nguyen, 2010; Martin,
1987; Rapp, 1988). “Tsk, tsk” we might say as we read about the doctor who refers to a
patient as the coronary in room B or the hysterectomy in the OR. This criticism, however,
takes for granted the idea that there exists a patient as a whole. A unified person becomes the
normative standard to which the reductions of medicine are compared. My research,
influenced by scholars in the social study of science (Latour, 1992; J. Law, 2000; J. Law &
Mol, 2002; J. Law, 2002; J. Law, 2003; J. Law & Mol, 2008; J. Law & Singleton, 2000; J.
Law, 2007; Mol & Berg, 1994; Mol & Law, 1994; Mol, 2002; Mol & Law, 2003), starts
from a different place. Following Berg and Mol (1998), I want to suspend the notion that the
unified patient body exists as self-evident in the beginning, preceding the practices of
medicine and instead focus on the practices that shape what counts as the individual with
ASD. Through this examination the notion of a single unified patient body gives way to an
image of a complex pastiche of bodies that are reduced in innumerable ways with various
measurements, practices, habits, conversations, spaces and instruments. To say that the body
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is reduced becomes uninteresting. What becomes important is to understand how these
inevitable reductions that multiply with varying practices relate to one another, contradict
one another, and coexist side-by-side one another. Understood in this way, the unity of the
individual is an effect, a consequence of much effort and work to make differences cohere.
The second phenomenon through which the notion of difference will be explored is
“autism”. Here, I want to compare how autism is enacted in the clinic, home, and the
laboratory. This is a complex task as the multiplicity of practices that are found in the
laboratory and clinic are layered with the complexity in the diagnosis of autism, a complex
and heterogeneous diagnosis with a broad spectrum of clinical manifestations (Freitag,
2007). In the practice of autism genomics, however, the complexity of this diagnosis may be
reduced. As I discussed in previous chapters, in practice, the complexity of the spectrum is
often reduced to a binary opposition: patients, siblings, parents, family members in an
extended pedigree were either on or off the spectrum. Diagnosed with autism or not.
Thus, in my analysis I will allow the binary reduction of the complexity and
specificity within the spectrum to remain reduced and unproblematized, as that is how it was
most often practiced by the participants in this study. Instead, I will focus on how autism
(taken as a unified phenomenon) is practiced in the clinic, laboratory and home.

7.1. Overview of Key Concepts
Before attending to 1) the individual diagnosed with autism and 2) autism, as they are
practiced in the context of autism genetics, I will first introduce a few ideas and texts that
have influenced my analyses and interpretations presented in this chapter. Much of what I
want to introduce here is intimately related to actor-network theory, previously explored in
Chapter 2. Many of these concepts are rooted within and often extend actor-network theory
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into new territory. In particular, I bring to the foreground the ideas of difference, multiplicity
and coordination.

7.1a Difference
While the idea of difference is at the heart of much of what I have been reading and
writing pertaining to actor-network theory and knowledge translation, difference is often an
unspoken assumption subsumed within other concepts or ideas. I did not come across a
formal analysis that focused squarely on the notion of difference until I had already begun
collecting data for this project. The idea of difference is so simple, so obvious, that it had
escaped my attention. It was an assumption that was always already there, just beneath the
words I was reading and writing. When I came across a book by Berg and Mol (1998) titled
Differences in Medicine: Unravelling Practices, Techniques, and Bodies, it struck me that
this was a fundamental concept underpinning what I was exploring. In some ways,
difference is at the very core of this dissertation. Knowledge translation is needed because
there are differences amongst those who inhabit the laboratory, the clinic and the homes of
individuals with autism.
With the notion of difference, scholars have begun to tease apart the assumptions of
unity in a variety of contexts. Berg and Mol (1998) explain how the unity of Western
medicine, for example, unravels when one considers the various techniques, measurements,
technologies, tools, and specialized vocabularies found within various fields of medicine.
Likewise the unity of the patient dissolves when approached in this manner. Finally the unity
of the present, as a time that breaks from the past, becomes problematic when approached
from the notion of difference. The present often contains traces of the past. Moreover, there
are differences in the times that make up the present such as the beginning and end of a
consultation. Thus, with a focus on differences, what was once taken for granted as a unified
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whole can be re-imagined as containing diversity. This diversity, state Berg and Mol (1998)
is a feature of any complex practice and is neither inherently good nor bad. We can attend to
the generative places where different practices are creatively coordinated as well as to the
sites of conflict and tension. Diversity and difference are not something to overcome.
Willems’ (1998) work offers an example of how differences might be explored. He
described and compared two cases of asthma. Willems suggested that the different treatment
practices engaged in each case enacted different asthmas. Asthma is made different in the
practices of Carl and Steven. Steven takes salbutamol, a bronchodilator which combats
airway obstruction. Carl takes steroids which act against inflammation. Conventional wisdom
might attribute these differences in treatments as reflecting different aspects of the same
disease, distinctions between mild and severe asthma or differences in prescribing habits of
the physician. Willems, instead, sets out to illustrate how drugs produce different asthmas
and different lungs. At times, a single patient may have to engage in two different treatment
regimes. Willems (1998, p.17) asked “how is this to be imagined? Do people indeed switch
from one disease to another, from one body to the other? Do their airways consist of
muscular tubes in one moment and of inflamed mucous membranes the next?” Through this
research Willems illustrates how lungs and diseases may be practiced differently as the
patient enters into multiple treatments which imply different geographies of the diseased
body.

7.1b Multiplicity
Multiplicity is related to the idea of difference. An object multiplies as it is practiced
differently in different contexts. Mol’s work (2002), for example highlights the differences in
atheroscleroses by comparing the practices of the clinical consultation and the pathology lab.
In the clinical consultation, patients complain that their legs hurt when they walk and the pain
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stops when they rest. A doctor might ask questions about where it hurts and how long the
patient can walk. She might hold a patient’s feet in her hands to feel and compare the
temperature. She might feel the pulsing of the arteries in different places along the legs.
Down the hall, through the closed doors of the pathology lab, however, atherosclerosis is
practiced quite differently. A leg has been amputated and refrigerated, a cross-section of an
artery is made, and cells are stained. The lumen of the vessel wall is measured. Under a
microscope, the pathologist sees arteries with thick intemas. This is what atherosclerosis is in
the pathology lab. The objects of the clinic and the pathology laboratory might coincide. The
patient with pain on walking and a weak pulse in the clinic might also be found to have a
thick intema in the pathology lab. This is not always the case, however. In some instances, a
post-mortem reveals extreme atherosclerosis in a patient who never complained.
Through these examples of difference, Mol suggests that atherosclerosis, the disease,
is not found within the body. Instead, it is performed through practices. As practices
multiply, in different areas of the hospital, so too does a disease. According to Mol, it is not
just that there are multiple perspectives of a single object. For her, more than that is going on.
She is not interested in understanding the meanings or interpretations of atherosclerosis.
When we focus on participants’ perspectives, the observers multiply but the object is left
alone.
A crowd of silent faces assembles around it. They seem to get to know the
object by their eyes only. Maybe they have ears that listen. But no one ever
touches the object. In a strange way that doesn’t make it recede and fade
away, but makes it very solid. Intangibly strong (Mol, 2002, p.12).
By foregrounding practices and all of the materials and activities involved, the disease itself
is examined as something that is done or enacted, in practice. Thus for Mol, an object
(whether it is a disease or a body) is allowed to multiply when we shift our attention from
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differences in interpretations to differences in localized practices.
Mol and others have gone to great lengths to describe how differences are made to
relate to one another, how they are sometimes coordinated and made commensurable.
Cussins (1996), for example, offered a thoughtful account of how women seeking services of
infertility clinics actively participate in constructing themselves in multiple ways. She refers
to a kind of “ontological choreography” which takes place when the body is constructed in
relation to technologies. She stated “the subject is dependent on the constant ontological
dance between ourselves and our environments that changes how many descriptions we fall
under, of how many parts we are built, and how integrated we are or need to be” (Cussins,
1998). The physical exam with the technology of the metal speculum brings into view the
woman’s vagina, cervix, ovaries and uterus. The ultrasound allows follicles in the ovaries to
be measured and counted. During a treatment cycle the woman is “rendered into multiple
body parts” (Cussins, 1998). The patient actively orients herself in relation to the part of the
body that is under scrutiny. If IVF treatment is successful the synecdocal relationship
between objectified body parts and long-range subjectivity are maintained. Conversely, a
metaphysical rupture ensues when treatments fail. In a single cycle a women moves “from
one to many and back again” (1998, p.193). Thus, the body multiple is, as Mol suggests,
“more than one but less than many”.
It should be stressed, however, that this notion of multiplicity does not necessarily
pose a problem for medicine. Different practices are distributed in different spaces and an
object is transformed as it moves among sites of practice. Mol suggests, “that the ontology
enacted in medical practice is an amalgam of variants-in-tension is more likely to contribute
to the rich, adaptable, and yet tenacious character of medical practice” (Mol, 2002, p.115).
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7.1c Coordination
There are many ways in which differences and multiplicity are made to relate. Law
and Mol (2002) describe what they call “fractional coherence”, in which things are drawn
together but not centred. Law draws on this metaphor of mathematical fractals which are
lines that occupy more than one dimension but less than two. For Law, single, coherent
objects are the effects or products. Focusing on the TSR2, Law (2002) begins with a thought
experiment in which the reader of a brochure is to assume a naïve position. The reader learns
that the TSR2 is an aircraft on one page. That the TSR2 is a weapons machine on another
page, a map-making navigational machine on still another page. A naïve reader who does not
take the TSR2 as a priori a single object will learn from the brochure that there are many
different objects held by the name TSR2. Law then outlines several strategies of coordination
used in the brochure to connect and coordinate the various TSR2s described. The brochure
itself wraps up all these different objects into one physically bounded place; the brochure has
a table of contents which hierarchically relates different elements together, and 3dimensional perspectival drawings hold various elements together at different angles. Rather
than starting with the assumption that an object is singular, Law suggests that we explore
how various objects are made to relate and cohere. The singularity of an object is
“precarious, uncertain, and reversible” (2002, p.36).

7.2. The Practiced Individual with Autism
In this section I explore how the individual diagnosed with autism is practiced
differently in the clinic, the laboratory, and the home. I illustrate how the body multiplies
when one focuses on different practices which draw together different networks of human
and non-human actors. As such, I will recount many of the activities that take place within
the different spaces in which autism genomics is carried out as they pertain to the individual
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with autism. I also want to comment on the ways in which the body(ies) is/ are made to
cohere and relate to one another. What I hope will become clear is that various technologies
and non-human actors are integral to the differentiation of objects and to their coherence and
coordination. The individual diagnosed with autism multiplies because s/he is practiced
within different assemblages of actors that are brought together in various spaces and places.
Before continuing with my analysis of the various practices of 1) the individual with
autism, and 2) autism, I would like to make a brief comment about the experience of treating
these two epistemic objects as separate. That is, treating the individual as separate from a
diagnosis. During the process of acquiring ethics approval from the Hospital X ethics review
board, I first had to pass an internal scientific review in the autism clinic. For this internal
review I had to present a research proposal. At one point in my proposal I used the phrase
“autistic individual”. This was immediately jumped on by all four of the reviewers sitting
around the meeting room table. No, no. The correct way to phrase this was “individuals with
autism”. Intrigued by the importance of this wording I asked if they could tell me more about
the preference for this particular phrasing. I learned that the clinicians felt the phrase “autistic
individual” carried a meaning that the person is autistic, that autism is part of who they are.
Conversely, they felt the phrase “individuals with autism” conveyed the meaning that autism
is just something the person has but it is not who that individual is. Since the separation of
individual and autism was clearly important to the clinicians, I have attempted to keep these
two objects of analysis separate. In practice, these two objects of analysis were not as cleanly
separable, or distinct as the clinicians suggested. The individual and autism are intimately
entangled, with different practices of autism implicated in the different practices of the
individual/ patient body. Autism and the individual are often co-constructed in relation to one
another.
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7.2a The Clinically Practiced Individual with Autism
What I call the clinic is actually a research unit inhabited by various clinicians who
perform clinical testing, monitoring and surveillance. The activities, technologies, and
recordings that take place in the spaces that form the clinic perform the individual with
autism in particular ways. Even within the clinic, a single human is performed in several
different and sometimes conflicting ways.

i) Practicing the Individual as a Social Being
As has been described in Chapter 5, the clinical testing carried out in the autism clinic
is highly standardized. These tests are conducted in relation to schedules or scales that are
considered the “gold-standard” for autism diagnosis. In all of the observations, the paper
documents were being closely followed and written on by the participating clinicians. In this
way, the patient was being constructed or performed in relation to very specific guidelines in
each of the different testing scenarios. These testing situations were highly controlled
environments, such that the size, colour, objects and people found in the room would be
similar in any testing situation. One of the first tests I came to observe in the unit was called
the Autism Diagnostic Observation Schedule (ADOS). Clinicians must be trained
(disciplined) in the ADOS to ensure that the test is being carried out and scored properly. In
this test the child is placed in a room with toys. There are various versions of the ADOS,
tailored for the developmental stage of the person being tested (pre-verbal, phrase speech,
etc.). While the clinician is interacting with the child, s/he is also writing on the ADOS
document, which is about 15 pages in length. Simultaneous to this, in another room
connected via video monitor, other clinicians are marking in the ADOS schedule. On several
occasions I was also given the schedule and expected to write in it as I observed.
The ADOS for Phase II (phrase speech) consists of 14 different tasks including: 1.
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construction task; 2. response to name; 3. make-believe play; 4. Joint interactive play; 5.
conversation; 6. response to joint attention; 7. demonstration task; 8. description of a picture;
9. telling a story from a book; 10. free play; 11. birthday party; 12. snack; 13. anticipation of
a routine with objects; 14. bubble play. On the first page of the ADOS there is a box
containing the child’s information including their ID, date of birth, gender, chronological
age, the examiner, and the date of the evaluation. Subsequent pages are set up such that the
tasks appear on the left hand side with a brief description and the right hand side is an empty
space in which notes are to be written. All of the tasks afford a different way of evaluating
the child’s social interactions. Specifically, the ADOS rates five different areas: language
and communication, reciprocal social interaction, play, stereotyped behaviours and restricted
interests, and other abnormal behaviours.
While watching the interaction on the video monitor the other people in the room
with me were silent so that they could hear what the child was saying. The little camera lens
could be moved by a joy-stick in order to orient our view to the movements of the childclinician interaction. In this little room we followed along the ADOS schedule, marking in
examples of language use or play as they pertained to each task. Occasionally, someone
would whisper, “what did he say?” At times one’s gaze would be directed at the schedule,
writing in an example, instead of at the monitor observing the interaction. The room was
often intense with concentration as the raters did not want to miss any interactions. The
observers in the little room would write down examples of the child showing shared
enjoyment (this was common in the bubble blowing exercise) or using facial expressions to
communicate feelings, pointing, or engaging in imaginative play with figurines or dolls.
Through the ADOS the clinician is oriented to the patient as a more or less “social”
being. The patient is practiced as a social entity, one who navigates social interactions. The
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patient is quite literally performed in this way, as an audience of evaluators observes the
contrived interactions, the props of play things are placed on the stage, and the script of the
ADOS is closely followed.

ii) Practicing the Individual as the Thinker/ Knower/ Puzzle Solver
Another test in the clinical unit, the Stanford Binet Intelligence test, was routinely
practiced. Through this test the patient was performed as a cognitive being, a thinker/
knower/ puzzle solver. Unlike the ADOS test, in the Intelligence test the eye contact or
experiences of shared enjoyment for example, were not of relevance. The patient as a social
being was bracketed off. The multitude of play objects included in the ADOS to provoke
play and interaction between the patient and the clinician administering the test were
noticeably absent in the physical context of the Intelligence test. In this scenario the room
was bare except for a table and two chairs and the little flip charts that sat on the table
between the clinician and patient. Whether the child whispered, yelled, or sang the answers
was not important; with eye contact or without; in this context what mattered was whether
the child answered the question correctly or not.
As with the ADOS, the Stanford-Binnet Intelligence test is highly standardized. The
examiner wrote down the verbal answers given by the patient while following along with the
various components of the test. The test would sometimes take hours with the examiner
allowing the patient to stop for breaks and snacks along the way. The test is divided up into
different booklets, each focusing on a different task.
During one session I observed, for example, the clinician asked a boy who looked to
be about ten years old, “which letter is missing from the picture?” Later he asked “what’s
happening in this picture?” following this he said, “Tell me what each word is: apple, dress,
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dog, hat, parrot, puddle, factory, allow, lend, eyelash, curiosity, skill”. The boy was not sure
how to define curiosity. He sat in his chair wiping away tears, clearly upset that he doesn’t
know the answer. When the clinician reassured the boy that he was not supposed to know all
the answers and that the same sets of words are used for adults the clinician was responding
to the boy as a social being. The boy was communicating, through tears and in his verbal
responses that he was feeling upset. This would be a highly informative interaction in the
ADOS test; I imagine the observers in the little room would be madly writing notes in the
margins of the schedule trying to capture all the verbal and nonverbal details of this social
interaction. In the intelligence test situation, however, the clinician did not write any of this
down. All that is captured are the boy’s words that he has spoken in trying to define
‘curiosity”. This is because the intelligence test practices the patient as a thinker/ knower/
puzzle solver. The social interaction in which affect is communicated is not relevant to the
specific incarnation of the individual that is practiced through the intelligence test.

iii) Practicing the Diachronic Individual through the ADI
A third way in which the individual is practiced in the autism clinic was through the autistic
diagnostic interview (ADI-Revised). This was a standardized interview that takes place
between a clinician and the parents of a child on the spectrum, designed to elicit a detailed
historical picture of the child. Through this interview, the individual is practiced as a
temporally located being. The interview asks questions about when the individual achieved
various developmental milestones (such as walking and talking); it also asks about school
performance and friendships. In some ways, the ADI-R captures similar information as the
ADOS and the intelligence testing, but it does so in a way that is diachronic. The individual
with autism is performed as a changing, growing person who has inhabited different places
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and situations over time. The ADI seeks to understand a more global historical overview of
the individual from the parents’ perspective(s).
There are many other ways in which the individual with autism is practiced in the
clinic. For example, the consent form practices the individual with autism as a voluntary
research subject. The photograph taken of a individual’s face practices him/ her as a unique
constellation of physical traits. The appearance of the patient’s photographed face is later
interpreted and labeled by a trained clinical geneticist as dismorphic or not. Moreover, in the
clinic patients come to be known as members of families. Clinicians may become aware
when families are going through difficult periods, such as divorce. Personality traits of
family members may be recalled when a patient is discussed. As such, in the clinic patients
also often come to be practiced as members of an extended family.

7.2 b Laboratory Practices of the Individual with Autism
I would like to turn now to some of the ways in which the individual with autism is
practiced in the laboratory. In the spaces of the laboratory, through a variety of technologies,
the individual with autism is translated many times. Each of the technologies goes about
ordering the individual in different ways. At various points these orderings are brought
together and made to cohere or relate to one another.

i) Practicing the Individual with Autism as a Geographic Entity
The individual with autism may be practiced in the laboratory as a geographic entity.
Hanging prominently on the bulletin board inside the main office of the genetics laboratory is
a collection of three world maps: the Hereford Mappa Mundi, the Mercator, and Wegener’s
Theory of Pangaea. Below each of these world maps is a map of the human body: the
chromosomal/ karyotype map, sequencing map, and CNV map. I learned that it was the
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director of the laboratory who combined these maps on this sheet of paper, a creative
signpost to the work being done within the laboratory: something akin to cartography. Just as
each of the world maps portrays a particular kind of world, so too is the human body
practiced slightly differently through the various maps constructed in the laboratory.
Figure 7.1: Image of Maps Pinned onto Laboratory X Bulletin Board
Figure 7.1

Through several of the technologies in the laboratory the individual with autism is
practiced as a kind of geographical entity, composed of genetic building blocks of various
sizes and resolutions. Microarray and sequencing technologies in the laboratory reduce the
individual with autism such that a string of nucleotide bases is made to stand in for the
individual. At a slightly larger scale, in cytogenetics, the individual is practiced as a set of
microscopically visible chromosomes. The particular components that are brought into view
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by various technologies reassemble the individual with autism in different ways. Practiced as
a geographical entity, there are many different tools in the laboratory that set out to map the
individual with autism. Just as a geographer has tools that she uses to map a region of the
earth (compass, GPS), so too does the scientist use a large number of tools to map the patient
body (e.g., see Appendix B for list of tools needed for various stages of Next Generation
Sequencing experiment).
The individual with autism is at times collapsed within a geographical location. For
example, a line from the minutes of one of the Monday morning meetings reads,
“ - 16q23.3 deletion who is on the waiting list to have an assessment so not
100% autism at this time”.
The state of a particular location, whether the genetic material is deleted or duplicated or
somehow rearranged in this single marked place, becomes the placeholder for the individual
person. Practiced in this synechtocal way the individual is 16q23.3, the twenty third band on
the short arm of the sixteenth chromosome. The part stands for the whole. In other instances,
the body is practiced as a series of locations, each location with a particular address. The
Next Generation Sequencing lab manager stated:
So at the end the instrument will look at all these pictures and try to assemble
the correlation. There’s actually a physical address. So the instrument knows ‘I
have a bead here and that bead is on the same place in all those pictures
(Interview with NGS manager).
In the geographic body, the distance between locations is also important.
There might be other types of regulation that go on. In some cases it might be
the actual physical distance between two genes that is important. So imagine, I
don’t know this is just a hypothetical situation, imagine something has to bind
somewhere to have an effect. If the effect is distance dependent and you delete

235

something in between then the distance will be wrong. So the regulation might
not work (Post-Doc in Laboratory X).
The practice of the body as a geographical entity also transforms the scientist into a kind of
geographer of the body. In constructing the individual with autism as a geographic entity the
scientist is also co-constructed. The body becomes a road of sequence and the scientist is
transformed into someone who must map this road. One scientist explained:
So say you have this, you line it up and it’s 3.1 billion bases long. You have
this road of sequence in front of you.
In mapping the geographic body, the scientist must become oriented to the different
landscapes constructed through different technologies. For example, when looking at a
Genome Browser together, a scientist explained what we were seeing on the screen in the
following way:
So when we say upstream and downstream, we mean relative to a gene. So, a
gene is always transcribed or translated, that is, made into a protein in one
direction. So the arrow on the figure will let you know which direction that is. So
it’s made this way. So this is the first exon, second exon, third exon, fourth exon.
So the PatchD1 actually just has two exons. And upstream of the gene, or sorry,
downstream. So when we say, upstream is before the start. So in the case of the
PathchD1 the gene was this way. (Ankit)
The scientist-geographer is re-oriented in relation to a mapped patient body. The
scientist is at once working above the genome map and also in the genome map.
Say you want to amplify a specific region of the genome, you would design what
is called a primer, which would specify whereabouts in the genome you are. And
then you can use the reaction to amplify that region from the primer. (Heather,
interview 2)
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The individual with autism when practiced geographically is an unknown territory,
comprised of distinct landscapes depending on the technologies being used in its exploration.
The scientist practiced as a geographer or cartographer approaches the patient landscape as
something that can be mapped out in comparison to a kind of master map, the human
genome. Prior to the mapping of the Human Genome, the human body contained huge tracts
of territory that were uncharted. With the master-map of the Human Genome, however, any
little region can be located.
So after the whole genome sequence was known, if you have a sequence of DNA,
like you isolated a particular sequence of DNA, you can kind of map it to that
genome sequence and see which chromosome it lies on and which gene it might
effect. So it sort of gives you a whole new context of location in terms of on a
genomic scale. (Ankit interview)
Practiced geographically, certain regions of the patient body are more or less elusive to the
scientist-geographer. Certain areas refuse to be captured, ordered, and mapped out with the
current technologies:
But the issue there is GC rich exomes, they don’t sequence well. In certain
places, if you have more than 80% GC, chances are you are not going to get
coverage there, even if you keep sequencing.
There are a multitude of examples that I have collected from the laboratory observations and
interviews in which the individual with autism is constructed as a geographical space to
which the scientist must orient herself with the aid of various technologies. In the laboratory,
the mapped body is a socio-technical assemblage. It is materially heterogeneous; at times
composed of cells and nuclei, at other times made up of chunks of nucleotide base pairs, and
still at other times the body is practiced as a series of single nucleotide bases. The various
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technologies construct the body as having different resolutions and orient scientists to the
body landscape in different ways.

ii) Textual Practices of the Individual with Autism
In other instances in the laboratory, the individual with autism was also practiced as a textual
entity. During an interview with a project coordinator in the laboratory, the textual practices
of individuals were stated in this way:
Project coordinator: [Describing a CNV] It’s a chunk, that’s exactly what it is;
it’s a whole stretch of nucleotides that are either missing or duplicated. And the
easiest analogy that I could say is if you summed up the genome as a book, a
really large book with a bunch of sequence, these smaller nucleotide changes
which we typically call a single nucleotide polymorphism or variant is just like
a typo in the book. OK, and these can mean nothing, they can be a severe
mutation; they can be anything. A copy number variation is like where you
would have a piece, a page either missing or duplicated and so it’s a whole
bunch of nucleotides involved. And some of these are just normal variation and
everybody has them and they could be acting on something. And then in other
cases we find these variations in genes that we think are involved in autism.
This analogy between the human genome and a book has been dominant in this discourse for
some time (Kay, 2000). It seems to be particularly prevalent when scientists explain genomic
work to a lay audience. Certainly, the members of the laboratory did not talk to each other in
this way. The excerpt above, for example, was taken from my first interview in the
laboratory, when it was clear to the project coordinator that I was unfamiliar with the work
and materials of the laboratory. It is a well-crafted analogy set aside to be pulled out and used
when explaining laboratory work to non-scientists.
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The ordering or assembling of the individual with autism as a text, however, is not
only practiced when talking to outsiders. When I open up Nvivo and read through my
interview transcripts and observation notes, the practicing of the individual with autism as a
text is present in almost every document. In particular, the technologies used in sequencing
(in which the body is explored at the highest resolution) involve materials and procedures
that when practiced together assemble the individual with autism as a text to be read. I
became familiar with Next Generation Sequencing through interviews with two of the post
docs running the NGS machines and analyzing NGS data, the manager of the NGS facility,
and a bioinformatics specialist. I also observed various steps in the NGS experiments and
read the protocol developed by the company that manufactures the technologies and
materials required in these experiments. As I observed, listened and read about NGS, I
became familiar with the textual practice of the human body. Obviously, in sequencing, the
nucleotide bases are labelled A, C, T, G and as such the body is practiced as a string of letters
to be read. One of the steps at the beginning of sequencing experiments is called “library
prep”. Scientists create a specific library out of the individual patient’s sample. A participant
from the NGS lab explained:
So the library preparation is the step where we have to process the sample…And
so for Next Generation Sequencing, you get the DNA, for the exome, what you
need to do is you have to select all the exomes of that genomic library. So when
you are sequencing what you need to do is to deep sequence all those regions.
(NGS lab manager)
This participant went on to explain:
So when you are doing the library preparation you start with a lot of DNA and
then you lose DNA as you go. So at the end, the reason you have to start with a
lot of DNA is that you’re expecting that you’re going to be losing DNA
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randomly. So you expect that in the final library you will have all of the DNA
fragments that you need. (NGS lab manager)
The individual with autism is practiced as a kind of textual entity through the activity of
library preparation. Another way in which the individual with autism is practiced as a textual
entity is in the concept of “read depth”. One of the common concerns raised in the weekly
sequencing lab meeting was the issue of “read depth”. Read depth pertains to how many
times a particular nucleotide base is captured in an experiment. A deeper read depth allows
for more confidence when a particular nucleotide at a particular location is different than
expected, different from the reference genome.
So one of the reasons we need to have a lot of reads mapped to a particular
region on the genome is because the error rates for some of those machines
are higher than they are for Sanger sequencing. So usually we are expecting
to see at least twenty reads mapping to a particular position. So when you are
looking at something and you see a mutation for example and you say, ok,
there are lots for reads here and I know, you can for sure say, this is really a
mutation. But let’s say you only have five reads, and let’s say two of them
actually point to a mutation and the other three are exactly the same as the
reference then you have to make a judgment call there. Is this real? (NGS Lab
Manager)
Some technologies allow the patient body to be read more deeply than others. A
biostatistician was looking forward to receiving the first data set collected from a newly
upgraded sequencing machine and stated, “The SOLID 5 is supposed to give us way more
read depth. So a lot more reads are supposed to be sequenced”. This idea of read depth was
further explained to me in an interview by the NGS manager:
So basically what you are doing is, since you have millions and millions of
fragments, let’s say, if you’re thinking about one exome. You maybe have one
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fragment that will cover the whole exome, another that will cover just parts of
it. So basically when you start aligning you have all these different fragments
spread all over the exome. So when they are talking about read depth what they
mean is on a particular position, how many reads are actually covering that
position. (NGS manager)
In the laboratory, the individual with autism is often practiced as a textual object. Depending
on which aisle you find yourself standing in and depending on the technology being used the
body is practiced as analogous to either the individual letters, words, or pages in a book. The
body is quite literally read and scientists may be likened to copy editors, honing in on any
typos that appear in the body as text.
Sometimes the body is practiced in different ways (as a geographical entity and as a
text) in the same instance. These practices are made to cohere. Consider the following
statement.
I just pulled out how the intensity chart looks like. This is a good graphical view.
So it’s P1428 [patient number]. So you can see the different chromosomes.
In this single statement, the individual with autism is being practiced in several ways: as an
intensity chart, a graph, a de-identified research subject, and a set of chromosomal building
blocks. The various translations of the patient body constructed through various technologies are
pulled together.
In other instances various technologies practice the individual in ways that do not
necessarily cohere. During my fieldwork, I found that many of the different technologies
were practiced separately. For the most part, researchers were either involved in microarray
experiments or in sequencing experiments. Researchers would be aware of research going on
through other technologies but an individual researcher tended to concentrate their research
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in either sequencing or microarrays or cytogenetics. As a single sample traversed the
laboratory, it was passed amongst different hands which were trained to practice a sample in
ways quite different from one another. The human body as constructed through one
technology did not always cohere with the body constructed through another technology. For
example, I interviewed a post-doctoral fellow whose main interest was comparing microarray
data and NGS data for a single patient. (Conversely, most of her colleagues in the laboratory
were concerned with populations.) She found that there was not always a straight-forward
relationship between the microarray and NGS data.
The sequencing data is really new. So we’ve only reported out one family so far
that had a single nucleotide variant which resulted in a stop-codon in an
important gene. They had microarray data but the mircoarray data didn’t come
up with any of the sort of normal suspects, the common things like the NRXNS
or Neurolygens or SHANKs. They had other copy number variants but of
unknown clinical significance. So it wasn’t until they did the sequencing that
they could figure out, ‘ok, there’s actually something going on here’ it’s just at
a different level of resolution.
At one level of resolution, the CNV, a particular mapping of this individual did not
distinguish between patient and non-patient, case vs control. Practiced in the laboratory
through the microarray technology, this body is not constructed as diseased, pathogenic.
When the body is constructed in another resolution, the NGS, the body is pathologized. Thus,
the same individual body is constructed differently, in ways that do not overlap, by different
technologies within the laboratory.

7.2c The Individual with Autism Practiced at Home
At home, individuals with autism are practiced through familial relationships - a son
or daughter, a sister or brother – or in relation to particular roles they play or abilities they
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might have – student, athlete, musician, scholar. The individual with autism constructed in
the home is, again, entirely different from either the constructions of the laboratory or the
clinic. In the laboratory the individual with autism is practiced as a geographical or textual
entity and in the clinic the individual with autism is practiced as a cognitive or social entity.
While the laboratory and clinical constructions of the individual are sometimes practiced in
the home, there are many other ways in which the individual with autism is practiced here as
well.
There were a few instances in which the individual with autism was practiced as a
patient in the home. For example, the individual is constructed as a patient when parents
described their child in relation to a previously imagined non-patient child. One parent stated:
I honestly think it’s an issue with coping. The one thing for me, I had difficulty
coping and then it got to a point, I actually had a parent say to me, ‘you know, it’s
OK to be angry. Just be angry’. I think you get to a point where you realize, you
don’t have the kids you thought you were going to have. You have to grieve that
and then in doing that you’re able to accept the one you’ve got.
This mother described going through a period of mourning when their child received a
diagnosis of autism; at this point she realized she did not have the child she thought she was
going to have. Through a diagnosis of autism a child is transformed into a patient. In this
way, the individual with autism is constructed in an emotional process of coming to terms
with the non-patient child that parents originally anticipated. Ironically, while the mother
mourned for the child she thought she was going to have, she also simultaneously had to
fight for her child to be recognized as a patient outside of the home. The mother who made
the statement above recognized that something was medically wrong with her child and in
this way constructed him as a patient in the home. She said:
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I really had to kick down our family doctor’s door to get a paediatrician involved.
So we went to the paediatrician sometime between two and three, closer to three.
And I had done my own research and I went in there and said I think he has
autism. And the paediatrician gets out a list and he goes through and he checks
them off and he goes, ‘well the problem is he only has fifteen out of sixteen
characteristics’. And I looked at him and said ‘are you kidding me?’ And I asked
what one is he missing and he said, ‘well according to your statements he seems
to sleep through the night’. And I said ‘he screams for eighteen hours a day, of
course he’s going to sleep’!
Thus, this participant described a situation in which her son was first constructed as a patient
at home and only later, after much effort on her part, was he recognized and practiced as a
patient in the clinic and laboratory.
While the laboratory and clinical constructions of the individual with autism are
sometimes practiced in the home, there are many other ways in which the family member
with autism is practiced in the home as well. In the home, the family member with autism is
also practiced as a biographical entity, with a past, present and future beyond that of a
genetic map. This biographical nature of the patient is practiced in the clinic to some extent;
through assessments such as the ADI-R the patient is constructed in relation to past events,
language and motor milestones for example. Armstrong (1998) has described how medical
records reconfigured the clinical patient as a biographical entity. Through medical records,
such as the patient chart, “clinical problems were not simply located in a specific and
immediate lesion but in a biography in which the past informed and pervaded the present”
(D. Armstrong et al., 1998). In the feedback session, the individual with autism is also
practiced in relation to the future; in particular, the individual is practiced as a possible future
parent whose offspring may inherit genetic variants. In the home, however, the individual
with autism is practiced biographically within a temporal trajectory that is deeply entangled
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in the biographies of families and friends. The milestones that are captured in the clinic as
aspects of an individual biography (captured in a single patient chart) are enmeshed in the
life course of family members in the home. Parents quit jobs, change careers in order to
accommodate the special needs of their child. The individual with autism at home is
practiced through an entangled relational biography. This deep entanglement of the
individual biography is not captured in the practices of the patient in the clinic.

7.2d Strategies of Coordinating the Multiply Practiced Individual
i) Feedback Session
During the feedback sessions which I observed, the genetic counsellor first began by
describing how the individual with autism is constructed in the laboratory. She enacted the
individual as a geographical entity by describing recent technologies which look for subtle
changes, missing or extra pieces at particular places on the genome. She showed parents
black and white photographs of chromosomes. She used map analogies to help families
understand how new technologies allow scientists to zoom in on particular locations on the
genome, like an inset on a map. She told them that they have a deletion or duplication at a
particular location and gave them details about the size of the deletion or duplication. She
drew two vertical lines with the number 16 underneath and marked an “X” on one of the
lines. She was orienting the family to the physical address, the place within the individual’s
body where the deletion had been mapped.
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16
She then described how there have been different sizes of this deletion found in
various individuals diagnosed with autism. She draws two more vertical lines on the paper to
indicate the size of the missing chink of DNA.

Here she switched to clinical constructions of the individual with autism. The
individual was constructed as a social being and a thinker/knower/puzzle solver as she
described that those with the smaller deletion have been reported in the literature as having
behavioural difficulties or learning difficulties. Finally, the genetic counsellor asked the
family to help her construct a family pedigree, gathering information about extended
relatives and any developmental or psychiatric problems they might have experienced.
During the making of the family pedigree, I observed that families often began talking about
the individual with autism as practiced in the home, in relation to school, friends, specific
family gatherings or events, traits or idiosyncrasies that revealed themselves throughout the
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practices of daily living. They were practiced as deeply entangled relational biographies.

ii) Patient Identification Number
There are other strategies for coordinating the different practices of the individual
with autism found within the laboratory, clinic and home. For example, the patient ID
number labelling the tube of extracted DNA ensures that the geographical practices of the
laboratory are kept in association with the clinical practices of the patient. This ID number is
placed on the top of the research report and is carried into publications as well. All of the
information contained within a single patient chart carries the same ID number. In this way,
all of the various ways of practicing the individual with autism in the different spaces of the
hospital are made to coordinate with one another, to relate to one another.

iii) Cases vs. Controls
The individual with autism was also practiced in the laboratory as a “case”, which
was always practiced in relation to “controls”. Cases are samples that have a clinical
diagnosis of ASD. The clinical practices of diagnosing individuals with autism were found
within the laboratory practice of the individual as a case. In the practicing of the individual as
a case vs. control the clinical constructions of the patient are made to relate to laboratory
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constructions. They are coordinated. Controls are samples that do not have a clinical
diagnosis. Practiced in this case-control relationship, patients are performed as a statistical
entity in relation to a control population. The database of genomic variance, for example, is a
technology which practices patients statistically, in comparison to a control population.
So what we do, when we find something like this we interpret this variant in the
context of the DGV. So this is from thousands and thousands of individuals in the
general population and after looking at all those thousands and thousands people
have reported only these many CNVs and there’s nothing similar to what you see
in the two patients.
In another interview, the case-control relationship was explained further:
Now I told you that everyone has CNVs like even normal healthy people. But
the difference is, what they kept finding is that patients with psychiatric
disorders they tended to have these rare deletions or duplications which are not
generally found in the normal population. Or even if it is found it’s really,
really rare. So it would be less than 1 in 10 thousand people or one in twenty
thousand. Whereas in cases, so they are rare in cases as well and they might be
one in a hundred as opposed to one in twenty thousand in controls. So these
rare deletions kept cropping up and perhaps most interestingly these rare
deletions seem to affect genes in known brain function more often than not. So
using this you sort of get an idea of which genes are being deleted. And this still
only explains a very small percentage of cases. So if you took a hundred
psychiatric cases and put them on arrays you’d probably get something of
relevance 15 to 20 percent of the time.
Through the Database of Genomic Variants, scientists can examine a single region of the
genome and the program will tell them how often a variant at that location is found in
controls and if a variant has been found in other cases. In this way, the individual body is
practiced as part of a population. A PhD student in the lab explained,
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These studies usually get a tonne of cases and they also get controls from the
general population. So ideally when you say controls you want them to not
have whatever disorder you’re studying. But that’s a little difficult to do in
practice for something like autism or ADHD because a) it’s relatively common
in the general population and b) it’s hard to find funding to actually phenotype
controls. Because physicians are hard-pressed for time and there’s not enough
money to line up a hundred people on the street and try to see if they have
ADHD or Autism. So what people generally do is take a huge number of
controls, like let’s say in the thousands, put them on arrays, but not phenotype
them too well. Then take cases, these are phenotyped pretty well because they
actually come to the hospital or their paediatricians. So they actually have
problems and they come to the hospital so they are pretty well phenotyped. So
they put them on microarrays or sequencing or whatever and then you see
particular regions of the genome which have either point mutations which you
can detect from sequencing or they have CNVs, like deletions or duplications
and see, exactly like you said before, look at genes in which two or more people
who are unrelated or two or more people with the same disorder who are
unrelated genetically, they have mutations in those genes. Whereas in the
controls you have either none or extremely few. So these might still be rare in
the cases. Like out of a hundred only two might have them.
In the above quote, several practices are juxtaposed in relation to one another. The
individual with autism is a geographical entity with different genetic regions that can
be mapped in different resolutions (point mutations or duplications/deletions). The
individual with autism as a thinker/knower/ puzzle solver and as a social entity is
held within the practice of clinical diagnosis, which turns the patient into a case. This
individual is also a statistical entity and practiced in relation to populations. In the
practicing of the individual with autism as a case vs a control, different constructions
of the individual are coordinated and come together.

7.3 Autism(s) in Practice(s)
In the previous section, I focused on the individual with autism as a site in which to
explore multiplicity. The ways that the individual is practiced in the clinic and in the
laboratory may or may not cohere. I now turn to another example in order to explore this idea
of multiplicity: autism as an entity in itself. In the context of the clinic, autism is invoked
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through psychological tests (ADOS, ADI-R, intelligence tests) and through taking a “history”
through discussions with parents and teachers. In the context of the laboratory, autism is
invoked through alleles, the human genome, microarrays, PCR, and “next generation
sequencing”. Each of these contexts has disciplined ways of focusing, centering on specific
features, so that autism is either arrived at or ruled out. In the clinic, various tests are scored.
In the laboratory, a risk classification from one to four is given. These scores and
classifications that are produced in the clinic and laboratory result from vary different
practices in either context. In each of the settings, autism is done in different ways. When the
scores in the clinic correspond to the risk classification given in the laboratory, the different
autisms practiced in each setting are made to cohere. In the following section I will describe
how autism is practiced in the laboratory and the clinic. I will then provide examples of how
these different enactments of autism are sometimes coordinated as well as instances in which
the practices do not cohere, at least, not yet.

7.3a Practicing Autism in the Clinic
“Nothing can replace clinical judgement. It all comes down to clinical judgment.” (Interview
with psychology student at an autism clinic)
In the clinic, autism is practiced as a nuanced and diverse phenotype. In the clinic,
autism has a complex social, behavioural, linguistic nature. Autism is practiced through
direct interaction between people. It is also practiced as something that unfolds over time.
One of the assessment tools that are involved in the clinical practice of autism is the ADI-R.
Through the ADI-R, autism is practiced as having a temporally unfolding ontology. One
participant explained the ADI-R in this way:
I start off by asking what were some of the first things that alerted them that there
might not be something quite right with their development. How old were they at
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that point. When did they start toileting, bowel, we ask about specifics around
imagination, about types of play they engaged in. The ADI, it all depends on the
age of the child. So let’s say the child is above age five, you ask about current
functioning but you also ask about what it was like between four and five. If the
child is younger than that then it’s around current functioning. You ask about
language development, first words, first phrases, you ask about gesture use, how
many gestures, you ask about facial expressions, anything that’s under
communication. Then you ask them about friendships, interest in other children,
things like that. Then there are questions around behaviors, repetitive behaviours.
So specific interests, unusual interests, how do they deal with changes in routine.
(Mary – psychology PhD Student)
Thus, different situations, events, important milestones in one’s life become implicated in the
clinical practice of autism. Toilet training, friendships, first words – all of these enter into the
network of autism as it is practiced in the clinic. There are various assessments which are
used to capture autism in the clinic. As such, autism in the clinic is practiced as a particular
score arrived at by a diagnostic algorithm. One participant explained the scoring in this way:
There’s a scoring system and you have to be trained and get reliability on that.
And the scores go from 0 where there’s nothing that indicates autism or any
kind of developmental issue, to a score of one or two. Two or three are usually
the highest you can get. So the diagnostic algorithm only uses scores of 0, one
and two. So a three turns into a two. There are other, in certain questions, in
language or motor movement where if a kid has a severe physical disability or
has a stutter or something like that then you would put a different type of score.
So each question indicates which number you should be putting in. (Mary –
psychology PhD student)
Scores from these various assessments are looked at together to form a large picture of
whether or not an individual has autism. The various clinicians who conducted the
assessments come together to do a “formulation”, discussing strengths and weakness of the
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child. These formulation sessions last about two hours. They take into consideration several
rating scales and standardized assessments as well as informal information gathered by
chatting with parents and interacting with the child. Based on all of this the clinicians make a
decision about whether the individual has autism or not. The clinicians compare what they
observed and heard in their meetings with the individual’s family with the criteria of autism
that is listed in the DSM. One participant stated:
So impairment of social interaction, impaired communication and stereotyped
behaviors and things like that. And then a lot of it just seeing whether the
information we gathered matches those things. (Clinical Psychologist)
At times, an individual receives scores on the various assessments that are considered
“borderline”. In these cases, clinical judgment is particularly important in the practicing of
autism. Some assessment tools practice autism in a particular way that may not capture
various nuances within the autism spectrum. For example, through the ADOS autism is
practiced as a lack of verbal communication.
A lot of times, especially for the higher functioning kids, and especially girls, like
girls with Aspergers, the ADOS does not capture autism very well. So most of the
time they will actually come out “not autistic”. So they won’t meet the criteria.
But that doesn’t mean they don’t have autism. So we have to figure out ways to
support our decision in giving them a diagnosis…On the ADOS you score for
things like if they don’t talk a lot, but they’re very chatty. They’re actually very
chatty but then it comes to a point where it’s like a fine line between do they
understand are they being too chatty, like someone may not want to listen to them
anymore. But those things aren’t what you score on the ADOS. They don’t score
for that but that is social impairment. So the ADOS itself doesn’t capture those
individuals very well. So they will actually score . . . their scores are under
basically on the ADOS. (Janine – psychology PhD Student)
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In clinical practice, ASD is a complex set of behaviours that are teased out through various
assessments and interactions with patients. Scores from these assessments are assembled
together to construct a nuanced understanding of ASD. While individuals are either given or
not given a diagnosis of ASD, within that diagnosis there is much variation in the way that
autism can be practiced.

7.3b Practicing Autism in the Laboratory

To describe the practice of autism in the laboratory is complicated, largely because
autism is a clinical diagnosis. A lack of laboratory findings does not preclude a clinical
diagnosis of autism. Indeed, there is no need for a genetic component for a clinical diagnosis
of autism. In the laboratory, however, phenotypic information is required to interpret the
genotype information produced. It is only after the genotype information has been coupled
with an autism phenotype that the genotype comes to be recognized as causing or
contributing to autism. The genotype can never stand alone as meaning autism. There could
be individuals who have a genetic variation consistent with autism that do not display the
phenotypic characteristics of autism, and are therefore not diagnosed with autism. However,
certain mutations are becoming closer to standing in for a diagnosis at the clinical level.
Certain mutations are repeatedly found to have an autistic phenotype. Certain CNVs or SNPs
are becoming recognized in the laboratory, according to one post-doctoral fellow, as “the
usual suspects”: the NRXNs, the SHANKs, the Neurolygens.
Autism is ontologically fuzzy and ambiguous as it is probed in the laboratory. Its
genetic ontology, the genetic nature of its existence is only achieved after its clinical
ontology has been established. There is a complicated reversal that occurs in which autism is
first clinically identified through the tests and examinations carried out in the clinic.
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Following this, a whole bunch of work is done in the laboratory which sometimes results in
genetic findings being reported. If the genetic findings segregate with the clinical findings
across the family pedigree, then the genetic ontology is recognized. In these cases, autism
becomes genetic in nature. The genetic ontology is used to explain the underlying cause of
the clinical nature of autism. Here, autism multiplies; it has both a clinical nature and a
genetic nature. However, if genetic findings do not segregate with the phenotypic findings of
a family pedigree then a genetic ontology for autism is thwarted and the clinical nature of
autism stands alone.
In practice, most of the variants found in the laboratory are classified as having
“unknown clinical significance”. Usually, this occurs when variants are found in genes for
which function is not yet known. The genes may or may not be impacting the brain in a way
that contributes to an autistic phenotype. These genetic variants may or may not relate to
autism as it is done in the clinic. Thus, most of the time in the laboratory, autism is still in the
process of becoming genetic. It is assumed that advances in technology will eventually lead
to a concrete and defined genetic nature of autism in all cases. But for now, the ontological
boundaries of autism as it is constructed through genetics are still being negotiated.
Therefore, when I describe how autism is practiced genetically, in the laboratory, it is to be
understood as a fuzzy autism. It will only become solid once it has been mapped onto the
clinical enactment of autism. Once that happens, only then do we look back on the genetics
being done in the laboratory and recognize the outputs as being autism. Autism is given a
genetic ontological status retrospectively. At this point the reversal occurs and it is assumed
that it was the genetics that was there all the time, lying behind the clinic ontology of autism.
A pervasive concern that hangs around all of the work in the laboratory is whether or
not findings are “real” or just “error”. Regardless of the technology being used, microarray or
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sequencing, error is a fundamental problem. Scientists in the laboratory want to be confident
about the existence of the CNVs or SNPs which they report out of the laboratory back into
the clinic. In order to gain confidence in the variants that are eventually reported, there are
many places along the experimental trajectory in which a different technology, a different
way of looking, seeing, measuring, is used for validation. Just as the individual with autism is
practiced in different ways within the clinic, through ADOS or Intelligence tests, so too is
autism done differently by the various technologies used in different spaces within the
laboratory. Previously I described how the laboratory is not actually a single, unified place
but rather a set of related spaces in which different technologies and tools are used to probe
the world in various ways. When walking from one place in the laboratory to another, from
one aisle to another, the object that is made to come into view changes. In the previous
chapter, I described the journey of DNA, in order to convey all of the changes, the
translations, that occur as DNA is probed by different technologies.
All of these various experiments are finally translated into the report. The words on
this report summarize the months of work that has been done and the results that were arrived
at. The report classifies genetic variants into four categories or classes. A class four indicates
that a variant is commonly found in controls. A class three is given to variants that are not
found in controls but which do not overlap with any genes. They are intronic rather than
exonic. A class two denotes variants that are not in controls and they do overlap genes;
however it is not known whether they are significant. Class one is reserved for a known
pathogenic locus. Something interesting happened here, when the scientist was explaining
these classifications to me. For classes four to two, he described the class in relation to a
variant. Specifically, he said: “class four is CNVs that are in controls as well, Class three is
CNVs that are not in controls but don’t overlap any genes, Class 2 are not in controls and
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they overlap some genes but we’re not sure what they mean. Like, they could be significant
or they might not be.” (Ankit)
When he described class one, however, he said “And class 1 is it’s a known syndrome”.
What is a known syndrome? The variant is a known syndrome. The variant at a particular
genomic location is the syndrome. Its ontological status is solidified. Class one variants are
allowed to stand in for the syndrome. When a class one variant is called and reported, autism
is done genetically. Autism acquires an ontological status. In that instance, autism is
practiced as a genetic variant at a particular locus on the human genome. Autism is practiced
as a genotype.
The practice of autism as a genotype is very precarious as associations between
genotype and phenotype are not always straight forward. When scientists are engaged in the
work they are doing with their hands, when I pay attention to the work of the technologies in
the laboratory, autism is being practiced as a genotype. However, when scientists in the
laboratory are asked to stop and think about it the tenuous nature of the relationship between
genotype and phenotype is brought to awareness. For example, in a Monday morning
meeting that I observed early on in my data collection the director of the laboratory explained
how someone at a conference had asked him to explain the difference between a mutation
and a single nucleotide variation. The people sitting around me laughed uncomfortably and
many of those in the room said there is not a difference. One scientist asked the laboratory
director how he had responded to this question. The director responded, “a mutation is
expressed phenotypically, while an SNV refers to the genotype”. Here, he makes clear a
distinction between genotype and phenotype. At times, however, genotype and phenotype are
becoming blurred in reports of class 1 variants; in some cases, the genotype is beginning to
stand in for a syndrome.
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7.3c Autism in the Family Home
How is autism done in the home? How is it practiced? All of the participants I
interviewed had previously been engaged in genetic feedback, meaning that a clinically
significant genetic result had been mapped to the clinical findings. For these families autism
had already been practiced both clinically and genetically. It already had two natures. It was
practiced as scores on clinical tests, such as the ADOS, and ADI-R and it was practiced as a
genetic variant. Autism was a genotype and a phenotype. Given the limitations of data
collection in the home, the lack of participant observation in this context, my understanding
of the practices of autism in the home are very limited. Through interviews, however, I have
come to learn that in the context of the home, the practice of autism proliferates. Autism is
done in a variety of ways. Moreover, it is difficult to separate the practice of autism from the
practice of the individual with autism. It becomes a part of so many different activities during
the day and night. I could say that autism is practiced through the lived experience of the
body. For example, participants described autism as a way of living temporally and spatially.
Routines are established and adhered to.
We’re very routine. We get up at the same time, we have breakfast, we do
everything in order in regards to getting to school.

Autism is also practiced retrospectively, as parents look back and remember specific,
memorable habits or abilities that set the child apart from other children. For example,
one mother said:
You see he was very eccentric since he was little and he was brilliant,
absolutely brilliant. At two and a half he could recite The Night Before
Christmas. And he would tell me when to turn the page and it was word for
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word. So we knew. And he always had difficulty socially and sensory and then
in grade four he got identified gifted LD.
Autism is practiced in relation to certain material objects:
We really started to see the stickiness, like he couldn’t handle, change the colour of
his socks and he’d freak out. He had this hat he had to wear. A hundred degrees and
he still had to wear a wool hat.
Autism is practiced in the roles that family members take on:
I’m an advocate for them. I’ve met advocates. They’ve trained me. I’ve had all
my training at [an autism centre]. I became an autism intervener for them, not
for anyone else. So they let me know what courses there are and I’ve taken
them all. So I think I know what I’m doing with them. I’m like their extra
teacher.
Autism is practiced in special foods that are prepared and eaten:
I give them power smoothies. I’m trying to enhance their brains. I spend a huge
amount of money on berries. So every day they have a 12 oz smoothy and that
motivates [my son].
A description of the enactments of autism in the home is particularly difficult for me to
capture. My difficulty in writing about autism practiced in the home is perhaps data in itself.
I think the difficulty is because, unlike the laboratory or the clinic, in the home autism is not
easily reduced; it can not be boiled down to scores on an assessment or a classification of
genetic variants. When I read over the interview transcripts with parents, I find it difficult to
discern where autism is not being practiced. Autism is part of the life of the family; it is
enacted through disparate situations, people, objects, settings, times, places. Moreover, each
home is different. While clinic and laboratory practices are very similar, or even standardized
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in some cases, from one lab to another or one clinic to another, homes are not. The interviews
I conducted only scratch the surface of autism as it is practiced in the home.

7.3d Non-Coherence in the Practices of Autism
i) Genetic Variant with no Clinical Diagnosis
At times the clinical and laboratory practices of autism did not cohere. One woman I
interviewed described the difficulty she was having in understanding the relationship
between the genetic and clinical constructions of autism. This woman had a son who was
diagnosed with autism and who had a Class 1 genetic variant, the NRXN3. The mother had
also given blood and been genetically tested. She too had been identified as having the
genetic variant but had never been given a diagnosis of autism. She had a genotype
associated with autism in the laboratory but she did not have the phenotype associated with
autism in the clinic. She described her uncertainty about the ambiguous relationship between
clinical and genetic practices of autism. For example, she stated:
Not to say that I have Asperger’s and I’ve never been diagnosed with ADHD but
it does help in understanding my tiny idiosyncrasies … it does explain some of
the things.
In respect to this woman’s son, autism had a clear clinical and genetic ontology. The two
practices of autism cohered. For her son, the gene is retrospectively recognized as the cause
of the clinical nature of autism. For this woman, however, the genetic practice of autism did
not cohere to the clinical practice of autism. This raised important questions for the mother:
I often wonder does that gene impact on, my question, I have a number of
questions. So what it does is it brings forth more questions about myself. So
because I have the gene I am the carrier or do I have autism on a lower part of the
spectrum? What does it exactly mean is my question?

259

At home, participants traverse a number of different practices of autism, translating in and
out of genetic and clinical constructions. For this woman, for whom the genetic and clinical
practices of autism did not cohere, being in the genetic research was like being on a
tightrope.
To have been a part of this research team is like being on a tight rope. You’re
on the edge and you don’t know anything more. So sometimes you feel like
you’re left hanging. OK I do have this gene but what does that mean? … Am I
a carrier or do I have it [autism]? So it does bring up a lot of questions and it
would be nice to have some follow up with the family so that you can ask these
questions. But you are like on a tightrope, like you’re wondering, okay, now
what does this mean? Where do I go from here?

For this woman, genetic and clinical practices of autism do not cohere. She does not have a
clinical diagnosis of autism. She does have a variant, NRXN3, which for her son did cohere
with a clinical practice of autism. For her son, the two practices, laboratory and clinic,
pointed in the same direction. One came to be understood within and explained by the other.
Conversely, the lack of coherence between laboratory and clinical practices as they pertain to
this woman has left her feeling stranded, confused, uncertain about whether or not she has
autism.

ii) Feedback Session
The feedback session can be particularly difficult because here clinical geneticists and
genetic counsellors have to navigate between different practices of autism. It is in the
feedback session that attempts are made to try to make the different practices of the clinic,
lab, and home cohere and connect meaningfully. The feedback sessions that the genetic
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counsellors reported to be the most difficult were the ones in which the different practices of
autism did not cohere. For example, when researchers in the laboratory sometimes
prematurely wrote a research report before the genetic results were classified as clinically
significant, feedback still had to be given to an individual. The findings of the laboratory did
not, in these cases, relate to the findings of the clinic. The laboratory report did not indicate
Class 1 variants but the clinical assessments did produce scores indicating autism. In this
situation, autism was practiced phenotypically but not genotypically. The genetic tests
capable of being carried out in Laboratory X were so new, and very few samples have been
deemed clinically significant thus far. During the time of my field work, the scientists and
clinicians were still figuring out when and under what circumstances a research report should
be written. Over the course of a few meetings, it was decided that research reports should
only be written when findings were clinically significant. In other words, when the various
practices of autism in the laboratory could be made to relate to the various practices of autism
in the clinic. When the different practices and enactments of autism did not cohere, the report
was not supposed to be written and feedback was not supposed to be given to the patient
family.
It was assumed that the lack of coherence between the laboratory and clinical
enactments of autism were consequences of the limitations in the technology. Patient samples
were kept in storage, immortalized cell lines established, so that as technology progressed
connections would eventually be made between the various practices of autism. Indeed, there
were several examples that I observed in which samples that had been collected a decade
earlier were re-run on current technologies and the laboratory work was able to be connected
to the work performed in the clinic.

261

7.3e Strategies of Coordination
i) The Pedigree
The “pedigree” is a ubiquitous site in which different practices of autism are
coordinated. Through the pedigree autism is practiced as a genotype and as a phenotype. It is
practiced as a geographic location and a clinical diagnosis. The construction of the pedigree
involves families, clinicians and scientists. Below is part of an extended pedigree copied in
my notes from a Monday morning meeting.

Figure 7.2: A Pedigree
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Through the pedigree, different practices of autism are brought together and made to cohere.
This coordination comes at a cost. Much of the detail, the nuances of practicing autism in the
clinic and laboratory and home are removed, bracketed off from the pedigree. For example,
in the pedigree clinical practices of autism are reduced to a basic binary opposition. One is
either on or off the spectrum, a circle or square on a pedigree is either coloured in black or
left white. The nuances and specific circumstances around which an autism diagnosis is made
are not part of the autism that is practiced through the pedigree. All of the clinical judgment
and interpretation of social, cognitive, language information gathered through clinical tests is
eclipsed from the pedigree.
Similarly, all of the actors, activities, translations that form the practices of autism in
the laboratory are not captured in the pedigree. A gene, perhaps SHANK or NRXN stands in
for all the other work, all the other actors in the laboratory. The microarray, primers, PCR,
chromosomes, buffers, robots, sequencers – all of these have been black boxed within a few
letters printed underneath the circle or square.
Likewise, the many of the practices of autism in the home are not found in the
pedigree. Indeed, the rich, complex daily minutia of getting the right socks on or adhering to
routines, through which autism is practiced in the home, are absent in the pedigree. Parents,
however, are not only involved in reporting the pedigree but are likewise re-made by the
pedigree. Through the process of making a pedigree, parents who just found out they passed
down a genetic marker for autism to their child began to reassemble themselves and their
connection with extended family members around genetics. A new type of kinship is
constructed and enacted through the pedigree. One of the mothers described in an interview
her complete shock in learning that her son had inherited a CNV from her. As the genetic
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counselor delivered the preamble about not having to share any of this new information with
anyone and how it was her own personal and private information, the woman thought to
herself, “Why is she telling me all this? This is strange.” She had anticipated that the genetic
variant would have been inherited through her husband. She said:
So I was quite surprised and shocked because I thought it was my husband. But
then when you look back it sort of made sense in some respects because my
mother. So I said to [the genetic counselor], well you know, my mother’s side,
my mother’s sister has three children and the oldest boy was very, very
eccentric…And then my mother’s first cousin has a grandson with autism. So it
just sort of made sense.
As the counselor began writing out the connections in the form of a pedigree, collecting
information on traits and neuropsychiatric diagnoses of extended family members, this
woman’s kinship ties were reassembled according to another layer of connection. Extended
family members who were once imagined as quite distant are suddenly transformed as new
lines of connection tracing phenotypic similarities are re-imagined with the possibility of
genetic similarity. Rabinow’s (1992) concept of biosociality is a particularly fertile concept
through which to explore how we will increasingly come to understand ourselves in terms of
genetics. Silverman (2004; 2008a; 2008b) described this process of biosociality among
individuals with autism and their family members. In particular, she describes how new
individual and collective identities formed around genetics were leveraged by a parent
advocacy group, Cure Autism Now (CAN), in order to change that way in which genomic
research was being practiced. Frustrated by competitive, rival scientists who would not
collaborate and share DNA samples, the parents who started CAN used their own new
genetic identities as parents of children with autism to access and recruit other parents in
order to create their own gene repository.
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Parent knowledge of the quirky traits of extended family members is increasingly
important and essential in the construction of the pedigree in a condition (ASD) with a broad
and variable phenotype. As the blurry boundaries of ASD are extending further and further,
with terms such as the broader autism phenotype (BAP), individuals who do not strictly meet
the criteria for diagnosis are included in the pedigree. While these types of pedigrees may
not show up in peer-reviewed publications, this anecdotal information gathered from parents
about extended family members was frequently included in the pedigrees exchanged at
Monday morning meetings. Descriptive traits and anecdotal information are increasingly
included in pedigrees for ASD, making parents a vital actor in the construction of the
pedigree. A new liminal type of potential patienthood is being practiced through the making
of the pedigree – one in which extended family members who do not have a clinical
diagnosis are reconstructed as interesting cases for the laboratory to explore. The changing
nature of the patient through genetic testing has been explored further by Kessler (1993).
Kessler explored how the category of “patient” has been reconfigured through DNA testing
from something that described an individual to a term applied to the entire family. Abby
Lippman (1998) coined the term “geneticization”, to indicate a process in which differences
between individuals are reduced to genetic explanations. Gibbon (2002) has specifically
explored family trees through the concept of geneticization. According to Novas and Rose
(2000), advances in science, including genetics, are constructing a new figure of an
individual “genetically at risk” (2000, p.486).
The pedigree has been the discussion of many science studies papers (Armstrong,
Michie, & Marteau, 1998; Atkinson, Parsons, & Featherstone, 2001; Nukaga & Cambrosio,
1997; Silverman, 2008). Pedigrees are extremely portable, produced with a pen, paper and
ruler. It is simple to produce and easily moved from one place to another. Fujimura (1996)
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has commented that the portability of a tool increases its likelihood of being reproduced in
other situations. I frequently observed pedigrees being constructed on the back side of journal
articles or loose paper available in genetic counseling situations. Claudia would often have
scribbled pedigrees along with her in the files she brought to Monday morning meetings at
Laboratory X; the pedigrees would be reproduced in PowerPoint presentations in later
Monday morning meetings and finally would be published in journal articles. Through the
pedigree the practices of the laboratory, clinic, and home intersect; the practice of autism as a
genotype is coordinated with the practice of autism as a phenotype. Nukaga (2002), for
example, adopted a historical approach in exploring the intersection of laboratory genetics
and clinical medicine through the pedigree in the specific case of Huntington’s disease. As
such, the pedigree can be thought of as a coordinating strategy that brings the fluid practices
of autism into coherence.

ii) The Published Manuscript
One of the primary goals of both the laboratory and the clinic is to publish findings in
peer-reviewed journals. These publications incorporate many different constructions of
autism. In the published manuscript connections are drawn between different constructions of
autism. Columns in tables, for example, lay down genotype and phenotype constructions of
autism, as well as bringing in new networks that construct autism in terms of brain function.
Consider a recent article (Berkel et al, 2010) published in Nature Genetics which describes
the SHANK2 mutation. In this article ASD is described as a “clinically distinct
neurodevelopmental disorder”; it is also described as having a “complex genetic aetiology”.
The article describes SHANK2 as a candidate susceptibility gene. This gene is involved in
the production of proteins that “localize to postsynaptic sites of excitatory synapses in the
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brain”. The article describes the phenotypic testing using ADOS and ADI assessments, as
well as the details of the microarray and sequencing performed on cases and controls.
A table in this article has eight columns, labelled: Nucleotide Change/ CNV, Amino
Acid Change, ASD, MR, controls, name, sex of proband, and transmission source. Under the
third column, ASD, there is either a 0 or a 1 for each of the cases. It is practiced as a binary
phenomenon, on or off the spectrum.
Over lunch one day, I was talking with Ankit about publications. I told him that in my
discipline, it is really great to publish a paper as a single author, to demonstrate that you can
work independently. He said that would never happen in science, that it would be rare to see
a paper with fewer than ten authors in human genetics. This is because so many different
groups, laboratories, experiments and technologies have to come together in order to produce
a paper. I probed more about how a paper is produced. He gave me the example a recent
paper produced in Laboratory X. One of the post docs had presented a poster at a conference
describing the deletions in SHANK3 that she had found in two ASD cases. While at the
conference, a few other people approached the post doc and told her that they too had
SHANK3 deletions in their samples. So they collaborated and brought their four cases
together to make a stronger argument for the significance of a SHANK3 deletion in autism.
There might also be experimental labs involved in the publication. These laboratories might
do work on understanding, for example, the function of SHANK3, elucidating what it does in
the brain. They might be working with mouse embryos to identify how a gene is expressed.
There might also be human cell lines showing where the gene is expressed in human body
tissue. There are also computational labs involved. These are the people who develop all the
algorithms used for analyzing data outputs, determining if variants are real or not. Such labs
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do not have any biological data of their own but instead constantly collaborate with other
labs. Finally, there are clinicians who provide the phenotypic information used in interpreting
the molecular biology results. Ankit said,
This is all done by different people. So the functional work was done by a
functional lab, and the pedigrees were done by the clinical, like the Autism
Clinic, and this figure was done in an array facility, the CNV analysis. So we put
the whole thing together, write a discussion and then get the editors and reviewers
to buy it. That’s the tricky part.
Author lists are so long in the area of human genetics because a variety of different people,
working in very different actor-networks, have to come together in order for the manuscript
to be produced. The manuscript is a coordinating strategy amongst the various ways of
constructing autism.

iii) Hybrid spaces as sites of coordination
Hybrid spaces bring together various combinations of clinical, home, and laboratory
practices. In these hybrid spaces, details, nuances, ambiguity are left aside. One hybrid space,
for example, was a monthly meeting between laboratory and clinical employees. It was
primarily a meeting to discuss and prioritize feedback sessions. At one meeting I observed,
the clinic research coordinator mentioned that the phenotype measure for a particular
genetics study had been a year in planning and they were still not sure about the exact
measurements they wanted to include. The laboratory coordinator responded bluntly: “All of
it is irrelevant to me.” In the laboratory, the details of the clinical practice of autism are not
important. All the laboratory needs to know is whether or not an individual is on or off the
spectrum. In hybrid spaces, the nuances of autism are truncated. Here, phenotypic and
genotypic constructions of autism are brought together; however, in an effort to discuss as
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many patients as possible in the meeting, the practices of the laboratory and clinic were
expected to be reduced, black-boxed within this hybrid space.

Conclusion
In this chapter I have tried to describe the various ways in which the patient body and
autism are practiced. Through the different practices of the clinic, laboratory and the home,
the individual with autism multiplies, and so too does autism. I have described instances in
which the practices have been brought together through strategies of coordination. In these
instances some of the practices cohere; they are made to relate to one another. I have also
described situations in which the various practices of the home, clinic, and laboratory do not
cohere. In these situations, practices point in different directions, exclude one another. The
individual with autism multiplies. Autism multiplies.
Thus far, I have not explicitly explored how these ideas of multiplicity and difference
relate to knowledge translation. The reader might be asking herself, ‘but how does a
discussion of the multiply practiced individual with autism relate to knowledge translation’?
Perhaps the reader is wondering why I have not focused on “knowledge” as it is practiced in
these various spaces. As such, questions pertaining to the validity of my interpretation may
be raised at this point. Have I really been describing knowledge? In the following chapter,
my goal is to convince the reader that I have, in fact, been describing knowledge all along.
Following actor-network theory, however, knowledge has been de-centred. It has been
treated as a materially heterogeneous practice. Knowledge is done, with the body; it is
practiced through patients, assessment tools, pedigrees, classifications, reports, meetings,
diagnoses, bedtime routines. Following practice theory, embedded within constructionism,
the “knowledge” that I have been describing does not only inhabit the mind of the subject but
is also incorporated in material heterogeneous practices. I aim to de-center an overly
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cognitive construction of knowledge by rejoining knowledge and practice. As Mol has
suggested, we can spread the activity of knowing more widely; “Instead of talking about
subjects knowing objects we may then, as a next step, come to talk about enacting reality in
practice” (2002, p.50).
In the particular case of autism genomics, knowledge translation involves
understanding how the various practices of the laboratory, clinic and home, which may enact
different realities, are made to relate to one another. Thus, in describing how the individual is
practiced or how autism is practiced in the laboratory, clinic, and home I am at the same time
describing a process of knowledge translation. Here, knowledge translation might be better
understood as an on-going process of ontological translations. It is this particular
conceptualization of knowledge translation, which is grounded in constructionist theories of
practice and heavily influenced by actor-network theory that I will explore more fully in
Chapter 8.

270

Chapter 8: Reassembling Knowledge Translation
The thesis under consideration is that the products of science are contextually
specific constructions which bear the mark of the situational contingency and
interest structure of the process by which they are generated, and which cannot
be adequately understood without an analysis of their construction. This means
that what happens in the process of construction is not irrelevant to the products
we obtain.
(Knorr-Cetina 1981, pp.5)

8.1 Reassembling Knowledge Translation
a) Conceptualizing KT – What is being translated?
8.2 KT according to the CIHR
a) Discussion of the KTA cycle
8.3 Time for a new Conceptualization of KT?
a) On the nature of knowledge: constructing reality through knowledge
practices
b) Local Translations of Knowledge in Practice (LTKP) Framework
c) The LTKP Model
8.4 Comparing the KTA and LTKP frameworks
a) Implications
8.5 Conclusion

Throughout this dissertation I have described how knowledge translation can be
reconceptualized through examples from a particular case study of autism genomics. I
explored the changes and transformations that occur through the process of translation in
Chapter 4, as I followed some of the important actors involved in autism genetic testing
amongst the clinic, laboratory, and family home. In chapter 5, I then unpacked the political
dimension of the translation process through a framework developed by Callon (1986).
Chapter 6 highlighted the ontological implications of knowledge translation, illustrating that
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it is not only knowledge that is being translated but also constructions of reality. In this
chapter, I take these insights laid out in previous chapters and apply them to a more general
discussion of knowledge translation.

8.1. Reassembling Knowledge Translation
The KT literature addresses the “research to practice” gap, with the goal of “moving
evidence into practice” (Lang, Wyer, & Hanes, 2007). A burgeoning literature has
developed to explore the process (D. Davis et al., 2003b; Davison, 2009) and evaluate the
outcomes of KT initiatives (Danseco et al., 2009; Bhattacharyya & Zwarenstein, 2009).
Knowledge translation (KT) has become an important concept in the Canadian health
research environment (Straus, Tetroe, & Graham, 2009). In this chapter, I will outline how
knowledge translation is typically described in the Canadian health sciences literature. After
this general discussion of KT, I then focus on knowledge translation as it is described by the
Canadian Institutes of Health Research (CIHR) through the Knowledge to Action (KTA)
model (I. Graham et al., 2006). I then juxtapose this CIHR understanding of KT with a
description of knowledge translation that emerges from my interpretation of the work going
on in the autism genetics study. I introduce an alternative description and framework for KT
that is based on a constructionist, post-humanist epistemology and strongly influenced by
actor-network theory. Finally, I compare the CIHR model with the framework I have
developed and explore ways in which they might complement each other as well as the
places where they disrupt and conflict with each other.

8.1a Conceptualizing Knowledge Translation – What is being
translated?
There are several frameworks or theories in the KT literature that unpack the idea of
knowledge translation in slightly different ways. For example, the diffusion of innovations
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theory (Rogers, 1962) highlights the spread of ideas and innovations and how the uptake or
use of knowledge differs depending on the user’s needs. Elsewhere, the push-pull framework
(Curry, 2000; Landry, Lamari, & Amara, 2007) proposes that knowledge is translated
according to push factors on the supply side by knowledge producers as well as pull factors
on the demand side by knowledge users. Lavis et al’s (Lavis et al., 2003) five-point
framework for KT highlights: the message, the target audience, the messenger, the
knowledge translation process and support and evaluation. Tugwell et al (Tugwell, Robinson,
Grimshaw, & Santesso, 2006) have put forward a framework that explicitly forefronts health
equity, with an emphasis on identifying barriers and facilitators to KT, choosing
interventions to address the barriers, evaluation, and facilitating knowledge sharing.
Meanwhile, the CIHR framework for knowledge translation highlights an iterative cycle between
knowledge producers and users (Canadian Institutes of Health Research, 2004). Finally, the two-

communities theory (Bowen, Martens, & Need to Know Team, 2005; Canadian Institutes of
Health Research, 2004; Caplan, 1979) emphasizes cultural differences between researchers
and decision makers. This idea is described in the CIHR Knowledge Translation Strategy
2004-2009 (2004, p.4) suggesting that the difficulty in moving research into practice could
be due to the “two-communities” problem, in which “researchers and policy makers inhabit
different worlds with different language and culture”.
Within the KT literature, some writers have made the distinction between tacit and
explicit knowledge (Kothari, Bickford, Edwards, Dobbins, & Meyer, 2011; McWilliams,
2007; Nonaka & Noboru, 1998; Straus et al., 2009). McWilliams (2007), captured the
complexities involved in integrating new knowledge into tacitly-held understandings and
beliefs, emphasizing the role of transformative learning and reflective practice in addressing
the social and cultural dimensions of KT. Greenhaalgh and Russel (T. Greenhalgh & Russell,
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2006) conceptualized knowledge in KT as being socially shared and tacit. Tacit knowledge is
“non-verbalized, intuitive, and unarticulated” (T. Greenhalgh & Russell, 2006; Polanyi,
1966). Explicit knowledge can be articulated in formal language, codified, and is more easily
transmitted amongst people (Collins, 2010). Nonaka and Noboru (Nonaka & Noboru, 1998)
likened the idea of tacit knowledge to the Japanese concept of ba. Ba, can be thought of as
“a shared space for emerging relationships…a context which harbors meaning” (1998, p.40).
According to Nonaka and Noboru, knowledge resides in ba; however, when separated from
ba knowledge turns into information. Elsewhere, in the context of knowledge management,
Alavi and Leidner (2001) have compared knowledge as a state of mind, an object, a process,
a condition of having access to information, and a capability. Each way of conceptualizing
knowledge has implications for how translation is imagined.
While KT research tends to focus on research knowledge (Collins, 2010; D. Davis et
al., 2003a; Grimshaw, Santesso, Cumpston, Mayhew, & McGowan, 2006; Lavis et al., 2003;
Lavis, 2006), the question of what constitutes knowledge and evidence is beginning to be
explored (Estabrooks, 1999) leading to calls for more theory-driven approaches to KT (R.
Greenhalgh et al., 2004; McWilliams, 2007). For example, Estabrooks (1999) problematized
the emphasis on research knowledge as evidence in KT, drawing attention to the many types
and sources of knowledge that are used in nursing practice. Weiss (1979) critically addressed
the various uses of research (problem solving, tactical, political, etc), indicating that the
practice-based goals or intended outcomes for knowledge use might be other than those
anticipated by researchers. Greenhalgh et al (2004, p.615-616) have called for a much
broader conceptualization of KT, arguing that it should be "theory-driven, process rather than
‘package’ oriented, ecological, address common definitions, measures, and tools, be
collaborative and coordinated, multidisciplinary and multi method, meticulously detailed,
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and participatory.” Drawing on concepts in continuing education, McWilliams (2007) has
also called for more theory-based strategies in KT.
One of the central concerns that has been repeatedly pointed out in various KT
publications is the issue of context (Jacobson, Butterill, & Goering, 2003; Reimer Kirkham,
Baumbusch, Schultz, & Anderson, 2007). Recent models of KT have explicitly considered
local contextual factors that can impede the objectives of knowledge uptake (Kitson, Harvey,
& McCormack, 1998; Logan & Graham, 1998; McCormack et al., 2002; Rycroft-Malone et
al., 2004). For example Dobrow et al (2006) questioned whether the same evidence should
lead to the same decisions in different contexts. Using a multiple case study design within a
policy-making context, they found that resource constraints, political interests, and varying
skills and abilities to use decision-support tools were some of the factors leading to different
interpretations and utilization of available evidence. The authors pointed out that while
hierarchies of evidence are useful tools when interpreting the quality of effectiveness for
interventions, as we shift toward an examination of appropriateness of interventions these
same hierarchies might not be as useful. The authors proposed a model that acknowledge
three different objectives for using evidence (effectiveness, appropriateness, and
implementation issues) alongside three stages of evidence utilization (identification,
interpretation, and application).
Kothari and Armstrong (2011) recently emphasized the need for local information
with contextual relevance in community-based knowledge translation. These authors
acknowledge that local information is often criticized for not being related to the broader
literature or mapping well onto “evidence hierarchies”. However, they suggest, a preference
for local information may be based on epistemological differences. These authors call for a
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broader conceptualization of evidence and state that “there are health service delivery
systems for which traditional ways of approaching KT are insufficient” (2011, p.e5).
Thus, a more complex conceptualization of the process of KT is starting to be captured in
this body of literature. Fox's description of practice-based evidence, "re-privileges the role of
the practitioner in generating useful knowledge" (Fox, 2003, p.82). Fox explored the role of
criteria such as internal and external validity in producing exclusionary definitions of
evidence and consequently setting up a binary dualism, constructing "practice as an
irrational other" to research. Within a post-structuralist and action-research-oriented
approach, Fox challenged this research-practice opposition by positioning research within
practice, adopting a perspective that knowledge is local and contingent. Thus, for Fox
(2003), research and evidence should be both produced and used within practice.

8.2. Knowledge Translation According to the CIHR
The Canadian Institutes of Health Research (CIHR) is the major funding agency in
Canada for health-related research. It was created in 2001 under an Act of Parliament
(http://laws-lois.justice.gc.ca/eng/acts/c-18.1/index.html). The CIHR consists of 13 institutes
which together shape Canada’s health research agenda. The CIHR funds four types of
research or “pillars” as they are called by the CIHR: clinical; biomedical; health systems and
services; and population and public health. Recent changes to the mandate of another tricounsel agency, the Social Sciences and Humanities Research Counsel (SSHRC), have
streamlined funding opportunities, forcing all social science and humanities research that is
related to health to be funded by the CIHR (J. Graham et al., February 7, 2011). The CIHR,
by mandating a knowledge translation component in each of its funded projects, has
popularized a particular conceptualization of KT for Canadian health researchers. The
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rationale for this keen interest in knowledge translation is given by CIHR as two fold: first,
the creation of new knowledge does not automatically lead to widespread adoption or health
impact, and second, the CIHR cites that it needs to be accountable for the tax dollars invested
in health research and wants to increase the benefits of this investment by moving research
into practice (www.cihr-irsc.gc.ca/e/33747.html). According to the CIHR, knowledge
translation is defined as:
…a dynamic and iterative process that includes synthesis, dissemination, exchange
and ethically-sound application of knowledge to improve the health of Canadians,
provide more effective health services and products and strengthen the health care
system (Straus et al., 2009).
According to Tetroe (2007, p.2) knowledge translation is a broad concept that “encompasses
all steps between the creation of new knowledge and its application to yield beneficial
outcomes for society”. Reading through the CIHR documents and publications, it is quickly
clear that the word knowledge has a very specific meaning and is confined to a particular
type of knowledge, namely knowledge acquired through research. Graham et al (2006)
described the confusion and inconsistency in terms related to the concept of knowledge
translation used in health research and health services. The authors then put forward the idea
of the knowledge to action (KTA) process, which they identify as having 2 components:
knowledge creation and action. Their KTA model involves two sets of individuals:
knowledge producers-researchers and knowledge implementers-users.
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Figure 8.1: The CIHR’s KTA Process

As stated above, the KTA process consists of a knowledge creation component as well as an
action component. According to Graham and co-authors (2006, p.18), the knowledge
creation component is best illustrated by a funnel, which the authors describe as follows:
As knowledge moves through the funnel, it becomes more distilled and refined
and presumably more useful to stakeholders. Another analogy would be to think
of the research being sifted through filters at each phase so that, in the end, only
the most valid and useful knowledge is left (Graham et al, 2006, p.18).
The funnel begins with knowledge inquiry. This knowledge is described by the authors as
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comprised of the “unmanageable multitude of primary studies or information of variable
quality that is out there”. The authors describe this as “first-generation knowledge that is in its
natural state and largely unrefined, like diamonds in the rough” (Graham et al 2006, p.18). In
order to make sense of all of this “first generation” knowledge, the second stage, knowledge
synthesis involves systematic reviews to appraise all the knowledge out there. Finally, the
most refined section of the funnel consists of knowledge tools or products, such as practice
guidelines, decision aides, and care pathways. These tools are intended to present knowledge
in clear concise and user-friendly formats “thereby facilitating the uptake and application of
knowledge” (2006, p.19). This then, the tools, are the end result of the knowledge creation
process. According to the KTA model it is practice guidelines, decision aides and care
pathways that are the objects of translation. These tools are what count as knowledge and what
ought to be applied in the second part of the KTA process, the Action Cycle.
The second component of the KTA process is what Graham and co-authors call the
Action Cycle, which “represents the activities that may be needed for knowledge
application” (Graham et al, 2006, p.20). This action phase is modeled after planned-action
theories which deliberately engineer change in groups. Lomas (Lomas, Sisk, & Stocking,
1993) for example, is often sited for his differentiation between dissemination (tailoring a
message for a particular audience), diffusion (a more passive process such as a journal
publication), and implementation (planned efforts to encourage adoption). Graham et al
(2006) suggest the following as being integral to a planned action approach:
Identify a problem that needs addressing; identify, review, and select the knowledge
or research relevant to the problem (e.g., practice guidelines or research findings);
adapt the identified knowledge or research to the local context; assess barriers to
using the knowledge; select, tailor, and implement interventions to promote the use
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of knowledge (i.e., implement the change); monitor knowledge use; evaluate the
outcomes of using the knowledge; sustain ongoing knowledge use’’ (Graham et al,

2006, p.20).
The authors are clear that “generic knowledge is seldom taken directly off the shelf and
applied without some sort of vetting or tailoring to the local context”. Graham et al (2006)
also describe various types of knowledge use. Conceptual use describes changes in
understanding or attitudes. Instrumental use describes changes in behaviour or practice.
Finally, strategic use is described by the authors as the manipulation of knowledge “to attain
specific power or profit goals”

8.2a Discussion of the KTA cycle as proposed by the CIHR
The KTA cycle developed by Graham et al (2006), widely promoted by the CIHR, is a
model of knowledge translation that is exclusively focused on widespread adoption of
research knowledge. It describes a large-scale, deliberate and planned attempt to move
research knowledge into practice. Furthermore, this model describes a process in which the
objects of translation are the distilled tools that culminate at the end of a research funnel. The
KTA model of translation put forward by the CIHR, however, excludes certain types of
research translation. For example, Graham et al 2006 stated:
Translational research (the transfer of basic science discoveries into clinical
applications) does not fall under our conceptualization of KTA because
translational research falls short of widespread adoption (Graham et al 2006, p.18).
In a related article, Tetroe further explained:
Translational research is about finding solutions to clinical problems. Ideally it
involves two-way interactions between basic/fundamental scientists and clinicians
and requires moving between scientific discoveries and clinical applications.
Translational research stops short of widespread dissemination of the clinical
application once it has been proved beneficial by clinical research (2007, p.2).
The KTA model, then, describes a process that is removed from the local practices and
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places in which knowledge is actually produced. There are many types of interactions and
activities that are not captured in the KTA model of knowledge translation. For example, the
on-going, day-to-day local interactions and meetings in which research is discussed between
different groups of scientists, clinicians, and families are not captured in this model.
Embedded within the “knowledge creation funnel” are some of the assumptions on
which the KTA model rests, assumptions about what constitutes knowledge, how this
knowledge is created and by whom. For example, in the KTA model the knowledge that is
created at the end of the funnel are tools and products. One of the limitations of the KTA
model which explores only distilled tools that have been tailored through the knowledge
creation funnel is that we loose appreciation for the underlying contexts in which research
knowledge is first produced. When we zoom in and examine the local conditions of knowledge
production, we are better able to pay attention to the assumptions, values, and cultures of the
groups of people who produce knowledge. These assumptions, values and cultures are not
necessarily lost when knowledge is distilled down to tools. They are, perhaps, embedded
within the tools.
However, the KTA model does not capture this context of knowledge production. The
KTA model considers the cultural and contextual factors that might impede widespread
adoption of knowledge by users but it is limited to exploring the culture and context of
knowledge users themselves, not the culture and context of knowledge production. Since this
model only begins after the research has already been published, how could it be otherwise?
By the time tools and products are tailored it would be very difficult to trace them back and
uncover the original contexts and cultures in which the research was conducted upon which
the tools are based.
The KTA model brackets off the work that occurs during the production of knowledge
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prior to publication from a discussion of knowledge translation. The conditions of knowledge
production are exempt from scrutiny and examination in the KTA model. In a positivist
epistemology, scientific knowledge mirrors nature or reality. Positivist science is not supposed
to have values or assumption, biases or culture. From a positivist perspective, the conditions of
knowledge production are irrelevant when considering cultural barriers to knowledge adoption
because the knowledge itself is assumed to be culture-free.
There is a second, related, concern that I have about the KTA model and the notion of
KT that is promoted by the CIHR. In the KTA model, knowledge is assumed to be something
that is separate from the contexts in which it was produced. It can be severed off from the
laboratories and clinics, captured in a journal article, distilled, funneled and tailored into tools
and products, all the while never losing its shape, its essence, its relation to nature. From an
actor-network theory perspective, however, knowledge cannot be extricated from the
network of humans and non-humans that constructed it, at least not without changing. To be
fair, an iterative and on-going quality to knowledge translation is captured in the KTA model.
The arrows move around in a circle, the cycle is repeated indefinitely. What is lost, however,
is an understanding of how the knowledge has changed as it has moved out of the contexts of
production and down through the Knowledge Creation Funnel. How is knowledge
synthesized and tailored? According to what values and assumptions? What new networks of
human and non-human actors does the knowledge become a part?

8.3. Time for a New Conceptualization of KT?
While the KTA cycle might accurately describe some of the activities that took place in
the settings in which I conducted my research, much more is going on that is not being
captured in this KTA model. All models have limitations and no single model could possibly
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hope to describe all contexts and situations in which one might consider KT. Limitations are
inevitable and this is not a criticism of the KTA model or of the CIHR definition of KT.
Unlike the KTA model, I propose that the local conditions in which knowledge is created are
important to the discussion of KT. In the KTA model the “doing” of science in the first place
is left untouched, unexamined. The KTA model starts with an “unmanageable multitude” of
peer-reviewed journal articles. All of the work and collaborations that lie behind these primary
studies is precluded from this model of KT. In other words, the KTA model begins where my
research ends. According to the KTA model, translation happens after knowledge has been
created. While my research suggests that knowledge translation is occurring long before
research results are reported in journals.
The recent calls for theory-driven conceptualizations of knowledge translation and the
fervent attention being paid to the concept of “context” are an entryway for a constructionist,
post-humanist description and framework of KT that I will put forward in this chapter, based
on my research in autism genomics and influenced by actor-network theory and theories of
practice. Knowledge translation is enacted very differently when approached through a
language of difference, multiplicity, non-coherence and partial connections. Approaching the
notion of knowledge translation through actor-network theory (ANT) raises questions about
some of the assumptions typically made in the KT literature. Specifically, ANT affords the
opportunity to forefront a different set of actors, events, and practices than those that are
typically acknowledged and explored in KT. Through ANT and constructionism, I aim to
explore the softer underbelly of KT, in which knowledge is not confined to the cold, hard
facts residing at the top of evidence hierarchies. Instead knowledge is viewed as
transforming and changing through the process of translation.
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ANT brings attention to the non-human actors (the material world) as central to a
discussion of translation. It also includes and focuses squarely on the networks of knowledge
production as integral to (and not separate from) the process of knowledge translation. As
Armstrong et al (R. Armstrong, Waters, Roberts, Oliver, & Popay, 2006) have commented,
most models of knowledge translation “have generally been used to explore links between
researchers and end-users rather than those involved in the generation of knowledge” (2006,
pp 384). Conversely, my research has attempted to explore the local contexts of knowledge
production and the day-to-day translations amongst laboratories, clinics, and families of
individuals with autism.

8.3a On the Nature of Knowledge: Constructing Reality through
Knowledge Practices
In this thesis, I have tried to illustrate how knowledge might be conceptualized as
much broader and more diffuse than it is typically represented in the scientific literature. In
particular, knowledge is not detached or separate from the actors bound together in the
networks that create knowledge. Knowledge is not something that lives in the mind, apart
from the physical world. Instead, I adopt a philosophical position in which knowledge is
practiced in the material world. The Cartesian split between mind and body is side-stepped
by focusing on how knowledge is continuously constructed, through interacting hands, tools,
bodies, machines. From this position, knowledge is not exclusively relegated to the mind; it
is performed and enacted through the body and through heterogeneous material objects in the
physical world. Following this, I propose that the science of knowledge translation should
consider the broader ontological implications of the KT endeavour.
Constructionism assumes that knowledge is not a perfect mirror of nature. From this
standpoint, the scientists in the laboratories and clinician-scientists in the clinics are not merely
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discovering nature, already there. They are actively participating in constructing and shaping
nature, and in turn being constructed by it. Latour views constructivism as the only way to
bypass the dichotomy between an unconstructed world that is "already there" and a world
made purely of subjective value claims (Latour, 2005). Starting from a constructionist
position, then, considering the conditions of knowledge production is very important in a
discussion of knowledge translation. When considering obstacles to widespread adoption, a
constructionist model might scrutinize not only the cultures of “so-called” potential knowledge
users but also the cultural contexts of knowledge producers. A constructionist model might be
better able to understand the conflicts and places of non-coherence that might arise between
the practices of knowledge production upon which tools and products are derived and the
practices of knowledge users.
Following from a notion of knowledge that is practiced in the material world,
translation could be conceptualized as a process of ontological politics (Mol, 2003), as actors
(e.g., researcher, stakeholders) vie to become obligatory passage points, constructing through
practice what counts as real. This conceptualization of KT is informed by Callon’s (1986)
framework which considered four moments of translation: problematization, interessement,
enrolment, and mobilization. Another way of approaching translation, however, is to follow
the work of Mol (2003) and Law (2000; 2012). These authors emphasize multiplicity and
coordination. From this perspective knowledge translation may be conceptualized as finding
windows of partial connection among networks of knowledge practices interacting with one
another. Translation might only require that connections are made between networks, that
actors might be simultaneously enrolled in several networks at once. Each of these
conceptualizations of the translation process allows us to redirect our focus, de-centering the
object of translation, and attend to the complex connections and associations through which
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the reality of an object is constructed and reconstructed.

8.3b Local Translations of Knowledge in Practice (LTKP) Framework
Drawing on theories of practice, a methodology of actor-network theory and based in
a constructionist epistemological position, I propose a new framework for exploring
knowledge translation. This framework is called the Local Translations of Knowledge in
Practice (LTKP). Underpinning this new framework for KT are five key ideas. First,
knowledge is intricately tied to the networks of human and non-human actors within which
knowledge is constructed. Knowledge is considered an on-going activity, a process, which is
constantly enacted or practiced. Perhaps it would be more useful to think of knowledge not as
a noun (a thing) but rather to think about knowing, a verb (an action). As this
conceptualization of knowledge relates to KT, it would probably be more accurate to
describe this as “knowing translation” rather than knowledge translation. From an ANT
perspective, understanding the process of knowledge translation depends on one’s ability to
unpack and “de-centre” knowledge. In many ways the framework I am putting forward
considers knowledge in the opposite way as the KTA model. Where the KTA model seeks to
distil and refine knowledge into a tangible applied tool or product, the LTKP framework
seeks to trace the expansive, heterogeneous practices which together shape a particular way
of knowing. Knowledge, here, is a much more diffuse concept and not as easily bounded as
the distilled tools and products described in the KTA model. In the KTA model, knowledge
is objectified; through the distillation of the knowledge funnel it becomes reified in an object
(e.g., a practice guideline or care pathway), separated from the practices in which it was
constructed. In my constructionist description of KT, knowledge is not understood as an
ontologically stable object but rather as a materially-heterogeneous practice.
Secondly, in the LTKP framework, translation is conceptualized as the fluid
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movement and associations of human and non-human actors between and amongst networks.
It is an on-going affair and is never completed. Translation implies change and
transformation. Stability is not an inevitable quality of that which is being translated. For
example, in Neylands (2006) work on a university strategy for managing information, the
movement of information is conceptualized as “a series of sociotechnical connections, each
connection forming an opportunity to confirm the continuity of information usage or to
reconstruct the usage and, thereby, the information itself” (2006, p.35). Any addition or
subtraction of an actor (human or nonhuman) in a network changes the network and all the
actors involved. Actors exist in practice as they relate to one another. As new humans and
non-humans enter or leave a network the relationships between the remaining actors change.
Thirdly, in the LTKP framework, both human and non-human actors are integral to
the enactment of KT. In any effort to describe and examine the KT process, one must
consider a wide range of heterogeneous materials involved. In the ANT literature this is often
referred to as agnosticism – remaining open to whom or what is doing the acting (Callon
1986). We can not assume that non-humans are passive in the KT process. Instead, nonhuman actors are acknowledged to play an active role in shaping how knowledge is
constructed and in how knowledge changes as it moves amongst various networks.
Fourthly, in the LTKP framework the knowledge translation process can be
approached as an inherently political process. Translation involves a process of
problematization and enrolment of actors, with certain actors vying to be the spokesperson,
attempting to mobilize a host of silent actors behind them. The stability of a network,
however, is always in question. A network can always fail. Over time, some networks
manage to maintain stability better than others.
Fifthly, actors may belong to more than one network and as such they may be
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practiced in relation to different sets of actors. An example from my research would be an
individual diagnosed with autism. Such an individual exists in a clinical network, a
laboratory network and a home network (as well as others). In each of these networks, “the
individual with autism” is enacted or practiced in relation to a different set of actors. As such,
the individual with autism changes as he/she moves amongst networks. Thus, any actor (in
this example an individual with autism) cannot be assumed to be a single unified
phenomenon. Indeed, the very process of translation (moving between networks) often
results in multiplicity. This is not an opening into a fragmented and incommensurable postmodern world. Instead, translation is the key to maintaining connections, points of coherence
amongst multiple ways of enacting the world.
Multiplicity, here, might be related to the literature on boundary objects (Star &
Griesemer, 1989), in which a single object is recognized by two different groups but retains
an idiosyncratic meaning within either group. Polzer & Robertson (2010) for example, have
explored the genetic pedigree as a boundary object between clinic and patient family. The
loosely recognized object enables and facilitates a point of connection and a conduit through
which members of different groups might interact.
With each of these ideas in mind, I have constructed a framework to illustrate how
KT might be considered from a constructionist, actor-network theory perspective. To be sure,
there are many different ways one could imagine the KT process and this framework is in no
way meant to replace or supplant any other KT model in the literature. One of the main
reasons for constructing this framework is to demonstrate that the epistemological
assumptions one holds deeply influence a discussion of knowledge translation. So far, in the
field of health research in Canada, this discussion has been overwhelmingly situated within
positivism. Thus, I have attempted to examine knowledge translation from another
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philosophical standpoint and in so doing I hope to open up new possibilities for
understanding the KT process.
This framework highlights five key components of a constructionist, ANT-informed
understanding of knowledge translation: (i) networks; (ii) human actors; (iii) non-human
actors; (iv) multiplicity, and (v) strategies of coordination. These five components are also
embedded within a political process of translation involving problematization, interessment,
enrolment, and mobilization. Below, I will consider each of these components in turn.
Appendix B illustrates how this framework might be modeled in the case of autism genomics
and Appendix C illustrates a more generalized model of the LTKP framework.

(i) Networks
In Appendix C, there happens to be three networks being examined as they relate to
autism genomics: the laboratory, the clinic, and the family. These networks are each depicted
by a circle circumscribed by a dashed line. The dashed line indicates the permeability of the
network, as human and non-human actors enter and leave a network over time. The
boundaries of a network can always change. The notion of the network is central to the
LTKP framework for understanding KT, as knowledge is not viewed as a black-boxed object
but rather as a complex practice that exists in the associations between and among actors
within a network. Each network, with its distinct constellation of actors, practices knowledge
in a particular way. A focus on the networks of associations amongst actors involved in
knowledge translation helps to ensure that knowledge is not reified as a single, stable object.
While I have considered three networks in this research, there are, of course, a multitude of
other networks that could be considered (e.g., a child’s school network, an autism support
group network, etc.). One of the effects of conceptualizing KT through an ANT approach is
that one becomes aware of the limitations of one’s understanding. One could not presume to

289

have explored all the networks that affect a particular local context of KT. This model
cannot determine how or where a researcher ought to “cut the networks”. The inclusion or
exclusion of various networks would presumably be informed by the specific, local, context
in which KT is being explored. There are also pragmatic and logistical considerations to be
taken into account (e.g., funding, time, the jurisdiction of ethics review boards, etc.) when
deciding how extended one’s exploration will be.

(ii) Human Actors
An important component of this framework of KT is to include all of the relevant
human actors within the networks. It is important not to assume too quickly who is and who
is not involved in the KT process. For example, when I first began my fieldwork a young
post-doctoral fellow approached me and stated that she would be happy to participate in my
study but that she felt her work would probably seem really boring and all she did was fiddle
about in the lab. She wasn’t sure if or how her role would be relevant but she was willing to
let me observe and talk with her. A project manager who happened to be listening to my
interaction with the post-doc stated, after the post-doc had left the room, “You won’t want to
talk with her for your study. She doesn’t talk to anyone. She wouldn’t be relevant to
knowledge translation”. In the end, I found this post-doc was actually an extremely important
actor in the KT process. She was intimately involved in the production of genetic information
and in tweaking the quality control processes which helped to filter out the real and true
variants from experimental artifacts. The project manager was correct that this post-doc was
not involved in directly translating genetic knowledge with clinicians through meetings or
research reports. She was however, deeply important to the production of the knowledge that
was later translated with clinicians and patient families. From a constructionist perspective of
KT, this post-doc was an important actor because the contexts and practices of knowledge
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production are part of a constructionist description of knowledge translation. The knowledge
itself cannot be considered in isolation from the human actors, such as this post-doc, who
shape the knowledge into being.

(iii) Non-Human Actors
While human actors are considered in the KTA model (although, not the humans who
produce knowledge before it is funneled down), non-human actors are perhaps less explicitly
acknowledged. In my model, along with humans, non-human actors are recognized as
important throughout knowledge production and translation. Knowledge is practiced in
relationship with a variety of non-human actors within any network. If you take away the
non-human actors, the knowledge could not be the same. For example, if there were no
microarray chips, no pipettes, no PCR, no tubes, no research reports, no ovens or centrifuges
– if any of these non-human actors were to be excluded in the network of the laboratory – the
genetic knowledge being translated amongst the laboratory, clinic and homes would not be
the same. Likewise, if you took away the ADOS, ADI-R, intelligence testing scores, patient
file or consent forms – if any of these non-human actors were to be removed from the clinic
network – the genetic knowledge translated amongst laboratory, clinic, and home would not
be the same. In a constructionist, ANT-informed understanding of knowledge translation,
non-human actors must be described.

(iv) Multiplicity
Multiplicity is another idea important to my constructionist understanding of KT. By
exploring multiplicity, one is able to understand how an object that is typically considered to
be a unified, taken-for-granted phenomenon is practiced or enacted differently in different
networks. Paying attention to multiplicity forefronts the ways in which a phenomenon might
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be practiced in different ways and thus attempts to prevent any single definition or practice of
a phenomenon from obfuscating other ways of practicing or defining that phenomenon. In
Appendix C, I have used the individual diagnosed with autism to illustrate this notion of
multiplicity. The individual with autism is an integral actor in each of the three networks but
the ways in which the individual with autism is constructed in relation to the human and nonhuman actors in each network is profoundly different. From a constructionist perspective,
this recognition of multiplicity allows one to explore the different, sometimes conflicting,
practices amongst (and even within) networks. Multiplicity allows us to understand how an
actor is practiced within local contexts, and how an actor changes as it is practiced in relation
to different sets of actors in different networks.

(v) Strategies of Coordination
If multiplicity illustrates how an object can be enacted differently in different
networks, then strategies of coordination describe the spaces in which differences are made
to cohere and to relate to one another (Law, 2000). In addition to describing the differences
and non-coherence amongst various networks, this model also explores the sites at which
practices are temporarily coordinated. These strategies of coordination are integral to the
knowledge translation process, linking the practices of one network with the practices of
another network. Opportunities which bring actors from various networks together might be
called hybrid spaces. For example, in my fieldwork the regular Monday morning meetings
brought laboratory and clinical actors together. Meanwhile the feedback session brought
clinical and family home actors together. Strategies of coordination often emerge out of these
hybrid spaces. For example, the pedigree is constructed in the feedback session and
reconstructed through Monday morning meetings. Related to hybrid spaces and strategies of
coordination is the notion of the boundary object. Boundary objects may be a key idea for
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coordination, as highly idiosyncratic practices in local contexts might only need to be loosely
or partially enacted in hybrid spaces or sites of coordination, such as the pedigree. Boundary
objects enable partial translations of multiply practiced phenomena. Through strategies of
coordination that often emerge through hybrid spaces, a phenomenon is practiced as “more
than one but less than many” (Mol, 2002).
Each of these five components of the LTKP framework can be viewed as embedded
within a political process of translation (Callon 1986). The networks described are involved
in an ongoing negotiation of problematization, interessement, enrolment, and mobilization
(as described in Chapter 5). Callon’s (1986) framework allows us to connect the local, dayto-day micro dynamics of translation amongst a few networks to a range of expanding
networks. For example, in the case of autism genomics, problematization of autism as
something that needed to be “cured” was contested by some participants in the clinical
network. These participants were also active in other networks, such as those associated with
disability rights. Thus, these participants worried about their ongoing enrolment as actors in
the laboratory network. This example of contested problematization illustrates that actors are
multiply positioned in other networks and as such there is a fluidity and instability to the
translation process. Thus, Callon’s framework highlights an element of uncertainty and
ongoing flux in the associations of actors.

8.3b The LTKP Model
In Appendix D the Local Translations of Knowledge in Practice framework is
illustrated in a general model. Each of the five components within the LTKP framework is
highlighted in the model. Networks are depicted as circles circumscribed by dashed lines;
human actors are illustrated with a face symbol; non-human actors are represented with
yellow triangles. Meanwhile, I have tried to demonstrate the concept of multiplicity with a
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star shape. As the star moves amongst the networks the colour changes. With this changing
of colours I am illustrating how we cannot assume that an actor remains the same as it
traverses various networks and is practiced in relation to different human and non-human
actors. Finally, the explosion symbol represents strategies of coordination which indicate
sites in which actors and practices from various networks are combined. For example, the
pedigree combines practices derived from the family, the clinic, and the laboratory. Hybrid
spaces, such as Monday morning meetings and feedback sessions are integral spaces that
bring actors together so that strategies of coordination can occur.

8.4. Comparing the KTA and LTKP Frameworks
There are several differences in the CIHR’s KTA model and the framework and
model I have proposed. Table 1, compares these models in respect to their conceptualization
of knowledge, conceptualization of translation, intended purpose, methodological
underpinnings, and epistemological and theoretical underpinnings.
Table 8.1: Comparison of the KTA model and LTKP framework
Knowledge-to-Action
(KTA)
Conceptualization of
Knowledge - What is
translated?
Conceptualization of
Translation Process

Distilled and tailored
products and tools; reified
objects
Occurs after knowledge has
been distilled; iterative
cycle between producers
and users of knowledge

Intended Purpose

Prescriptive; directive;
widespread adoption of
knowledge
Quasi-experimental
research; survey research
Planned Action Theories;
Cognitive Psychology
Theories of Change;

Methodological
Underpinnings
Theoretical and
Epistemological
Underpinnings

Local Translations of
Knowledge in Practice
(LTKP)
Less tangible, materially
heterogeneous practices;
ontologically fluid
Process in which
associations among human
and non-human actors are
reassembled in a new
network; implies change
Descriptive exploration of
local translations in
everyday practice
Actor-Network Theory;
Ethnography
Practice Theory;
Constructionism/
Interpretivism
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Objectivism/ Positivism

Conceptualization of Knowledge
First, the KTA model and LTKP framework differ in what they considered to be the object of
translation, particularly in how knowledge is conceptualized. In the KTA model knowledge is
distilled and tailored into products and tools through a funnel. The knowledge that is
translated consists of these tools and products. In the KTA model knowledge is bound within
an object, a best practice guideline for example. In my framework, knowledge is diffuse and
less tangible. Knowledge is a practice. Again, it would be more useful to think of the verb
knowing (an action that is engaged in) rather than the noun knowledge (a thing that one can
possess). The LTKP model attempts to describe the processes of translation between
different ways of knowing in practice. The KTA model explores how a reified piece of
knowledge, a tool or product, is translated. The object of translation in each of these models
is derived from very different epistemological starting points. While the KTA model might
be best described as being situated within an epistemology of possession, my model can be
described as positioned within an epistemology of practice (Brown & Cook, 1999). From an
Actor-Network Theory perspective, the KTA model treats knowledge as if it were a black
box, a singe actor. The LTKP model, however, seeks to peer inside the box and uncover the
vast networks of associations amongst a multitude of human and non-human actors; here,
knowledge is a permeable, changing network-in-practice rather than a tailored, filtered actor
being tossed about amongst producers and users. Central to my framework for KT is an
appreciation for the ontological fluidity of that which is translated.

Conceptualization of Translation
A second difference between the two models is in how translation is conceptualized.
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In particular, these models have very different starting points. In the KTA model, the very
raw materials that enter the knowledge funnel are the journal articles derived from primary
studies. It is assumed that the knowledge producers are not the same as the knowledge users.
In my model, the translation of knowledge occurs far before journal articles are produced and
it is assumed that knowledge producers are also knowledge users and vice versa. Every
network both produces and uses knowledge. The distinction between knowledge producers
and users becomes moot when one considers knowledge from a constructionist epistemology.
Instead, it might be more helpful to acknowledge that all networks practice or enact
knowledge. It is knowledge practices that are translated, rather than a reified hunk of
knowledge. This translation occurs long before a tool or product is distilled. From a
constructionist, ANT perspective, when a best practice guideline or care pathway is
translated, it is does not exist in isolation. It carries with it its association with a host of
hidden actors, both human and non-human with which it was constructed through practice.
Translation is the process in which associations between actors are re-assembled and
practiced in relation to other networks of actors.

Intended Purpose
A third difference is in the purpose of the models and how they might be used. The
KTA model is directive; it aims to prescribe a step-by-step template of how translation
should happen and what factors should be considered for successful translation to occur. The
KTA model, as proposed by the CIHR, limits its application to the widespread adoption of
knowledge. The KTA model might best be used when attempting to implement a particular
tool across a widespread group of users. Conversely, the LTKP framework that I propose is
descriptive. It explores the undirected, sometimes haphazard, local dynamics of translation
that unfold in everyday practice. It is not a “how-to” guide or template for moving a piece of
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evidence into practice. The LTKP framework might be considered when trying to
understand who and what is involved in knowledge translation. The LTKP emphasis on
knowledge as a materially heterogeneous practice affords a more symmetrical, multidirectional understanding of the KT process. The emphasis on multiplicity, difference and
coordination could contribute, for example, to an exploration of why a tool is not being used
in a particular situation.

8.4a Implications
When I think back to my fieldwork experiences, the focus of the interactions between
the laboratory, clinic, and families was not just the translation of genetic results or any
reified, tangible piece of information. To be sure, the construction and communication of
genetic results were important. However, much more than that was going on. The translation
process that I observed was not only about genetic results, but about coordinating different
ways of practicing autism. As I explored in my research, the nature of autism multiplied as it
was practiced through different sets of human and non-human actors. In the context of
knowledge translation, I think when we focus on a particular object (a best practice guideline
or tool) to be translated we miss the boat; we fail to appreciate that what is being translated
are different ways of practicing the world. Instead of paying such fervent attention to an
object of translation (distilled guideline or care pathway), I wonder if the KT process might
be better understood if we de-centre the object and approach the object as a mere vehicle
through which we might understand difference, multiplicity and non-coherence as well as the
places where practices overlap and come together amongst various networks of actors.
In the quickly changing, cutting-edge world of genomics where new technologies
rapidly reconfigure the way the body is practiced, it is assumed that results are contingent
and could change in the future. It is not only a result that is being translated in a feedback
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session, but a way of practicing autism, such that autism is becoming genomic. By decentering the object of translation, we are able to step back and explore what practices and
ways of knowing and doing the world are implicit in that object. How might these implicit
practices, which carry epistemological and ontological assumptions, rub up against another
way of knowing and doing the world? Are there places where partial connections and
coherence can be found or might a particular object with its implicit epistemological and
ontological assumptions be incommensurable with another context?

8.5 Conclusion
My research has explored the process of knowledge translation from a constructionist
epistemology and an Actor-Network Theory methodology with an emphasis on theories of
practice. This approach has informed my interpretation of knowledge translation within the
context of autism genomics. Insights emerged from my case study of autism genomics that
might be applied to a more general discussion of knowledge translation. In particular, the
idea that translation involves transformation and change was demonstrated as I followed
human and nonhuman actors amongst the clinic, laboratory, and family home. I also raise the
idea that knowledge translation is an inherently political process and explore Callon’s (1986)
framework for unpacking the political dynamics involved in translation. Finally, when
knowledge is conceptualized as being practiced in the material world, knowledge translation
becomes reassembled as ontological translation; the KT endeavour becomes one of
translating between different ways of practicing reality. With each of these insights in mind, I
have constructed the Local Translations of Knowledge in Practice framework and model of
knowledge translation which highlights networks of human and non-human actors,
multiplicity, and strategies of coordination.
My aim in doing this research is to contribute to the current Canadian
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discussion on the science of knowledge translation by exploring KT from a
philosophical and theoretical position that is novel to the prevailing positivist
discourse championed by the CIHR. I have tried to demonstrate how a
constructionist, actor-network theory- inspired conceptualization of knowledge
translation might offer new insights into the on-going, local micro-dynamics of
knowledge translation. My aim is to demonstrate how the methodological and theoretical
starting point of any KT research profoundly shapes what is examined and what is left
untouched and unexplored. Methodological pluralism is needed in order to explore
knowledge translation in new ways. Expanding the range of philosophical positions attended
to in KT research will contribute to a richer understanding of the KT process.
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Appendices
Appendix A: Key Concepts in Genomics
Allele - A form of a gene. We inherit one allele of a gene from our mother and the other
allele from our father. These two alleles can be the same (homozygous) or they can be
different (heterozygous).
Phenotype denotes the observable characteristics of an organism. For example, having
brown eyes is a phenotypic expression. In the context of this research, rigid and repetitive
interests and activities is considered a phenotypic expression of autism.
Genotype – A genotype is an organism's full hereditary information, even if not expressed.
Single nucleotide polymorphism (SNP) - There are four nucleotides (Adanine, Thymine,
Cytosine, and Guanine) that make up deoxyribonucleic acid (DNA). Normally, A and T align
together and C and G align together; these are called nucleotide base pairs. Sometimes,
however, DNA is not replicated exactly and a different nucleotide is inserted. If this occurs
the DNA sequence has been altered. SNPs can be inherited or spontaneous.
Copy number variation (CNV) – A copy number variation includes either a deletion or
duplication of DNA. In a CNV, a chunk of DNA is either deleted or duplicated. All humans
have CNVs and most of the time these CNVs have no noticeable effect on the individual’s
phenotype. When CNVs are located in particular places within the genome, such that they
interrupt a gene, CNVs can affect the phenotype. When CNVs occur in regions that are generich they are more likely to be clinically significant that CNVs in regions of the genome that
are gene-poor. Generally, deletions tend to be more pathogenic than duplications (Gropman
& Batshaw).
Genome – The genome is the entire sequence of DNA for an individual organism. Each
individual has a unique genome, with slight variation. In 2001, the Human Genome Project
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completed the first mapping of a complete human genome. A reference genome is an
aggregated genome, in which several human genomes are sequenced and the most frequent
nucleotide base in each position is adopted. In the laboratory in which I conducted fieldwork,
reference genomes were ubiquitous and invaluable in the process of data interpretation.
Polymerase Chain Reaction (PCR) – PCR allows one to identify precise segments of DNA
and to produce millions of copies (called amplification) of that segment of DNA. The
invention of PCR completely altered the microbiology laboratory and is described in detail
by Rabinow (Rabinow, 1996). This technology is ubiquitous in laboratory experiments I
observed.
Microarray – A microarray, or gene chip, contains a collection of various sections of a
genome. Each of these sections is called a probe. A single array contains millions of probes
at specific locations across the genome. Different arrays are designed to specifically probe
particular areas on the genome. When patient DNA is added to the chip, the sections that
align to the probes will bind to the probes through hydrogen bonding. A dye is added to the
chip so that when scanned in the microarray machine each location will become florescent
and can be photographed. The strength of a florescent signal for any one location is
dependent on the amount of patient DNA that binds to a particular probe. The microarray is
used to detect copy number variations (CNVs).
Next Generation Sequencing – This technology is used to sequence the order of nucleotide
bases (A, C, T, G) in a particular stretch of DNA. This sequencing technology is used to
detect single nucleotide polymorphisms (SNPs) but can also detect CNVs.
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Appendix B: Some of the Equipment Needed for Next Generation Sequencing
Agilent 2100 Bioanalyzer Agilent p/n G2938C Thermal cycler Applied Biosystems Veriti
Thermal Cycler, BioRad (MJ Research) DNA Engine PTC 200, or equivalent Covaris S,
series Single Tube Sample Preparation System, Model S2 Covaris Covaris microTUBE
with AFA fiber and snap cap Covaris p/n 520045 Eppendorf Microcentrifuge Model
5417R Eppendorf p/n 022621807 (120 V/60 Hz), Eppendorf p/n 022621840 (230 V/50
Hz) or equivalent Eppendorf fixed angle rotor with standard lid Eppendorf p/n 022636006
DNA LoBind Tubes, 1.5 mL PCR clean, 250 pieces Eppendorf p/n 022431021 or
equivalent E, Gel Safe Imager Combo Kit, 2 magnetic stand, 21D or equivalent P10, P20,
P200 and P1000 pipettes Pipetman P10, P20, P200, P1000 or equivalent Vacuum
concentrator Savant SpeedVac or equivalent Mx3005P Real Time PCR System Stratagene
p/n 401449 or equivalent Ice bucket Powder free gloves Sterile, nuclease, free aerosol
barrier pipette tips, Timer, Vortex mixer, Heat block at 37°C
Optional Equipment
Mx3000P/Mx3005P 96-well tube plates Agilent p/n 410088 or equivalent
Mx3000P/Mx3005P optical strip caps Agilent p/n 401425 or equivalent MicroAmp Clear
Adhesive Film Applied Biosystems p/n 4306311 or equivalent BD Clay Adams Nutator
Mixer BD Diagnostics p/n 421105 or equivalent Dynal DynaMag-2 magnetic stand
Invitrogen p/n 123-21D or equivalent P10, P20, P200 and P1000 pipettes Pipetman P10, P20,
P200, P1000 or equivalent Pipet-Light Multichannel Pipette, 12 channels Rainin p/n L12-20
or equivalent Sterile, nuclease-free aerosol barrier pipette tips Thermal cycler Applied
Biosystems Veriti Thermal Cycler, BioRad (MJ Research) DNA Engine PTC-200, or
equivalent Timer Vortex mixer Water bath or heat block set to 65°C, Tube-strip capping tool
Agilent p/n 410099
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Appendix C: Knowledge Translation in Autism Genomics
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Appendix D: The Local Translation of Knowledge in Practice
(LTKP) Model
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